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ABSTRACT
Metabolic Flux Analysis (MFA) has emerged as a tool of great significance for metabolic
engineering and the analysis of human metabolic diseases. An important limitation of MFA,
as carried out via stable isotope labeling and GC/MS measurements, is the large number of
isotopomer equations that need to be solved. This restriction reduces the ability of MFA to
fully utilize the power of multiple isotopic tracers in elucidating the physiology of complex
biological networks. Here, we present a novel framework for modeling isotopic distributions
that significantly reduces the number of system variables without any loss of information.
The elementary metabolite units (EMU) framework is based on a highly efficient
decomposition algorithm identifies the minimum amount of information needed to simulate
isotopic labeling within a reaction network using knowledge of atomic transitions occurring
in the network reactions. The developed computational and experimental methodologies
were applied to two biological systems of major industrial and medical significance.
First, we describe the analysis of metabolic fluxes in E. coli in a fed-batch fermentation for
overproduction of 1,3-propanediol (PDO). A dynamic 13C-labeling experiment was
performed and nonstationary intracellular fluxes (with confidence intervals) were determined
by fitting labeling patterns of 191 cellular amino acids and 8 external fluxes to a detailed
network model of E. coli. We established for the first time detailed time profiles of in vivo
fluxes. Flux results confirmed the genotype of the organism and provided further insight
into the physiology of PDO overproduction in E. coli.
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Second, we describe the analysis of metabolic fluxes in the pathway of gluconeogenesis in
cultured primary hepatocytes, i.e. isolated liver cells. We applied multiple 13C and 2H-labeled
tracers and measured isotopomer distributions of glucose fragments. From this
overdetermined data set we estimated net and exchange fluxes in the gluconeogenesis
pathway. We identified limitations in current methods to estimate gluconeogenesis in vivo,
and developed a novel [U- 13C,2H8]glycerol method that allows accurate analysis of
gluconeogenesis fluxes independent of the assumption of isotopic steady-state and zonation
of tracers. The developed methodologies have wide implications for in vivo studies of
glucose metabolism in Type II diabetes, and other metabolic diseases.
Thesis Supervisor: Gregory Stephanopoulos
Title: Professor of Chemical Engineering
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Chapter 1
Introduction
1.1 Metabolic network and flux analysis
Metabolic fluxes of pathways provide a key to quantifying physiology in fields ranging from
metabolic engineering to the analysis of human metabolic diseases. Understanding the
regulation of cellular processes and intervening in these processes affords insight into
treating disease and achieving other biotechnological objectives. Living cells are complex
biological entities that are regulated at many levels, e.g. transcription, translation, protein
modification, etc. A large number of reactions, comprising a well-organized system of
enzymatic activities, accomplish the conversion of relatively simple molecules such as
glucose into a wide variety of small- and macromolecules. The conversion of each individual
reaction may be overseen easily, however, the result of the overall system of reactions is
often not trivial. Identification of targets for pathway manipulation and determining the
required magnitude of biological changes requires an enhanced, quantitative understanding
of cellular metabolism and regulation. Metabolic flux analysis (MFA) has emerged as an
important tool to assess the metabolic state of living cells and to evaluate the effects of
genetic and environmental manipulations. Fluxes of metabolic pathways are considered
fundamental determinants of cell physiology and informative parameters in evaluating
cellular mechanisms, regulation and causes of disease. The key to quantifying metabolic
fluxes is to analyze biological systems as integrated and interacting networks, rather than a
set of individual components.
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1.2 Metabolite flux balancing
Tools for estimating metabolic fluxes are fundamentally different from the tools for
obtaining static measurements such as metabolite concentration and transcript levels, which
provide relatively little insight into the dynamics of cellular metabolism. Initially, metabolic
flux analysis relied solely on balancing fluxes around metabolites within an assumed network
stoichiometry. Assuming metabolic steady-state, fluxes (v) are constrained by the
stoichiometry matrix (S).
S-v = 0 (1.1)
Stoichiometric constraints can be combined with the flux measurements matrix (R) that
contains a row with a unity entry for each measured external flux. The combined
stoichiometry and measurement matrices are then used to obtain the generalized solution to
the metabolite flux balancing problem by solving a set of linear equations. The solution to
this problem is given by the following expression:
v = . )+ null ( P (1.2)
Here, 'pinv' denotes the pseudo inverse, and 'null' is the null space of the combined
stoichiometry and measurement matrix. Vector 0 contains the linear coefficients of the
columns that span the null space. In most practical situations, however, stoichiometric
constraints and external flux measurements did not provide enough information to estimate
all fluxes of interest in complex biological systems with reversible reactions, parallel
pathways and internal cycles. This limitation let to the development of isotopic tracer
techniques to determine fluxes.
- 24-
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1.3 Estimating fluxes from stable isotope measurements
A more powerful method for flux determination in complex biological systems is based on
the use of stable isotopes. Figure 1-1 shows schematically the procedure for quantifying
metabolic fluxes from stable isotope experiments. The first two important decisions are the
choice of the isotopic tracer and the structure of the metabolic network model (steps 1 and
6). Methods for experiment design are aimed at finding the most informative tracer(s) for a
given set of stable isotope measurements using criteria from linearized statistics and
sensitivity analysis (Mollney et al., 1999). Metabolic flux studies further require some prior
knowledge of the biochemical reactions involved in the pathway of interest. The decision
which reactions and metabolites to include in the network model is still mainly driven by the
investigators' insight into the physiology and may in some cases be somewhat arbitrary.
However, we will illustrate in Chapter 3 that proper statistical analysis of isotopomer data
can be instrumental in identifying the most likely network structure. Steps 2-4 are
experimental in nature and require good laboratory skills. In labeling experiments, metabolic
conversion of isotopically labeled substrates generates molecules with distinct labeling
patterns (i.e. isotopomers) that can be detected by mass spectrometry (MS) and nuclear
magnetic resonance (NMR) spectroscopy (Szyperski, 1995; Des Rosiers, 2004) (step 4). In
general, the NMR technique requires expensive equipment and a fairly large amount of
sample, which limits the use of this technique to a few expert groups. On the other hand,
GC/MS analysis is a more rapid and sensitive technique that is readily accessible to many
research labs. Raw data from both techniques needs to be further processed before it can be
used for flux determination. In both cases, data processing consists of the detection of
metabolite peaks in NMR and MS spectra and integration of peak intensities (step 5). The
isotope measurements provide many additional independent constraints for MFA.
Quantitative interpretation of the isotopomer data requires the use of large-scale
mathematical models that describe the relationship between metabolic fluxes and
isotopomer abundances (step 7). Schmidt developed an elegant method for automatically
generating the complete set of isotopomer balances for any given network using a matrix
based method (Schmidt et al., 1997), and more recently Wiechert et al. (1999) provided an
efficient method for solving these isotopomer models using the cumomer framework.
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Experimental steps Modeling steps
{1.
Choose isotopic tracer, i.e.
which metabolite
and what labeling pattern
Perform isotopic tracer experiment
3. Harvest biomassand
collect medium samples
4. Measure labeling distribution
in cellular components and excreted
metabolites by GC-MS and/or NMR
5. Analyze measured data.
Transfer data to suitable format
and estimate measurement errors. `r
6. Set up model for the
pathway of interest, i.e.
identify relevant
reactions and metabolites
7. Set up mathematical moc
simulate isotopomer distribut
8. Calculate fluxes by least-sq
regression, i.e. minimize devi•
between observed and simulate
lelto
el toions
uares
ati'
d
ons
data
9. Evaluate goodness-of-fit
and calculate confidence
intervals of estimated fluxes
10. Report fluxes, confidence intervals
and network structure
Figure 1-1: A schematic of metabolic flux estimation from tracer experiments. Metabolic
flux analysis is characterized by both experimental and analytical steps. The dotted lines
indicate that MFA is an iterative process that requires reevaluation of metabolic network
assumptions and the choice of optimal tracer.
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In the forward calculation, these isotopomer models simulate a unique profile of isotopomer
abundances for given steady-state fluxes. In MFA we solve the more challenging inverse
problem, i.e. determining the cell's flux state from measurements of isotopomer
distributions. Analytical solutions to this inverse problem are only available for very simple
systems. Therefore, fluxes in complex biological systems have to be determined by iterative
least-squares fitting procedures, where the objective is to evaluate a set of feasible fluxes that
best accounts for the observed isotopomer measurements (step 8). At convergence, the
goodness-of-fit is evaluated using statistical criteria and confidence intervals of fluxes are
determined (step 9). The final result of this whole process is a detailed flux map (with
confidence intervals) that describes the contribution of various metabolic reaction pathways
to the overall cellular metabolism. The dotted lines in Figure 1-1 illustrate that metabolic flux
analysis is an iterative process that requires constant reevaluation of metabolic network
assumptions and the choice of optimal tracer.
1.4 Previous work
A range of stable isotopes such as 13C, 2H, 15N, and 180 can be used to trace metabolic
pathways using GC/MS and NMR measurements. Currently, methods based on carbon-13
tracing are most widely used. In this section we provide a short review of the most
important concepts currently used in metabolic tracer analysis, i.e. isotopomers, fractional
enrichments, NMR fine spectra, mass isotopomers, and cumomers.
1.4.1 Isotopomers
Positional isotopomers (or simply isotopomers) are isomers of a metabolite that differ only
in the labeling state of their individual atoms, for example, 13C VS. 12C in carbon-labeling
studies, and 2H vs. 1H in hydrogen-labeling studies. For a metabolite comprising N atoms
that may be in one of two (labeled or unlabeled) states, 2" isotopomers are possible. Thus, a
molecule consisting of 3 atoms can exist in 8 specific labeling states (see Figure 1-2). We can
represent the labeling patterns of isotopomers as sequences of ones and zeros that can be
interpreted as binary numbers that provide a unique way of ordering the 2N isotopomers.
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The isotopomer distribution vector (IDV) contains the molar fractions of the 2N
isotopomers. For example, the first element in the IDV contains the molfraction of the
isotopomer with labeling pattern 000, i.e. unlabeled molecule. The second element
corresponds to labeling pattern 001, i.e. molecule with a single labeled atom at the third
position, and so forth. Note that by definition, the sum of all elements of IDV equals one. In
practice, isotopomer fractions are not measured directly. Instead, available measurements are
expressed as functions of isotopomer fractions. The two most widely used techniques for
measuring labeling distribution are nuclear magnetic resonance (NMR) spectroscopy and
mass spectrometry (MS), which are discussed next.
Isotopomers
000
060
OS
amO
IDV =
A001
AM))
AIM
Allo
IDV = 1
Figure 1-2: Isotopomers of a 3-atom molecule. The 8 (=23) isotopomers are shown on the
left. The spheres represent labeled (full) and unlabeled (open) atoms. The isotopomer
distribution vector (IDV) contains the molfractions of all isotopomers. By definition, the
sum of all isotopomer fractions equals one.
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1.4.2 Fractional enrichments
The NMR technique detects magnetic interaction between 13C-nuclei and adjacent nuclei
with magnetic spins, e.g. 1H and adjacent 13C nuclei. NMR analysis provides two types of
labeling information. First, one can determine the fractional abundance of 13C at a specific
carbon atom position, which is called the fractional enrichment (FE) measurement.
Determination of fractional enrichments is based on the fact that the 1H-' 2C interaction
gives rise to a different peak in the 1H-NMR spectrum than the 1H-13C interaction.
Fractional enrichments of individual carbon atoms can be interpreted as linear functions of
isotopomer fractions. For example, consider the fractional enrichment of the first atom of
the 3-atom molecule A, i.e. A#1, which is simply the sum of the four isotopomer fractions
for which the first atom is labeled (i.e. A1oo, Ao10 , Allo0, and A111). Figure 1-3 shows the linear
relationship between fractional enrichments and isotopomer fractions. Note that the term
fractional enrichment is somewhat misleading, i.e. one doesn't actually measure the
enrichment of 13C. The term 'positional abundance of t3C' would have been more
appropriate.
Fractional enrichments
AoOO
A#1  A#2  A#3  A
A 00001111
O)O 06OO 8 FE A#2  0 0 1 1 0 0 1 1 - A01
S Oft A#3, 0 1 0 1 0 1 0 1 A
4+ A11
Figure 1-3: Fractional enrichments are linear functions of isotopomer fractions.
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1.4.3 NMR fime spectra
Adjacent 13C-13C nuclei influence each others NMR signal by peak splitting (a phenomenon
called J-coupling), which is observed in the 13C-NMR spectrum. Peak splitting leads to the
formation of multiple fine structures in the NMR spectrum, e.g. singlets, doublets, triplets,
doublets of doublets, etc. The relative contribution of individual multiplets to the resulting
overall multiplet pattern provides not only information on the labeling state of individual
carbon atoms of a molecule, but also detailed positional information. For example, consider
a molecule consisting of 2 carbon atoms. The 13C-multiplet peak areas can be expressed as a
nonlinear function of three isotopomer fractions. Eq. 1.3 converts 13C-multiplet peak areas
to relative areas, in this case two singlets and a doublet in the 13C-NMR spectrum.
singlet 2
singlet 1
doublet 12)
Ao - (A,, + Ato +A )
A ,
(1.3)
Eq. 1.4 shows the relationships for a secondary carbon atom, where we also take into
account long range 13C-13C interactions.
singlet 2
doublet 24
doublet 23
double doublet 234
doublet 12
double doublet 124
double doublet 123
quadruple doublet 1234
A0101
A01 0
A111c
Alo
A1101
A
AlillAllO
q Allll
S(A,,oo + A01l +A,,010 + A,0 11 +A 11,,, 1+A +A1+110 +A 1111)-
(1.4)
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1.4.4 Mass isotopomers
Mass spectrometry (MS) is an analytical technique where molecules are separated according
to their mass to electric charge ratio, i.e. m/z ratio. Isotopomers that have incorporated the
same number of labeled atoms, called mass isotopomers, contribute to the intensity of the
same ion peak in a mass spectrum. Mass isotopomer distribution reflects the relative
amounts of each mass isotopomer (including the unlabeled fraction). Mass isotopomer
distribution (MID) can be interpreted as a linear mapping of isotopomer fractions, as is
illustrated in Figure 1-4. Note that the sum of the mass isotopomer distribution vector is by
definition one.
Mass isotopomers
Ai,)l
Amo Am-, AM+2  AM 3  A+ '  1 0 0 0 0 O A100
000 0 C"C MID = 0 1 1 0 1 0 0 0 A MID - 1A M+2  0 0 1 0 1 1 0 A,)OA 0 0 0 0 0 0 0 1 A1
S00066 M00
A,,
Figure 1-4: Mass isotopomer abundances are linear functions of isotopomer fractions. By
definition the sum of all mass isotopomer fractions is one.
1.4.5 Cumomers
Wiechert et. al. (1999) introduced the concept of cumomers, i.e. short for cumulative
isotopomers, as a method to simplify isotopomer simulations (see section 1.6). In essence,
cumomers are simply a linear mapping of isotopomers. For example, consider a 3-atom
molecule A. The so called 0-cumomer fraction is the sum of all isotopomer fractions, and is
therefore by definition one.
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(1.4)1Ax = AA ik
- 1
i,j,k=0
Here, subscript 'x' has the meaning '0 or 1'. Using the same convention, the 1-cumomer
fractions are defined as follows:
1
AIXX= 
-Alik ,
j,k=0
1
A x =, Ailk ,
i,k=0
(1.5)
1
A• = - Ai,
i,j=0
Thus, the 1-cumomer fractions are sums of those isotopomer fractions that are labeled at
least at the position indicated by the index 1. By this definition, 1-cumomer fractions are
identical to fractional enrichments, i.e. A#1 =Ai, A#2=Ax,x, and A#3=Axx1. Following the
same convention, the 2-cumomer fractions are sums of those isotopomer fractions where at
least two of the three atoms are labeled indicated by the index 1:
Al x = Allk ,
k=O
1
AIx, = EAl,
i=0
(1.6)AXl, = Ai1M
i=o
Finally, the 3-cumomer fraction A11 corresponds to the fully labeled isotopomer fraction
All1.
A I -- AllI  (1.7)
Wiechert showed that there is always a linear one-to-one relationship between cumomer and
isotopomer fractions. For an N atom molecule, the transformation from its 2-N isotopomer
fractions to the corresponding 2N cumomer fractions is given by the transformation matrix
T, which is constructed recursively in the following manner.
(1.8)0 Ti]1
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Thus, for a 3-atom molecule
fractions is given by Eq. 1.9.
A xxaXX
Alx,
Axlxx
AlxX
All _
the transformation from isotopomer fractions to cumomer
A000
A001
A010
A011
A101
A110
All
_Alll
(1.9)
The reverse transformation, i.e. from cumomer fractions to isotopomer fractions, is achieved
by inverting the transformation matrix. Wiechert showed that the transformation matrix of
any size is always full rank, i.e. invertible.
1.5 Simulating labeling distributions by isotopomer balancing
Here, we describe the method that is currently used for simulating labeling distributions in
reaction networks. This method was originally based isotopomer balancing, but has been
replaced more recently by cumomer balancing. Consider the simple network model shown in
Figure 1-5 that consists of 4 metabolites, 3 extracellular fluxes and 3 intracellular reactions.
Here, the third reaction is considered reversible and is modeled by separate forward and
backward reactions. Metabolite A is the network substrate with known labeling and
metabolites C and D are the two products whose labeling pattern we would like to predict
for given fluxes. Figure 1-5 (right panel) also shows the assumed atom transitions for the
reactions in this network. Similar to metabolite balancing, we can set up material balances for
all 12 unknown isotopomers in this system. The complete set of isotopomer balances is
shown below.
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Reaction stoichiometry
A - - B
Atom transitions
AB--------------------------------------
I V3b
C D
W , W37, , 23
S3----- ---
2 3
Figure 1-5: Simple metabolic network model used as example for generating isotopomer
balances. Reaction stoichiometry is shown in the left panel and the assumed atom transitions
are shown in the right panel.
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0 = vlyaoo + V3b'doo - (v3f+v2)-boo (1.10a)
0 = vl-aol + V3b'd01 - (v3 f+v2)'bo0 (1.10b)
0 = vlalo + V3b'dl0 - (v3f+v2)-blo (1.10c)
0 = vlall + V3b'dl - (v3f+v2)-'bl (1.10d)
0 = v2-(aoo0boo + aoo-bo1 + aor-boo + ao-bol) - w2-C00 (1.10e)
0 = v2-(aoob00o + aoo-bil + aol-bio + aol-bil) - w2"CO (1.10f)
0 = v2-(aio-boo + aiobol + aiboo + allbol) - w2-C0 (1.1Og)
0 = v2-(aio-bio + a0o-bi, + al-bio + ali-bi) - w2-CI (1.10h)
0 = vl-(aoo-boo + aoo-blo + alo-boo + alo-blo) + v3fboo- (v3b+W3)-doo (1.10i)
0 = vl-(aoo-bo1 + aoo-bi1 + alo-bol + alo-bi) + v3f-bol- (V3b+W3)-do0 (1.10j)
0 = vy-(ao-boo + aoi'blo + ailboo + ali-bio) + v3f-bo- (v3b+W3)-d0o (1.10k)
0 = vl'(aol-boi + aol'bil + all-boi + aull-bi) + v3f-bi- (v3b+w3)-dul (1.101)
For given fluxes and labeling input, the isotopomer balances provide 12 nonlinear equations
in 12 unknown isotopomer fractions, which can be solved using Newton's iterative method.
As the result we obtain the isotopomer fractions for all 12 unknown isotopomers in this
system.
1.6 Simulating labeling distributions by cumomer balancing
Wiechert et. al. (1999) recently showed that the complete set of nonlinear isotopomer
balances can be converted into a corresponding set of cumomer balances. It was shown that
cumomer balances are less strongly coupled then isotopomer balances, which allows
cumomer balances to be solved explicitly as a cascade of linear subproblem, from which the
1-, 2-, ... cumomer fractions are successively computed. The cumomer fractions are then
transformed to isotopomer fraction as described in section 1.4.5. The major difference
between cumomer and isotopomer balances is the fact that cumomer balances are always
linear in the unknown variables. Thus, each subproblem can be solved using linear algebra
techniques, which significantly reduces computational time. Note, however, that the total
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size of the problem is same for both methods, i.e. there are always as many cumomer
balances as there are isotopomer balances.
1.7 Aim and outline of thesis
Our research group has actively participated in the development of experimental and
computational methods for MFA based on stable isotope experiments. The first general
mathematical model for interpreting of fractional enrichments was developed by Zupke and
Stephanopoulos (1995). In the last decade MFA has reached a state of relative maturity. The
experiments themselves have become a routine procedure, measurement techniques such as
GC/MS are widely used, and advanced mathematical procedures are available for
quantitative interpretation of stable isotope measurements.
The most important limitation of current methodology for MFA, as carried out via stable
isotope labeling and GC-MS measurements, is the large number of isotopomer/cumomer
equations that need to be solved, especially when multiple isotopic tracers are used for the
labeling of the system. This reduces the ability of MFA to fully utilize the power of multiple
isotopic tracers (i.e. 13C and 2H tracers) in elucidating the physiology of realistic situations
comprising complex bioreaction networks. As such, the realm of tracer experiments is
currently limited to carbon-13 tracers only. Therefore, the main goal of this thesis work was
the development of a novel methodology for comprehensive analysis of metabolic pathways
through the combined use of multiple isotopic tracers.
Chapter 2 describes the novel framework for modeling isotopic distributions that
significantly reduces the number of system variables without any loss of
information. The elementary metabolite unit (EMU) framework is based on a highly
efficient decomposition algorithm that identifies the minimum amount of
information needed to simulate isotopic labeling within a reaction network using the
knowledge of atomic transitions occurring in the network reactions. For a typical
carbon labeling system the total number of equations that needs to be solved is
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reduced by one order-of-magnitude (100s EMUs vs. 1000s cumomers). As such, the
EMU framework is most efficient for the analysis of labeling by multiple isotopic
tracers. For example, analysis of the gluconeogenesis pathway with 2H, 13C, and 180
tracers required only 300 EMUs compared to 3,000,000 isotopomers/cumomers.
* Chapter 3 describes novel methodologies for flux determination and statistical
analysis that have been developed. A serious drawback of the flux estimation
method in current use is that it does not produce confidence limits for the estimated
fluxes. Without this information it is difficult to interpret flux results and expand the
physiological significance of flux studies. To address this shortcoming we derived
analytical expressions of flux sensitivities with respect to isotope measurements and
measurement errors. These tools allow determination of local statistical properties
of fluxes and relative importance of measurements. Furthermore, we developed an
efficient algorithm to determine accurate nonlinear confidence intervals of fluxes
and demonstrated that confidence intervals obtained with this method closely
approximate true flux uncertainty.
* Chapters 4 and 5 describe experimental protocols that were developed for accurate
and precise measurement of labeling distributions by GC/MS. In the context of this
thesis work, the main focus was on accurate measurement of mass isotopomer
distributions of cellular amino acids and glucose. Based on preliminary simulations
and sensitivity analysis of realistic metabolic networks we determined that errors in
mass isotopomer abundances should be less than 0.5 mol%. The main result of our
work is a detailed procedure for the assessment of mass isotopomer distributions of
cellular amino acids and glucose with an accuracy of 0.4 mol% and precision of 0.2
mol%, or better.
* Chapter 6 describes analysis of metabolic fluxes in a nonstationary biological
system of with industrial relevance, i.e. microbial fed-batch fermentation of E. coli
for the overproduction of 1,3-propanediol (PDO). A drawback of current methods
for MFA is the requirement of isotopic steady state. To address this shortcoming
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and to extend the scope of flux determination from stationary to nonstationary
systems we developed a novel modeling strategy that combines key ideas from
isotopomer spectral analysis (ISA) and stationary MFA. In this study, metabolic
fluxes were determined at multiple time points during a fed-batch culture, and as
such we established for the first time detailed time profiles of intracellular fluxes in a
fermentation.
Chapters 7 and 8 describe analysis of fluxes in the gluconeogenesis pathway from
cultured primary hepatocyes, i.e. isolated liver cells. We applied multiple 13C-, and
2H-labeled tracers and analyzed the resulting mass isotopomer distributions of
glucose fragments. From this overdetermined data we estimated, for the first time,
both net and exchange fluxes in the gluconeogenesis pathway and calculated
confidence intervals for fluxes. We identified limitations in current methods to
estimate gluconeogenesis fluxes in vivo, and developed a novel multiple-tracer
method for accurate and quantitative analysis of this pathway independent of the
isotopic steady-state assumption.
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Elementary Metabolite Units (EMU):
a novel framework for modeling isotopic
distributions
2.1 Introduction
2.1.1 Metabolic flux analysis
Accurate flux determination is of great importance for the analysis of cell physiology in fields
ranging from metabolic engineering to the study of human metabolic diseases (Brunengraber
et al., 1997; Hellerstein, 2003; Stephanopoulos, 1999). Initially, metabolic flux analysis (MFA)
relied solely on balancing fluxes around metabolites within an assumed network
stoichiometry. However, stoichiometric constraints and external flux measurements often
cannot provide enough information to estimate all fluxes of interest. A more powerful
method for flux determination in complex biological systems is based on the use of stable
isotopes (Wiechert et al., 2001). Metabolic conversion of isotopically labeled substrates
generates molecules with distinct labeling patterns, i.e. isotope isomers (isotopomers), that
can be detected by mass spectrometry (MS) and nuclear magnetic resonance (NMR)
(Szyperski et al., 1995). Isotope measurements provide many additional independent
constraints for MFA. It has been shown that at metabolic and isotopic steady state the
isotopomer composition of metabolic intermediates is fully determined by the cell's flux
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state and the administered isotopic label. Quantitative interpretation of isotopomer data
requires the use of mathematical models that describes the relationship between metabolic
fluxes and the observed isotopomer abundances. Similar to metabolite balancing, balances
can be set up around all isotopomers of a particular metabolite. Schmidt described an elegant
method for automatically generating the complete set of isotopomer balances using a matrix
based method (Schmidt et al., 1997). More recently, Wiechert introduced the concept of
cumulative isotopomers (cumomers) and provided and efficient procedure for solving
isotopomer models (Wiechert et al., 1999). In the forward calculation, isotopomer models
are used to simulate a unique profile of isotopomer abundances for given steady-state fluxes.
In MFA we are concerned with the more challenging inverse problem, i.e. to determine the
flux state of the cell from measurements of isotopomer distributions. Analytical solutions to
the inverse problem are only available for very simple systems. Thus, in general, fluxes in
complex biological systems will be determined by iterative least-squares fitting procedures.
2.1.2 Limitations of isotopomer modeling method
Isotopomers are defined as isomers of a metabolite that differ only in the labeling state of
their individual atoms, for example, 13C vs. 12C in carbon-labeling studies, and 2H vs. 1H in
hydrogen-labeling studies. For a metabolite comprising N atoms that may be in one of two
(labeled or unlabeled) states, 2N'' isotopomers are possible. Consequently, the number of
isotopomers can increase quickly when multiple tracers are applied. Consider for example
glucose (C6H 120 6). There are only 64 (=26) carbon atom isotopomers of glucose and 4096
(=212) hydrogen atom isotopomers, but there are 2.6x10 5 (=26x2 12) isotopomers of glucose
carbon and hydrogen atoms, and 1.9x108 (=2 6x2 12x3 6) isotopomers of glucose carbon,
hydrogen and oxygen atoms. Note that oxygen may be present in one of three stable forms,
i.e. 160, 170, and 180. Thus, a typical isotopomer model may contain thousands or even
millions of isotopomers for multiple isotopic tracers. The number of isotopomers may be
reduced somewhat by omitting unstable carboxyl and hydroxyl hydrogen atoms from the
model, which exchange with the solvent at rates much faster than biochemical reactions and
are also lost in chemical derivatization in preparation for GC/MS analysis. For example, if
we consider only the seven stable (i.e. carbon bound) hydrogen atoms of glucose, then there
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are 128 (=2D) hydrogen atom isotopomers, 8192 (=26x2D isotopomers of glucose carbon
and hydrogen atoms, and 6x106 (=2 6x27x3 6) isotopomers of glucose carbon, hydrogen and
oxygen atoms. Thus, even with this reduction there are still too many isotopomers to
simulate labeling distributions efficiently for multiple isotopic tracers. Note that the
cumomer method suffers from the same problem, because there are always as many
cumomers as isotopomers, i.e. there is a one-to-one relationship between cumomers and
isotopomers (Chapter 1). As such, the realm of tracer experiments is currently limited solely
to 13C-tracers. However, multiple isotopic tracers are more powerful in elucidating the
physiology of realistic situations comprising complex bioreaction networks (see Chapters 7
and 8). Therefore, the development of a methodology that extends the capability of MFA
beyond the use of a single isotopic tracer is the main goal of this work.
2.1.3 Alternative modeling methods
The isotopomer/cumomer modeling framework is a generic top-down modeling strategy. It
provides the most detailed description of the labeling state of a system given by the
isotopomer fractions of all metabolites. However, the large number of variables generated in
this modeling approach limits its application and has driven the development of alternative
modeling methods for specific isotope measurements. For example, it is well know that
fractional enrichments of carbon atoms can be simulated efficiently using atom mapping
matrices, the method that was originally proposed by Zukpe et al. (1994). More recently, Van
Winden et al. (2002) developed the concept of bondomers that allows efficient simulation of
NMR fine spectra and MS data without the use of isotopomers. However, the bondomer
method is only valid for 13C-labeling data from experiments where a single uniformly 13C_
labeled substrate is applied. If multiple carbon sources are present, then all substrates need
to be uniformly 13C-labeled with the same enrichment. This requirement significantly limits
the applicability of the bondomer method. As such, there is still no general method for
simulating mass isotopomer distributions in complex biological systems that avoids the use
of isotopomers/cumomers.
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2.1.4 A novel framework for modeling isotopic tracer systems
Here, we present a novel framework for modeling isotopic tracer systems that significantly
reduces the number of system variables without any loss of information. The elementary
metabolite units (EMU) framework is a bottom-up modeling approach that is based on a
highly efficient decomposition algorithm that identifies the minimum amount of information
needed to simulate isotopic labeling within a reaction network. The functional units
generated by the decomposition algorithm, called elementary metabolite units, form the new
basis for generating system equations that describe the relationship between fluxes and
isotopomer abundances. Isotopomer abundances simulated using the EMU framework are
identical to those obtained using the isotopomer and cumomer methods, however, require
significantly fewer variables. For a typical carbon labeling system the total number of
variables and equations that needs to be solved is reduced by one order-of-magnitude (100s
EMUs vs. 1i000s isotopomers/cumomers). As such, the EMU framework is most efficient
for the analysis of labeling by multiple isotopic tracers. For example, analysis of the
gluconeogenesis pathway probed with 2H and 13C tracers required only 145 EMUs compared
to more than 4x10 4 isotopomers/cumomers.
2.2 Theory
2.2.1 Elementary Metabolite Units (EMU)
We define elementary metabolite units as distinct subsets of metabolite's atoms. For
example, consider metabolite A consisting of 3 atoms. An EMU is a subset of any number
of these 3 atoms. The size of an EMU is defined as the number of atoms that are included in
the EMU. There are 7 possible EMUs for metabolite A: 3 EMUs of size 1 (A1, A2, A3), 3
EMUs of size 2 (A12, A13, A23), and 1 EMU of size 3 (A123), where the subscript denotes the
atoms that are included in the EMU (see Figure 2-1). Note that atoms in an EMU are not
necessarily connected by chemical bonds, for example consider EMU A13. In general, for a
metabolite comprising N atoms 2" -1 EMUs are possible.
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Theoretical maximum number of EMUs = = 2N - 1 (2.1)
In this Chapter, we will illustrate that the EMU framework can be used for simulation of
isotopic labeling within a reaction network using the minimum number of variables, all of
which are expressed in terms of EMUs. In most cases, only a small number of all possible
EMUs is required to simulate the isotopic labeling. In the next section, we will illustrate the
EMU approach for simulating MS measurements, and in section 2.2.8 we will show how
NMR measurements can be simulated using EMUs.
2.2.2 EMU reactions
First, we need to introduce the concept of an EMU reaction. Figure 2-2 shows three types of
biochemical reactions that we can distinguish: a condensation reaction, a cleavage reaction,
and a unimolecular reaction. For each reaction type in Figure 2-2 we would like to determine
the minimum amount of information that is needed to determine the mass isotopomer
distribution (MID) of product C, i.e. EMU C123. For the condensation reaction, MID of C123
is fully determined by the MIDs of EMUs A12 and B1. For example, the M+O abundance of
C123 is equal to the product of M+0O abundances of A12 and B1, i.e. C123,M+o=A12,M+o'B1,M+o.
The full MID of C123 is obtained from the convolution (or Cauchy product, denoted by 'x)
of MIDs of A12 and B1, i.e. C123=A12xB 1.For the cleavage and unimolecular reactions, MID
of C123 is equal to MID of the EMU A123. Note that for the cleavage reaction atoms of A
that are not transferred to C123 are not considered in the EMU reaction, i.e. their labeling
doesn't affect the labeling state of C. Note also that EMU reactions are always size balanced,
i.e. the EMU product is formed either from EMUs of the same size, or by condensation of
smaller EMUs such that the total size of substrate EMUs equals the size of the EMU
product. Thus, there can only be only two types of EMU reactions: condensation and
unimolecular EMU reactions. Table 2-1 shows the EMU reactions corresponding to the
biochemical reactions in Figure 2-2.
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Elementary Atoms included
metabolite unit in the EMU EMU size
A,1 O 1
A2  Oo 1
A3  1
A12  KD 2
A13  D 2
A23  2
A 1 2 3  O____ 3
Figure 2-1: Elementary metabolite units (EMU) are defined as distinct subsets of
metabolite's atoms. There are 7 EMUs for a 3-atom metabolite A. The subscript in the first
column denotes the atoms that are included in the respective EMU. The EMU size is
defined as the number of atoms included in the EMU.
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A) Condensation reaction
A12 C123A 1 2
C123 = A12 x B1
C 123,M+O = A12,M+0 B1,M+O
C123,M+1 = A12,M+O. B1,M+1 + A12,M+1" 1,M+O
C 1 23,M+2 = A12,M+1 B,M+1 + A12 ,M+2 Bl,M+o
C123,M+3 = A12,M+2* B1,M+1
B) Cleavage reaction
A123 C123
0
C) Unimolecular reaction
A123
-
S C123
C123 = A123
C123,M. o = Ai23,M+0
C123,M+1 = A123,M+ 1
C123,M+2 = A123,M+ 2
C123,M+3 = A123,M+3
C123 = A123
C123,M+O = A123,M+O
C 123,M+1 = A123,M+1
C 123,M+2 = A123,M+2
C123 ,M+3 = A123,M+3
Figure 2-2: Three types of biochemical reactions and the corresponding EMU reactions.
Shaded areas indicate atoms included in the EMUs. The mass isotopomer distribution
(MID) of product C is fully determined by MIDs of substrate EMUs. Thus, for the
condensation reaction, MID of C123 is obtained from the convolution (or Cauchy product,
denoted by 'x') of MIDs of A12 and B1. For the cleavage reaction and unimolecular reaction
MID of C123 equals MID of A123.
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Table 2-1
EMU reactions corresponding to the three reactions shown in Figure 2-2. Note that EMU
reactions are always EMU size balanced, i.e. the size of the EMU product always equals the
total size of substrate EMUs.
Reaction type Biochemical reaction EMU reaction EMU size balance
Condensation A + B - C A12 + B1 - C123  2 + 1 = 3
Cleavage A B + C A1 23 -C 123  3 = 3
Unimolecular A - C A123 - C123  3 = 3
2.2.3 Decomposing metabolic networks into EMU reactions
We will now describe the algorithm that systematically decomposes any biochemical reaction
network into EMU reactions using the knowledge of atomic transitions occurring in the
network reactions. These EMU reactions will then form the basis for generating model
equations for isotopic simulations (see section 2.2.4). Consider the example network shown
in Figure 2-3 that will be used to illustrate the theory behind EMU modeling. In this
network, metabolite A is the sole substrate and metabolites E and F are two network
products. The intermediary metabolites B, C and D are assumed to be at metabolic and
isotopic steady state. The stoichiometry and atom transitions for the five reactions are given
in Table 2-2, and the assumed flux distribution is shown in Figure 2-3. The structural input
that is required for the EMU decomposition is threefold:
1. The assumed metabolic network stoichiometry
2. Atom transitions for all reactions in the network
3. List of metabolites/metabolite fragments that need to be simulated
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A 060
V1= 100 O E
B C000 (D C
v2= 110 V 50 = 205=
D CCO 20 E
V6 = 80j
F 000
Figure 2-3: Simple metabolic network used to illustrate the decomposition of a metabolic
system into EMU reactions. The assumed steady-state fluxes have arbitrary units. The
network substrate A is fully labeled on the second atom. Atom transitions for the reactions
in this model are given in Table 2-2.
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Table 2-2
Stoichiometry and atom transformations for reactions in the example metabolic network.
This simple metabolic network is used to illustrate the decomposition of a metabolic system
into EMU reactions.
Reaction Reaction stoichiometry Atom transformations*
number
1 A --+ B abc --+ abc
2 B - D abc <- abc
3 B - C + E abc -> bc + a
4 B + C - D+ E + E abc + AB -- bcA + a + B
5 D -+ F abc -+ abc
* For each compound atoms are identified using lower case letters to represent successive atoms of
each compound. Uppercase letters represent a second compound in the reaction.
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In this example, we would like to set up the simplest possible model to simulate the MID of
metabolite F, i.e. EMU F123. The following algorithm systematically identifies all EMU
reactions that are needed for this simulation model. First, we identify in the network model
all EMU reactions that form EMU F123. In this case, F123 is formed only in reaction 6 from
EMU D 123. We record this EMU reaction and the newly identified EMU(s), and repeat this
process for all newly identified EMUs starting with the largest size EMU, i.e. D 123. Here,
D 123 is formed in two reactions, i.e. in reaction 2 from B123, and in reaction 5 from B23+C 1.
Next, B123 is formed in reactions 1 and 3 from A123 and D 123, respectively. Note that A123 is a
network substrate, i.e. it is not produced by any reaction in the network, and D 123 was
already considered in the previous step. Thus, we have identified all EMUs of size 3 that
need to be considered. Next, we proceed with EMUs of size 2 that were previously
identified, i.e. B23, which is formed in reaction 1 and 3 from A23, and D 23, respectively, etc.
We complete this process for EMUs of size 2 and 1, until all the EMUs have been traced
back to EMUs of network substrate A, or EMUs that were already visited. Table 2-3 shows
schematically the complete EMU decomposition for this network. In this case, 18 EMU
reactions were identified connecting 14 EMUs. Of these 14 EMUs, 10 EMUs correspond to
intermediary metabolites whose labeling is unknown, and 4 EMUs are fully defined by the
choice of substrate labeling of metabolite A. The complete list of EMUs for this example is
shown in Table 2-4. It should be clear that the described decomposition algorithm is
exhaustive, unsupervised, and always identifies the minimal set of EMUs that need to be
considered in the simulation model. Furthermore, this algorithm is easy to implement and is
computationally efficient, i.e. it converges within seconds even for the largest network model
that we have considered. The main advantage of the EMU decomposition is that metabolites
are never broken into smaller pieces than is strictly required to describe the labeling state of
the selected metabolite(s). In contrast, the isotopomer frameworks always uses all 2N
isotopomers per metabolite to simulate the system. In this case, the complete set of 36
isotopomers describe the system (i.e. 28 unknown isotopomers and 8 substrate
isotopomers). Thus, in this example the number of system variables was reduced by more
than 50% using the EMU framework. Figure 2-4 shows schematically the complete
algorithm for the decomposition of metabolic networks into EMU reaction networks (see
sections 2.2.4-2.2.7 for further details).
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Table 2-3
Complete list of EMU reactions generated for metabolite F. The complete set of EMU
reactions for molecule F was identified using the described decomposition algorithm. The
subscripts denote the atoms that are included in the respective EMUs. Note that EMU
reactions are always size balanced.
Reaction No. EMU reaction EMU reaction size balance
6 D123 - F123 3 = 3
2 B123 -- D12 3  3 = 3
5 B 23 + C1 - D123  2 + 1 = 3
1 A123 - B123  3 = 3
3 D123 - B123  3 = 3
1 A23 - B23  2 = 2
3 D23 - B23 2 = 2
2 B23 - D23 2 = 2
5 B3 + C- D23  1 + 1 = 2
4 B2->CA 1=1
1 A -+ B2  1 = 1
3 D- - B, 1 = 1
2 B2- D 2  1 = 1
5 B3 - D2 1 = 1
1 A3 -> B3  1 = 1
3 D3 -> B3  1 = 1
2 B3 D3 1 -1
5 CI -> D3 1
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Table 2-4
Complete list of EMUs generated for metabolite F from network decomposition. The
complete molecule F corresponds to EMU F123. The subscript denotes the atoms that are
included in the respective EMUs.
EMU size
size 1 size 2 size 3
C1  B23  F123
B2  D23 D123
D2 A23  B123
B3  A123
D3
A2
A3
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Create a list of metabolites and/or
metabolite fragments that need to be simulated
Make a list of corresponding EMUs, and
sort them according to EMU size
Locate the largest unvisited EMU on the list, 4
and identify all equivalent EMUs
For each equivalent EMU
record all EMU reaction(s) that produce the EMU
For all EMUs that were involved in the above reactions
identify all equivalent EMUs
Check if these EMUs are already present on the list.
If not, then add them to the list.
Have all EMUs on the list been traced back
to EMUs of network substrates, and/or EMUs
that were already visited ? No
I Yes
Separate EMU reactions into independent EMU reaction networks:
(i) based on EMU size
(ii) based on network connectivity of EMUs
For each decoupled EMU network:
(1) set up EMU balances for all unknown EMUs
(2) calculate and store matrices dAldv and dB/dv
(3) record the identity of EMUs in matrices X and Y
Figure 2-4: Schematic overview of the algorithm for decomposition of metabolic networks
into EMU reaction networks. This algorithm systematically identifies the minimal set of
EMUs that need to be considered in the simulation model. The algorithm is exhaustive,
unsupervised, and efficient (see sections 2.2.4-2.2.7 for further details).
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2.2.4 Setting up EMU balances and simulating labeling distribution
The EMU reactions obtained from the decomposition algorithm form the new basis for
generating system equations. EMU reactions are much less connected than corresponding
isotopomer reactions. Thus, we can group EMU reactions into independent reaction
networks based on: (i) the EMU size, and (ii) network connectivity (see section 2.3.4 for an
example). For the example network we obtain three independent reaction networks of EMU
size 1, 2, and 3, respectively. Figure 2-5 shows the independent EMU reaction networks.
Similar to metabolite and isotopomer balancing, we can set up balances around all unknown
EMUs.
EMU balances for reaction network of EMU site 1
v4-C1 -= v4-B2 (2.2a)
(vi+v 3)'B2 = V-A2 + v3-D 2  (2.2b)
(v5+v2)-D2 = v 5"B3 + V2-B2 (2.2c)
(vl+v3)'B 3 v= v-A3 + v3-D 3  (2.2d)
(v5+v2)-D 3 = v 5"C1 + v2-B 3  (2.2e)
EMU balances for reaction network of EMU site 2
(vs+v2)-D23 = v 5 (B3XC1) + v2'B 23  (2.2f)
(vl+v3)-B23 = V1A23 + V3-D 23  (2 .2 g)
EMU balances for reaction network of EMU site 3
v6-F1 23 
= V6"D123  (2.2h)
(v5+v2)-D123 = v5'(B 23XCi) + v2B 123  (2.2i)
(vl+v3).B123 = V1-A123 + V3-D123 (2.2j)
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Reaction network for EMU size 1
V 1
A3
A 2
V2
B3
V5 1 V3
D2 V5
211 V3
V4
Reaction network for EMU size 2
Reaction network for EMU size 3
Figure 2-5: Independent EMU reaction networks generated for metabolite F.
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In general, EMU balances can be written as a set of linear equations in matrix form:
Al,k(V) Xl,k = Bl,k(V) Yl,k(yl in)  (2.3a)
A2,k(V) X2,k= B2,k(v) Y2,k(y2 in , Xt) (2.3b)
A3,k(V) " X3,k = B3,k(V) YV3,k(y3 in, X2, X1) (2.3c)
Here, the first subscript denotes the EMU size and the second the subnetwork number, i.e.
in case there are multiple independent EMU networks of the same EMU size. For now we
will omit the second subscript. The EMU balances written in matrix corresponding to the
EMU networks in Figure 2-5 are shown below.
-v 4  V4  0 0 0 C O0 0
0 -v, - V3  v 3  0 0 B 2  -v1  0
0 v2  -V2 - v5 v5 0 D2  = 0 [ - (2.4a)
0 0 0 -vi -v 3  v3  B3  0 -vi
V5 0 0 v 2 -V2 -v 5 D3 0 0
[-V5V- - V2 V32 [D 23 ] = [-5- 01 [B3 xC 1] (2.4b)V3 -v 1 -v 3] B23  0  v A23
A1230 -V5V2 235 123 L.1(2.4c)0 v 3  -v -v 3  B123  0 -vT
In Eq. 2.3, matrices Yi and Xi represent the known and unknown EMUs, respectively, and
yiin are EMUs of the network substrate(s). Each row in matrix Yi and Xi contains the MID
for the corresponding EMU. The product term B3xC 1 in Eq. 2.4b represents the
convolution (or Cauchy product) of MIDs of B3 and Ct (see section 2.2.2). Matrices X2 and
Y2 written out in full for the example network are shown below.
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[D D23,M+O D23,l+l D23,M+2  (2.5)
B 23  23,M+ 23,M++1 23,M+2
B, xCI B3,h[o -CI,M+O (B3,MCO + B3,XI -C1,V+)) B3, * C (26)
23 23,M+A 23,N+1 A3,MI+2
The size matrix Ai depends on the number of unknown EMUs for the corresponding EMU
network, and the size of matrix Bi depends on the number of known input EMUs. Thus, for
n unknown and m known EMUs, Ai is an n x n matrix and Bi is an n x m matrix. Note that
matrices Ai and Bi are always strictly linear functions of fluxes. We can therefore easily
compute Ai and Bi for given steady-state fluxes from first derivative matrices dAi/dvi and
dBi/dvj, which are constant for a given network:
Ai dA(j vi (2.7)
dB,
Bi • I dBi i (2.8)
dv)
To simulate isotopic labeling distribution in the network, EMU balances are solved
sequentially starting with the smallest size EMU network(s). Since matrix Y1 is always
known, i.e. it is fully determined by EMUs of network substrate A, we can easily calculate X1
using standard matrix algebra techniques:
Xi = A-' - B1 - Yi (2.9)
For subsequent EMU networks, matrices Yi may depend on previously determined EMUs of
smaller size. Thus, for larger EMU sizes we must first update matrix Yi and then calculate Xi.
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X2 = A2-1 - B2 Y2 (2.10)
X3 = A3-1 - B3 'Y3 (2.11)
After all unknown EMUs have been computed we can simply read out the simulated MIDs
for the metabolites of interest from the rows of matrices Xi. For example, MID of F123 is
found in the first row of matrix X3.
2.2.5 Calculating first order derivatives of simulated measurements
Here, we present analytical expressions for calculating first order derivatives of simulated
measurements with respect to fluxes. Knowledge of these derivatives is important for
calculating the optimal search direction of fluxes in least-squares fitting algorithms (Chapter
3). In general, EMU balances are expressed in the following matrix form:
Ai - Xi = Bi - Yi (2.12)
Where, matrices Ai and Bi are strictly linear functions of fluxes and matrices Xi and Yi are
nonlinear functions of fluxes. To determine dXi/dv (which is a 3D-matrix), we take the first
order derivative of Eq. 2.12:
d d
-(Ai Xi) = (Bi -Y) (2.13)
dv dv
After applying the product rule we obtain the following expression:
dA + A dX _ dB dY
- Xi + A d d Yi + B- (2.14)dv i dv dv i dv
Note that matrices dAi/dv i and dBi/dvi are constant for a given network (because Ai and Bi
are strictly linear functions of fluxes). After rearrangement of Eq. 2.14 we obtain the
following general expression for dXi/dv:
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dX dB dY dA.dXi _ A " "di + Bi dY (2.15)
dv , dv +  dv dv
The above expression may be simplified for the smallest size EMU network. For EMU-seize
1 all terms in matrix Y1 are constant, i.e. dYi/dv=0O. Thus, the solution to the first EMU
problem is given by:
X, = A,'- B,"Y ,  (2.16)
dX, A (dB, dA. (2.17)
dv ~dv dv
For each next EMU network of larger EMU size, matrices Yi may depend on previously
determined EMUs of smaller size, e.g. for the example network model Y2 was given by:
Y2 B=  A (2.18)
Where, B3 and C1 are EMUs of size 1 that are calculated from EMU-size 1 balances. By
applying the product rule, we derive the following expression for the first order derivative of
the convolution of B3 and Ci:
d dB dC((B, xC ) = C, + B3 x (2.19)
dv dv dv
Where, dCl/dv and dB3/dv matrices that are obtained from dX1/dv. Note that the second
row of Y2 contains A23 which is a network substrate EMU, i.e. it is considered known and
constant (dA23/dv=0O). Thus, we obtain the following expression for dY2/dv:
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dY2  d-3-xC + B 3 x 12  dv-  dv (2.20)
dv 0
Where, (dB3/dv)xCi denotes the 2D-convolution of matrix (dB3/dv) and vector C1. First
order derivatives for any EMU size can be obtained this way. Figure 2-6 summarizes the
general procedure for simulating labeling distributions and calculating first order derivatives
of simulated measurements with respect to fluxes, using the EMU framework.
2.2.6 Global stability and computation time of EMU simulations
It should be clear that for non-zero fluxes matrices Ai are diagonally dominant, and using
Gerhorgin's eigenvalue theorem we can easily prove that therefore matrices Ai are always
invertible. In other words, the EMU approach will always compute a unique and stable
solution for the unknown EMUs. The most time consuming computation involved in
solving EMU balances and calculating first order derivatives is the inversion of matrices Ai,
or rather LU decomposition of Ai. In general, the computational time for LU decomposition
increases with the size of the matrix, i.e. the number of unknown EMUs. We found
empirically that for sparsely connected EMU networks, such as the ones shown in
Figure 2-5, the computation time increased linearly with the number of unknown EMUs, i.e.
O(n). For more highly connected networks, for example the EMU networks corresponding
to central carbon metabolism of E. coli (Chapter 6), the computational time increased as
O(n3). Therefore, it is often worthwhile to reduce the number of EMUs by eliminating EMU
nodes that only have a single influx, i.e. lumping linear EMU pathways. This will be
illustrated in detail in section 2.3.2.
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Start with:
EMU size: i =1
Subnetwork: k=1
L
Steady-state fluxes Calculate Ai,k and Bi, k
<t (Eqs. 2.7 and 2.8 ) I updatek->EMU network model Calculate Yk and
Substrate labeling dYik/dv
[Calculate and store Xi,k (Eq. 2.9)
SCalculate and store dXi,k/dv (Eq. 2.15)
Is this the last subnetwork
of current EMU size ? No
Yes
Extract simulated measurements from Xi,k
and first order derivatives of measurements from dXi,k/dv
Figure 2-6: A schematic of the algorithm for simulating labeling distributions and
calculating sensitivities using EMU balances. EMU balances are solved sequentially starting
with the smallest EMU-size networks up to the largest EMU-size network. Simulated
measurements and sensitivities are extracted from the matrices X and dX/dv, respectively.
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2.2.7 Identifying equivalent EMUs of metabolites
There are a number considerations regarding the chemical structure of metabolites that need
to be taken into account to make sure that EMU simulation models are accurate. Here, we
will discuss in detail how to account for chiral, prochiral and rotationally symmetric
metabolites, and how biochemically equivalent hydrogen and oxygen atoms should be
modeled within the EMU framework. These considerations are equally important for the
construction of isotopomer models, however, until now they have not received proper
attention.
Chiral and prochiral metabolites
Tetrahedral carbon atoms with four different ligands are called chiral, whereas the term
prochiral applies to a carbon atoms that hold two stereoheterotopic groups. In other words,
prochiral carbon atoms are one step removed from being chiral (Moss, 1996). Many
biological metabolites contain one or more chiral and/or prochiral carbon atoms. It is well
known that biochemical reactions are highly stereospecific, i.e. enzymes can differentiate
between prochiral atoms and prochiral atom groups. Therefore, it is important to keep track
of individual prochiral atoms in a network model and assign stereospecific atom transitions
to all biochemical reactions. Consider for example the enzymatic reaction catalyzed by
aconitase that converts cirate to isocitrate (Figure 2-7). Three of the six carbon atoms of
citrate are prochiral, i.e. C2, C3 and C4. The enzyme aconitase stereospecifically transfers the
pro-R hydrogen from the pro-R arm (i.e. C1-C2) of citrate to C3 of isocitrate, and produces
only one of four possible stereoisomers of isocitrate, i.e. (2R,3S)-isocitrate. Note also that
the prochirality of C4 is not altered by aconitase. The absolute stereochemistry for most
bioreactions has been worked out in detail and can be found in many biochemistry books,
and other general literature.
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OH OH
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pro R-arm C=O C0=O
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I Ipro-S H_ Hpro-R ... HO-C-H
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13 6 0O
pro-R H-C-Hpro-S
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5
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SH--C-C '
1 3 6 O
pro-R H- -Hpro-S
C= O
5
OH
Citrate (2R,3S)-Isocitrate
Figure 2-7: Stereospecific atom transitions for the reaction catalyzed by aconitese. Aconitase
stereospecifically transfers the pro-R hydrogen from the pro-R arm of citrate to C3 of
isocitrate, and produces only one of four possible stereoisomers of isocitrate, i.e. (2R,3S)-
isocitrate.
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Equivalent hydrogen and oxygen atoms
Biological molecules often contain groups of atoms that are biochemically indistinguishable.
Consider for example the chemical structure of pyruvate shown in Figure 2-8. The three
hydrogen atoms at C3 are biochemically equivalent, i.e. enzymes cannot distinguish between
these atoms. Furthermore, the two oxygen atoms at C1 are biochemically equivalent due to
resonance stabilization. Thus, not all of pyruvate's EMUs are independent. For example,
there are six equivalent EMUs of pyruvate that contain three carbon atoms, two of the three
hydrogen atoms at C3, and one of two oxygen atom at C1. Figure 2-8 shows the six
equivalent EMUs. We can predict the number of equivalent EMUs for any EMU as follows:
EMo. o X e ( fv qvent aoms)!
No. of equivalent EMUs = H (no. of equivalent atoms)! (2.21)
for each groupf (no. of atoms in EMU) x (no. of equivalent atoms)!
equivalent atoms
When setting up EMU balances, we need to consider equivalent EMUs. We propose to do
that as follows. First, whenever a new EMU is generated during EMU network
decomposition, we identify all equivalent EMUs for that EMU. Then, for each equivalent
EMU we find the EMU reaction(s) that produce that EMU, and divide the contribution
from each reaction by the total number of equivalent EMUs. Note that this way we only
introduce one unknown EMU variable for each set of equivalent EMUs. For example,
consider the enzymatic reaction catalyzed by malic enzyme that converts malate to pyruvate
shown in Figure 2-9 (arbitrary numbering of atoms). The six equivalent EMUs of pyruvate
from Figure 2-8 are produced by the following six EMU reactions:
Mal1 3478 + H -- Pyr134678 (2.22a)
Mal134789 -- Pyr1346789 (2.22b)
Ma113479 + H - Pyr134689 (2.22c)
Mal12478 + H -> Pyr12 4678  (2.22d)
Mal124789 - Pyr1246789 (2.22e)
Mal1 24 79 + H -> Pyr124689 (2.22f)
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O-H O-H O-HI I I
H-
-H
=0
=0
-H H-
Figure 2-8: Equivalent EMUs of pyruvate. The three hydrogen atoms of pyruvate at C3 are
biochemically equivalent. The two oxygen atoms at C1 are also equivalent (due to resonance
stabilization). There are six equivalent EMUs of pyruvate containing all three carbon atoms,
two of the three hydrogen atoms at C3, and one of two oxygen atom at C1. Shaded areas
indicate the atoms that included in the EMUs.
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Figure 2-9: Malic enzyme converts malate to pyruvate. Note that one of the three hydrogen
atoms at C# 6 of pyruvate is derived from the solvent. The two prochiral hydrogen atoms of
malate at C#7 (which are biochemically distinct) become indistinguishable after malate is
converted to pyruvate.
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Next, we determine that Mal 3478 and Mall 2478; Ma113479 and Ma112479; and Mall34789 and
Ma1124789 are equivalent EMUs. Taken together, we obtain the following overall EMU
reaction:
Pyrl34678
Pyr 134679
Pyr 3468) 1 Ma 3478  1 a134 9  1 Ma134789x H + M- , H + - 134 (2.23)
Pyr 246 8  3 Ma247 3 Ma2479 3 Ma1, 489 ,
PYV 2467 9
PVr1 24689
Note that the two prochiral hydrogen atoms of malate that are initially biochemically distinct
become indistinguishable after malate is converted to pyruvate.
Rotationally symmetric metabolites
A number of metabolites of central carbon metabolism are also rotationally symmetric, i.e.
they are superposable on themselves by rotation. In isotopic labeling studies these molecules
cause scrambling of isotopic labeling. We should note that there is a clear difference between
molecules with a center of inversion and molecules with a rotation axis. The two types of
symmetry have different characteristics. Only molecules with a rotation axis are superposable
on themselves. Figure 2-10 shows the structures of (2S,3R)-butane-1,2,3,4-tetraol (i.e.
erythriol) which has a center of inversion, and (2R,3R)-butane-l ,2,3,4-tetraol which has a
rotation axis. Carbon atoms C1 and C4, and C2 and C3 of erythriol are chemically equivalent
(react identically in chemical reactions and have the same chemical properties), however, in
enzymatic reactions these atoms are biochemically distinct. In contrast, carbon atoms C1 and
C4, and C2 and C3 of (2R,3R)-butane-l ,2,3,4-tetraol are both chemically and biochemically
equivalent, i.e. they are not distinguished by enzymes.
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CH3OH
HO-C-H
2
I
H-C-OH
3
CH30H
(2R,3R)-butane-1,2,3,4-tetraol
Rotation axis
Chemically equivalent
Biochemically equivalent
IH-C-OH
2
I
H-C-OH
3
CH3OH
(2S,3R)-butane-1,2,3,4-tetraol
(i.e. erythritol)
Center of inversion
Chemically equivalent
Biochemically different
Figure 2-10: Differences between molecules with a rotation axis and center of inversion.
(2S,3R)-butane-l1,2,3,4-tetraol (i.e. erythritol) has a center of inversion; it is not superposable
on itself. Therefore, carbon atoms C1 and C4, and C2 and C3 of erythritol are biochemically
distinct. (2R,3R)-butane-l ,2,3,4-tetraol, on the other hand, has a rotation axis and is
superposable on itself. Therefore, carbon atoms C1 and C4, and C2 and C3 are
biochemically indistinguishable, which results in scrambling of isotopic labeling.
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The most important examples of rotationally symmetric molecules in metabolism are
fumarate, succinate, and D-mannitol. Figure 2-11 shows the structure of fumarate (with
arbitrary numbering of atoms). It should be clear that fumarate has a rotation axis, i.e. after
rotating 1800 fumarate superposes on itself. Furthermore, the two oxygen atoms at first
carbon and the two oxygen atoms at the last carbon atom of fumarate are biochemically
equivalent. These additional characteristics of fumarate need to be considered when we
identify equivalent EMUs. The number of equivalent EMUs may increase due to rotational
symmetry, i.e. EMUs of rotationally symmetric molecules may have twice as many equivalent
EMUs as nonsymmetric molecules:
K (no. of equivalent atoms)!
No.of equivalent EMUs 2x ch group of (no. of atoms in EURJ)D! x (no. of equivalent atoms)!
equivalent atoms
(2.24)
For example, Figure 2-11 shows the four equivalent EMUs of fumarate Fum12467. However,
fumarate EMU F1468 has no equivalent EMUs, because its rotational equivalent is F146 8 itself.
Thus, when enumerating equivalent EMUs it is very important that we separate the effect of
rotational symmetry, which is a global characteristic of a molecule, from the effect of
equivalent hydrogen and oxygen atoms, which are local characteristics of a molecule. To
better illustrate this, consider hydrogen atoms #5 and #7 of fumarate. These atoms cannot
be treated as equivalent atoms, because that would incorrectly identify Fum12465 as being
equivalent to Fum1246 7.
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Figure 2-11: Equivalent EMUs of the rotationally symmetric fumarate. Shaded areas indicate
atoms included in the EMUs. The following four EMUs are equivalent: Fum1 2467, Fum13467,
Fum45689, and Fum 4568,10 (numbering of fumarate atoms is arbitrary).
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2.2.8 Simulating NMR measurements using EMUs
Thus far, we have shown how MS measurements can be simulated using the EMU approach.
We will now illustrate the method for simulating NMR measurements, in particular we will
show how fractional enrichment measurements, and NMR fine spectra are simulated.
Simulation of fractional enrichments
Fractional enrichments measure the fractional abundance of 13C-atoms at specific carbon
positions in a molecule. For example, Wiechert et al. measured fractional enrichments of 25
carbon atoms of amino acids (Wiechert et al., 1997). Each fractional enrichment
measurement provides exactly one flux constraint. In the EMU framework fractional
enrichments are modeled by EMUs of size 1 that contain a single carbon atom. In other
words, to simulate fractional enrichments we only have to solve EMU balances of size 1.
Network decomposition is accomplished with same algorithm as was described before
(section 2.2.3). In the EMU balances (Eq. 2.3), however, Xi and Yi are now vectors (not
matrices) that contain values for fractional labeling of carbon atoms. Note that the EMU
simulation model for simulating fractional enrichments is very similar to the atom mapping
matrix model that was originally proposed by Zupke and Stephanopoulos (1994), and the
weight-1 cumomer model as proposed by Wiechert et al. (1999).
Simulation of NMR fine spectra
Data obtained from 2D [13C, 1H] COSY spectra, also known as NMR fine spectra, provide
information on the relative amount of 13C_13C and 13C-12C carbons at specific carbon
positions, where the observed carbon atom is always 13C-labeled and the adjacent carbon
atoms are either labeled or unlabeled (Szyperski, 1995). For a secondary carbon atom, NMR
fine spectra are expressed as ratios of four isotopomer fractions.
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singlet Ao010
doublet 3 A01  (A, 0  A0 + A0 A1,1 )- (2.25)
doublet 1 A ]1o
double doublet Al,,
We can obtain these four isotopomer fractions from cumomer fractions Axix, Ax11, Allx, and
All 1, as was shown previously by van Winden et al. (2002). Alternatively, we have derived
that these isotopomer fractions can also be obtained from the following four EMUs A2, A23,
A12, and A123.
a °  10 1 1 1  Al 1  1 1  A
Al 0 o 0 1 0 1 Axl O 1 0 1 A23  (2.26)
A011  0 0 1 1 Allx 0 0 1 1 A12
AAt11  0 0 1 Ali, O [ 00 1 LA123
In Eq. 2.26, Axlx denotes the weight-1 cumomer fraction for which the second atom is 13C_
labeled and the other two atoms are labeled or unlabeled (i.e. x = '0 or 1 ). We can easily
show that the cumomer fraction Ax1x is equal to the M+1 abundance of EMU A2.
Furthermore, weight-2 cumomer fractions Allx and Axli are equal to the M+2 abundances of
EMUs A23 and A12, respectively (i.e. fully labeled EMUs); and finally, weight-3 cumomer
fraction Alll is equal to the M+3 abundance of EMU A123 (i.e. fully labeled EMU). Thus, we
can simulate NMR fine spectra either by solving weight-I, 2, and 3 cumomer balances (van
Winden et al., 2002), or alternatively by solving EMU balances for the EMUs A2, A23, A12,
and A1 23. In this case, in the EMU balances Xi and Yi are now vectors (not matrices) that
contain the fractional abundances of fully labeled EMUs. It should be clear that the number
of EMUs generated for the EMUs of size 1, 2, and 3, will always be smaller, or equal to the
number of weight-I, 2, and 3 cumomers. Therefore, it is always more efficient to simulate
NMR fine spectra using the EMU framework.
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The EMU framework can be further extended to include NMR fine spectra for tertiary
carbon atoms, and to describe long-range 13C-13C couplings. In that case, the following eight
EMUs of size 1, 2, 3, and 4 are needed: A2, A1 2, A23, A24, A123, A234, A124, and A1234. We can
convert the simulated fractional abundances of fully labeled EMUs to isotopomer fractions
using Eq. 2.27, and then obtain the NMR signal intensities using Eq. 2.28.
A1n1)
A0101
.A0110
A0111
Al 100
A111
ALlol
1 0 1
0 1 1
0 0 11 1 1
1 0 1
0 1 1
0 0 1
A 2
A24A,
A 234
Ai,
A124
A 123
A1234
(2.27)
singlet
doublet 4
doublet 3
double doublet 34
doublet 1
double doublet 14
double doublet 13
quadruple doublet
A0101
AoO
A liA0110
Al111
Alll_A1101
Ali
A1111
(A ) + A0101 + + All01 + At( +Alll)-1
(2.28)
Note that in Eqs. 2.27 and 2.28 we assume the observed carbon atom is C2.
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2.3 Practical applications
2.3.1 Simple network model
In this example we will compare the EMU framework for simulating mass isotopomer
distributions with the isotopomer and cumomer frameworks. Consider the simple network
model that was introduced in section 2.2.3 (Figure 2-3). The assumed steady-state fluxes and
labeling of substrate A are shown in Figure 2-3. The solution to the EMU balances from Eq.
2.4 are shown below.
Solution of EMU balances for reaction network of EMU site 1
C,  -20 20 0 0 0 - 0 0 0.0667 0.9333
B2  0 -150 50 0 0 -100 00.0667 0.9333
D 2  = 110 -130 20 0 0 0 1 0 = 0.2000 0.8000
B3  0 0 0 -150 50 0 -100 0.9333 0.0667
D3_ 20 0 0 110 -130 0 0 0.8000 0.2000
Solution of EMU balances for reaction network of EMU site 2
[D23] = [-130 110 - 1 [-20 0] .[0.0622 0.8756 0.0622] = [0.0133 0.9733 0.0133]
B23  50 -150] -10 0 1 0 0.0044 0.9911 0.0044
Solution of EMU balances for reaction network of EMU site 3
F123  -80 80 0 -1 0 0 00003 0.0702 0.9253 0.0041 0.0001 0.8008 0.1983 0.00091
D123  0 -130 110 • -20 0 0 1 0 0 = 0.0001 0.8008 0.1983 0.0009
B123  0 50 -150 0 -100 0.0000 0.9336 0.0661 0.0003
Thus, we find that the simulated MID of F is: 0.0 mol% (M+0), 80.1 mol% (M+1), 19.8
mol% (M+2), and 0.1 mol% (M+3), i.e. the first row in matrix X3. These simulated
abundances were identical to those obtained using the isotopomer and cumomer methods.
The main difference between the methods was the number of equations that needed be
solved to simulate the labeling. For the isotopomer method, 28 nonlinear isotopomer
balances were solved using Newton's iterative method. For the cumomer method, 4 linear
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problems of size 4, 11, 10, and 3, respectively, were solved using standard linear algebra
techniques. Note that the total number of cumomers was the same as the number of
isotopomers, as expected. Table 2-5 summarizes the main differences between the three
modeling methods for this simple example.
2.3.2 Tricarboxylic acid cycle
The second example that we consider is the simplified model of tricarboxylic acid (TCA)
cycle shown in Figure 2-12. The stoichiometry and atom transitions for the eight reactions
are given in Table 2-6. In this network, acetyl coenzyme A and aspartate are two substrates,
and glutamate and carbon dioxide are the products. Here, we simulated the steady-state
labeling distribution of glutamate assuming a mixture of 25% [2-13C]AcCoA and 25% [1,2-
13C]AcCoA as the tracer input. The assumed flux distribution is shown in Figure 2-12. In
this example, we only consider the labeling of carbon atoms and for simplicity we ignore
natural isotope enrichments. The algorithm described in section 2.2.3 decomposed the TCA
cycle network into 4 independent EMU reaction networks that are shown in Figure 2-13.
The total number of unknown EMUs was 24, i.e. 8 EMUs in the first network (EMU size 1),
5 EMUs in the second (EMU size 2), 8 EMUs in the third (EMU size 3), and 3 EMUs in the
fourth network (EMU size 5). The EMU balances for the four decoupled networks are
shown in Figure 2-14. The rotational symmetric molecules fumarate and succinate were
modeled as described in section 2.2.7. The following groups of EMUs were identified as
equivalent: Fum2 and Fum 3; Suc 2 and Suc3; Fum123 and Fum234; Suc123 and Suc 234. The 24
unknown EMUs constituted a significant reduction from the complete set of 176
isotopomers that were required to describe this system (a reduction of 86%). Here, the
cumomer model consisted of seven subproblems of size 6, 28, 53, 52, 28, 8, and 1,
respectively. As expected, all three modeling methods (i.e. EMU, isotopomer, and cumomer)
predicted identical mass isotopomer abundances for glutamate: 34.64 mol% (M+0), 26.95
mol% (M+1), 8.07 mol% (NM+2), 2.86 mol0 (oM+4), and 0.39 mol% (M+5).
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Table 2-5
Comparison of three modeling approaches for simulating mass isotopomer labeling. MID of
F in the example network (Figure 2-3) was simulated using the EMU, isotopomer, and
cumomer methods. The simulated abundances were identical for all methods. The EMU
method required only 10 variables to simulate the labeling, as opposed to 28 variables for the
isotopomer and cumomer methods (a reduction of 64%).
isotopomer cumomer EMU
model model model
Simulated mass isotopomer M+0 0.0001 0.0001 0.0001
distribution (MID) of M+1 0.8008 0.8008 0.8008
metabolite F (molfractions) M+2 0.1983 0.1983 0.1983
M+3 0.0009 0.0009 0.0009
Type of model equations nonlinear linear linear
Number of variables in each subproblem 28 4, 11, 10, 3 5, 2, 3
Total number of variables 28 28 10
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AcCoA
V8 = 50
SOAC v,= o100
V7= 75 ( V6= 125 V2
Cit
= 100 C02
Fum AKG - Glu
V3= 50
50 v4 =v=
Suc co2
Figure 2-12: Simplified model of the tricarboxylic acid cycle. Abbreviations of metabolites:
OAC, oxaloacetate; Asp, aspartate; AcCoA, acetryl coenzyme A; Cit, citrate; AKG, Ia-
ketoglutarate; Glu, glutamate; Suc, succinate. The assumed fluxes have arbitrary units.
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Table 2-6
Stoichiometry and atom transformations for the reactions of the TCA cycle. This network
model was used simulate the mass isotopomer distribution of glutamine.
Reaction Reaction stoichiometry Atom transformations*
number
1 OAC + AcCoA -, Cit abcd + AB -+ dcbBAa
2 Cit -- AKG + CO 2  abcdef -+ abcde + f
3 AKG -- Glu abcde - abcde
4 AKG -Suc +C0 2  abcde - bcde + a
5 Suc - Fum 1/2 abcd + /2 dcba - 1/2 abcd + 1/2 dcba
6 Fum -> OAC 1/2 abcd + '/2 dcba -+ abcd
7 OAC - Fum abcd - 1/2 abcd + /2 dcba
8 Asp -+ OAC abcd -abcd
* For each compound atoms are identified using lower case letters to represent successive atoms of
each compound. Uppercase letters represent a second compound in the reaction. Abbreviations of
metabolites: OAC, oxaloacetate; Asp, aspartate; AcCoA, acetyl coenzyme A; Cit, citrate; AKG, a-
ketoglutarate; Glu, glutamate; Suc, succinate.
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Reaction network for EMU
Asp 2
V8O
OAC2
1/2 V7
- Fum
V6
Suc
Sv 4 /
AKG 3
V2 I
- Cit 3
V6
2 -2
1/2 V 7
2
\ V4
AKG4
V2 1
Cit 4
V1
AcCoA2
size 1
AsP3,
V8
OAC 3
Reaction network for EMU size 3
AsP 123  Asp234
V 1/2V 7  V6
OAC 123  Fum 123  OAC234
V6  V5 1/2 V7
Suc12
3
1/2 v ,2 V 4
AKG 234  AKG 345
V2 1 V2 1
Cit 234  Cit345
v,1  v,1
OAC 23+AcCoA 2 OAC 2+AcCoA 12
Figure 2-13: EMU reaction networks generated for glutamate from EMU network
decomposition. The complete molecule of glutamine corresponds to EMU Glu1 2345.
Subscripts denote carbon atoms that are included in the EMUs. Abbreviations of
metabolites are the same as in Figure 2-12.
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Reaction network for EMU size 2
V8Asp23 - OAC23
V7 1j V6
Fum 23
I V5
Suc23
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AKG3
I V2
Cit 34
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OAC2+AcCoA2
Reaction network for EMU size 5
Glu 12345
tV3
AKG 12345
SV2
Cit12345
t 1
OAC 123+AcCoA12
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-VJ Cit12345j -V1
Figure 2-14: EMU balances for the EMU networks of the TCA cycle. Subscripts denote
carbon atoms that are included in the EMUs. Abbreviations of metabolites are the same as
in Figure 2-12. A dot denotes a zero entry.
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2.3.3 Reducing EMU balances
In section 2.2.6 we indicated that the computational effort for solving EMU balances
depends on the number of unknown EMUs. It is often possible to reduce the number of
unknown EMU variables in decomposed EMU networks by eliminating EMU nodes with a
single influx. Note that no information is lost in this process. We applied this strategy the
simplify the EMU networks for the TCA cycle example from the previous section. The
reduced EMU networks are shown in Figure 2-15. In this case, the number of EMUs was
reduced from 24 to only 9 unknown EMUs, i.e. 95% reduction compared to the complete
set of 176 isotopomers. The corresponding EMU balances are shown below.
-v - v0], v6 O OAC, -v O 01 Asp2
V+-v v -V V,  v' Fum = 0 0 -v5  Asp 3
0 v 6, -v8 - v6, OAC, O -v,8  0 AcCoA,
-V[-V v6 6 . [OAC23] [- 8 0 Asp23
v7 -v- v Fum,  -v- OAC2 x AcCoA 2
v -v v, O OAC1 2 3 0 0 01
1v -v 1 . Fum 0 0 -- v - I vSV7 v5 -v 28 v F AC 23  0 -v 2 5 0
vL 6 8 -8 v 6 OAC34 J L -v8 0 0
Glul2345 = OAC 23 AcCoA12
With the reduced EMU model we can simulate the labeling of glutamate in this system for
any steady-state fluxes and any substrate labeling by solving four very simple linear problems
of size 3, 2, 3, and 1, respectively. The solutions to the EMU balances for the assumed
steady-state fluxes and labeling of acetyl-CoA are shown below. As expected, the simulated
MID of glutamate was identical to the one obtained with the full EMU model and the
isotopomer and cumomer methods. Table 2-7 summarizes the main advantages of the EMU
method for the TCA cycle example.
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Reaction network for EMU
Asp2
1/2 V7  V6OAC2 - Fum2 -
6 1/2 V7
12 v/2 V5
AcCoA2
size 1
Asp,
V8
OAC3
Reaction network for EMU size 3
Asp 123  Asp234
8  1/2 V7  6  V8
OAC 123  - Fum 123  OAC 234
V 6  1/2 V7
11/2 v 5
OAC 23+AcCoA 2
OAC2+AcCoA 12
Reaction network for EMU size 2
Reaction network for EMU size 5
Figure 2-15: Simplified EMU reaction networks for glutamate. EMU networks from
Figure 2-13 were simplified by lumping linear EMU nodes, i.e. having only one influx.
Abbreviations of metabolites are the same as in Figure 2-12.
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Solution of EMU balances for reaction network of EMU site 1
OAC2  -175 125 0 -50 0 0 1 0 0.8333 0.1667
Fum2  = 62- -125 37j - 0 0 -25 l 1 0 =0.7667 0.2333
OAC3  O 125 -175 0 -50 0 0.5 0.5 0.8333 0.1667
Solution of EMU balances for reaction network of EMU site 2
OAC23] = [-175 125 '.[-50 0 1 0 0 [0.7083 0.2500 0.0417]
Fum 23 75 -125 0 -50  0.4 167 0.5000 0.0833 L0.5917 0.3500 0.0583
Solution of EMU balances for reaction network of EMIU size 3
1 0 0 0OAC123 -175 125 0 -50 0 0 0 0.6927 0.1927 0.0990 0.0156Fum,, 371 -125 37 0 0 -25 -25 - = 0.5698 0.2698 0.1385 0.02191 2 2 0.3542 0.4792 0.1458 0.0208
OAC4_ 0 125 -175 0 -50 0 0 0.6927 0.1927 0.0990 0.01560.4167 0.2917 0.2500 0.0417
Solution of EMU balance for reaction network of EMU size 5
[Glu,345] = [0.3464 0.2695 0.2708 0.0807 0.0286 0.0039]
2.3.4 Central carbon metabolism of E. coli
In this example we have applied the EMU framework to the realistic metabolic network
model of E. coli central carbon metabolism. The network is comprised of 73 reactions (with
corresponding carbon transitions) utilizing 76 metabolites (5 substrates, 65 balanced
intracellular metabolites, and 6 products). The network model included reactions for
glycolysis, pentose phosphate pathway, Entner-Doudoroff pathway, TCA cycle, product
formation, amphibolic reactions, one-carbon metabolism, and amino acid biosynthesis
reactions (see Chapter 6 for details). For this network we simulated the mass isotopomer
distributions of 26 amino acid fragments that can be measured experimentally by GC/MS.
Table 2-8 provides an overview of the simulated amino acid fragments. To simulate the
labeling distribution of the 26 amino acid fragments, the network model was decomposed
into 14 independent EMU reaction networks of EMU size 1 to 9. Table 2-9 summarizes the
details of the EMU decomposition. The largest EMU subnetwork was the EMU size-1
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Table 2-7
Comparison of modeling approaches for simulating mass isotopomer labeling. MID of
glutamate in the TCA cycle model (Figure 2-12) was simulated using the EMU, isotopomer,
and cumomer methods. The assumed fluxes are shown in Figure 2-12. The assumed labeling
of AcCoA was 25% [2- 13C]AcCoA and 25% [1,2- 13C]AcCoA. The simulated abundances
were identical for all methods. The reduced EMU model required only 9 EMU variables to
simulate the labeling of glutamate, as opposed to 176 variables for the isotopomer and
cumomer models (a reduction of 95%).
isotopomer cumomer EMU EMU
model model full reduced
model model
Simulated mass istopomer M+0 0.3464 0.3464 0.3464 0.3464
distribution (MID) of M+1 0.2695 0.2695 0.2695 0.2695
glutamate (molfractions) M+2 0.2708 0.2708 0.2708 0.2708
M+3 0.0807 0.0807 0.0807 0.0807
M+4 0.0286 0.0286 0.0286 0.0286
M+5 0.0039 0.0039 0.0039 0.0039
Type of model equations nonlinear linear linear linear
Number of variables in each subproblem 176 6, 28, 53, 52, 8, 5, 8, 3 3, 2, 3, 1
28, 8, 1
Total number of variables 176 176 24 9
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Table 2-8
Ion fragments of TBDMS derivatized amino acids simulated using the EMU framework.
The identity of amino acid ion fragments was verified previously (Chapter 4).
Amino Monitored intensities Amino acid carbon atoms Fragmentation
acid
Ala 232 - 239 2-3 M - C 5H 90
260 - 268 1-2-3 M - C4H9
Gly 218 - 224 2 M - C5H90
246 - 253 1-2 M - C4H9
Val 260 - 269 2-3-4-5 M - C5HO90
288 - 298 1-2-3-4-5 M - C4H 9
Leu 274 - 283 2-3-4-5-6 M - CsH 90
Ile 274 - 283 2-3-4-5-6 M - C5H90
Ser 288 - 296 2-3 M - CH11502Si
362 - 370 2-3 M - C5H90
390 - 399 1-2-3 M - C4H 9
Thr 376 - 382 2-3-4 M - C-sHO
404 - 414 1-2-3-4 M - C4H9
Met 292 - 298 2-3-4-5 M - C5H90
320 - 327 1-2-3-4-5 M - C4H9
Phe 302 - 307 1-2 M - C-H-
308 - 316 2-3-4-5-6-7-8-9 M - C5H 9O
336 - 345 1-2-3-4-5-6-7-8-9 M - C4H9
Asp 302 - 309 1-2 M -- CsH 1-OaSi
376 - 382 1-2 M - C6HIIO
390 - 397 2-3-4 M - C5H 90
418 - 428 1-2-3-4 M - C4H 9
Glu 330 - 336 2-3-4-5 M -. C-Hi j50Si
404 - 411 2-3-4-5 M - C5H90
432 - 443 1-2-3-4-5 M - C4H9
Tyr 302 - 307 1-2 M - CI3H-2 OSi
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subnetwork that contained 141 unknown EMUs (i.e. one carbon EMUs). The total number
of unknown EMUs was 307, which could be further reduced to 223 unknown EMUs by
eliminating EMU nodes with a single influx. In comparison, there were 4,612
isotopomers/cumomers required to simulate the same amino acid fragments, i.e. a reduction
of 93-95%. It is interesting to note that there were 241 carbon atoms in this network model,
but only 141 EMUs of size 1 were required. Thus, clearly not all individual carbon atoms
needed to be simulated in this network. In contrast, the cumomer method required balancing
of all 241 weight-1 cumomers. The simulated mass isotopomer distributions from the three
methods (i.e. EMU, isotopomer, cumomer) were identical.
Table 2-9
Comparison of modeling approaches to simulate the labeling of 26 amino acid fragments in
the E. coli network model. With the EMU method, the E. coli network model was
decomposed 14 EMU networks with 307 unknown EMUs (223 EMUs after further model
reduction), compared to 4,612 isotopomers/cumomers, i.e. a reduction of 93-95%.
isotopomer cumomer EMU EMU
model model full model reduced model
Type of model nonlinear linear linear linear
Number of 4,612 54, 241, 527, 771, (EMU size 1): 141 (EMU size 1): 101
variables 876, 832, 655, 404, (EMU size 2): 87 (EMU size 2): 62
in each 183, 57, 11, and 1 (EMU size 3): 46 (EMU size 3): 32
subproblem (EMU size 4): 12, 8, 1, 1 (EMU size 4): 9, 7, 1, 1
(EMU size 5): 5, 1, 1, 1, 1 (EMU size 5): 4, 1, 1, 1, 1
(EMU size 6): none (EMU size 6): none
(EMU size 7): none (EMU size 7): none
(EMU size 8): 1 (EMU size 8): 1
(EMU size 9): 1 (EMU size 9): 1
Total number
of variables 4,612 4,612 307 223
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2.3.5 Gluconeogenesis pathway
In this final example we consider the pathway of gluconeogenesis shown in Figure 2-16. We
constructed a detailed biochemical network model for this pathway, where we considered all
carbon, hydrogen, and oxygen atom transitions. This pathway is suitable for probing with
multiple isotopic tracers, i.e. 13C, 2H, and 180. In this example, we simulated the mass
isotopomer distribution of glucose. Glucose is the main product of gluconeogenesis and is
easily analyzed by GC/MS. The gluconeogenesis network model was comprised of 24
reactions utilizing 21 metabolites, with 5 substrates (oxaloacetate, glycerol, glycogen, NADH,
and water), 14 balanced intracellular metabolites, and 2 product (glucose, and C02) (see
Chapter 7 for details). Table 2-10 shows the number of carbon, hydrogen, and oxygen atoms
for each of the 21 metabolites in this system. Here, we only considered stable, i.e. carbon-
bound, hydrogen atoms for each metabolite (see section 2.1.2). Simulation of this system
using isotopomer and cumomer methods is impossible, because that would require
2,637,120 variables. With the EMU approach, however, the network was decomposed into
60 independent EMU reaction networks of EMU size 1 to 19, with only 493 unknown
EMUs, which was further reduced to 354 unknown EMUs by eliminating EMU nodes with
a single influx. Table 2-11 shows the details of the EMU decomposition. The largest EMU
network contained only 12 unknown EMUs (9 for the reduced EMU model). The simulation
of the mass isotopomer distribution of glucose for given fluxes and labeling input took less
than 0.1 sec. Thus, in this example we have reduced the computational problem of
simulating the gluconeogenesis pathway from an impossible problem to solve, to a problem
that is trivial to solve. In Table 2-12 we compare the EMU method vs. the
isotopomer/cumomer methods, where we consider alternative labeling strategies. In all cases
the EMU method was superior compared to the isotopomer/cumomer method.
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Glucose
t
G6P-+ G1P+- Glycogen
EC2 + E4P 4-- F6P -+ M6P
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Figure 2-16: Reactions of the gluconeogenesis pathway used to simulate the labeling of
glucose.
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Table 2-10
Metabolites in the gluconeogenesis pathway. For each metabolite we only considered the
stable (i.e. carbon-bound) hydrogen atoms.
Metabolite name Carbon Hydrogen Oxygen Total
atoms atoms atoms atoms
Balanced metabolites
Glucose 6-phosphate (G6P) 6 7 6 19
Fructose 6-phosphate (F6P) 6 7 6 19
Fructose 1,6,-bisphosphate (FBP) 6 7 6 19
Dihydroxyacetone phosphate (DHAP) 3 4 3 10
Glyceraldehyde 3-phosphate (GAP) 3 4 3 10
1,3-Bisphosphoglycerate (BPG) 3 3 4 10
3-Phosphoglycerate (3PG) 3 3 4 10
2-Phosphoglycerate (2PG) 3 3 4 10
Phosphoenolpyruvate (PEP) 3 2 3 8
Glucose 1-phosphate (G1P) 6 7 6 19
Mannose 6-phosphate (M6P) 6 7 6 19
Glycerol 3-phosphate (Glyc3P) 3 5 3 11
Erythrose 4-phosphate (E4P) 4 5 4 13
Transketolase+C2-unit (E-C2) 2 2 2 6
Products
Glucose 6 7 6 19
Carbon dioxide 1 0 2 3
Substrates
Oxaloacetate 4 2 5 11
Glycerol 3 5 3 11
Glycogen 6 7 6 19
NADH 0 1 0 1
Water 0 2 1 3
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Table 2-11
Complete list of EMUs generated for glucose from EMU network decomposition of the
gluconeogenesis pathway. The EMU method was used to simulate the mass isotopomer
distribution of glucose, including all carbon, hydrogen, and oxygen atoms. This required only
493 EMUs (354 EMUs after further model reduction). In comparison 2,637,120
isotopomers/cumomers would have been required with the cumomer modeling approach.
In this example, we only considered stable (i.e. carbon-bound) hydrogen atoms for each
metabolite.
EMU EMU
full model reduced model
(EMU size 1): 11, 8 (EMU size 1): 8, 5
(EMU size 2): 12, 11, 9 (EMU size 2): 9, 8, 6
(EMU size 3): 11, 11, 11, 10, 9 (EMU size 3): 8, 8, 8, 7, 6
(EMU size 4): 12, 11, 11, 11, 9, 9, 9, 6, 1 (EMU size 4): 9, 8, 8, 8, 6, 6, 6, 4, 1
(EMU size 5): 12, 12, 11, 10, 9, 9, 9, 9, 5, 6, 1, 1, 1 (EMU size 5): 9, 9, 8, 7, 6, 6, 6, 6, 4, 4, 1, 1, 1
(EMU size 6): 12, 10, 10, 10, 10, 9, 9, 9, 5, 1, 1 (EMU size 6): 9, 8, 7, 7, 7, 6, 6, 6, 4, 1, 1
(EMU size 7): 11, 10, 10, 10, 9, 8 (EMU size 7): 9, 7, 7, 7, 6, 6
(EMU size 8): 10, 9, 8 (EMU size 8): 7, 7, 6
(EMU size 9): 9, 5 (EMU size 9): 7, 3
(EMU size 10): 5 (EMU size 10): 3
(EMU size 11): none (EMU size 11): none
(EMU size 12): none (EMU size 12): none
(EMU size 13): 6 (EMU size 13): 4
(EMU size 14): none (EMU size 14): none
(EMU size 15): none (EMU size 15): none
(EMU size 16): none (EMU size 16): none
(EMU size 17): 5 (EMU size 17): 4
(EMU size 18): 5, 4 (EMU size 18): 4, 4
(EMU size 19): 6 (EMU size 19): 4
Total number of EMUs = 493 Total number of EMUs = 354
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Table 2-12
Comparison of modeling approaches for simulating glucose labeling in the gluconeogenesis
pathway. A range of stable isotopes can be used to trace this pathway. Here, we considered
13C-carbon tracers, 2H-hydrogen tracers, and/or 180-oxygen tracers. The total number of
variables required to simulate the labeling of glucose was determined for the EMU method
and the isotopomer/cumomer methods.
Total number of variables
Tracer
used
13C
2H
180
13C + 2H
13C + 180
180 + 2H
13C + 180 + 2H
isotopomer/cumomer
model
396
768
420
42,224
21,392
42,416
2,637,120
EMU
full model
51
121
88
206
142
379
493
EMU
reduced model
35
84
61
145
100
268
354
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Chapter 3
Determination of fluxes and confidence
intervals from stable isotope measurements
3.1 Introduction
Fluxes of metabolic pathways are fundamental determinants of cell physiology and
informative parameters in evaluating cellular mechanisms and causes of disease
(Brunengraber et al., 1997; Hellerstein, 2003; Stephanopoulos, 1999). The tools for
estimating metabolic fluxes are fundamentally different from the tools for obtaining static
measurements, such as concentration profiles or transcript levels. Currently, the most
powerful method for metabolic flux determination in complex biological systems is based on
the use of stable isotopes (Wiechert et al., 2001). Metabolic conversion of isotopically labeled
substrates generates molecules with distinct labeling patterns (i.e. isotopomers) that can be
detected by mass spectrometry (MS) and nuclear magnetic resonance (NMR) (-Klapa et al.,
2003; Szyperski, 1995). The isotopic abundances of metabolites in a metabolic system are
strongly dependent on relative flux values. Different flux patterns result in significant tracer
redistribution and yield different labeling profiles.
Comprehensive mathematical models that describe the relationship between metabolite
labeling patterns and fluxes allow one to simulate isotopic abundances of all metabolites in a
network for any set of steady state fluxes. These models are nonlinear because the full set of
isotopomer equations contains product terms of fluxes with isotope abundances, and
product terms of abundances with abundances due to linear and condensation reactions in
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the system (Schmidt et al., 1997). The goal of Metabolic Flux Analysis (MFA) is to find the
set of fluxes that minimizes the difference between observed and simulated isotope
measurements. In essence, flux determination is a large-scale nonlinear parameter estimation
problem. Various iterative search strategies, for example, gradient-based Newton methods,
or evolutionary search algorithms may be employed to find the optimal metabolic fluxes
(Schmidt et al., 1999; Wiechert et al., 1997). Metabolic flux analysis of this type has been
successfully applied to determine fluxes in various prokaryotic and eukaryotic systems
(Christensen and Nielsen, 2000; Kelleher, 2004; Malloy et al., 1988; Park et al., 1999; Sauer et
al., 1997). However, rigorous statistical analysis of estimated flux has received much less
attention. Linearized statistics have been used to describe the uncertainty of fluxes (Arauzo-
Bravo and Shimizu, 2003; Dauner et al., 2001; Wiechert et al., 1997). Most often, however,
flux estimates are not accompanied by a corresponding range of accuracy/precision, which
makes such results difficult to interpret. For example, when the measured isotope abundance
is not very different from the simulated abundance, does this mean that the measurement is
reliable or does it simply results from a lack of redundancy in the measurement set? A
common mistake in assessing the benefit of flux estimation in over-determined systems is to
believe that a large redundancy in the measurement set necessarily results in reliable
estimates for all fluxes. To address these questions proper nonlinear statistical techniques are
needed, otherwise metabolic flux analysis will remain a black box whose inner workings are
hard to decipher.
Here, we describe here techniques that can be applied a posteriori to gain insight into the
statistical significance of flux estimation results. The same tools may then also be applied a
priori for optimal design of tracer experiments. We show how accurate flux confidence
intervals are efficiently calculated, and we quantify the relative importance of measurements.
We show that approximated confidence intervals obtained from local estimates of standard
deviations do not accurately describe the true uncertainty of fluxes. We have applied these
tools to analyze the statistical significance of gluconeogenesis fluxes determined from human
studies probed with [U- 13 C]glucose as tracer. We calculated accurate confidence intervals for
all fluxes in this system and identified potential flaws in experimental setup that may prevent
accurate determination of the gluconeogenesis flux in vivo. The methods presented here are
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general in scope and may also be applied to other parameter estimation problems.
Furthermore, these algorithms are easily implemented into already developed software
platforms for flux estimation.
3.2 Methods
3.2.1 Flux estimation
The methods described here are appropriate for metabolic systems investigated with isotopic
tracers at metabolic steady state. Thus, fluxes are required to satisfy the following
stoichiometric constraints:
S-v = 0 (3.1)
Here, S is the stoichiometry matrix and v is the flux vector. For a reaction network with m
intermediary metabolites and k fluxes, the stoichiometry matrix is an m x k matrix.
Reversible reactions are normally modeled as separate forward and backward fluxes, such
that all fluxes are additionally required to be non-negative. From a computational standpoint,
it is more convenient to work with independent flux variables, also called free fluxes
(Schmidt et al., 1997; Wiechert et al., 1997), rather than with all individual fluxes. The
number of independent fluxes is usually much smaller than the number of individual fluxes,
which significantly reduces the computational time of simulations. Independent fluxes are
obtained from the general solution to Eq. 3.1:
v = N-u (3.2)
Here, N is the null space matrix of S, and u is the vector of independent fluxes. There are
many methods to calculate a valid null space matrix (Foster, 1986), and in general there is
not a unique null space matrix for any given stoichiometry matrix. The size of the null space
matrix and the number of independent flux variables, however, are fully determined by the
rank of the stoichiometry matrix. With r = rank(S) • m, the null space matrix is a k x k-r
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matrix and the number of independent fluxes equals k-r. Note that Eq. 3.2 may be used to
translate results expressed in terms of independent fluxes into individual fluxes.
At least k-r measurements are needed to determine the k-r independent flux variables.
External flux measurements often do not provide enough constraints to estimate all fluxes in
complex biological systems containing reversible reactions, parallel pathways and internal
cycles (Schmidt et al., 1998). In these cases, isotopic tracer experiments can provide
additional constraints from the measurement of isotope incorporation into metabolite pools
by techniques such as GC/MS and NMR. The fate of isotopic tracers in a metabolic system
is determined by the atoms transitions occurring in biochemical reactions. These transitions
are well established for the majority of metabolic pathways and have been documented in
biochemical textbooks. Assuming metabolic and isotopic steady state, the mathematical
model that is used for isotopic simulations comprises the complete set of isotopomer
balances, which may be derived using a matrix based method as described by Schmidt et al.
(1997). More recently, alternative modeling strategies were proposed by other authors based
on the concept of cumomer balances and bondomer balances (van Winden et al., 2002;
Wiechert et al., 1999). In Chapter 2 we described a novel strategy for modeling isotopic
distributions based on the concept of elementary metabolite units (EMU). All modeling
strategies are equivalent in the sense that they produce the same numerical results, i.e.
isotopomer abundances, for a given set of fluxes and substrate labeling. The sensitivity
matrix of simulated measurements with respect to flux values, i.e. (dx/du), may be obtained
either by approximation using finite differences, or from algebraic such as the ones derived
in Chapter 2 (section 2.2.5). Metabolic fluxes are estimated from labeling data by minimizing
the difference between the observed and simulated measurements. Flux estimation is in
essence a large-scale constrained least-squares minimization problem:
min D (x(u) -_x ' bs )T .- _ (X(U)- Xobs)U N(3.3)
s.t. N-u>20
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The objective function (1 is the covariance-weighted sum of squared residuals, x(u) is the
vector of simulated measurements , xobs is the vector of experimental data containing both
labeling measurements and extracellular rate measurements, and x, is the measurement
covariance matrix with measurement variances located on the diagonal. Eq. 3.3 requires an
iterative solution scheme, where at each iteration Eq. 3.3 is transformed into a
corresponding quadratic programming (QP) subproblem (Gill et al., 1991). First, the
simulated measurements are formally expressed as a function of free fluxes using Taylor
series expansion:
x = x + - ).Au + O(Au 2) (3.4)
Here, x* is the vector of simulated measurements for the current set of fluxes, (dx/du) is the
matrix of sensitivities of the simulated measurements with respect to fluxes, and Au is the
vector of flux changes. Substituting Eq. 3.4 into Eq. 3.3 and neglecting second and higher
order terms, we obtain the following expression for the objective function as a function of
flux changes:
T T
a( X (du (du)
s.t. N-u2O
(3.5)
Note that the first term in Eq. 3.5 is the value of the objective function for the current
fluxes. We define the change in the objective function as:
Aq =- - (x* - obs) .- 1 (* - xObs) (3.6)
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With this, we obtain the following QP subproblem at each iteration:
minAO - 2 -Au T .J + AuT H. AuAu (3.7)
s.t. N -u 0
with J dx-•-2- .(x -x bs) (3.8a)J du
_(dx •T-du . (dxu
and H -) (3.8b)
The Hessian matrix H and the Jacobian J are evaluated at each iteration for the current
fluxes. Differentiation of the objective function in Eq. 3.7 with respect to flux changes
yields:
d(A) = 2 J + 2-H-Au (3.9)
d(Au)
The minimum of Eq. 3.7 occurs when d(AcD)/d(Au) = 0 (Gill et al., 1991), which is the
solution to the system of linear equations given in Eq. 3.9. Thus, the optimal search direction
for the independent fluxes at each iteration is:
Au = -H-' J (3.10)
A numerically stable form for the inverse of H may be obtained from singular value
decomposition of H (see Appendix 3.A). The following updated flux vector is obtained at
each iteration:
Uk+l = uk + Au (3.11)
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Inequality constraints on fluxes, i.e. N-u _ 0, can be included without difficulty to this
general scheme, and all kinds of step controlling strategies can be applied (Byrd et al., 1999;
Gill et al., 1991). Flux estimation is generally initiated with random values for all fluxes and
the estimation algorithm continues until a predefined convergence criterion is met. The final
vector of independent fluxes is then transformed using Eq. 3.2 to obtain the optimal values
for all metabolic fluxes in the system. The complete algorithm for covariance-weighted flux
estimation is outlined in Appendix 3.B.
3.2.2 Goodness-of-fit analysis
The fact that MFA yields a set of fluxes that minimize the difference between the observed
and simulated measurements does not mean that the flux model is adequate. At
convergence, the minimized variance-weighted sum of squared residuals, as defined in Eq.
3.3, is a stochastic variable with X2-distribution with the number of degrees of freedom equal
to the number of independent measurements (n) minus the number of estimated free fluxes
p = k-r. The expected value for the minimized sum of squared residuals equals the number
of degrees of freedom of the X2-distribution. To test the goodness of fit, we test the null
hypothesis that the model is adequate:
P((O ( (i) (- X2 (n-p)) > cx (3.12)
Here, ii are the fluxes at the optimal solution. The null hypothesis is rejected when the
calculated P-value is smaller than a certain chosen threshold value a, for example 0.05. If
previous investigations have excluded the possibility of gross errors in the measurements,
then it must be concluded that the model is not adequate, and thus should be reevaluated.
Individual residuals should also be analyzed at convergence. If the flux model is correct, then
the standard deviation-weighted residuals are expected to be normally distributed with a
mean of zero and standard deviation of one, i.e. N(0,1). A normal probability plot is a useful
tool for assessing whether the residuals are indeed normally distributed. Alternatively, one
- 97 -
CHAPTER 3. DETERMINATION OF FLUXES AND CONFIDENCI; INTERVALS
can use the Kolmogorov-Smirnov and Lilliefors tests to evaluate the hypothesis that the
residuals are normally distributed (Conover, 1999). If the standard deviation of the weighted
residuals is significantly different from one, then that indicates that the residuals have been
improperly weighted, which may result in biased flux estimates.
3.2.3 Local linearized statistical properties
The first goal of MFA is to improve our knowledge of internal fluxes, however, assessing the
reliability of flux estimates is also important. Without this information it is difficult to
interpret flux results and expand the physiological significance of flux studies. At
convergence, a number of local statistical properties of fluxes are easily derived. First, we
calculate the inverse of the Hessian, which gives the local estimate for the covariance matrix
of the estimated independent fluxes (Hartmann and Hartwig, 1996):
2E = H' (3.13)
Combining Eqs. 3.2 and 3.13 we obtain the following covariance matrix for all individual
fluxes in the system:
NE =  - -N ' = N H -N' r  (3.14)
We can then calculate local estimates for standard deviations of metabolic fluxes, i.e. the
square roots of the diagonal elements of ,E. The local approximation for the 95%
confidence interval of flux i is thus given by:
Approx. 95% confidence intervala)= flux() +± 2- (3.15)
Similarly, we may also calculate covariance matrices and confidence intervals for other
system variables. For example, the covariance matrix for the simulated measurements is
given by:
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Y - d E d (3.16)
3.2.4 Calculating accurate flux confidence intervals
Confidence intervals of fluxes obtained from estimated local standard deviations may not
accurately describe the true flux uncertainty due to inherent nonlinearities of isotopomer
balances. In addition, flux constraints, e.g. v 2 0, may be violated within the approximated
confidence interval resulting in overestimation of flux uncertainty. To address these issues
we propose an alternative strategy for determination of more accurate flux confidence
intervals. This technique is an extension to the flux estimation procedure described in
section 3.2.1. In the proposed method, confidence intervals are calculated for each flux
individually. The goal is to determine the sensitivity of the objective function, i.e. the
minimized sum of squared residuals, as a function of the flux value. Small sensitivities, i.e.
large changes in the flux value resulting in small changes in the minimized sum of squared
residuals, indicate that the flux cannot be estimated precisely. Large sensitivities, on the other
hand, indicate that the flux is well determined. The optimization problem associated with
minimizing the sum of squared residuals as a function of one particular flux has n-p-1
degrees of freedom, compared to n-p degrees of freedom for the original MFA problem.
The difference between the objective function evaluated at the optimal solution and the
objective function when one flux is fixed follows a X2-distribution with one degree of
freedom:
(((U)i=v - (I()) X2(1) (3.17)
It should be noted that Eq. 3.17 assumes that the residuals are correctly weighted. If
measurement errors are unknown, or the residuals are incorrectly weighted then Eq. 3.17
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may produce inaccurate results. In these cases, the following alternative F-statistic is
preferred:
0 (u) • - d (u)
p) F(1,n- p) (3.18)S(^) / (n-p)
In the above equations, (D(u) Ivi=-io indicates the value of the objective function for the model
where one flux i is fixed at vio, and the other degrees of freedom have been used to minimize
the objective function. The 1-a confidence interval for flux i is given by all flux values for
which the following statement is true:
(u)Iv , '_(^u) + X2(1)) (3.19)
The threshold values for X7•,(1) corresponding to 80%, 90% , 95% and 99% confidence
intervals are 1.64, 2.71, 3.84, and 6.63, respectively. Thus, in order to obtain accurate
confidence intervals of fluxes we need to determine the minimized sum of squared residuals
as a function of the flux value. Here, we describe an efficient algorithm for this purpose.
Starting at the optimal solution, the value of one flux whose sensitivity we seek to determine
is increased step-by-step, while the other fluxes are determined by minimizing the objective
function. We obtain the following QP subproblem at each iteration:
min A) - 2. AuT .J + Au -H -Au
Au
s.t. Ni Au = h (3.20)
N-u>0
Eq. 3.20 is similar to Eq. 3.7, with the additional constraint that flux vi is required to increase
with a step size 'h'. In the above equation N, denotes the ith row of matrix N. The above
constrained optimization problem is transformed to a problem without equality constraints
using the Lagrange formulation (Byrd et al., 1999; Gill et al., 1991):
- 100 -
CHAPTER 3. DETERMINATION OF FLUXES AND CONFIDENCE INTERVALS
minL = 2 -AuT .J + AuT H Au + (Ni -Au-h)-· .
s.t. N-u>O
(3.21)
Here, X is the Lagrange multiplier. The minimum of Eq. 3.21 occurs when the following
stationary conditions are satisfied:
-> 2.J + 2-H-Au + NiT .A = 0dL 0d(Au.)
Cd 0DdLAX
(3.22)
(3.23)-> Ni 'Au - h = 0
We define a square matrix A and vectors b and Ad as follows:
A = [2 HN i
INi
Ni]
0
b = -2 Jb=h]
Ad =
The stationary conditions from Eqs. 3.22 and 3.23 can be written as follows:
A-Ad = b
(3.24a)
(3.24b)
(3.24c)
(3.25)
Thus, the optimal adjustment of the variables in vector d, i.e. independent fluxes and the
Lagrange multiplier, that minimizes the objective function is given by:
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Ad = A' -b (3.26)
and we obtain the following updated variables vector at each iteration:
dk+1 = dk + Ad (3.27)
The flux value is increased this way until either the flux reaches infinity, or the objective
function has increased by 3.84 compared to the value at the optimal solution, which then
corresponds to the upper bound of the 95% flux confidence interval. The above procedure
is then repeated starting at the optimal solution, but now the flux value is gradually
decreased, i.e. the linear constraint in Eq. 3.20 is changed to:
-N i " Av = h (3.28)
Eqs. 3.21 to 3.24 are also changed accordingly. The selected flux is decreased until either the
flux reaches the lower bound, or the objective function has increased by 3.84 compared to
the value at the optimal solution, thus corresponding to the lower bound of the 95% flux
confidence interval. If the flux model was linear, then the profile of the minimized sum of
squared residuals versus the flux value would be a parabola. However, because of the
inherent nonlinearities of isotopomer models observed profiles will often deviate from the
parabola-shape. In section 3.3.1 we show that confidence intervals of metabolic fluxes
obtained with the above described method accurately reflect the true uncertainty of flux
estimates. Note that additional fluxes constraints, i.e. N-u > 0, and step controlling strategies
are again easily applied to this general scheme (see Appendix 3.C). The complete algorithm
for accurate determination of confidence intervals of fluxes is outlined in Appendix 3.D.
3.2.5 Relative importance of measurements
Next, we address the question how the precision of estimated fluxes is influenced by
measurement uncertainty. In particular, we wish to identify measurements that contribute
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significantly to the variance of estimated fluxes. This will allow us to quantify the relative
importance of measurements and identify key measurements, i.e. measurements for which an
enhancement of precision would result in significant improvement in the quality of flux
estimates (Heyen et al., 1996). These measurements should be carried out with special
attention and it may prove wise to measure them more precisely. First, we rewrite Eq. 3.14
as follows:
v, = N H-1 . N  = N -H -H -' 1.N (3.29)
Substitution of the definition for the Hessian matrix from Eq. 3.8 into Eq. 3.29 yields an
expression that directly links measurement variances, i.e. on the diagonal of matrix Ex, with
flux variances, i.e. on the diagonal of matrix Ev:
E = N-H-1'- .- E-1 -- I H-' NT (3.30)
(du) x du
We can use Eq. 3.30 to construct the contribution matrix. Elements in this matrix reflect the
fractional contribution of the variance of measurement j to the local variance of flux i:
N -H-' -1 )
Contribution 0, ( = ,i) (3.31)
v(i,i) x,Ji)
The sum of each row in the contribution matrix equals one. Matrix elements with large
values indicate important measurements. From the contribution matrix we can easily
determine the number of redundant measurements for each individual flux. In general, it is
desirable that more than one measurement significantly contributes to the flux estimation.
Fluxes that depend only on one measurement are very sensitive to errors in that one
measurement. We can use this as a criterion to determine the quality of tracer experiment
design. For example, a tracer experiment is considered poorly designed if a significant
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number of estimated fluxes have little or no redundant measurements. Note that this
situation may occur even if the total number of measurements is much greater than the
number of unknown fluxes. On the other hand, we may also encounter experiments that are
specifically designed to determine only a subset of fluxes which are of interest. In that case,
the overall flux estimation problem can be underdetermined, as long as the fluxes of interest
are over-determined. Thus, in general there is not a single optimal tracer experiment.
Instead, depending on the fluxes that need to be determined, different experimental designs
may be optimal. Note that our method for evaluating experiment design places emphasis
redundant measurements, which sets it apart from the methods used by other investigators
which are based on the D-criterion (Mollney et al., 1999).
In addition to the contribution matrix, we also derived the following expressions for local
sensitivities of estimated fluxes with respect to changes in measurement values and assumed
measurement errors:
dv N H' . - (3.32)
dx (du)
dv dx2 N -H-' - - E - ding x(^r)-Xobs) (3.33)
dax (du)
These two expressions indicate how much flux estimates are affected by a change in a
particular measurement. It is clear that different measured values will result in different
estimated fluxes. However, the significance of assumed measurement errors on flux
estimates is often overlooked. The assumed measurement errors determine the relative
weighting of residuals in the objective function, and have a significant impact on flux
estimation results. This is particularly true for measurements with very small assumed errors,
which may introduce a bias towards these measurements. Therefore, as part of a posteriori
analysis it is important to analyze the sensitivity of fluxes with respect to changes in
measurement values and measurement errors. In particular, high sensitivities with respect to
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changes in measurement errors indicate disagreement between the measurement and the
network model that should be further investigated. This inconsistency may be caused by
measurement gross errors, inappropriate weighting of residuals, or errors in the metabolic
network model.
3.3 Results
To illustrate the developed methods two examples are provided. The first example is a
simple metabolic system with only six fluxes, where we compare flux confidence intervals
calculated by the described method to 'true' confidence intervals obtained using an
exhaustive grid search and by Monte Carlo simulations. The second system is taken from
human physiology literature, i.e. mammalian glucose metabolism evaluated by constant
infusion of [U- 13C]glucose.
3.3.1 Simple example network
Consider the simple network shown in Figure 3-1. This system will serve as the test case for
our method of calculating accurate confidence intervals. We will simulate data from this
system and then use the simulated data to estimate fluxes and calculate flux confidence
intervals as we described in sections 3.2.1 and 3.2.4. In this network, metabolite A is the sole
substrate and metabolites E and F are two final products. The intermediary metabolites B, C
and D are assumed to be at metabolic and isotopic steady state. Atom transitions for the five
reactions are given in Table 3-1. The assumed flux distribution is shown in Figure 3-1. All
fluxes are expressed as percentages of the substrate uptake rate, which is fixed at 100. In this
example, 100% [2- 13C]A is chosen as the isotopic tracer and the mass isotopomer
distribution (MID) of product F is measured. At isotopic steady state the following MID for
metabolite F is obtained, 0.01 mol% (M+O), 80.08 mol% (M+1), 19.83 mol% (M+2), and
0.09 mol% (M+3).
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Figure 3-1: Simple metabolic network used here to illustrate the computation of confidence
intervals of metabolic fluxes. The assumed steady-state fluxes have arbitrary units. The
network substrate A is fully labeled on the second atom. Atom transitions for the reactions
in this network are shown in Table 3-1.
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Table 3-1
Stoichiometry and atom transformations for reactions in the example metabolic network in
Figure 3-1.
Reaction Reaction stoichiometry Atom transformations*
number
1 A -+ B abc -+ abc
2 B ++ D abc ++ abc
3 B-+C+E abc -- bc + a
4 B + C -+>D + E + E abc +AB - bcA + a + B
5 D - F abc -+ abc
* For each compound atoms are identified using lower case letters to represent successive atoms of
each compound. Uppercase letters represent a second compound in the reaction.
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3.3.2 Grid search
With the substrate uptake rate fixed at 100 this metabolic system has two remaining degrees
of freedom. Here, we choose fluxes v2 and v4 as the independent fluxes. For this simple
problem it is computationally feasible to apply a grid search strategy to determine the
sensitivity of the objective function as a function of flux values, from which the uncertainty
of fluxes can then be calculated as described in section 3.2.4. Here, we evaluated all
combinations of fluxes v2 ranging from 0 to 500 (with step size 0.5) and v4 ranging from 0 to
100 (with step size 0.1), i.e. one million flux combinations were evaluated. For each flux
combination we calculated the sum of squared residuals assuming a measurement error of
0.3 mol% for all mass isotopomer fractions. Figure 3-2 provides a one-dimensional
representation of this 2D-grid search. The dots in Figure 3-2A correspond to the minimal
sum of squared residuals for fixed value of v2, but variable value of v4. In Figure 3-2B flux v4
was fixed and v2 varied. Note that for this simple example with two degrees of freedom, the
grid search method for calculating flux confidence intervals is closely related to our
proposed method described in section 3.2.4.
3.3.3 Monte Carlo simulations
Confidence intervals were also determined using Monte Carlo simulations. For this purpose,
we generated 10,000 simulated data sets corrupted with noise with a standard deviation of
0.3 mol%. Metabolic fluxes were estimated from this data and we obtained 10,000 estimates
of fluxes v2 and v4. It is expected that the estimated fluxes will differ somewhat from the true
flux values (i.e. v2,tm,A=110 and v4,true=20) due to measurement errors. Furthermore that the
spread in the estimated fluxes corresponds to the flux uncertainty. Figure 3-3 shows the
histogram of estimated fluxes v2 and v4. To determine flux confidence intervals, flux
estimates were first sorted in ascending order. The 80% confidence interval was then
obtained by discarding the top 10% and bottom 10% of flux estimates; the 90% confidence
interval was obtained by discarding the top 5% and bottom 5% of flux estimates, etc. The
calculated confidence intervals for v2 and v4 are summarized in Table 3-2.
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Figure 3-2: Determination of confidence intervals of metabolic fluxes. The minimized sum
of squared residuals is plotted against the flux value for fluxes v2 and v4. Circles represent the
smallest sum of squared residuals observed for a given flux value from the exhaustive grid
search. The solid line represents the profile determined with our method, and the dashed
line represents the profile obtained assuming linearized statistics. The dashed horizontal lines
represent the threshold values for the 80%, 90% and 95% confidence intervals, respectively
(see section 3.2.4 for details).
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Figure 3-3: Histogram of estimated fluxes v2 and v4 from 10,000 Monte Carlo simulations.
For each simulation isotopomer data was corrupted with random noise with a standard
deviation of 0.3 mol% abundance, and fluxes were estimated by least-square optimization.
Estimated fluxes were then collected into bins with a width of 2 for v2, and 1 for v4 (shown
here). The estimated fluxes are different from the true flux values due to the introduced
measurement errors, i.e. v2,true=110 and v4,true=20.
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3.3.4 Linearized statistics
Approximated confidence intervals were obtained from estimated standard deviations of
fluxes after linearization, as described in sections 3.2.1 and 3.2.3. The following optimal
solutions for fluxes v2 and v4 were obtained: v2 = 110+86.4; and v4 = 20±5.5 (best fit ± SD).
3.3.5 Comparison of methods for calculating flux confidence intervals
Next, confidence intervals of fluxes were determined with our method using the algorithm
described in section 3.2.4. The calculated 80%, 90% and 95% confidence intervals for fluxes
v2 and v4 obtained with all four methods are summarized in Table 3-2. The values obtained
using the grid search method, the Monte Carlo simulations and our method agreed well.
However, values obtained from linearized statistics differed significantly. In Figure 3-2 we
visualize the confidence intervals obtained with the grid search method, linear approximation
and our method. It is clearly seen that the confidence intervals in this system are non-
symmetric and highly nonlinear. As such, confidence intervals approximated from local
estimates of standard deviations agreed well only in a small area surrounding the optimal
solution. The lower and upper bounds for flux v2 were significantly underestimated, and for
flux v4 the size of the 95% confidence interval was overestimated by almost a factor of 2.
Note that most metabolic systems of interest will have more than two degrees of random,
which limits the use of grid search and Monte Carlo simulations due to computational
limitations. Even for this simple example network, the grid search method and Monte Carlo
simulations required hours of calculations. In contrast, our method took less than one
second. It should be noted that the above observations are specific to our particular network
structure, substrate labeling, measurements and assumed measurement errors. However, it is
clearly illustrated that for reasonable values of measurement errors, highly nonlinear
confidence intervals can be expected. In summary, we have shown that approximated flux
confidence intervals do not accurately describe true uncertainty of estimated fluxes.
Therefore, more accurate flux confidence intervals must be determined using nonlinear
tools. We have developed an efficient technique for calculating these intervals without the
need to perform computationally demanding grid searches, or Monte Carlo simulations.
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Table 3-2
Comparison of methods for the calculation of confidence intervals of fluxes. Confidence
intervals were calculated for fluxes v2 and v4 in the example network model shown in Figure
3-1.
Confidence intervals for flux v2 Confidence intervals for flux v4
Method 80% 90% 95% 80% 90% 95%
Grid search 67.0 - 253 66.5 - 323 66.5 - 405 16.5 - 25.6 16.4 - 27.1 16.4 - 28.3
Monte Carlo 66.7 - 251 66.5 - 317 66.4 - 407 16.5 - 25.6 16.4 - 27.0 16.4 - 28.4
Our method 66.5 - 252 66.4 - 322 66.3 - 403 16.4 - 25.6 16.3 - 27.1 16.3 - 28.3
Linearization* (-0.6) - 220 (-31.8) - 252 (-62.8) - 283 12.9 - 27.1 11.0 - 29.0 9.0 - 31.0
* Confidence intervals were approximated from local estimates of standard deviations for the fluxes
after linearization.
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3.3.6 Mammalian gluconeogenesis
As the second metabolic system we chose mammalian gluconeogenesis at metabolic and
isotopic steady state evaluated by constant infusion of [U- 13C]glucose. Figure 3-4 shows the
metabolic model for mammalian glucose metabolism, which is described in more detail in
Appendix 3.E. Investigation of glucose metabolism is of major physiological and clinical
significance in the study of obesity, diabetes and other disease (Groop et al., 1989; Landau et
al., 1996). Of particular interest are the rates of glucose production and utilization, and the
pathways by which glucose is formed during fasting. Tayek and Katz were the first to
propose a method for estimating several parameters of glucose metabolism in human from
the mass isotopomer distributions of plasma glucose and lactate upon constant infusion of
[U- 13C]glucose as the single isotopic tracer (Tayek and Katz, 1996). However, since the
introduction of this method several authors raised questions regarding the reliability of flux
estimates from this system (Kelleher, 1999; Landau et al., 1998; Radziuk and Lee, 1999).
Here, we address these questions using the developed tools.
We selected two studies from recent literature where the [U-13C]glucose method was applied
to study glucose metabolism in vivo. Tayek et al. investigated glucose metabolism in healthy
and diabetic subjects (Tayek and Katz, 1996). Human subjects were infused with [U-
13C]glucose for 3 hours at a rate of 0.59 pImol/kg/min. Mass isotopomer distributions (MID)
of plasma glucose and plasma lactate were measured at the end of the infusion period and
several parameters of glucose metabolism were estimated. The authors found a near linear
correlation between hepatic glucose production and plasma glucose levels suggesting a key
role of liver metabolism in diabetes. In a more recent publication, Sunehag investigated the
effects of supply of parental lipids and amino acids to very premature infants (Sunehag,
2003). After an 8 hr infusion with [U-13C]glucose at a rate of 17 l±mol/kg/min, MID of
plasma glucose and lactate were measured and the rate of gluconeogenesis was estimated.
This study revealed the primary role of lipids in supporting gluconeogenesis in very low
birthweight infants. The key difference between the two studies was the rate of tracer
infusion. In the study by Tayek [U- 13C]glucose was infused at a rate corresponding to 4% of
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Figure 3-4: Metabolic model of mammalian glucose metabolism evaluated by constant
infusion of [U-13C]glucose. Abbreviations of metabolites: G6P, glucose-6-phosphate; R5P,
ribose-5-phosphate; Pyr, pyruvate; OAC, oxaloacetate; SucCoA, succinyl coenzyme A; Fum,
fumarate; AcCoA, acetyl coenzyme A; FA, fatty acids; PEP, phosphoenolpyruvate; TP,
triose phosphates.
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Table 3-3
Stoichiometry and carbon transformations for the reactions in the network of mammalian
glucose metabolism. Abbreviations of metabolites are the same as in Figure 3-4.
Reaction Reaction Carbon transformations*
number
1 [U13C]Gluc -- Gluc abcdef -+ abcdef
2 Gluc -> G6P[M] abcdef-+ abcdef
3 G6P[M] - TP[M] + TP[M] abcdef - cba + def
4 G6P[M] -+ R5P[M] + C02 abcdef - bcdef + a
5 R5P[M] + R5P[M] - S7P[M] + TP[M] abcde + ABCDE -> abABCDE + cde
6 S7P[M] + TP[M] - G6P[M] + E4P[M] abcdefg + ABC -+ abcABC + defg
7 R5P[M] + E4P[M] -- G6P[M] + TP[MI abcde + ABCD -> abABCD + cde
8 TP[M] - Pyr[M] acb -+ abc
9 Pyr[M] - Lact abc -> abc
10 Lact[O] -+ Lact abc - abc
11 Lact -+ other abc -> abc
12 Lact - Pyr[L] abc -+ abc
13 Pyr[L] + C0 2[L] - OAC[L] abc + A -> abcA
14 OAC[L] + AcCoA[L] -+ SucCoA[L] + 2 CO 2  abcd + AB -+ ABbc + a + d
15 SucCoA[L] - Fum[L] abcd -+ (/2 abcd + 1/2 dcba)
16 Fum[L] <- OAC[L] (/2 abcd + /2 dcba) ++ abcd
17 FA[L] -+ AcCoA[L] ab -> ab
18 AcCoA[L] + AcCoA[L] - ketone[L] ab + AB - abAB
19 OAC[L] -4 PEP[L] + CO 2  abcd -> abc + d
20 PEP[L] -> Pyr[L] abc -> abc
21 PEP[L] -+ TP[L] abc -> abc
22 Glycerol[O] -+ TP[L] abc -+ abc
23 TP[L] + TP[L] -+ G6P[L] abc + ABC -- cbaABC
24 Glycogen[L] -+ G6P[L] abcdef - abcdef
25 G6P[L - Gluc abcdef-+ abcdef
26 Gluc -+ other abcdef-+ abcdef
* For each compound carbon atoms are identified using lower case letters to represent successive
carbon atoms of each compound. Uppercase letters represent a second compound in the reaction.
Because fumarate is a rotationally symmetric molecule no distinction can be made between carbon
atoms 1 and 4, and carbon atoms 2 and 3.
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glucose turnover, whereas in the study by Sunehag tracer infusion contributed very
significantly to the total rate of glucose appearance (- 58%).
The MIDs of plasma glucose and lactate from these two studies are shown in Table 3-4.
One representative data set was selected from each study. The data was corrected for natural
isotope enrichments of 13C and other stable isotopes. In keeping with pervious conventions,
we represent mass isotopomers of glucose as Mi and mass isotopomers of lactate as mi. We
fitted both data sets to the glucose metabolic model assuming measurement errors of 0.1
mol% abundance for all measured abundances. In both cases a good fit was obtained,
resulting in a minimized sum of squared residuals of 0.3 and 0.5 for the Tayek and Sunehag
data, respectively. We then calculated accurate confidence intervals for all fluxes in the
network. The results are summarized in Table 3-5.
One of the key fluxes in this model is the rate of gluconeogenesis, i.e. de novo glucose
synthesis from precursors such as lactate, amino acids and glycerol. The calculated
confidence intervals for this flux from the two studies were significantly different
(see Figure 3-5). For the study by Tayek et al., the observed flat profile of the confidence
interval indicates that gluconeogenesis flux cannot be determined precisely. There was a wide
range of equally likely solutions for the gluconeogenesis flux, ranging between 3.6 and 14.4
ýLmol/kg/min, for which the minimized sum of squared residuals was the same. Other fluxes
in this model display similar flat profiles. Thus, in this case we could not identify a unique
optimal solution for fluxes, but rather a range of optimal solutions as is indicated in
Table 3-5. In cases like this, it is informative to determine the search direction of fluxes at
the optimal solution, i.e. Ad from Eq. 3.26. This vector reveals metabolic pathways that
cannot be determined independently of one another. Considering the gluconeogenesis flux,
we found that it was not possible to distinguish between hepatic glycerol intake and
glycogenolysis. Indeed, several authors recently raised concerns regarding the [U-13C]glucose
method. Based on physiological insight Landau and colleagues concluded that the only
fluxes that can be determined from this system are hepatic glucose output (HGO) and the
fractional contribution of pyruvate to gluconeogeneis (Landau et al., 1998).
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Table 3-4
Measured and fitted mass isotopomer abundances. Mass isotopomer of plasma glucose (Mi)
and plasma lactate (mi) were measured after constant infusion of [U- 13C]glucose (molar
abundances, mol%/o). Mass isotopomer abundances were corrected for natural isotope
enrichments.
Tayek study* Sunehag study**
Mass isotopomer Measured Fitted Measured Fitted
Mo 95.20 95.20 28.90 28.91
Mt 0.29 0.31 4.40 4.39
M2 0.22 0.19 3.36 3.38
M3 0.33 0.33 3.65 3.66
M4  0.00 0.00 0.80 0.82
Ms 0.00 0.00 0.47 0.42
M6 3.96 3.96 58.42 58.43
mo 98.07 98.07 57.78 57.78
mi 0.38 0.36 5.48 5.50
m2 0.19 0.22 5.23 5.21
m3 1.36 1.36 31.51 31.51
* Data was taken from Tayek et al. (1996) for diabetic subject no. 5 (D5). Tracer infusion rate was
0.59 jmol/kg/min [U- 13C]glucose.
** Data was taken from Sunehag et al. (2003) for the infant receiving supplementation of glucose,
amino acids and parental lipids (g + AA + IL). Tracer infusion rate was 17 ýLmol/kg/min [U-
13C]glucose.
-117-
CHAPTER 3. DETERMINATION OF FLUXES AND CONFIDENCE INTERVALS
Table 3-5
Estimated glucose metabolic fluxes and their 95% confidence intervals. Fluxes
(p[mol/kg/min) were estimated from mass isotopomers of glucose and lactate using the
network model of mammalian glucose metabolism in Figure 3-4.
Tayek study (1996) Sunehag study (2003)
Tissue Flux Best fit* 95% Conf. Best fit* 95% Conf.
Plasma Tracer infusion rate 0.59 0.59 17.0 17.0
Influx of unlabeled lactate 0 - 32 0 - 49 5.6 - 36.1 5.1 - 36.4
Muscle Cori cycle** 1.8 - 15.0 1.1 - 15.6 4.5 - 29.2 4.2 - 29.3
Pentose pathway 0 0 - 8.5 3.6 - 23.2 3.1 - 23.8
Liver Hepatic glucose output (HGO) 14.3 13.7 - 15.0 12.2 12.1 - 12.3
Glycogenolysis (GL) 0 - 10.7 0- 11.5 5.3 4.3 - 5.6
Gluconeogenesis (GNG) 3.6 - 14.4 2.5 - 15.0 6.9 6.6 - 7.9
Glycerol uptake 0 - 21.5 0 - 23.1 0.3 0 - 3.1
Unlabeled anaplerotic sources 0 - 9.0 0 - 26.6 0.3 0 - 3.1
TCA Cycle 10 - 22 0.2 - 180 18.0 14.3 - 21.1
Pyruvate carboxylase (PC) 15.1 5.3 -23.9 13.5 12.6 - 14.4
Pyruvate kinase (PK) 6.0 - 12.1 0 - 22.2 0 0 - 0.8
Backward flux of fumarase 6 - 19 0 - 550 40.0 28.9 - 56.0
Ketogenesis 0 - Inf 0 - Inf 0 - Inf 0 - Inf
* 'Best fit' denotes flux value at the optimal solution, or the region of flux values with the same
minimized sum of squared residuals.
** Cori cycle refers to the total flux from plasma glucose to plasma lactate.
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Figure 3-5: Confidence intervals of gluconeogenesis flux for selected studies by Tayek and
Sunehag. The minimized sum of squared residuals minus the optimal solution value is
plotted against the gluconeogenesis flux. The solid line represents the profile determined
with our method, and the dashed line represents the profile obtained from the local estimate
of standard deviation. The dashed horizontal line represents the threshold values for the
95% confidence interval of gluconeogenesis flux.
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Our results support their conclusions for the Tayek study. Note that the only two fluxes that
were uniquely determined were HGO and the pyruvate carboxylase flux, which is the first
step in the pathway from pyruvate to glucose.
We also calculated local standard deviations for fluxes at the optimal solution to compare
approximated confidence intervals with the results obtained by our method. For most fluxes
the approximated values did not agree with the true confidence intervals. The only exception
was HGO flux for which the local standard deviation reasonably described the true
uncertainty (14.3 ± 0.4 p~mol/kg/min). We also determined the most important
measurements for the estimated gluconeogenesis flux. The two most important
measurements were glucose mass isotopomers M4, Ms. However, in this study neither of
these isotopomers were formed in significant abundance. We can therefore conclude that in
order to estimate the gluconeogenesis flux in this system one must either find a more precise
technique to measure glucose isotopomers M4 and Ms, or find a alternative method to
quantify either hepatic glycerol uptake or hepatic glycogenolysis.
In contrast, Sunehag applied a significantly higher tracer infusion rate, i.e. 17 ptmol/kg/min
vs. 0.59 ýtmol/kg/min as employed by Tayek et al. Consequently, glucose isotopomers M4
and M5 were formed in significant abundance, i.e. 0.80 and 0.47 mol%/ respectively. In this
case, MFA produced a unique solution for the gluconeogenesis flux (6.9 .Lmol/kg/min) with
a narrow 9 5 % confidence interval (6.6 - 7.9 ptmol/kg/min). Here, glucose mass isotopomers
M4, M3 and M5 were the most important measurements for estimating gluconeogenesis flux
with relative contributions of 59%, 18% and 9 % respectively. Other fluxes in this system
were also estimated more precisely than in the Tayek study (see Table 3-5). Here, most fluxes
had a well defined optimal flux value, with the notable exceptions of the influx of unlabeled
lactate, the Cori cycle flux, the pentose pathway in muscle, and hepatic ketogenesis.
Comparing the overall quality of flux results from both studies it is clear that high tracer
infusion rates are desirable in order to obtain reliable flux estimates in this system. The main
concern is, however, that high infusion rates of glucose may alter endogenous glucose
metabolism. Therefore, the optimal infusion rate will depend on the desired precision of
fluxes and the ability to measure glucose mass isotopomers M 4, M3 and Ms precisely.
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3.4 Discussion
Metabolic flux analysis based on the application of stable isotopes and subsequent
measurement of labeling patterns is a powerful technique for measuring metabolic fluxes in
vivo. However, reliable physiological knowledge can only be obtained from these studies if
the statistical significance of estimated fluxes is determined as well. This is complicated by
the highly nonlinear relationships inherent to isotopic systems. Unfortunately, detailed
statistical analysis of estimated metabolic fluxes is still not common practice. Most often,
fluxes obtained from stable isotope studies are reported without any statistical significance.
In some cases, linearized statistics have been used to describe the uncertainty (Arauzo-Bravo
and Shimizu, 2003; Wiechert et al., 1997). Wiechert et al. showed that linearized statistical
properties are inappropriate for large exchange fluxes. A nonlinear mapping of exchange flux
improved the approximation for an example network probed with NMR measurements
(Wiechert et al., 1997). In this contribution, however, we have shown that even for very
simple systems probed with MS measurements confidence intervals of net and exchanges
fluxes are highly nonlinear and non-symmetric. The true confidence intervals of fluxes may
be much smaller, or much larger than the linearized confidence intervals suggest. For
example, van Winden et al. determined the 90% confidence interval for the split ratio
between glycolysis and the pentose phosphate pathway in yeast from MS measurements of
intracellular metabolites (van Winden et al., 2005). The 90% confidence interval ranged from
0.05 to 0.52, indicating that the split ratio could not be determined precisely due to a
correlation with the glycogen flux. In this study, we have also provided examples of fluxes
with very large confidence intervals. The gluconeogenesis flux determined from experiments
with low [U- 13C]glucose infusion could not be determined accurately resulting from a
correlation between hepatic glycerol influx and glycogenolysis. These types of problems
cannot be detected by MFA alone, or using linearized statistics. To eliminate these problems,
nonlinear statistical tools are required for careful design of tracer experiments.
In summary, in this contribution we have presented comprehensive techniques that allow
accurate determination of the significance of fluxes obtained from stable isotope
measurements. The advantage of our approach is that it provides an efficient method to
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calculate nonlinear confidence intervals that reflect the true uncertainty of estimated fluxes.
It allows the construction of confidence intervals in underdetermined and over-determined
systems. The derived analytical expressions for sensitivities of fluxes with respect to
measurements and measurement errors allow the identification of key measurements for
specific fluxes. We applied these methods to re-analyze the statistical significance of
estimated gluconeogenesis fluxes from two human studies with [U- 3C]glucose as tracer. As a
result, we identified a theoretical limitation to estimate the gluconeogeneis flux in one of the
studies. We confirmed concerns raised by several authors and identified the source of the
limitations, i.e. low isotopic abundance of key mass isotopomers resulting in the inability to
distinguish between hepatic glycerol intake and glycogenolysis. Through these examples we
have demonstrated the importance of rigorous design and analysis of tracer experiments and
the importance of calculating accurate flux confidence intervals for reliable interpretation of
physiological studies.
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APPENDIX 3.A
Numerically stable form for matrix inverse using singular value decomposition
Inversion of Hessian matrix H may be numerically unstable if H is singular, or ill
conditioned. A numerically stable from for the inverse may be obtained from singular value
decomposition of H (Foster, 1986):
H = U-S.V T  (3.A1)
The diagonal elements of matrix S correspond to the eigenvalues of H. Eigenvalues smaller
than a given tolerance, for example tol = 10-10, are considered insignificant. Matrix V is then
split into two matrices, V1 and V2. The columns of V1 form an orthogonal basis for the
column space of H, while V2 provides an orthogonal basis for the null space of H.
V = [V1 I V2] (3.A2)
A numerically stable from for the inverse is then given by:
H- (H + to/.V2. V2T) (3.A3)
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APPENDIX 3.B
Algorithm for covariance-weighted flux estimation
* Choose starting values for free fluxes, in general random values are preferred.
* Set the iteration counter k = 0.
* At each iteration k:
1. Simulate measurements x for current fluxes.
2. Calculate the sensitivity matrix dx/du.
3. Calculate the Hessian matrix H and the Jacobian J using Eq. 3.8.
4. Calculate Au using Eq. 3.10. Additional inequality constraints may be included here.
5. Check for convergence. If the error in the necessary condition is smaller than the
desired tolerance, then stop. Otherwise, go to step 6.
6. Update the fluxes using Eq. 3.11.
7. Set the iteration counter k <- k + 1, and go to step 1.
* Transform the free fluxes into individual metabolic fluxes using Eq. 3.2.
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APPENDIX 3.C
Controlling the step size for determination of accurate flux intervals
In order to calculate accurate confidence intervals the step size 'h' in Eq. 3.20 needs to be
carefully controlled. Using very small step size increases the number of iterations and is
computationally demanding. On the other hand, using a step size that is too large results in
significant loss of accuracy due to the inability to follow nonlinearities in the system. Using
Taylor series expansion, we can express the increase in the objective function formally as a
polynomial function of the step size:
Ac = aI .h + a2 .h 2 + a 3 h3 + ... (3.B1)
The first two coefficients al and a2 are given by:
al = 2 Au T . J (3.B2)
22 = Au T H - Au (3.B3)
Higher order coefficients are normally not calculated, because that would require
computation of higher order derivatives of simulated measurements with respect to fluxes,
i.e. d2x/du2, d3x/du3, which is computationally demanding and requires large amounts of
memory to store multidimensional matrices. However, we can approximate the third
coefficient a3 computationally at each iteration. For this purpose, we calculate the actual
increase in the objective function A(Daact u for the flux map given by (u + h-Au) and compare
this to the predicted increase in the objective function using the quadratic approximation, i.e.
A(tapprox = al h + a2-h 2. The value for a3 is then approximated from the difference between
ADca •l and A)approx:
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a3 • 3 (3.B4)
If the difference is too large then the step size needs to be decreased and if the difference is
very small then we may increase the step size without loss of accuracy. For our calculations
we require the difference to be less than 10-4 at each iteration. The step size h is updated at
each iteration according to the following formula:
h=o- (3.4 5)h = - (3.B5)
a3
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APPENDIX 3.D
Algorithm for accurate determination of confidence intervals of fluxes
* Calculate the variance-weighted sum of squared residuals at the optimal solution ((i).
* Choose a confidence level (1-a), and calculate the corresponding threshold value
X21_-(l), e.g. X20.95(1) = 3.84 for the 95% confidence interval.
* For each flux i:
* Initialize all fluxes at the optimal solution obtained from flux estimation, u() =  .
* Initialize the Lagrange multiplier at X(o) = 0.
* Initialize the variables vector d(o) = [u(o) X(0)]T.
* Set the iteration counter k = 0.
* At each iteration k:
1. Simulate measurements x for current fluxes.
2. Calculate the sensitivity matrix dx/du.
3. Calculate the variance-weighted sum of squared residuals ((u).
4. Calculate the Hessian matrix H and the Jacobian J using Eq. 3.8.
5. Calculate matrix A and vector b using Eq. 3.24.
6. Calculate Ad using Eq. 3.26. Additional inequality constraints may be included
here.
7. Update the step size h as described in Appendix 3.C.
8. Check for convergence. If the flux value for flux i reaches the upper bound, or
if (D(u)- #(f) > X21-a(1) then stop. Otherwise, go to step 9.
9. Update the variables vector d using Eq. 3.27.
10. Transform the free fluxes into individual metabolic fluxes using Eq. 3.2.
11. Record current value for flux i and the corresponding (I(u).
12. Set the iteration counter k -- k + 1, and go to step 1.
* Initialize all fluxes at the optimal solution obtained from flux estimation, u(o) = u.
* Initialize the Lagrange multiplier at X(o) = 0.
* Initialize the variables vector d(o) = [u(o) ,(o)]T .
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* Set the iteration counter k = 0.
* At each iteration k:
1. Simulate measurements x for current fluxes.
2. Calculate the sensitivity matrix dx/du.
3. Calculate the variance-weighted sum of squared residuals D(u).
4. Calculate the Hessian matrix H and the Jacobian J using Eq. 3.8.
5. Replace -Ni for Ni in Eq. 3.24, and calculate matrix A and vector b.
6. Calculate Ad using Eq. 3.26. Additional inequality constraints may be included
here.
7. Update the step size h as described in Appendix 3.C.
8. Check for convergence. If the flux value for flux i reaches the lower bound, or
if (D(u)- d(ui) > X 2 1_-(1) then stop. Otherwise, go to step 9.
9. Update the variables vector d using Eq. 3.27.
10. Transform the free fluxes into individual metabolic fluxes using Eq. 3.2.
11. Record current value for flux i and the corresponding D(u).
12. Set the iteration counter k <- k + 1, and go to step 1.
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APPENDIX 3.E
Metabolic model of mammalian glucose metabolism
We constructed a detailed metabolic model for mammalian glucose metabolism in which we
consider all major pathways that affect the observed labeling patterns of plasma lactate and
glucose (Figure 3-4). Here, [U- 13C]glucose is infused into the blood, taken up by the tissues
and metabolized by glycolysis and pentose phosphate pathway to form lactate, which is then
released into circulation. While the infused glucose is comprised of the fully labeled NM
isotopomer, the action of the glycolysis pathway and scrambling in the pentose pathway
produces both fully labeled m3, and partially labeled mi and m2 lactate molecules. The
labeling of plasma lactate is additionally diluted by unlabeled endogenous sources, such as
from glycogen breakdown in the muscle and amino acid oxidation. This dilution of plasma
lactate labeling is modeled here by one lumped dilution flux. Lactate then enters the liver
where it is converted to pyruvate. We assume that plasma lactate and hepatic pyruvate are at
isotopic equilibrium, which has been experimentally validated by several authors (Wykes et
al., 1998). In the conversion to glucose, pyruvate undergoes carboxylation to form
oxaloacetate that is shared with the TCA cycle. Scrambling of labeling may occur at the point
of fumarate since fumarate is rotationally symmetric. The conversion of amino acids to
glucose without pyruvate as an intermediate, such as from aspartate and glutamine, is
modeled by one lumped dilution flux into the succinyl-CoA pool. Fatty acid oxidation,
ketogenesis and the possibility for pyruvate recycling through the action of pyruvate kinase
are also considered in the model. Glycerol is another potential gluconeogenic precursor that
we consider. Finally, the labeling of hepatic glucose-6-phosphate pool is diluted by
glycogenolysis pathway, i.e. the release of unlabeled glucose molecules from glycogen
storages. In our model, the reaction between oxaloacetate and fumarate is the only
observable reversible reaction. The remaining reactions in the model may therefore be
considered irreversible without affecting flux calculations. The list of all reactions in this
model together with the corresponding carbon transitions are shown in Table 3-3.
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GC/MS analysis of amino acids
4.1 Introduction
4.1.1 Flux analysis requires accurate data
Accurate assessment of isotopomer distributions of cellular amino acids is of great
importance for quantitative analysis of cell physiology. In carbon labeling experiments 13C-
distributions measured by gas chromatography / mass spectrometry (GC/MS) and nuclear
magnetic resonance (NMR) provide rich information for estimating metabolic fluxes in
complex biological systems. The NMR technique requires expensive equipment and fairly
high concentration of metabolites. In contrast, GC/MS is a rapid and much more sensitive
technique. Powerful computational tools have been developed for quantitative interpretation
of mass isotopomer data; however, the statistical significance of carbon-13 tracer studies has
been limited due to inaccuracies and imprecision in isotopomer data. Metabolic flux analysis
is very sensitive to measurement errors due to the highly nonlinear relationships of models
that link fluxes and isotopomer abundances. Thus, small errors in isotopomer data may
result in large errors in estimated fluxes. It is therefore essential that isotopomer data are
accurate and precise. Based on preliminary sensitivity analysis of realistic metabolic networks
we determined that errors in mass isotopomer abundances should be.less than 0.5 mol% for
most systems. The required accuracy depends mainly on the complexity of the network
model (i.e. degrees of freedom), and the number of redundant measurements. In general,
complex networks with fewer redundant measurements will require more precise data than
more simple systems with large number of measurements.
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4.1.2 Potential sources of error
GC/MS analysis of cellular components provides rich information on isotopomer
distributions of common metabolites. However, several studies have shown that mass
isotopomer data may under-, or overestimate true enrichments. For example, it was reported
that metabolite concentration may affect the accuracy of GC/MS data for fatty acid methyl
esters (Fagerquist et al., 2001; Patterson & Wolfe, 1993). It was shown that isotopomer ratios
deviated significantly from expected natural abundance ratios with increasing metabolite
concentration. Although it is uncertain what the exact cause is of this concentration
dependence, gas phase ion/molecule chemistry in the ionization chamber appears to be a
significant factor (Fagerquist et al., 2001). Klapa et al. reported that mass spectra obtained
with ion trap mass spectrometers may suffer from hydrogen abstraction and other artifacts,
resulting in inaccurate mass isotopomer ratios and significant M-1 abundances (Klapa et al.,
2003). Empirical corrections were proposed to reduce the effect of these artifacts; however,
it is unclear how accurate these corrections are for labeled samples. Furthermore, errors may
be introduced due to incomplete resolution of mass spectra in time, or in the m/z domain.
For example, if compounds are not completely resolved by gas chromatography, co-eluting
compounds will contribute to the observed mass spectra. Mass spectra may also overlap in
the m/z domain. For example, electron impact ionization typically generates more than 20
ion fragments for each metabolite and some of these fragments may be overlapping. Thus,
even if compounds are well separated by chromatography, mass isotopomer distributions of
adjacent fragments may still be unresolved. In practice, it is not be possible to deconvolute
unresolved mass spectra with the desired accuracy of 0.5 mol%. In is important to identify
these situations a priori. Finally, errors may be introduced during integration of mass
chromatograms due to inaccurate integration algorithms, or failure to account for
background noise in MS data.
4.1.3 Reported accuracy and precision in literature
Detailed assessment of accuracy and precision of MS data has received limited attention in
the literature. Mass isotopomer abundances from tracer studies are often reported without
any indication of error. Dauner and Sauer (2000) were the first to analyze the accuracy of MS
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data from TBDMS derivatized amino acid by comparing mass isotopomer abundances of
unlabeled amino acids with theoretical abundances. They reported differences between
observed and theoretical abundances up to 6 mol0/o. Of the 38 accepted amino acid
fragments, 8 fragments had errors <0.5 mol0/o, 20 fragments had errors 1-2 mol%, 13
fragments had errors 2-3 mol0/o, and 10 fragments had errors >2 mol%. Klapa et al. (2003)
reported standard deviations for mass isotopomer abundances of TBDMS derivatized amino
acids ranging between 0.2 and 4 mol%, with the majority of standard deviations larger than
0.5 mol0/o. Here, we report our findings from an extensive study of GC/MS analysis of
TBDMS derivatized amino acids. In this study we validated the identity of amino acid
fragments using 13C-labeled standards, identified potential sources of inaccuracy and
imprecision in MS data, and established a technique to minimize these errors. The main
result of this work is a procedure for accurate and precise assessment of mass isotopomer
distributions of cellular amino acids, with an accuracy of 0.3 mol% and precision of 0.2
mol%, or better.
4.2 Materials and methods
4.2.1 Labeled amino acid standards
A mixture of [U-13C]algal amino acids (99+ At% 13C) and [4-13C]aspartic acid (99 At% 13C)
were purchased from IsoTec Inc. (NMiamisburg, OH). [5- 13C]glutamic acid (99 At% 13C) was
purchased from Cambridge Isotope Laboratories Inc. (Andover, MA).
4.2.2 Cellular amino acids
Cellular amino acids were obtained hydrolyzed biomass samples taken from batch cultures
of E. coli. In one culture no tracers were used (as control), and in a separate culture a mixture
of [1- 13C]glucose and [U- 13 C]glucose was provided as carbon-13 input. Samples from these
cultures were centrifuged and the supernatant separated from the biomass pellet. About 20
mg of wet biomass pellet was transferred to 700 p.L of 6 N HCl and heated at 110 0 C for 24
hrs in a closed vacuum hydrolysis tube. After cooling to room temperature the solvent was
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evaporated and the residue dissolved in 150 jpL of distilled water and filtered through a 0.2
pLm pore size filter to remove cell debris. The filtrate was then evaporated to dryness.
4.2.3 TBDMS derivatization
Amino acids were dissolved in 50 jpL pyridine followed by addition of 70 pL N-methyl-N-
(tert-butyldimethyl-silyl)-trifluoroacetimide (MTBSTFA). The mixture was heated at 60'C
for 30 min, allowed to cool to room temperature and transferred to injection vial for
GC/MS analysis.
4.2.4 GC/MS Analysis
Gas Chromatography-Mass Spectrometry (GC/MS) analysis was performed using HP 5890
Series II GC (Gas Chromatograph) equipped with a DB-1701 [30 m x 0.25 mm (inner
diameter) x 0.25 pmn] capillary column, connected to HP 5971 quadrupole MSD (Mass
Selective Detector) operating under ionization by electron impact (EI) at 70 eV. The mass
spectrometer was calibrated using the 'Max Sensitivity Autotune' setting. The injection
volume was 1 [L and samples were injected in purged splitless mode. The amount of sample
analyzed was controlled by varying the purge activation time between 1 sec and 1.5 min.
Helium flow was maintained at 0.74 mL/min via electronic pressure control. The injection
port temperature was 2700C. The temperature of the column was started at 100 0C for 1.5
min, increased to 1300C at 20 0C/min and increased to 2200C at 100C/min and held for 3
min. The temperature was then increased to 2800C at 50C/min and held for 3 min. The
interface temperature was maintained at 3000 C. Mass spectra were analyzed in the mass
range 195-445 atom mass units (amu) at a rate of 2.7 scans/sec. Measured intensities were
corrected for the contribution of noise (baseline correction), and mass isotopomer
distributions were obtained by integration. Mass isotopomer values for each fragment were
expressed as fractional abundances, i.e. for each fragment the sum of all mass isotopomers
equals one.
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4.2.5 Natural isotope abundances
Most elements of biological interest (including C, H, O, N, and S) have two or more stable
isotopes. Relatively large variations occur for the 13C isotope in nature, varying between
1.097 At%/o for C4-plants and 1.082 At%/o for C3-plants (Coplen et al., 2002). This small
difference may contribute to significant differences in the calculated natural isotopomer
distributions of molecules containing large number of carbon atoms, such as TBDMS
derivatized amino acids. For our calculations we used 1.082 At%/o for the natural abundance
of 13C. For other elements we assumed the following isotope abundances: 2H (0.0156 At%/o),
'
5N (0.366 At%/o), 170 (0.038 At%/o), 180 (0.204 At%/o), 29Si (4.69 At%), 30Si (3.09 At/), 33S
(0.749 AtO/o), 34S (4.197 At%), 36S (0.015 At%/o) (Coplen et al. 2002).
4.3 Results
4.3.1 TBDMS derivatization of amino acids
Amino acids are not volatile enough to be analyzed by GC/MS directly. Therefore, chemical
modification of the polar side groups, e.g. -OH, -NH2, -COOH, is required. Here, amino
acids were chemically modified to their respective tert-butyldimethylsilyl (TBDMS)
derivatives for GC/MS analysis (see Figure 4-1)
4.3.2 Gas chromatography of TBDMS derivatized amino acids
Figure 4-2 shows a representative total ion chromatogram from GC/MS analysis of TBDMS
derivatized amino acids from hydrolyzed biomass samples. The retention times of the
detected amino acids are reported in Table 4-1. We detected 15 of the 20 amino acids in the
hydrolyzed biomass samples. Cysteine and tryptophan were lost in hydrolysis due to
oxidation, and glutamine and asparagine were deamidated to glutamate and aspartate,
respectively. Histidine was not detected. The insert in Figure 4-2 shows the observed mass
spectrum of TBDMS derivatized aspartic acid that eluted at 17.1 min. TBDMS derivatized
amino acid displayed characteristic fragmentation patterns resulting from electron impact
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Figure 4-1: Schematic of TBDMS derivatization of polar side groups. Amino acids and
other biological metabolites are easily derivatized to their respective TBDMS derivatives in
preparation for GC/MS analysis.
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Figure 4-2: Representative total ion chromatogram from GC/MS analysis of TBDMS
derivatized amino acids from hydrolyzed biomass. The total ion chromatogram corresponds
to the sum of ion intensities measured at each scan. The insert shows the electron ionization
mass spectrum of TBDMS derivatized aspartic acid.
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Table 4-1
Gas chromatography retention times and main ion fragments of TBDMS derivatized amino
acids. Cellular amino acids from hydrolyzed biomass samples were derivatized with TBDMS
and analyzed by electron impact GC/MS.
Amino acid Retention time Molecular weight* Main ion fragments (m/z)
Alanine 9.3 min 317 232, 260
Glycine 9.7 min 303 218, 246
Valine 10.5 min 345 260, 288, 302
Leucine 10.9 min 359 200, 274, 302
Isoleucine 11.3 min 359 200, 274, 302
Proline 11.8 min 343 258, 286
Serine 14.1 min 447 230, 288, 302, 362, 390
Threonine 14.4 min 461 376, 404, 417
Methionine 14.6 min 377 218, 244, 292, 320
Phenylalanine 16.4 min 393 234, 302, 308, 336
Aspartate 17.1 min 475 244, 258, 302, 316, 376, 390, 418
Glutamate 19.1 min 489 272, 330, 358, 404, 432
Lysine 20.3 min 488 329, 431
Arginine 22.5 min 515 340, 442
Tyrosine 24.7 min 523 302, 364
* Molecular weight of TBDMS derivatized amino acids.
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ionization (EI). Characteristic for TBDMS derivatized amino acids were ion fragments at m-
57, m-85 and m-159, where 'm' denotes the molecular weight of the derivatized amino acid.
4.3.3 Integration of mass chromatograms
To obtain accurate mass isotopomer distributions (MIDs) from raw GC/MS data, mass
chromatograms have to be integrated over the full peak range of the corresponding amino
acid. Mass isotopomer ratios obtained at each scan have a much lower signal-to-ratio and
may not reflect the true isotopomer distribution. For example, it is well known that mass
isotopomers may separate on the GC column and elute at slightly different times. This effect
is generally more significant for 2H-labeled compounds than for 13C-labeled compounds. In
either case, the observed mass isotopomer ratios will be different at the beginning and the
end of a metabolite peak. Several software packages allow one to integrate mass
chromatograms and calculate mass isotopomer distributions. However, we found that
different integration algorithms often produced significantly different integrated mass
isotopomer distributions. Here, we will illustrate two potential sources of error due to
incorrect integration. First, it is important that all mass chromatograms of a particular
metabolite are integrated over the same scan range, i.e. time interval. If peak detection
algorithms are applied to each mass chromatogram individually then slightly different
integration bounds may be identified for each ion, resulting in biased integrated intensities.
Furthermore, it is necessary to correct measured intensities for background noise. This
correction should be applied to each mass chromatogram individually, because the level of
background noise may be different at each scanned ion. In our experience, good calibration
of the mass spectrometer reduced the level of background noise, and the use of high
electron multiplier voltages (EMV) increased background noise. To illustrate these effects we
quantified the mass isotopomer distribution of glycine ion fragment at m/z 246-250 in the
unlabeled biomass sample. Three integration methods were used. In Method 1, fixed
integration bounds were used for each mass chromatogram and baseline correction was
applied. In Method 2, each mass chromatogram was integrated independently, which could
result in slightly different integration bounds for each mass chromatogram. Correction for
baseline was applied. In Method 3, fixed integration bounds were used for each mass
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chromatogram, but no baseline correction was applied. Figure 4-3 clearly shows the
differences between the integration methods. The shaded areas in Figure 4-3 correspond to
the integrated intensities. Fractional abundances were obtained from the integrated
intensities by dividing the integrated intensity by the sum of all intensities. In Table 4-2 we
compare the calculated MID for glycine-246 to the theoretical MID. Overall, the first
integration method produced mass isotopomer abundances that corresponded best with
theoretical abundances, i.e. less than 0.1 mol% deviation. The second method overestimated
M+0 abundance slightly (+0.4 mol0 /o), and underestimated M+1 and M+2 abundances (-0.1
and -0.2 mol%) caused by slightly smaller integration bounds for the M+1 and M+2 mass
chromatograms. The third method, i.e. no baseline correction, produced the largest errors.
The M+0 abundance was underestimated by 2.2 mol%/o and other abundances were
overestimated by 0.3-0.7 mol%. It should be clear that without baseline correction low
abundance isotopomers will always be overestimated, and the most abundant mass
isotopomer will be underestimated. Analysis of other amino acid fragments supported all of
these findings. Taken together, our results indicate that the first integration method is the
most accurate one: using fixed integration bounds for all mass chromatograms and applying
baseline correction. This integration method was used in the remainder of this work.
4.3.4 Concentration dependence of mass isotopomer distributions
We found significant correlation between measured mass isotopomer abundances and the
amount of amino acid that was analyzed. In this study, all amino acid samples were analyzed
35 times at varying concentrations. The observed abundances varied up to 2 mol%
depending on the amount of amino acid analyzed. Figure 4-4 shows the observed mass
isotopomer abundances for glycine fragment at m/z 218 plotted against the total ion counts
for this fragment (i.e. sum of integrated intensities at m/z 218-222). The dashed horizontal
line in Figure 4-4A represents the expected abundances for unlabeled glycine. We found
good agreement between the observed and theoretical abundances for low concentrations of
the sample, however, the M+0 abundance of unlabeled glycine decreased with increasing
glycine concentration and M+1 and M+2 abundances increased. We found a near linear
relationship for this concentration effect. All other fragments of TBDMS derivatized amino
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Figure 4-3: Comparison of three methods for integration of mass chromatograms. Mass
isotopomer distribution of glycine ion fragment at m/z 246 was determined using three
integration methods: (1) fixed integration bounds for all mass chromatograms, and baseline
correction; (2) independent integration of each mass chromatogram, resulting in slightly
different integration bounds, and baseline correction; (3) fixed integration bounds, but no
baseline correction. Shaded areas indicate integrated intensities for each method.
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Table 4-2
Effect of integration method on the accuracy of calculated mass isotopomer distributions.
MID of glycine fragment at m/z 246-250 was determined by integration using three
different integration methods. The calculated isotopomer abundances were compared to
theoretical natural isotope abundances (molar abundances, mol%).
METHOD 1 METHOD 2 METHOD 3
Fixed integration bounds Independent integration Fixed integration bounds
and baseline correction and baseline correction no baseline correction
Ion Fig. 4.3 (1) Fig. 4.2 (2) Fig. 4.2 (3)
m/z Theory Data Error Data Error Data Error
246 75.4 75.4 0.0 75.8 +0.4 73.2 -2.2
247 16.5 16.4 -0.1 16.4 -0.1 16.8 +0.3
248 6.9 7.0 +0.1 6.7 -0.2 7.4 +0.5
249 1.0 1.1 +0.1 1.0 0.0 1.7 +0.7
250 0.2 0.2 0.0 0.1 -0.1 0.9 +0.7
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Figure 4-4: Concentration dependence of mass isotopomer abundances of TBDMS
derivatized glycine. Glycine samples were analyzed 35 times at different concentrations.
Mass isotopomer distributions were obtained by integration of mass chromatograms. Peak
area (plotted on the x-axis) denotes the sum of integrated intensities at m/z 218-222. (A)
Mass isotopomer abundances for unlabeled glycine. The dashed horizontal line represents
the theoretical mass isotopomer abundances; (B) abundances for glycine from 13C-labeled
biomass sample; (C) abundances for [U-13C]glycine standard. Glycine ion fragment at m/z
218 contains only the second carbon atom of glycine.
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acid fragments displayed a similar linear correlation (see Appendix A). Figure 4-4B shows the
concentration dependence for glycine from a 13C-labaled biomass sample, and Figure 4-4C
shows the concentration dependence for [U-13C]glycine standard. In all three samples we
observed a linear relationship between mass isotopomer abundances and metabolite
concentration. We identified the following pattern for this concentration effect: the intensity
of the most abundant mass isotopomers always decreased with increasing concentration,
whereas intensities of the other mass isotopomers increased. Furthermore, the magnitude of
this effect became smaller for less abundant mass isotopomers. Further investigation
revealed that this sample effect could not be explained by nonlinearities of the detector.
When we re-analyzed the samples at increasing electron multiplier voltages (EMV) for the
detector, the ion counts increased up to 10-fold, however, the observed mass isotopomer
distributions did not change significantly (less than 0.3 mol% difference) and the
concentration effect remained. Taken together, these findings indicate that this effect is most
likely caused during ion formation/fragmentation. A similar effect of sample concentration
on the accuracy of GC/MS data was reported for fatty acid methyl esters (Fagerquist et al.
2001; Patterson & Wolfe 1993). To our best knowledge, this is the first time that a sample
size effect is reported for TBDMS derivatized amino acids. After careful analysis of all data
we concluded that mass isotopomer abundances extrapolated to a theoretical zero
concentration (i.e. infinite dilution) correlated best with theoretical abundances. Mass
isotopomer abundances obtained this way deviated less than 0.3 mol% from theoretical
abundances for all accepted amino acid ion fragments (see section 4.3.6). We found that
extrapolation produced more accurate and precise MIDs than could be obtained solely from
diluted samples. This was caused by the low signal-to-noise ratio at low concentrations, i.e.
the standard deviation of measurements was as high as 0.6 mol% for diluted samples
compared to <0.2 mol% for samples at high concentrations. In addition, we observed a
slight underestimation of low abundance mass isotopomers in the diluted samples, again
caused by low signal-to-noise ratio. Therefore, we strongly recommend that MIDs are always
obtained using the extrapolation technique. The main disadvantage of using this method is
that it requires multiple injections of samples at different concentrations, which is time
consuming. However, MIDs obtained this way are both very accurate (<0.3 mol% error) and
very precise (SD <0.2 mol%), which is required for detailed analysis of metabolic fluxes. In
-144-
CHAPTER 4. GC/MS ANALYSIS OF AMINO ACIDS
the remainder of this work mass isotopomer abundances of TBDMS derivatized amino acids
were always obtained using the extrapolation technique.
4.3.5 Validating identity of ion fragments using DC-standards
TBDMS derivatized amino acids have characteristic fragmentation patterns resulting from
electron impact ionization (EI). The most common ion fragment (m-57) results from the
loss of a tert-butyl group (C4H-I9) of the derivatizing agent. This fragment contains the
complete carbon backbone of the amino acid. Ion fragments at m-85 and m-159 are formed
from cleavage of tert-butyl-CO (C5H90) and C0 2-TBDMS (C7H150 2Si) groups, respectively,
where the carboxyl group of the amino acid is lost. Another common ion fragment is found
at m/z 302. This fragment is formed by cleavage of the carbon bond between ac- and 3-
carbon atoms, i.e. this fragment retains the first two carbon atoms of the amino acid. To
validate the assumed identity of ion fragments of TBDMS derivatized amino acids we
measured mass spectra for unlabeled and [U-13C]labeled amino acids. For example, consider
the mass spectrum of unlabeled and [U- 13C]alanine shown in Figure 4-5. Ala-232 (m-85) ion
fragment in unlabeled alanine corresponded to Ala-234 in [U- 13C]alanine, which was
consistent with cleavage of the carboxyl group of alanine. Ala-260 (m-47) ion fragment in
unlabeled alanine corresponded to Ala-263 in [U- 13C]alanine, which was in agreement with
cleavage of just the tert-butyl group of the derivatizing agent. However, Ala-302 in unlabeled
alanine corresponded to Ala-305 in [U-13C]alanine, which was not in agreement with the
cleavage of the bond between a- and 3-carbon atoms. This fragment clearly contained all
three carbon atoms of alanine, and must have been formed by an alternative fragmentation
where the methyl group of the derivatizing agent was cleaved. This example clearly illustrates
the importance of validating the assumed identity of fragments using 13C-labeled standards
to avoid mistakes in the interpretation of mass isotopomer data for metabolic flux analysis.
In Appendix A we show the mass spectra for all TBDMS derivatized unlabeled and [U-
13C]labeled amino acids.
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Figure 4-5: Electron ionization mass spectra of TBDMS derivatized alanine. Top spectrum
was obtained for unlabeled alanine, and the bottom spectrum for [U- 13C]alanine standard
(99+ At% 13C).
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We identified three amino acids where the ion at m/z 302 was formed from multiple
fragmentations, i.e. Val-302, Leu-302 and Ile-302. Val-302 in unlabeled valine corresponded
to two peaks in [U-13C]alanine mass spectrum, i.e. Ala-304 and Ala-306. Two ion fragments
of valine were clearly overlapping here, one fragment containing the first two carbon atoms
of valine (m/z 302->304) and a second fragment containing four of the five carbon atoms
of valine (m/z 302->306), i.e. either C1,2,3,4 or C1,2,3,5. Leu-302 and Ile-302 ion fragments
corresponded to two peaks in [U-13qlabeled amino acid standards, i.e. at m/z 304 and 308.
The peak m/z 304 resulted from a fragmentation in which the first two carbon atoms of the
respective amino acid were retained (i.e. cleavage of the bond between ax- and 0-carbon
atom), whereas the peak at m/z 308 resulted from the loss of the tert-butyl group of the
derivatizing agent, i.e. all carbon atoms of the amino acid were retained. Data from these
fragments cannot be used for flux analysis, because we have no means of deconvoluting
individual mass isotopomer distributions from the observed mass spectrum.
Fragments of aspartate and glutamate required additional validation with specifically labeled
standards. Aspartate and glutamate each have two carboxyl groups, and it was not known a
priori which of the two carboxyl groups was cleaved in the m-159 (Asp-316 and Glu-330)
and m-85 (Asp-390 and Glu-404) fragmentations. Therefore, we measured mass spectra for
[4-13C]aspartic acid and [5- 13 C]glutamic acid. For [4- 13C]aspartic acid we observed peaks at
m/z 317 and 391, and no peaks were observed at m/z 316 and 390. Thus, we concluded that
only the first carboxyl group of aspartate was cleaved in these fragmentations. For [5-
13C]glutamic acid we observed peaks at m/z 331 and 405, and no peaks were observed at
m/z 330 and 404. Thus, only the first carboxyl group of glutamate was cleaved.
4.3.6 Validating accuracy of mass isotopomer distributions
Next, we determined the accuracy of measured mass isotopomer distributions for all
accepted amino acid ion fragments by comparing the observed mass isotopomer
distributions from unlabeled and [U-13C]labeled amino acids to theoretical distributions.
Table 4-3 compares the measured and theoretical abundances for alanine ion fragment at
m/z 260. Abundances in Table 4-3 were normalized with respect to the most abundant ion.
- 147 -
CHAPTER 4. GC/MS ANALYSIS OF AMINO ACIDS
Table 4-3
Comparison of measured and theoretical mass isotopomer distribution of TBDMS
derivatized alanine. Shown are the measured and theoretical mass isotopomer abundances
for unlabeled and [U- 13C]alanine (99+ At%/o 13C), for the alanine ion fragment at m/z 260.
Abundances were normalized to the most abundant ion.
Ala-260 [U- 13C]-Ala
Formula : Cn H2602NSi2
Exact mass : 260.150
C-atoms : 1-2-3
m/z theory data difference
259 0.0 0.0 0.0
260 100.0 100.0 0.0
261 23.0 23.2 +0.2
262 9.4 9.4 0.0
263 1.4 1.4 0.0
264 0.3 0.2 -0.1
265 0.0 0.0 0.0
266 0.0 0.0 0.0
267 0.0 0.0 0.0
268 0.0 0.0 0.0
m/z theory data difference
259 0.0 0.0 0.0
260 0.0 0.3 +0.3
261 0.0 0.4 +0.4
262 3.1 3.3 +0.2
263 100.0 100.0 0.0
264 1.9.9 20.5 +0.6
265 8.7 9.0 +0.3
266 1.1 1.2 +0.1
267 0.2 0.1 -0.1
268 0.0 0.0 0.0
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We found very good agreement for the Ala-260 fragment. The maximum difference between
measured and theoretical abundances was less than 0.2 mol%. As expected, we observed
larger differences for [U-13C]alanine standard, which was caused mainly by incomplete 13C-
labeling (99 At%/o 13C-labeling according to manufacturers' specifications). Taking into
account potentially incomplete labeling of [U- 13C]alanine, the observed agreement for [U-
13C]labeled alanine was acceptable. In Appendix A we show tables for all 47 amino acid
fragments that were analyzed in detail where we compare measured and theoretical
distributions. For our purposes, amino acid fragments for which the observed abundances
deviated more than 0.5 mol% from theoretical abundances (for unlabeled amino acids) were
considered inaccurate. The following fragments were rejected: for Leu-200 M+O was too
high (+0.9 mol%), for Asp-316 M+3 was too high (+0.7 mol%), and for Glu-404 M+0 was
too low (-0.6 mol0 /o). In general, we did not observe M-1 peaks for most amino acid
fragments (<0.1 mol%), indicating that hydrogen abstraction was not a problem in our
GC/MS analysis. Only two fragments displayed significant M-1 peaks: for Glu-358 M-1 was
1.8% of M+O, and for Lys-431 M-1 was 1.7% of M+0. Proline fragments were omitted from
further analysis because proline co-eluted with other compounds that contributed to the
measured intensities resulting in inaccurate mass isotopomer abundances. Lys-329 and Tyr-
364 were omitted due to low signal-to-noise ratio. Finally, we could not validate the identity
of the following fragments: Ser-230, Thr-417, Met-244, Asp-244, Asp-258, and Glu-272.
Taken together, of the 47 amino acid fragments that were analyzed in detail, 29 fragments
satisfied our strict criteria, i.e. they had acceptable accuracy (<0.3 mol% error for 28 of the
29 fragments) and acceptable precision (<0.2 mol% SD). The 29 accepted fragments provide
110 independent constraints for carbon-13 flux analysis. Tables 4-4 and 4-5 summarize the
results from this extensive study. For the 29 accepted amino acid fragments, Table 4-4
shows the recommended mass range for measuring intensities, the identity of retained
carbon atoms, the specific fragmentation mechanism, the maximum observed error between
theoretical and measured abundances, and the maximum observed measurement precision.
For the 18 rejected amino acid fragments, Table 4-5 shows the scanned mass range, the
identity of the retained carbon atoms (if known), the main reason for rejection, and any
alternative ion fragments that may be used to obtain the same isotopomer information.
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Table 4-4
Overview of accepted amino acid fragments. TBDMS derivatized amino acids were analyzed
by electron impact GC/MS. Using 13C-labeled standards we validated the identity of all
fragments. Measured mass isotopomer distributions were then analyzed for accuracy and
precision.
Max. deviation Precision of
Amino Mass Amino acid from theoretical measurements
acid range carbon atoms Fragmentation abundances (mol%) (mol%)
Ala 232 - 238 2-3 M - CsH90 0.1 0.1
260 - 267 1-2-3 M- C4 H9  0.1 0.1
Gly 218 - 223 2 M - C5H90 0.1 0.1
246 - 252 1-2 M - C4H9  0.1 0.1
Val 260 - 268 2-3-4-5 M - C5H90 0.3 0.1
288 - 297 1-2-3-4-5 M - C4 H9  0.1 0.1
Leu 274 - 283 2-3-4-5-6 M - C5H9s0 0.1 0.1
Ile 200 - 208 2-3-4-5-6 M - C7H1sO 2Si 0.2 0.1
274 - 283 2-3-4-5-6 M - C5H 90 0.1 0.1
Ser 288 - 294 2-3 M - C7H15O2Si 0.1 0.1
302 - 308 1-2 M - C7H 17OSi 0.2 0.2
362 - 369 2-3 M - C5H90 0.3 0.2
390 - 398 1-2-3 M - C4H9  0.5 0.2
Thr 376 - 382 2-3-4 M - C5H90 0.3 0.2
404 - 413 1-2-3-4 M - C4H9  0.3 0.2
Met 218 - 226 2-3-4-5 M - C7H1502 Si 0.2 0.1
292 - 298 2-3-4-5 M - C5H 90 0.2 0.2
320 - 327 1-2-3-4-5 M - C4H 9  0.2 0.2
Phe 234 - 243 2-3-4-5-6-7-8-9 M - C7H 1502Si 0.3 0.1
302 - 307 1-2 M - C7H7 0.3 0.2
308 - 316 2-3-4-5-6-7-8-9 M - C5H90 0.1 0.1
336 - 345 1-2-3-4-5-6-7-8-9 M - C4H9  0.1 0.1
Asp 302 - 308 1-2 M - C8H1 70 2Si 0.1 0.1
376 - 382 1-2 M - C6H1 10 0.3 0.2
390 - 398 2-3-4 M - C5H90 0.3 0.1
418 - 427 1-2-3-4 M - C4H9  0.3 0.1
Glu 330 - 336 2-3-4-5 M - C7H1502Si 0.1 0.1
432 - 442 1-2-3-4-5 M - C4H9  0.1 0.1
Tvr 302 - 305 1-2 M - C13H210Si 0.3 0.1
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Table 4-5
Overview of rejected amino acid fragments. TBDMS derivatized amino acids were analyzed
by electron impact GC/MS. Measured mass isotopomer distributions were analyzed for
accuracy and precision. The following 18 amino acid fragments failed to satisfy our criteria
for accuracy and precision.
Amino Mass At
acid range ca
Val 302 - 308 1-;
Leu 200 - 208 2-.
Leu 302 - 312 1-:
Ile 302 - 312 1-:
Pro 258 - 266 2-.
Pro 286 - 295 1-;
Ser 230 - 237 un
Thr 417 -424 un
Met 244 -250 ur
Asp 244 - 249 ur
Asp 258 - 266 ur
Asp 316 - 323 2-.
Glu 272 - 280 ur
Glu 358 - 367 1-.
Glu 404 -408 2-.
Lys 329 - 336 2-.
Lys 431 - 441 1-
Tyr 364 - 375 2-
nino acid
rbon atoms
2 and 1-2-3-4/5
3-4-5-6
2 and 1-2-3-4-5-6
2 and 1-2-3-4-5-6
3-4-5
2-3-4-5
Lknown
Lknown
Lknown
Lknown
iknown
3-4
iknown
2-3-4-5
3-4-5
3-4-5-6
2-3-4-5-6
3-4-5-6-7-8
Reason for rejection
Overlapping fragments
Inaccurate. M+2 too high (+0.9 mol%)
Overlapping fragments
Overlapping fragments
Co-eluting with other compounds
Co-eluting with other compounds
Unknown fragmentation
Inaccurate. M+0 too low (-4.0 mol%)
Unknown fragmentation
Unknown fragmentation
Inaccurate. M-1 too high (4.4 % of M+0)
Inaccurate. M+3 too high (+0.7 mol%)
Unknown fragmentation
Inaccurate. M-1 too high (1.8 % of M+0)
Inaccurate. M+0 too low (-0.6 mol%)
Low signal-to-noise ratio
Inaccurate. M-1 too high (1.7 % of M+0)
Low signal-to-noise ratio
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Alternative
fragment
n/a
Leu-274
n/a
n/a
Glu-330
Glu-432
unknown
unknown
unknown
unknown
unknown
Asp-390
unknown
Glu-432
Glu-330
none
none
Phe-308
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Chapter 5
GC/MS analysis of glucose
5.1 Introduction
In the pathway of gluconeogenesis labeled hydrogen atoms are incorporated into glucose
from medium containing deuterated water. The amount of label incorporated at each carbon
position depends on the deuterium enrichment in the medium, the relative activity of
gluconeogenesis (GNG) and glycogenolysis (GL), and the extent of equilibration of
reactions in the gluconeogenesis pathway, i.e. phosphoglucose isomerase (PGI) and triose
phosphate isomerase (TPI). It has been suggested that the relative contribution of GNG to
hepatic glucose production (HGP) can be determined from the ratio of deuterium labeling
on C5 vs. C2 of glucose, and that deuterium labeling on C6 vs. C2 corresponds to the
contribution of PEP to HGP. Assessment of positional isomers of glucose can be
accomplished either by NMR or by GC/MS methods. The NMR technique requires
expensive equipment and a fairly large amount of sample. In contrast, GC/MS is a rapid and
more sensitive technique. Electron impact (EI) or chemical ionization (CI) of glucose
derivatives generates ion fragments containing different carbon and hydrogen atoms of the
glucose molecule resulting from carbon bond cleavage at different positions. Mass
isotopomer analysis of ion fragments allows determination of 2H, or 13C-labeling at each
position in the glucose molecule. Guo et al. (1992) presented a GC/MS method for
quantitative assessment of the 2H-labeling pattern of glucose from measurements of eight
selected ion fragments obtained by two glucose derivatization methods. The aldonitrile
pentaacetate derivative of glucose yielded ion fragments at m/z 328, 242, 217, 212, 187, and
145; and the pentaacetate derivative of glucose yielded ion fragments at m/z 331 and 169.
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The authors derived expressions to calculate the enrichment of positional isomers of
glucose. However, the proposed method required the use of calibration curves and
correction factors to account for artifacts in the isotopomer data. For example, significant
deuterium-hydrogen exchange was observed for m/z 187 fragment. The authors also
reported isotope discrimination for m/z 169 and 328 fragments in samples containing 2H-
labeled glucose diluted with unlabeled glucose. Furthermore, the mass spectrum of m/z 145
fragment contained a constant contaminating ion amounting to 30 % of the total ion counts.
The authors proposed to correct for this by dividing the observed enrichment at m/z 145 by
0.7 to obtain the 'true' enrichment. However, even after all these corrections the estimated
2H-enrichments of glucose deviated up to 25% from the expected enrichments for mixtures
of glucose standard. Desage et al. (1989) presented a procedure to determine the 13C-labeling
pattern of glucose based on 6 methyloxime trimethylsilyl ion fragments of glucose at m/z
103, 160, 205, 217, 262, 319, and the assumption that glucose molecules are labeled
symmetrically. Beylot et al. (1993) provided an improved method for analysis of 13C-labeling
of glucose based on 21 selected ion fragments from four glucose derivatives, i.e. m/z 314,
242, 225, 217, 212, 200, and 187 from aldonitrile pentaacetate; m/z 319, 217, 205, 160, 117,
and 103 from methyloxime trimethylsilyl; m/z 297, 210, 181, and 168 from
bisbuthylboronate acetate; and m/z 149, 101, 88, and 75 from permethyl glucose. However,
both methods relied on ion fragments that were previously identified as inaccurate. Here, we
present an improved protocol for measuring the labeling of glucose by GC/MS. In this
study, we critically evaluated the accuracy and precision of more than 200 ion fragments
from 18 glucose derivatives. In addition to four widely used derivatization methods we
synthesized 14 novel derivatives of glucose that have not been reported previously. We
tested all ion fragments for accuracy and validated the assumed fragmentation patterns using
13C- and 2H-labeled standards, and by carefully prepared mixtures of glucose standards. The
accuracy was assessed by comparing the observed mass isotopomer distributions to
theoretical abundances for glucose standards. The vast majority of fragments that were
analyzed were inaccurate, including a number of the most widely used ion fragments. From
the 200+ analyzed ion fragments, we selected six most accurate ion fragments that provided
sufficient information for quantitative assessment of deuterium labeling of glucose. The
selected fragments were derived from three novel glucose derivatives, i.e. aldonitrile
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pentapropionate, di-O-isopropylidene propionate, and methyloxime pentapropionate. The
main result of this work is a detailed procedure for accurate assessment of deuterium
labeling in glucose for the entire range of enrichments (0 to 100 mol% enrichment), with an
accuracy of 0.3 mol0/o and precision of 0.2 mol%, or better.
5.2 Materials and methods
5.2.1 Materials
[1- 2H]glucose (97 At% 2H), [2- 2 H]glucose (97 At% 2H), and [6,6-2H2]glucose (98 At% 2H)
were purchased from IsoTec Inc. (Miamisburg, OH). [3-2H]glucose (98 At% 2H), [4-
2H]glucose (94 At%/o 2H), [5- 2H]glucose (98 At%/0 2H) were purchased from Omicron
Biochemicals (South Bend, IN). [U-13C6]glucose (99 At% 13C) and [1,2,3,4,5,6,6- 2H7]glucose
(98 At%/o 2H1-) were purchased from Cambridge Isotope Laboratories Inc. (Andover, MA).
Stock solutions of unlabeled and specifically labeled glucose standards were prepared at 10
mM in distilled water. For each derivatization procedure 50 tL of glucose standard was
evaporated to dryness under airflow. Tissue culture media for hepatocyte cultures were
obtained from Sigma (St. Louis, MO).
5.2.2 Hepatocyte isolation and cell culture
The procedure for hepatocyte isolation and cell culture was described in detail elsewhere
(Chapter 7). Briefly, hepatocytes were isolated from C57BL/6 mice fed ad libitum by
modified two step-collagenase perfusion as described by Seglen (1976). Purified cells were
suspended in Hepatocyte Attachment Medium (HAM) and seeded in 6-well plates (1.3x10 6
cells/well) for 90 minutes at 37 0C. Attached cells were washed once and cultured overnight
in Hepatocyte Growth Medium (HGM). After 18 hr incubation at 37 0C and 5% CO 2 the
attached hepatocytes were washed once and cultured in glucose-free HGM enriched with
gluconeogenic carbon sources, i.e. 1mM glycerol, 10 mM lactate, 1 mM pyruvate, 5 mM
glutamine, and 2 mM acetate. The cells were incubated for 2, 5, or 8 hr at 370C and 5% CO 2
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in medium containing 2H 20 at 10% enrichment. At the end of the incubation period
medium samples were collected and stored at -800 C prior to analysis.
5.2.3 Preparation of experimental samples for glucose derivatization
Deuterium labeling of glucose from experimental samples was determined by GC/MS
analysis of glucose aldonitrile pentapropionate, methyloxime pentapropionate and di-O-
isopropylidene propionate derivatives. For each derivatization procedure, 100 iL of medium
sample (-1 mM glucose) was deproteinized by addition of 300 pL of cold acetone, followed
by vortexing vigorously for 30 sec, and centrifugation at 2000xg for 1 min. The supernatant
was evaporated to dryness under airflow and the residue derivatized as described next.
5.2.4 GC/MS analysis
Gas Chromatography/Mass Spectrometry (GC/MS) analysis was performed using HP 5890
Series II gas chromatograph (GC) equipped with a DB-XLB (30 m x 0.25 mm i.d. x 0.25
ipm) capillary column, interfaced with a HP 5971 mass selective detector (MISD) operating
under ionization by electron impact (EI) at 70 eV. The mass spectrometer was calibrated
using the 'Max Sensitivity Autotune' setting. The injection volume was 1 [LL and samples
were injected in purged splitless mode. Helium flow was maintained at 0.88 mL/min via
electronic pressure control. The injection port temperature was 2500 C. The temperature of
the column was started at 800 C for 1 min, increased to 2800 C at 200 C/min, and held for 4
min. The interface temperature was maintained at 3000 C. Mass spectra were recorded over
the range of m/z 100-500 at a rate of 2.0 scans/sec. Measured intensities were corrected for
the contribution of background noise (baseline correction), and mass isotopomer
distributions were obtained by integration. Mass isotopomer values for each fragment were
expressed as fractional abundances, i.e. for each fragment the sum of all mass isotopomers
equals one. Reported mass isotopomer abundances are averaged values from at least four
injections per sample.
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5.2.5 Preparation of glucose esters
This procedure is based on that introduced by Biemann et al. (1963). Evaporated glucose
samples were dissolved in 50 p.L pyridine, followed by addition of 100 jiL of acetic,
propionic, or butanoic anhydride to obtain the respective acetate esters, or 70 g[L of N-
methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) + 1% trimethylchlorosilane (TMCS) to
obtain the trimethylsilyl (TMS) ether. After 30 min incubation at 600 C, samples were
evaporated to dryness, dissolved in 100 PL of ethyl acetate and transferred to injection vials
for GC/MS analysis.
5.2.6 Preparation of aldonitrile esters of glucose
This procedure is based on that introduced by Szafranek et al. (1974). Evaporated glucose
samples were dissolved in 50 jtL of hydroxylamine hydrochloride solution (20 mg/mL in
pyridine), heated at 900 C for 60 min, followed by addition of 100 piL of acetic, propionic, or
butanoic anhydride to obtain the respective aldonitrile acetate esters, or 70 [iL of MSTFA +
1% TMCS to obtain the aldonitrile TMS ether. After 30 min incubation at 600 C, samples
were evaporated to dryness, dissolved in 100 liL of ethyl acetate and transferred to injection
vials for GC/MS analysis.
5.2.7 Preparation of methyloxime esters of glucose
The basic procedure for preparing methyloxime esters of glucose is based on that introduced
by Laine and Sweeley (1971), and is essentially identical to the aldonitrile method, except that
methylhydroxylamine hydrochloride solution (20 mg/mL in pyridine) is used in the first
reaction instead of hydroxylamine hydrochloride solution.
5.2.8 Preparation of di-O-isopropylidene esters of glucose
This procedure is based on that presented by Hachey et al. (1999). Glucose samples were
transferred to a 10 mL screw-cap culture tube and evaporated to dryness. 500 ýiL of 0.38 M
sulfuric acid in acetone was added, and samples were incubated at room temperature for 60
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min. 400 jiL of 0.44 M sodium carbonate was added to neutralize the reaction, followed by
addition of 1 mL of saturated sodium chloride. The di-O-isopropylidene derivatives were
extracted by partitioning with 1 mL of ethyl acetate. The upper, organic layer was evaporated
to dryness. 100 iL of acetic, propionic, or butanoic anhydride was added to obtain the
respective acetate esters, or 70 41L of MSTFA + 1% TMCS to obtain the respective TMS
ether. After 30 min incubation at 600 C, samples were evaporated to dryness, dissolved in 100
ptL of ethyl acetate and transferred to injection vials for GC/MS analysis.
5.2.9 Preparation of permethyl and perethyl derivatives of glucose
This procedure is based on that introduced by Ciucanu and Kerek (1984) and recently
updated by Ciucanu and Caostello (2003). A cloudy suspension of NaOH powder in DMSO
was prepared (0.25 g/mL), vortexed vigorously, and 100 p.L of the suspension was added to
the glucose samples, followed by incubation at room temperature for 3 min. 75 pL of
iodomethane, or iodoethane was then added to the samples, and the samples were incubated
at room temperature for 6 min to obtain the respective permethyl and perethyl derivatives. 1
mL of chloroform and 2 mL of distilled water were added, and the samples were vortexed
vigorously. The top, aqueous layer was removed and the organic layer washed at least three
times with 2 mL of distilled water, or until the aqueous layer was no longer basic. The
organic layer was then evaporated to dryness, dissolved in 100 4tL of ethyl acetate and
transferred to injection vials for GC/MS analysis.
5.2.10 Data analysis
The amount of deuterium enrichment at each carbon position was determined using a least-
squares approach. First, we constructed a simulation model that predicts the mass
isotopomer distributions of selected ion fragments for a given isotopomer distribution of
glucose hydrogen atoms. Isotopomers are isomers of a metabolite that differ only in the
labeling state of their individual atoms, i.e. 2H vs. IH in deuterium labeling studies. For the
seven stable (i.e. carbon bound) hydrogen atoms of glucose that may be in one of two
(labeled or unlabeled) states, we have 128 (=27 ) possible isotopomers. Our simulation model
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predicts mass isotopomer abundances of glucose fragments taking into account natural
isotope enrichments of carbon, oxygen, hydrogen, nitrogen and silicon atoms.
x = [mid 301, midi45, mid 173, mid 259, mid2 84, mid 370 ] = f(IDV) (5.1)
In Eq. 5.1, midmiz denotes the simulated mass isotopomer distributions of a particular ion
fragment, and IDV is the isotopomer distribution vector. To determine IDV from
experimental data we solve the following least-squares regression problem:
min = (X - Xobs) . (X - obs)T (5.3)
s.t. x = f(IDV)
0 • IDVi < 1
Z IDVi = 1
Where the objective function (D is the sum of squared residuals, x is the vector of simulated
mass isotopomer abundances, and Xobs is the vector measured (i.e. uncorrected) mass
isotopomer abundances. From the estimated IDV, we then calculated positional deuterium
enrichments via a linear transformation:
[ D 1, D2, D3, D4, D 5, D66 ] = T IDV (5.2)
Where T is a constant transformation matrix. We identify the deuterium enrichment of C-H
in carbon 1 as D1, the enrichment in carbon 2 as D 2, and so forth. Since there are two
hydrogen atoms at carbon 6 that cannot be distinguished, we only determined the average
enrichment at carbon 6, i.e. D6 = D66/2.
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5.3 Results
5.3.1 Synthesis and evaluation of glucose derivates
We synthesized 18 glucose derivatives and analyzed them in detail by electron impact
GC/MS. We created four families of related glucose derivatives based on four commonly
used derivatization methods, i.e. aldonitrile pentaacetate, pentaacetate, methyloxime
trimethylsilyl, and permethyl glucose. Figure 5-1 illustrates the basic two step procedure for
generating all glucose derivatives. In the first step, we derivatized the carbonyl group at C1
of glucose to produce aldonitrile and methyloxime derivatives via reaction with
methylhydroxylamine and hydroxylamine, respectively. Alternatively we produced the di-O-
isopropylidene derivate via reaction with acetone. In the second step, we derivatized the
hydroxyl groups of glucose with acetic, propionic, or butanoic anhydride to obtain the
respective esters, or with iodomethane, iodoethane, or N-methyl-N-
trimethylsilyltrifluoroacetamide to obtain the permethyl, perethyl, and trimethylsilyl ethers of
glucose, respectively. We successfully generated 18 of the 24 possible glucose derivatives
based on this two step procedure. We obtained electron impact mass spectra for all 18
glucose derivatives for unlabeled and specifically labeled glucose standards. The 18 mass
spectra for unlabeled glucose are shown in Appendix B. For each glucose derivative we
identified the most abundant ion fragments (shown in Table 5-1), and quantified the mass
isotopomer distributions. To assign structural positions of glucose carbon and hydrogen
atoms to each ion fragment, mass spectra of specifically labeled glucose standards were
analyzed: [1- 2H]-, [2- 2H]-, [3- 2H]-, [4- 2H]-, [5- 2H]-, [6,6- 2H2]-, [1,2,3,4,5,6,6- 2H7]-, and [U-
13C6]glucose. For example, the mass spectrum of aldonitrile pentapropionate glucose was
characterized by fragments arising from bond cleavage at C5-C6 (m/z 240 and 370), C4-C5
(m/z 173 and 284), C3-C4 (m/z 259), and C2-C3 (m/z 345) positions. These assignments
were apparent from increases in m/z for specifically labeled glucose standards. Based on
these assignments we postulated chemical formulae for all ion fragments and calculated
theoretical mass isotopomer distributions. We then compared the observed mass isotopomer
abundances for unlabeled and singly labeled glucose standards to theoretical abundances.
Fragments with abundances deviating more than 0.4 mrol% were considered inaccurate.
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Figure 5-1: Schematic of the two step procedure for generating glucose derivatives. In the
first reaction step the carbonyl group at C1 of glucose is derivatized, and in the second
reaction step hydroxyl groups of glucose are derivatized. Based on this procedure 18
different glucose derivatives were successfully synthesized and analyzed by GC/MS.
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Table 5-1
Overview of 18 derivatives of glucose that were synthesized and analyzed by electron impact
GC/MS. For each derivative, the most abundant ion fragments (m/z) were identified and
mass isotopomer distributions were analyzed for accuracy. The six most accurate ion
fragments are shown in bold and underlined.
1St reaction step -- none Isopropylidene Aldonitrile Methyloxime
J, 2nd reaction step
Acetate 98, 103, 109, 115, 109, 113, 127, 143, 103, 115, 127, 141, 85,89, 115, 127,
140,145,157,169, 169, 185,201,229, 145,157,187,212, 131,145,155,173,
200, 242, 331 287 217, 225, 242, 272, 187, 197, 215, 226,
314 257,286,289,331
Propionate 109, 129, 131,154, 109, 113, 127,157, 129,131,141,155, 89,112, 141,145,
183,185,187,210, 1.83,215, 243, 301 173, 185, 187,197, 155,198,201,215,
227, 284, 387 215, 240, 253, 259, 254, 328, 345, 384,
284, 345, 370, 384 387,416
Butanoate 98, 110,127,143, 109,113,127,171, 112,143,155,159, 89,112, 124, 138,
159, 168, 186, 198, 197,229,257,315 169, 193, 201, 211, 155, 159,212,229,
213, 229, 255, 302, 213, 229, 243, 268, 243, 282, 370, 401,
326,444 281,301,326,370, 443
426, 440
Trimethylsilyl 103,117,129,133, 129,131,143,145, 103,117,129,133, 103, 117,129,133,
147,191,204,217, 173, 185,201,231, 147,157,189,191, 147,160,189,205,205,217,229,291,
305 259,317 319 217,229,291,319,
364
Permethyl* 75, 88, 101, 149 n/a n/a n/a
Perethyl* 103,116,129,191. n/a n/a n/a
* 'n/a' indicates that we were unable to synthesize this particular derivative of glucose.
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Figure 5-2: Overview of positional information obtained from the selected glucose
fragments. Glucose carbon and hydrogen positions included in the selected ion fragments
are: m/z 173 (C5-6, H5-6), m/z 259 (C4-6, H4-6), m/z 284 (C1-4, H2-4), and m/z 370 (Cl-s, H2-5)
all derived aldonitrile pentapropionate glucose; m/z 301 (C1-6, H1-6) derived from di-O-
isopropylidene propionate glucose; and m/z 145 (C1-2, H1-2) derived from methyloxime
pentapropionate glucose.
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Figure 5-3: Electron impact mass spectra of the selected glucose derivatives. The three
panels show the electron impact mass spectra of aldonitrile pentapropionate (top), di-O-
isopropylidene propionate (middle), and methyloxime pentapropionate glucose (bottom).
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Table 5-2
Evaluation of accuracy of selected glucose fragments. We compared measured and
theoretical mass isotopomer abundances of the selected ion fragments at m/z 301 (di-O-
isopropylidene propionate), m/z 145 (methyloxime pentapropionate), and m/z 173, 259,
284, and 370 (aldonitrile pentapropionate) for unlabeled glucose. Data shown are mean ± SD
(n=6) (molar percentages, mol%).
m/z C-H
(formula) positions M+0 M+1 M+2 M+3 M+4
301 1,2,3,4,5,6,6 measured 84.1 ± 0.15 13.5 ± 0.11 2.2 ± 0.10 0.2 ± 0.08 0.0 ± 0.01
(C14H210 7) theory 84.2 13.4 2.2 0.2 0.0
145 1,2 measured 92.3 ± 0.05 6.8 ± 0.03 0.8 ± 0.01 0.1 ± 0.01 0.0 ± 0.00
(C6H1103N) theory 92.5 6.7 0.8 0.0 0.0
173 5,6,6 measured 90.6 ± 0.02 8.2 ± 0.02 1.1 ± 0.02 0.1 ± 0.01 0.0 ± 0.00
(CSH 130 4) theory 90.6 8.3 1.1 0.1 0.0
259 4,5,6,6 measured 86.2 ± 0.09 11.7 ± 0.07 1.8 ± 0.02 0.2 ± 0.01 0.0 ± 0.00
(C12H190 6) theory 86.2 11.8 1.8 0.2 0.0
284 2,3,4 measured 85.2 ± 0.10 12.7 ± 0.05 1.9 ± 0.03 0.2 ± 0.04 0.0 ± 0.02
(C13Ht 80 6N) theory 85.0 12.8 1.9 0.2 0.0
370 2,3,4,5 measured 81.1 ± 0.02 15.7 ± 0.05 2.9 ± 0.01 0.3 ± 0.03 0.0 ± 0.01
(C17H24 08N) theory 80.9 15.9 2.8 0.4 0.0
Data shown are the observed mass isotopomer abundances obtained from mass chromatogram
integration, i.e. not corrected for natural isotope enrichments.
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We evaluated over two hundred ion fragments. From these fragments, we then selected the
six most accurate fragments that provided sufficient information for quantitative assessment
of deuterium labeling at all carbon positions of glucose. These selected fragments were
derived from three novel glucose derivatives: aldonitrile pentapropionate ion fragments at
m/z 173 (C5-6, H 5-6), m/z 259 (C4-6, H4-6), m/z 284 (C1-4, H2-4), and m/z 370 (C1_s, H2-5); di-
O-isopropylidene propionate ion fragment at m/z 301 (C1-6, HI-6); and methyloxime
pentapropionate ion fragment at m/z 145 (CI-2, H 1-2). Figure 5-2 shows schematically the
positional information that is obtained from these fragments. The electron impact mass
spectra of the three glucose derivatives are shown in Figure 5-3. In Table 5-2 we compare
the measured and theoretical mass isotopomer distributions for the selected ion fragments.
As expected, we observed very good agreement between the theoretical and observed
abundances, i.e. the maximum deviation was 0.2 mol%, and the measurement precision
better than 0.15 mol% (i.e. standard deviation of 6 repeated injections).
5.3.2 Determining deuterium labeling of glucose standards
To assess the accuracy of our method for determining positional enrichments of singly
labeled glucose, we obtained mass spectra for specifically 2H-labeled glucose standards, i.e.
[1- 2H]-, [2-2H]-, [3- 2H]-, [4- 2H]-, [5- 2H]-, and [6,6-2H2]-glucose, and quantified the mass
isotopomer distributions for the selected ion fragments. Table 5-3 shows the observed mass
isotopomer distributions (data not corrected for natural isotope enrichments). The
deuterium enrichments at the six glucose carbon positions were determined by least-squares
regression as described in the Methods section. Table 5-4 shows the estimated enrichments
at each carbon position for the purchased glucose standards. The estimated values
corresponded well with the expected enrichments based on manufacturers' specifications for
isotopic purity. All singly labeled glucose standards showed slight contaminations at various
carbon positions. The least pure of the glucose standards was [4- 2H]glucose, which was
92.3% labeled at C4 and had significant contaminations at C1 and C2 (2.9 mol% and 1.9
mol% enrichment, respectively), compared to 94 At% 2H-labeling according to
manufacturers' specifications. The most pure of the glucose standards was [5-2H]glucose,
which was 99.8% labeled at C5 and had only a small contamination at C1 (0.8 mol%
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Table 5-3
Mass isotopomer distributions of selected ion fragments from 2H-labeled glucose standards.
Specifically labeled glucose standards were derivatized and analyzed by electron impact
GC/MS. Data shown have not been corrected for natural isotope enrichments.
m/z C-H positions M+0 M+1 M+2 M+3 M+4
-... -.......... .......... [1- 2-- -g --UCOS
301 1,2,3,4,5,6,6 0.0 82.1 15.1 2.5 0.3
145 1,2 0.2 89.4 9.4 1.0 0.1
173 5,6,6 90.6 8.2 1.1 0.1 0.0
259 4,5,6,6 86.5 11.6 1.8 0.2 0.0
284 2,3,4 82.7 14.9 2.2 0.2 0.1
370 2,3,4,5 78.8 17.5 3.3 0.4 0.0
[2- 2 -]glucose
301 1,2,3,4,5,6,6 0.0 83.1 14.3 2.4 0.2
145 1,2 0.8 90.4 7.8 0.9 0.1
173 5,6,6 90.5 8.3 1.1 0.1 0.0
259 4,5,6,6 86.3 11.7 1.9 0.2 0.0
284 2,3,4 0.8 84.6 12.6 1.9 0.2
370 2,3,4,5 0.8 80.7 15.4 2.8 0.4
................................... 3 O.............
301 1,2,3,4,5,6,6 1.3 81.3 14.7 2.4 0.3
145 1,2 90.0 8.9 1.0 0.1 0.0
173 5,6,6 90.5 8.3 1.1 0.1 0.0
259 4,5,6,6 86.3 11.6 1.9 0.2 0.0
284 2,3,4 1.1 83.3 13.3 2.0 0.2
370 2,3,4,5 0.9 79.8 16.1 3.0 0.4
301 1,2,3,4,5,6,6 4.1 80.8 12.7 2.1 0.2
145 1,2 87.5 11.2 1.2 0.1 0.0
173 5,6,6 90.4 8.3 1.1 0.1 0.0
259 4,5,6,6 6.1 81.1 10.9 1.7 0.2
284 2,3,4 5.1 80.9 12.0 1.8 0.2
370 2,3,4,5 4.5 77.5 15.0 2.7 0.3
-167-
CHAPTER 5. GC/MS ANALYSIS OF GLUCOSE
Table 5-3 (continued)
Mass isotopomer distributions of selected ion fragments from 2H-labeled glucose standards.
Specifically labeled glucose standards were derivatized and analyzed by electron impact
GC/MS. Data shown have not been corrected for natural isotope enrichments (molar
percentages, mol%).
m/z C-H positions M+0 M+1 M+2 M+3 M+4
[5- 2H]glucose
301 1,2,3,4,5,6,6 0.0 84.1 13.4 2.2 0.2
145 1,2 91.3 7.7 1.0 0.1 0.0
173 5,6,6 0.0 90.6 8.3 1.1 0.1
259 4,5,6,6 0.0 86.4 11.6 1.8 0.2
284 2,3,4 85.0 12.9 1.9 0.2 0.0
370 2,3,4,5 0.0 81.0 15.7 2.9 0.4
[6,6-2H2]glucose
301 1,2,3,4,5,6,6 0.1 2.9 79.3 14.9 2.6
145 1,2 91.3 7.0 1.6 0.2 0.0
173 5,6,6 0.6 1.5 86.2 10.4 1.3
259 4,5,6,6 0.3 2.3 81.8 13.5 2.2
284 2,3,4 84.8 12.8 2.2 0.2 0.0
370 2,3,4,5 78.6 17.5 3.3 0.4 0.2
Data shown are integrated mass isotopomer abundances not corrected for natural isotope
enrichments.
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Table 5-4
Estimated deuterium enrichments of glucose standards. Deuterium enrichments (mol%
enrichment) at the six glucose carbon positions were determined by least-squares regression
of mass isotopomer distributions of selected glucose fragments as described in the Methods
section. Numbers in parentheses denote manufacturers' specifications of isotopic purity.
Glucose standard
[1-2H]- [2-2H]- [3-2H]- [4-2H]- [5-2H]- [6,6-2H2]-
glucose glucose glucose glucose glucose glucose unlabeled
Position (97 At%) (97 At%) (98 At%) (94 At%) (98 At%) (98 At%) glucose
D1  99.7 2.1 1.4 2.9 0.8 0.8 0.1
D2 2.6 98.2 1.6 1.9 0.2 0.2 0.0
D3 0.2 1.0 97.8 0.0 0.0 0.0 0.0
D4 0.0 0.0 0.0 92.3 0.0 0.2 0.0
Ds 0.0 0.0 0.0 0.1 99.8 2.4 0.0
D66/2 0.0 0.0 0.0 0.0 0.1 95.8 0.0
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Table 5-5
Mass isotopomer distributions of mixtures of glucose standards. Solution of [2-2H]- and [5-
2H]glucose was prepared (1:1 mol/mol) and diluted with unlabeled glucose solution to
obtain final deuterium enrichments at C2 and C5 of 1%, 5%, 10%, and 50%, respectively.
m/z C-H positions M+0
[2- 2H]glucose
301
145
173
259
284
370
1,2,3,4,5,6,6
1,2
5,6,6
4,5,6,6
2,3,4
2,3,4,5
0.0
46.6
44.5
42.3
44.1
0.1
M+1 M+2
+ [5-2H]glucose (50:50)
M+3 M+4
83.1 14.3
48.7 4.2
50.1 4.8
49.8 6.9
47.8 7.1
81.0 15.7
12- 2HIglucose + 15- 2Hglucose + unlabeledglucose (10:10:80)
...................................................................... 2 . ....... ............. ............................................................................... ............................ .................................... ...........................
301 1,2,3,4,5,6,6 68.4 26.7 4.3 0.6 0.0
145
173
259
284
370
1,2
5,6,6
4,5,6,6
2,3,4
2,3,4,5
83.3
81.3
77.4
77.0
65.4
15.1
16.7
19.4
19.5
28.4
....................................................................................... . . ... ...............................................................................
301 1,2,3,4,5,6,6 76.0 20.2 3.3 0.4 0.0
145 1,2 87.6 11.2 1.1 0.1 0.0
173 5,6,6 85.7 12.6 1.5 0.1 0.0
259 4,5,6,6 81.9 15.6 2.3 0.3 0.0
284 2,3,4 80.8 16.1 2.5 0.4 0.2
370 2,3,4,5 72.9 22.3 4.1 0.6 0.1
.._.._..._......Hg.......... -?H ucose + 15-2 -]glucose + unlabeled lucose (1:1:98)
301 1,2,3,4,5,6,6 82.4 14.9 2.5 0.3 0.0
145 1,2 91.5 7.7 0.7 0.1 0.0
173 5,6,6 89.6 9.1 1.2 0.1 0.0
259 4,5,6,6 85.2 12.7 2.0 0.2 0.0
284 2,3,4 84.2 13.3 2.2 0.2 0.1
370 2,3,4,5 79.2 17.2 3.2 0.4 0.0
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Table 5-6
Estimated deuterium enrichments of mixtures of glucose standards. Deuterium enrichments
(mol% enrichment) at the six glucose carbon positions were determined by least-squares
regression of mass isotopomer distributions of selected glucose fragments. The estimated
enrichments corresponded well with the expected enrichments at C2 and C5 of 0%, 1%, 5%,
10%, and 50%, respectively.
Mixture of standards
[2- 2H]glucose + [5- 2H]glucose + unlabeled glucose
Position 0:0:100 1:1:98 5:5:90 10:10:80 50:50:0
D1  0.1 0.1 0.3 0.2 1.5
D2 0.0 1.0 4.9 9.6 48.7
D3 0.0 0.0 0.0 0.0 0.0
D4 0.0 0.1 0.0 0.0 0.0
Ds 0.0 1.0 5.0 9.8 51.0
D66/2 0.0 0.0 0.0 0.1 0.0
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enrichment). The estimated enrichments for the unlabeled glucose standard were not
significantly different from zero, i.e. the highest estimated enrichment was 0.1 mol% at C1.
These results clearly illustrate the validity of our method and the high accuracy and precision
of MS data obtained from the selected ion fragments.
To assess the accuracy of determining deuterium labeling specifically at C2 and C5 positions
of glucose, a standard mixture of [2- 2H]glucose and [5- 2H]glucose was prepared in the
proportion 1:1 (mol/mol). Solution of the standard mixture was then diluted with unlabeled
glucose solution to obtain final deuterium enrichments at C2 and C5 positions of 1%, 5%,
10%, and 50% (undiluted), respectively. Table 5-5 shows the measured mass isotopomer
distributions for the 4 mixtures of glucose standards. Table 5-6 shows the estimated
enrichments at each carbon position. The estimated enrichments at C2 and C5 corresponded
well with the true enrichments of the prepared mixtures. The deviation from the expected
enrichments was less than 0.3 mol%. Furthermore, the estimated enrichments at C1, C3, C4
and C6 positions were not statistically different from zero for three of the four mixtures.
The observed 1.5 mol% enrichment at C1 in the 50/50% mixture could be explained by
small contaminations at C1 in the [2-2H]glucose and [5- 2H]glucose standards (see Table 5-4).
5.3.3 Study of gluconeogenesis
Incorporation of deuterium into glucose in experiments with 2H20 depends on a number of
biochemical reactions where hydrogen atoms are exchanged with, or incorporated from the
solvent. Incorporation at C2 occurs mainly via PGI. It is generally assumed that there is
rapid exchange between F6P and G6P catalyzed by PGI, and thus we would expect that the
labeling at C2 is equal to the enrichment of the solvent. If that is indeed the case, then the
overall flux of hepatic glucose production can be measured by the incorporation of
deuterium at C2. Incorporation at C5 occurs in the gluconeogenesis pathway, in particular in
the reactions catalyzed by enolase and TPI. Deuterium incorporation at C1 and C6 positions
occurs via the pyruvate -> oxaloacetate -4 PEP pathway. Therefore, the ratio of enrichment
of C5 to that of C2 is a measure of gluconeogenesis relative to glucose production, and the
ratio of enrichment of C6 to that of C2 is a measure of the contribution of PEP to glucose
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production. The difference between incorporation at C5 and C6 relative to C2 represents the
amount of glucose produced from trioses (including glycerol). In a previous study with
cultured primary hepatocytes we applied [U- 13C]glycerol, [2Hs]glycerol and 2H20 tracers to
estimate net and reversible fluxes in the gluconeogenesis pathway (Chapter 7). Our results
suggested that TPI and PGI reactions were not fully equilibrated. In particular, we estimated
that the PGI reaction was only 80-86% equilibrated. Based on our flux results we predicted
that the labeling of GAP-C2 (which eventually becomes C5 of glucose) would be >95%
equilibrated with the solvent (mainly via the enolase reaction), and that C2 of glucose would
only be 80% equilibrated with the solvent. To validate these predictions we re-analyzed our
samples from 2H 20 experiments (10% enrichment) using the newly identified glucose
fragments, and estimated the amount of deuterium at each carbon position of glucose.
Table 5-7 shows the measured mass isotopomer distributions for three experimental samples
taken at 2, 5, and 8 hr, respectively, and Table 5-8 shows the estimated deuterium
enrichments at all carbon positions. In all three samples the deuterium labeling at C2 was
incomplete. The measured deuterium labeling at C2 varied between 8.1 and 8.6%, indicating
81- 8 6 % equilibrium between the solvent and C2 hydrogen of glucose. Thus, these results
fully support our previous finding that the PGI reaction was not fully equilibrated. Table 5-9
shows the fractional contributions of gluconeogenesis, glycogenolysis, glycerol, and PEP to
glucose production, as we estimated from the deuterium labeling of glucose. Here,
gluconeogenesis (GNG) was estimated as the ratio of enrichment of C5 relative to that of
the solvent, glycogenolysis (GL) was estimated as 100 - GNG, the flux of PEP to glucose as
2 x enrichment of C6 relative to that of the solvent, and the flux of glycerol to glucose as 2 x
GNG - flux of PEP to glucose. Fractional equilibration of the PGI reaction was estimated
from the ratio of enrichment of C2 relative to that of the solvent. Table 5-9 compares these
estimated fluxes to the previously determined fluxes based on comprehensive analysis of
isotopomer data from [U-13C]glycerol, [2Hs]glycerol, and 2H20 experiments. We found good
agreement between fluxes estimated from deuterium incorporation and our previous results.
Compared to the previous results GNG was slightly underestimated (by about 10%), and
GL slightly overestimated. Note that if we used the C5/C2 ratio as a measure of GNG, then
we would have overestimated GNG at 85%, 106%, and 105% for the 2, 5, and 8 hr samples,
respectively.
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Table 5-7
Mass isotopomer distributions of experimental samples. Hepatocytes were cultured in
medium containing 2H20 at 10% enrichment. Samples collected after 2, 5, and 8 hrs of
incubation were derivatized and analyzed by GC/MS. Shown are mass isotopomer
distributions of selected glucose fragments (molar percentages, mol%/).
m/z C-H positions M+0 M+1 M+2 M+3 M+4
Sample collected after 2 hr of incubation
301 1,2,3,4,5,6,6 56.3 31.5 9.8 2.2 0.2
145 1,2 81.1 16.6 2.1 0.2 0.0
173 5,6,6 76.5 19.7 3.3 0.4 0.1
259 4,5,6,6 69.1 24.7 5.3 0.8 0.1
284 2,3,4 70.4 23.7 5.0 0.9 0.0
370 2,3,4,5 62.0 29.1 7.6 1.3 0.1
Sample collected after 5 hr of incubation
301 1,2,3,4,5,6,6 54.1 32.8 10.5 2.3 0.4
145 1,2 80.2 17.6 2.1 0.2 0.0
173 5,6,6 75.7 20.7 3.2 0.4 0.0
259 4,5,6,6 68.0 25.6 5.4 0.9 0.1
284 2,3,4 69.3 24.9 4.9 0.8 0.1
370 2,3,4,5 60.5 29.8 8.0 1.5 0.2
............................................................................................................................  ........... .  .....................................................
301 1,2,3,4,5,6,6 53.1 33.2 10.9 2.4 0.4
145 1,2 79.8 17.9 2.1 0.2 0.0
173 5,6,6 75.0 21.1 3.4 0.4 0.0
259 4,5,6,6 67.3 26.2 5.6 0.9 0.1
284 2,3,4 69.0 25.1 4.9 0.9 0.1
370 2,3,4,5 60.1 30.3 7.9 1.5 0.2
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Table 5-8
Estimated deuterium enrichments of experimental samples. Deuterium enrichments (mol%/o
enrichment) at the six glucose carbon positions were determined for three experimental
samples from hepatocyte cultures with 2H20 at 10% enrichment.
Length of incubation time
Position 2 hr 5 hr 8 hr
D, 4.2 5.7 6.1
D2 8.6 8.1 8.2
D3  5.4 6.4 6.6
D4 5.0 5.6 5.7
D5  7.3 8.6 8.6
D66/2 5.0 4.6 5.1
- 175 -
CHAPTER 5. GC/MS ANALYSIS OF GLUCOSE
Table 5-9
Comparison of previously estimated fluxes and fluxes determined from deuterium
incorporation. Metabolic fluxes in the gluconeogenesis pathway were previously estimated
by fitting experimental data from [U-13C]glycerol, [2H5]glycerol, and 2H 20 experiments to a
detailed flux model (Chapter 7). In this study, fluxes were estimated from the incorporation
of deuterium into specific carbon positions of glucose from 2H20 experiments.
2 hr 5 hr 8 hr
This Previous This Previous This Previous
Flux study study study study study study
Glucose production (fixed at 100) 100 100 100 100 100 100
Gluconeogenesis (GNG) 73 81 86 90 86 90
Glycogenolysis (GL) 27 18 14 10 14 10
Glycerol to glucose flux 46 70 80 72 70 67
PEP to glucose flux 100 92 92 108 102 114
Equilibration of PGI (%) 86% 79% 81% 81% 82% 86%
* 'Previous study' refers to flux results from Chapter 7
* GNG = 2H-C5 / 10%
* GL = 100 - GNG
* PEP to glucose flux = 2H-C6 / 10%
* Glycerol to glucose flux = 2 x GNG - (flux of PEP to glucose)
* Equilibration of PGI = 2H-C2 / 10%
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5.4 Discussion
Measured mass isotopomer distributions may deviate from true isotopomer abundances for
many reasons, e.g. unresolved metabolite peaks, overlapping mass spectra of adjacent ion
fragments, hydrogen abstraction, deuterium-hydrogen exchange, gas phase ion/molecule
chemistry in the ionization chamber, isotope discrimination during ionization and detection,
sample size effects, and imprecision due to low signal-to-noise ratio and background noise.
Mass isotopomer data may therefore underestimate, or overestimate true enrichments.
Because positional enrichments are determined from differences in enrichments of different
ion fragments, small errors in data propagates to the calculated positional enrichments as
large deviations. Thus, mass isotopomer data of individual ion fragments should be as
accurate as possible. In this study, we developed a novel protocol for accurate determination
of positional deuterium labeling of glucose that avoids the use of calibration curves and
correction factors by ensuring that data from the selected ion fragments are very accurate
and precise. In order to find the most accurate ion fragments we synthesized 18 different
glucose derivatives and evaluated over 200 ion fragments. We used specifically labeled
standards for structural assignments and for validating the accuracy of mass isotopomer
distributions. The six selected ion fragments provided sufficient information to determine
positional 2H-labeling of glucose hydrogen atoms with precision. Comprehensive analysis of
mass isotopomer distributions by least-squares regression allowed quantitative determination
of glucose labeling from pure glucose standards, mixtures of glucose standards, and from
experimental samples. Our method determines positional enrichments of deuterium with
accuracy better than 0.3 mol% and precision better than 0.2 mol%. An example of
quantification of deuterium incorporation into glucose was provided in a study of
gluconeogenesis in cultured primary hepatocytes. We found that 42-61% deuterium atom
was incorporated into C1, 81-86% into C2, 54-66% into C3, 50-57% into C4, 73-86% into
C5, and 46-51% into C6 of glucose. These deuterium enrichments indicated that 14-27% of
glucose was derived from glycogenolysis and that gluconeogenesis accounted for the
remaining 7 3 -8 6 %. In support of our previous finding that suggested incomplete
equilibration of PGI, we found that deuterium labeling at C2 of glucose in 2H20
experiments was incomplete.
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Chapter 6
Nonstationary metabolic flux analysis
of E. coli
6.1 Introduction
Isotopic tracer experiments are routinely used to quantify fluxes in biochemical networks
(Stephanopoulos, 1999). In a typical carbon-13 labeling experiment, a labeled substrate, e.g.
[1- 13C]glucose, is introduced to the metabolic system where it is taken up and metabolized by
the cells. Atoms of the specifically labeled substrate are biochemically rearranged generating
molecules with specific labeling patterns that can be detected by nuclear magnetic resonance
(NMR) and mass spectrometry (MS) (Klapa, 2003; Szyperski 1995). The labeling patterns of
cellular components provide rich information for the estimation of metabolic fluxes. The
goal of metabolic flux analysis (MFA) is to extract as much flux information as possible from
stable isotope measurements and external flux measurements. Currently, MFA requires that
the system is at metabolic and isotopic steady state, i.e. that the labeling of the substrate and
the labeling of the sampled pools are equilibrated (Wiechert et al. 2001). For example, this
condition is approximated in continuous culture experiments after four or more residence
times. The isotopic steady state assumption simplifies the computational problem that needs
to be solved for flux determination from a problem with differential-algebraic equations
(DAE) to a problem involving only algebraic equations (Wiechert et al., 2005). In this
contribution, we extend the scope of MFA to nonstationary systems, i.e. systems that do not
approximate isotopic steady state, without increasing the complexity of computations. The
extension of MFA to nonstationary systems is important because many systems of industrial
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and medical importance never reach isotopic steady state (Drysch et al. 2003; Kelleher 2001).
To account for isotopic transients we have developed a novel modeling strategy that
combines key ideas from isotopomer spectral analysis (ISA) and stationary MFA. ISA was
initially introduced as a general method for modeling polymerization biosynthesis reactions
in systems that do not approximate isotopic steady state (Kelleher and Masterson, 1992). In
analogy with the ISA method we introduce two dilution parameters to account for the
observed isotopic transients. These parameters are the dilution of the tracer before it is
metabolized by cells (the D-parameter), and the dilution of labeled products in the sampled
pools (the G-parameter). We illustrate the new modeling strategy with a nonstationary
system that closely resembles industrial production conditions, i.e. microbial fed-batch
fermentation of E. coli that overproduces 1,3-propanediol (PDO). In this experiment neither
the labeling of the tracer, nor the labeling of the sampled biomass pools were at isotopic
steady state. Metabolic fluxes were estimated in this system by fitting labeling profiles of
cellular amino acids (measured by GC/MS) and external flux measurements to a detailed
model of E. coli metabolism that included the additional dilution parameters. We obtained an
over-determined system with 66 redundant measurements from which we calculated
metabolic fluxes and confidence intervals of fluxes. With the additional D and G parameters
we successfully modeled the observed isotopic transients and for the first time determined
time profiles of in vivo fluxes during a fed-batch fermentation. The fits were statistically
acceptable as judged by the small magnitude of the sum of squared residuals. Flux results
provided insights into the physiology of industrial overproduction of PDO. The results
indicated that intracellular fluxes were relatively constant during the fed-batch fermentation.
The intracellular flux associated with production of PDO increased only by 10% during 20
hr of fermentation, which was in contrast with the efflux of PDO that fluctuated
significantly. We observed only a slight decrease in the split ratio at the branch point
between glycolysis and pentose phosphate pathway. The TCA cycle flux, on the other hand,
remained constant throughout the fermentation. The general modeling strategy that is
introduced here is not limited to fed-batch fermentations, but may be used to analyze other
metabolic systems that are not at isotopic steady state.
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6.2 Materials and methods
6.2.1 Stable isotope tracers
Isotopically labeled glucose tracers, i.e. [1-a 3C]glucose (99 AtO/ 13C) and [U- 13C]glucose (99
At%/o 13C) were purchased from IsoTec Inc. (Miamisburg, OH) and Cambridge Isotope
Laboratories Inc. (Andover, MA), respectively.
6.2.2 Medium
Defined mineral salts medium was used for the fermentation. The unlabeled feed contained
46.2 wt/o glucose as the carbon source. The '3C-labeled feed was chemically identical, but
contained 75 wt%/o [1- 13C]glucose and 25 wt%/o [U-13 C]glucose instead of unlabeled glucose.
6.2.3 Strain and growth conditions
In this study, we used an E. coli K12 strain that was metabolically engineered to overproduce
1,3-propanediol (Nakamura, 2003). The cultivation was performed as a fed-batch
fermentation (see Figure 6-1). E. co/i was cultured in an aerobic fermentor with a working
volume of 1 L. The pH was controlled at 6.8 ± 0.04 by addition of NH40H, the temperature
was controlled at 34 oC, and the dissolved oxygen was controlled at 10% ± 0.7 of saturation
by adjusting the stirrer speed. The aeration rate was constant at 0.5 standard liters per minute
(SLPM). The batch phase was initiated with 45.1 g of unlabeled glucose medium. Glucose
feed was initiated after 16.3 hr and controlled such that glucose concentration in the medium
was maintained at 45 ± 5 mM. After 18.6 hr, unlabeled glucose feed was replaced with 13C-
labeled glucose feed containing 75 wt0 /o [1- 13C]glucose and 25 wt% [U-13C]glucose. After
30.0 hr, labeled glucose feed was replaced with unlabeled glucose feed and the fermentation
was continued for 14.6 hr.
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Figure 6-1: A schematic of fed-batch fermentation setup and measurement points. The fed-
batch fermentation was performed in an aerobic fermentor with a working volume of 1 L.
The pH was controlled at 6.8, the dissolved oxygen at 10% of saturation, and glucose
concentration at 45 mM. Online measurements included: weight of the fermentor and feed
bottles (scales), flow rate of the inlet air stream (flow meter), the composition of the inlet
and outlet air streams (MS). Medium samples were periodically taken for offline analysis:
metabolite concentrations (HPLC), biomass concentration (optical density at 550 nm),
isotopic labeling of glucose in the medium (GC/MS), and isotopic labeling of cellular amino
acids (GC/MS) were measured.
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6.2.4 Off-gas analysis
Molfractions of oxygen, carbon dioxide and nitrogen in both the inlet and outlet air streams
were measured online by a Prima 600S mass spectrometer (VG Gas, Manchester, UK). The
flow rate of the inlet air stream was measured in standard liters per minute (SLPM defined at
1 Atm and 250 C) using a Brooks 5850 series mass flow controller. Fractional labeling of CO 2
in the off-gas was determined from relative intensities of 12C0 2 (m/Z 44) and 13C0 2 (m/z
45).
6.2.5 Sampling and sample processing
Medium samples were periodically taken during the fed batch fermentation for HPLC and
GC/MS analysis. In total 21 samples of 11-21 mL were collected between time points 15.4
hr and 44.6 hr. Samples were centrifuged, and the supernatant separated from the biomass
pellet. The biomass pellet was stored at -80 OC and the supernatant at -20 OC prior to
analysis.
6.2.6 Biomass concentration
Biomass concentration was determined by measuring the optical density at 550 nm (OD550),
assuming 3.0 g/L/OD55o cell dry weight. The molecular weight of dry biomass was assumed
to be 25.3 g/C-mol.
6.2.7 HPLC analysis
The concentrations of glucose, glycerol, 1,3-propanediol (PDO), acetate, citrate, and
pyruvate in the medium samples were measured by high-performance liquid chromatography
(Waters HPLC, Shodex SH1011 sugar column, RI detector).
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6.2.8 GC/MS analysis
Gas Chromatography-Mass Spectrometry (GC/MS) analysis was performed using HP 5890
Series II GC (Gas Chromatograph) equipped with a DB-1701 [30 m x 0.25 mm (inner
diameter) x 0.25 jtm] capillary column, connected to HP 5971 quadrupole MSD (Mass
Selective Detector) operating under ionization by electron impact (EI) at 70 eV. The mass
spectrometer was calibrated using the 'Max Sensitivity Autotune' setting. Measured
intensities were corrected for the contribution of noise (baseline correction), and mass
isotopomer distributions were obtained by integration. Mass isotopomer values for each
fragment were expressed as fractional abundances, i.e. for each fragment the sum of all mass
isotopomers equals one.
6.2.9 GC/MS analysis of cellular amino acids
Labeling patterns of cellular amino acids were determined by GC/MS analysis of their tert-
butyldimethylsilyl (TBDMS) derivatives. For each derivatization, about 20 mg of wet
biomass pellet was transferred to 700 ýtL of 6 N HC1 and heated at 110 OC for 24 hr in a
closed vacuum hydrolysis tube. After cooling to room temperature the solvent was
evaporated and the residue was dissolved in 150 tiL of distilled water, which was then
filtered through a 0.2 jim pore size filter to remove cell debris. The filtrate was evaporated to
dryness. The dried hydrolysate was dissolved in 50 tL of pyridine followed by addition of 70
[L of N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide (MTBSTFA). The mixture
was heated at 60 OC for 30 min and transferred to an injection vial for GC/MS analysis. The
injection volume was 1 pL and samples were injected in purged splitless mode. The amount
of sample analyzed was controlled by varying the purge activation time between 1 sec and
1.5 min. Helium flow was maintained at 0.74 mL/min via electronic pressure control. The
injection port temperature was 270 OC. The temperature of the column was started at 1000C
for 1.5 min, increased to 130 OC at 200C/min and increased to 220 OC at 10 oC/min and
held for 3 min. The temperature was then increased to 2800C at 5 OC/min and held for 3
min. The interface temperature was maintained at 300 OC. Mass spectra were analyzed in the
mass range 195-445 atom mass units at a rate of 2.7 scans/sec. Figure 6-2 shows a
representative total ion chromatogram of TBDMS derivatized amino acids from hydrolyzed
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Figure 6-2: Representative total ion chromatogram. Cellular amino acids from hydrolyzed
biomass were derivatized by TBDMS and analyzed by electron impact GC/MS. The total
ion chromatogram corresponds to the sum of the ion intensities measured at each time point
in the analysis. The insert shows the electron ionization mass spectrum for TBDMS
derivatized aspartic acid.
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Table 6-1
Ion fragment of TBDMS derivatized amino acids used for flux analysis. The identity of
amino acid ion fragments was verified previously (Chapter 4). Assignment of precursor
metabolites reflects the metabolic network model of E. coli shown in Appendix 6.A.
Amino Monitored Amino acid Fragmentation Precursor metabolite(s)
acid ions carbon atoms
Ala 232 - 239 2-3 M - C5 H 90 Pyr(2-3)
260-268 1-2-3 M-C 4 H 9  Pyr
Gly 218 - 224 2 M - CsH 90 multiple pathways*
246-253 1-2 M-C 4 H 9  multiple pathways*......................................................................................................................................................................................................  .  ................. .......... 
Val 260 - 269 2-3-4-5 M - C5H90 Pyr(2-3) + Pyr(2-3)
288 - 298 1-2-3-4-5 M -C 4 H9  Pyr( 2 3) + Pyr(23)
Leu 274 - 283 2-3-4-5-6 M -C 5 90 AcCoA(2) + Pr(2-3) + Pyr(2-3)
Ile 274 - 283 - 2-3-4-5-6 M- C5H90 OAC(2 3 - + Pyr(23)
Ser 288 - 296 2-3 M - C 7H 15O2 Si multiple pathways*
362 - 370 2-3 M - C5H90 multiple pathways*
............ .......................................  ............................. -   ................... .......................... -  ....... .................  . ................................................................
Thr 376 - 382 2-3-4 M - C5H9O OAC(2-3-4)
404-414 1-2-3-4 M-C 4 H 9  O 1 ---. . . . . .
Met 292 - 298 2-3-4-5 M - C5H 90 OAC(2-3-4) + C-1
320 - 327 1-2-3-4-5 M - C4H 9  OAC 1-2-3-4) + C-1
Phe 302 - 307 1-2 M - C7H7  PEP(_2)
308 - 316 2-3-4-5-6-7-8-9 M - CsHO9  PEP(2-3) + PEP(2.3) + E4P(1-2-3-4)
336 -345 123-4-5-6-7-8-9 M-C 4H9  PEP(,-, 3) + PEP(23) + E4P(1 2 -3 -4 ).............................. ..............  -  .... . ... ..... ......... . ................................ ......__....  .. . .... . .. . . . . . .
Asp 302 - 309 1-2 M - C8H 17O2Si OAC(I.2)
376 - 382 1-2 M - C6HIO1  OAC(..2)
390 - 397 2-3-4 M - C5H90 OAC(2-3-4)
418 -428 1-2-3-4 MI - C4H9  OAC(1-2-34)
Glu 330 - 336 2-3-4-5 M - C7H50s2Si AKG(2-3-4- 5)
404 - 411 2-3-4-5 M - C5H90 AKG(2-3-4-5)
432 - 443 1-2-3-4-5 M - C4H9  AKG(1-2-3-4-5)
Tyr 302 - 307 1-2 M - C13H21OSi PEP(..2)
Abbreviations: 3PG, 3-phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; E4P, erythrose-
4-phosphate; AKG, a-ketoglutarate; OAC, oxaloacetate; AcCoA, acetyl coenzyme-A; R5P, ribose-5-
phosphate; C-I, one-carbon unit.
* Glycine and serine are produced by multiple pathways (see Metabolic Network in Appendix 6.A).
The labeling of these fragments depends on the relative contribution of these pathways.
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biomass. We detected 15 of the 20 amino acids in hydrolyzed biomass samples.
Table 6-1 shows the 26 amino acid ion fragments that were used for metabolic flux analysis.
All samples were injected 35 times at varying concentrations. For each fragment the
integrated mass isotopomer abundances were plotted as a function of total ion counts and
extrapolated to a theoretical infinite dilution to correct for the concentration effect of
electron impact GC/MS analysis (see Chapter 4).
6.2.10 GC/MS analysis of glucose
Labeling of glucose was determined by GC/MS analysis of aldonitrile pentapropionate
derivative of glucose. For each derivatization, 20 [IL of medium sample was deproteinized by
addition of 300 p.L of acetone (-4 oC). The mixture was centrifuged and the supernatant
evaporated to dryness. 50 [IL of 2 wt% hydroxylamine hydrochloride in pyridine was added
to the dry residue and the mixture was heated at 90 OC for 60 min. This was followed by
addition of 100 [tL of propionic anhydride and heating at 60 OC for another 30 min. After
cooling, the sample was evaporated to dryness and dissolved in 100 [IL of ethyl acetate and
transferred to an injection vial for GC/MS analysis. The injection volume was 1 [IL and
samples were injected in purged splitless mode. Helium flow was maintained at 0.88
mL/min via electronic pressure control. The injection port temperature was 250 OC. The
temperature of the column was started at 80 oC for 1 min, increased to 280 oC at 20 OC/min,
and held for 4 min. The interface temperature was maintained at 300 oC. Mass spectra were
analyzed in the mass range 150-450 atom mass units at a rate of 2.3 scans/sec. Labeling of
glucose was determined from the ion fragment at m/z 370 (C17H240 8sN) that contained
carbon atoms C1-C5 of glucose. Measured mass isotopomer distributions were corrected for
natural isotope enrichments as described by Fernandez et al. (1996). The corrected intensity
at m/z 370 corresponded to the fraction of naturally labeled glucose, the intensity at m/z
371 corresponded to the fraction of [1-1 3C]glucose, and the sum of intensities at m/z 374
and 375 corresponded to the fraction of [U-13C]glucose.
-187-
CHAPTER 6. NONSTATIONARY METABOLIC FLUX ANALYSIS OF E. Coil
6.2.11 Calculating external fluxes
Cumulative consumption of glucose and citrate, and cumulative production of biomass,
glycerol, PDO and acetate were calculated from the measured concentrations and fermentor
weight, after accounting for losses due to sampling. Consumption and production rates
(mol/h) were then determined by fitting a smooth curve through the data points. Rates of
total oxygen uptake (TOUR) and total carbon dioxide production (TCER) were calculated
from off-gas analysis as follows:
TOUR (mol/h) = o,,n - x0o,,out X,,in SLPMin • 2.454 (6.1)
X N,,out
TCER (mol/h) = Xco,,out  N,i--- - XCO,in SLPMR -2.454 (6.2)
X N,out
The above equations assume that nitrogen is not consumed, produced or accumulated in the
system. These equations inherently correct for temperature and pressure differences between
the inlet and outlet air streams.
6.2.12 Metabolic network model
A detailed network model for E. coli was constructed (see Appendix 6.A). The model was
comprised of 73 reactions (with corresponding carbon transitions) utilizing 76 metabolites,
with 5 substrates (i.e. glucose, citrate, 02, NH 3, SO 4), 5 products (i.e. 1,3-propanediol,
biomass, CO2, acetate, and ATP), and 65 balanced intracellular metabolites. Glycerol was
allowed to be either a substrate or a product depending on the calculated external flux. The
network model included reactions of glycolysis, pentose phosphate pathway, Entner-
Doudoroff pathway, TCA cycle, PDO biosynthesis pathway, amphibolic reactions, one-
carbon metabolism, and amino acid biosynthesis reactions. Reversible reactions were
modeled as separate forward and backward fluxes. Net and exchange fluxes were determined
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as: vnet = Vf - Vb; Vexch = min(vf, Vb). All forward and backward fluxes were required to be
non-negative at the final solution.
6.2.13 Flux determination and statistical analysis
Metabolic fluxes were determined by fitting 8 external fluxes and 191 mass isotopomer
abundances of cellular amino acid to the metabolic network model of E. coli including
additional flux parameters to account for isotopic transients (see section 6.3.5). The
minimized objective function was the variance-weighted sum of squared deviations between
the observed and simulated measurements. The iterative algorithm that was used for least-
squares optimization was based on successive quadratic programming (see Chapter 3). At
convergence, accurate confidence intervals of fluxes were calculated by evaluating the
sensitivity of the objective function with respect to fluxes as described previously (Chapter
3). Flux validation was accomplished by a statistical test for the goodness-of-fit (chi-square
test for model adequacy), and a normality test for the weighted residuals. To ensure a global
optimum, flux estimation was repeated at least four times starting with random initial values
for all fluxes. Sensitivity analysis was used to determine the relative importance of
measurements for the estimation of individual fluxes as described previously (Chapter 3).
6.3 Results
6.3.1 External fluxes
Figure 6-3A shows the calculated external fluxes as a function of fermentation time. The
calculated external fluxes were consistent, i.e. the carbon balance closed within 2% and
degree of reduction balance closed within 4%. Figure 6-3B shows the consumption and
production rates expressed as specific fluxes (mmol/h/gDW). The specific fluxes decreased
significantly during the fermentation. This indicates that the cells were either becoming less
metabolically active, or that the fraction of metabolically active cells decreased, i.e. fraction
of dead cells increased. We did not measure cell viability in this experiment, thus the exact
cause for the decreased specific fluxes remains uncertain. External fluxes normalized to
glucose uptake rate shown in Figure 6-3C. The flux of glucose to biomass decreased in time
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Figure 6-3: Characterization of external fluxes in the fed-batch culture. Top panel shows the
observed absolute external fluxes (mmol/h) as a function of fermentation time. Negative
fluxes correspond to consumption rates. Bottom panel shows specific external fluxes
(mmol/h/gDW) that significantly decreased in time.
- 190-
CHAPTER 6. NONSTATIONARY METABOLIC FLUX ANALYSIS OF E. COLu
150
100
50
-50
-100
20 25 30
Time (hr)
35 40 45
Figure 6-3 (continued): Characterization of external fluxes in the fed-batch culture. Shown
are external fluxes normalized to glucose uptake rate that was fixed at -100 (i.e. uptake rate
of 100).
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and flux towards PDO gradually increased. Note that glycerol was initially produced by the
cells, but after 25 hr glycerol was taken up by the cells and co-metabolized with glucose as a
carbon source. The rates of acetate production and citrate uptake were negligible compared
to the other fluxes (not shown in Figure 6-3; see Appendix 6.E).
6.3.2 Characterization of glucose feed
Based on preliminary simulations and sensitivity analysis of the metabolic system we
determined that the optimal labeling of glucose in this study would be 75% [1- 13C]glucose
and 25% [U-13C]glucose. The composition of the labeled feed was validated by GC/MS
analysis. First, we validated the isotopic purity of the purchased tracers. We measured 99.7 +
0.2 At% isotopic purity for the [1-1 3C]glucose tracer, and 99.4 ± 0.1 At% isotopic purity for
the [U- 13C]glucose tracer. These enrichments were higher than 99 At% isotopic purity
according to manufactures' specifications. The two tracers were mixed as follows: 105 g [1-
13C]glucose + 35 g [U-13C]glucose (i.e. 75/25 wt/wt, or 75.5/24.5 mol/mol). The
composition of labeled glucose feed was then validated by GC/MS analysis. The measured
composition was 75.4 ± 0.2 mol% [1-1 3C]glucose and 24.6 ± 0.2 mol% [U-13C]glucose.
6.3.3 Dynamics of glucose labeling
Figure 6-4 shows the observed isotopic composition of glucose in the medium as a function
of fermentation time. Labeled glucose feed was initiated at 18.6 hr and continued until 30.0
hr, when it was replaced with unlabeled glucose feed. The labeling of glucose underwent a
transient phase of about 5 hr after the introduction of the tracer (between 18.6 - 23.6 hr),
and a second transient phase of about 5 hr after the switch to unlabeled glucose feed
(between 30.0 - 35.0 hr). The isotopic composition was constant for samples taken between
23.6 and 29.6 hr, with 75.4% [1-1 3C]glucose and 24.6% [U- 13C]glucose (measured by
GC/MS). The length of the observed isotopic transients is determined by glucose
concentration in the reactor and the rate of glucose feed and uptake. In this study, glucose
concentration was maintained at 45 + 5 mM, i.e. much higher than the typical limiting levels
of glucose achieved in continuous cultures.
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Figure 6-4: Measured isotopic composition of glucose in the medium as a function of time.
The isotopic composition of glucose in medium samples was determined by GC/MS
analysis. Isotopically labeled glucose was introduced at 18.6 hr. The labeling of glucose
approached isotopic steady state at -24 hr. The isotopic composition of glucose was
constant for samples between 23.6 and 29.6 hr, with 75.4% [1- 13 C]glucose and 24.6% [U-
13C]glucose. After 30.0 hr the feed was switched back to unlabeled glucose feed. The dashed
lines represents the predicted composition of glucose based on the balance model in Eq. 6.7.
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To describe the observed labeling transients quantitatively, we constructed a simple material
balance model assuming ideally mixed reactor. The equations for total glucose concentration
and glucose labeling are:
d(V- cgiu)c 
(6
dt gluc,in - gluc
d(V -Cguc .x)
dt = F Cgluc,in . Xin - g1uc . X  (6.4)dt
Here, F (L/hr) is the flow rate of feed to the reactor, cgluc (mmol/L) is glucose concentration
in the reactor, cgluc,in (mmol/L) is the glucose concentration in the feed, V (L) is the reactor
volume, rgluc (mmol/hr) is glucose uptake rate, x is the molfraction of labeled glucose in the
reactor, and xin is the molfraction of labeled glucose in the feed. In this experiment, glucose
concentration and reactor volume were relatively constant during the observed isotopic
transients, however, the feed rate changed significantly. Assuming constant glucose
concentration and reactor volume, Eq. 6.3 simplifies to:
rluc = F'Cglucin (6.5)
Substitution of Eq. 6.5 into Eq. 6.4 yields:
dx luc (Xin - X) (6.6)
dt V -cgu
glue
During the first transient phase, glucose uptake rate increased linearly from 21.7 mmol/h at
18.3 hr to 50.2 mmol/hr at 23.6 hr, i.e. rgluc = 5.40-t - 77 (linear fit, R2=0.99), while glucose
concentration and reactor volume were 43 mmol/L and 0.98 L, respectively. During the
second transient phase, glucose uptake rate decreased linearly from 68.7 mmol/h at 30.6 hr
to 54.7 mmol/h at 35.0 hr, i.e. rglui = -3.25-t + 169 (linear fit, R2=0.99), while glucose
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concentration and reactor volume were 48 mmol/L and 1.06 L, respectively. Integration of
Eq. 6.6 assuming a linear function for glucose uptake as a function of time (rgluc=a+b.t)
yields the following expression for the labeling of glucose as a function of time:
-a It b .t2
x(t) = xin + (xo- xx). e( V- c, (6.7)
The dashed lines in Figure 6-4 represent the predicted isotopic composition of glucose based
on Eq. 6.7. We found good agreement between the predicted and the observed isotopic
transients.
6.3.4 Dynamics of fed-batch fermentation
Atoms of 13C-glucose pass through multiple extracellular and intracellular pools in the
pathway from glucose to cellular amino acids. Metabolites in this pathway undergo a
transient labeling phase similar to the one observed for glucose labeling in the medium. The
characteristic time that describes this process is given by the ratio of the pool size (mmol/L)
relative to the turnover rate of the pool (mmol/L/hr). Metabolite pools with short
characteristic times relative to the length of the experiment reach isotopic steady state
quickly, whereas pools with long characteristic times may never reach isotopic steady state.
Figure 6-5 shows time profiles of enrichment for four intermediate metabolite pools in the
pathway from glucose to biomass. The first panel shows the labeling of glucose feed that
was changed instantaneously from unlabeled glucose to 13C-labeled glucose at 18.6 hr, and
visa versa at 30.0 hr. The second panel shows the observed labeling profile of glucose that
was discussed in detail in the previous section. The characteristic time for glucose was about
1 hr. The third panel shows the observed enrichment of carbon dioxide in the off-gas, which
is a measure of the labeling of intracellular metabolites, i.e. carbon dioxide is produced in the
pentose pathway and the TCA cycle from intracellular metabolites. We found that CO 2
enrichment in the off-gas closely followed the profile of glucose labeling in the medium.
This suggested that intracellular metabolite pools approximate isotopic steady state, as was
expected since intracellular pools are relatively small. The estimated characteristic time for
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Figure 6-5: Time profiles of isotopic enrichment of four intermediate metabolite pools in
the pathway from glucose to biomass. 13C-Labeled glucose was introduced between 18.6 hr
and 30.0 hr. We observed the first isotopic transient for glucose in the reactor with a
characteristic time of about 1 hr. The labeling of carbon dioxide in the off-gas reflects the
labeling state of intracellular metabolites, which followed closely the labeling state of glucose
in the medium, which suggested pseudo steady state for intracellular metabolites. The
labeling of biomass components never reached isotopic steady state. The characteristic time
for cellular amino acids was about 10 hr.
- 196 -
Feed Labeling
o0EE
Time (hr) Time (hr)
CHAPTER 6. NONSTATIONARY METABOLIC FLUX ANALYSIS OF E. COLt
intracellular metabolites was on the order of minutes. The last panel in Figure 6-5 shows the
enrichment of cellular amino acids as a function of time, where we plotted the time profiles
of four representative mass isotopomers. Similar profiles were observed all other amino acid
fragments. In this experiment cellular amino acids never reached isotopic steady state. We
estimated a characteristic time of about 10 hr for cellular amino acids.
6.3.5 Nonstationary model for fed-batch fermentation
Based on these observations we propose the following nonstationary model for fed-batch
fermentation, which is shown in Figure 6-6. This model builds on the classical stationary
MFA model with the addition of two dilution parameters, i.e. D and G parameters, that were
initially proposed by Kelleher and Masterson (1992) for isotopomer spectral analysis (ISA).
ISA is a general method for modeling polymerization biosynthesis reactions in systems that
do not approximate isotopic steady state. Here, we distinguish between two dilution effects:
dilution of the tracer (i.e. glucose), and dilution of the product (i.e. cellular amino acids).
Glucose labeling that is observed by cells during the labeling period is a mixture of 13C-
glucose and unlabeled glucose. In this framework, parameter D(t) describes the apparent
fractional labeling of glucose during the labeling phase. Thus, the D value is zero if there are
no tracers in the system, and is one at isotopic steady state for glucose. The parameter G(t)
describes the fraction of 13C-labeled biomass in the sampled biomass pool, while 1-G(t)
corresponds to the fraction of unlabeled biomass. We could introduce one G parameter for
all biomass components, or separate G parameters for each measured amino acid. In the
absence of protein turnover we expect the same G value for all cellular amino acids.
However, protein turnover may cause differences between G values for proteinogenic amino
acids. In our initial model we used a separate G parameters for each amino acid pool. The
nonstationary model for fed-batch fermentation closely resembles classical isotopic steady
state model. Here, the D and G parameters were included in the model as additional fluxes
that were estimated together with the other fluxes. Thus, we could apply the already
developed flux estimation tools for stationary MFA to estimate all flux parameters in this
system without increasing the complexity of calculations.
-197-
CHAPTER 6. NONSTATIONARY METABOLIC FLUx ANALYSIS OF E. COLi
Figure 6-6: Two parameter model for modeling nonstationary tracer experiments. We
distinguish two dilution effects: the dilution of the tracer (i.e. glucose), and the dilution of
the sampled product (i.e. cellular amino acids). The apparent labeling of glucose observed by
the cells during the labeling period is a mixture of 13C-glucose and unlabeled glucose. The
value of parameter D(t) reflects the average labeling of glucose during the labeling period.
The value of parameter G(t) corresponds to the fraction of total biomass that is 13C-labeled,
and 1I-G(t) is the fraction of unlabeled biomass.
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6.3.6 Metabolic flux analysis
We estimated metabolic fluxes for 18 sample points, corresponding to biomass samples
taken between 18.3 hr and 40.7 hr. Fluxes were estimated for each sample point individually.
For each sample point we fitted 8 external fluxes and 191 mass isotopomer abundances (95
independent mass isotopomers) to a detailed flux model. The minimized objective function
was the weighted sum of squared deviations residuals (SSRES) between the observed and
simulated measurements. For each sample point we estimated 37 independent flux
parameters, i.e. we had 95+8-37 = 66 redundant measurements. At convergence, the
goodness-of-fit was assessed by statistically evaluating SSRES. The maximum allowed value
for SSRES was 86 (at 95% confidence level with 66 degrees of freedom; see Chapter 3). Fits
where SSRES was larger than 86 were considered statistically not acceptable. To illustrate
that both D and G parameters were required, we fitted data using models without D and G
parameters. The SSRES values for these fits were statistically not acceptable as is shown in
Figure 6-7. Only the model that included both parameters produced statistically acceptable
fits for all sample points. The small magnitude of SSRES, the high accuracy and precision of
MS data (0.3 mol%/o), and the large number of redundant measurements gave us very high
degree of confidence in the fidelity of the calculated fluxes for all sample points. Table 6-2
shows the optimally-fitted mass isotopomer distributions for sample #12 (taken at 29.6 hr).
We found excellent agreement between the observed and predicted mass isotopomer
abundances with SSRES=65.2. The maximum deviation between the measured and fitted
mass isotopomer abundances was 0.3 mol%. At convergence, nonlinear confidence intervals
of estimated fluxes were determined using the method described in Chapter 3. Figure 6-8
shows the estimated fluxes for sample point #12.
Metabolic fluxes were determined at multiple time points during the fed-batch culture. As
such we established for the first time detailed time profiles of intracellular fluxes. Fluxes
were normalized to glucose uptake rate, which was given the value 100. Figure 6-9 shows
time profiles of selected intracellular fluxes, where we plotted the optimally-fitted flux value
and 68% confidence interval as a function of fermentation time. The time profiles in Figure
6-9 clearly illustrate that intracellular fluxes were relatively constant during the fed-batch
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fermentation. The split ratio between glycolysis and pentose phosphate pathway decreased
only slightly from 60/40 at 20 hr to about 50/50 at 40 hr. The flux of lower glycolysis
(GAP--Pyr) decreased from 70±2 to 50±2 in the same period of time. On the other hand,
the TCA flux remained constant at 47±2 throughout the fermentation. The intracellular flux
towards PDO and glycerol increased by about 10% from 118+_6 to 130±6. An interesting
finding was that this intracellular flux was relatively constant compared to the large
fluctuations in the efflux of PDO, i.e. PDO efflux increased from 78 (at 18.6 hr) to 137 (at
28.6 hr), and to 130 (at 40.7 hr). Our results further indicated that the Entner-Doudoroff
pathway was inactive, i.e. the estimated flux of 0.0±0.5 was not statistically different from
zero. This result confirmed the known genotype of this organism, i.e. phosphogluconate
dehydratase a key enzymes of the Entner-Doudoroff pathway was knocked-out in this strain
of E. coli. Our flux results revealed the presence of a futile cycle between oxaloacetate and
phosphoenolpyruvate. The estimated phosphoenolpyruvate carboxylase and
phosphoenolpyruvate carboxykinase fluxes were 14±2 and 5+2, respectively. The
simultaneous activity of these two reactions created a futile cycle where 1 ATP was lost at
each turn of the cycle. It is not clear what the physiological significance is of this futile cycle.
The total activity of malic enzyme was estimated at 5+1; we could not distinguish between
the two isoforms of malic enzyme, i.e. NADH and NADPH dependent malic enzyme. Thus,
only the combined malic enzyme flux was determined. We estimated only a slightly positive
net transhydrogenase flux (i.e. NADH -- NADPH) of about 20±15, which was not
statistically different from zero. Finally, we estimated significant net production of ATP of
210+18, which was not accounted for by the ATP consuming reactions in our model.
Potential sinks for this ATP are cell maintenance, transport of metabolites across cell
membrane, and futile cycles.
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Figure 6-7: Evaluation of goodness-of-fit for models with a D-parameter, a G-parameter
and both parameters. Mass isotopomer data from 18 biomass samples were fitted
independently to the three models. Shown are the minimized variance-weighted sum of
squared residuals for the 18 sample points. Shaded area indicates the statistically acceptable
95% confidence region for the sum of squared residuals. Models lacking the D or G
parameters were statistically not acceptable. Only the model that included both parameters
produced statistically acceptable fits for all sample points.
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Table 6-2
Measured and fitted mass isotopomer abundances. Mass isotopomer abundances of cellular
amino acid were measured by GC/MS, after TBDMS derivatization. Data shown are the
uncorrected mass isotopomer abundances (molar percentages, mol%) for biomass sample
#12 (taken at 29.6 hr) (mean + SD). The optimally fitted mass isotopomer distributions
('Calc') corresponded well with the measured values ('Exp').
Fragment M+0 M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8
Ala-232 Exp 49.1 ±+0.2 24.3_+0.2 20.6 +0.2 4.4 ± 0.2 1.4±+0.2 0.2± 0.1
Calc 49.1 24.4 20.5 4.4 1.4 0.2
Ala-260 Exp 46.6+0.2 24.4+0.2 11.0+0.2 14.0+0.2 2.9 +0.2 1.1 +0.2 0.1 +0.1
Calc 46.7 24.5 10.7 14.1 2.9 1.1 0.1
Gly-218 Exp 62.5 0.3 27.1 ±+0.2 8.2 ± 0.2 1.,9± 0.2 0.3 +0.1
Calc 62.2 27.3 8.2 2.0 0.3
Gly-246 Exp 57.4 +0.3 19.8 +0.2 17.9 ±0.2 3.6 0.2 1.2+0.2 0.2 +0.1
Calc 57.7 19.7 17.7 3.5 1.2 0.2
Val-260 Exp 35.9 0.2 22.5 +0.2 23.2+0.2 11.1 0.2 5.7 +0.2 1.3 ± 0.2 0.3 ± 0.1
Calc 36.2 22.7 23.1 10.9 5.6 1.3 0.3
Val-288 Exp 35.1 +0.2 22.2 +±0.2 17.4 +0.2 13.8 0.2 6.3 +0.2 4.0 + 0.2 0.9 0.1 0.3 (
Calc 34.8 22.3 17.6 13.7 6.4 4.0 0.9 0.3
Leu-274 Exp 28.5 0.2 22.7+ 0.2 21.8 +0.2 15.4+0.2 7.8 ± 0.2 3.1 +0.2 0.7 +0.1 0.2+ (
Calc 28.5 22.5 21.9 15.5 7.8 3.1 0.7 0.2
Ile-274 Exp 28.7±0.2 22.6+0.2 21.8±0.2 15.3 +0.2 7.8 +0.2 3.0 ± 0.2 0.7 ± 0.1 0.2 +
Calc 28.7 22.5 21.9 15.4 7.7 3.0 0.7 0.2
Ser-288 Exp 45.6 0.2 29.7 +0.2 18.4+0.2 4.8 +0.2 1.3 ± 0.2 0.2 ± 0.1
Calc 45.6 29.6 18.5 4.8 1.3 0.2
Ser-362 Exp 40.9 +0.2 29.8 +0.2 20.1 +0.2 6.5 ± 0.2 2.1 +0.2 0.4 0.1 0.1 +±0.1
Calc 41.0 29.7 20.1 6.5 2.1 0.4 0.1
Ser-390 Exp 39.0 +0.2 27.2 +0.2 15.5 0.2 12.6 ± 0.2 3.9 +0.2 1.4 0.2 0.3 +0.1 0.1 +
Calc 38.9 27.1 15.8 12.5 3.9 1.4 0.3 0.1
Thr-376 Exp 31.7 +0.2 28.9 0.2 22.1 + 0.2 12.0+0.2 4.0 + 0.2 1.2 +0.2 03 + 0.1
Calc 31.8 28.9 22.0 11.9 3.9 1.2 0.3
Thr-404 Exp 28.1 ±+0.2 26.1 +0.2 21.8 0.2 13.9 +0.2 7.1 +0.2 2.3 +0.2 0.7 ±0.1 0.1 +'
Calc 28.0
).1
0.1
0.1
0.1
0.1
26.1 21.8 13.9 7.1 2.3 0.7 0.1
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Table 6-2 (continued)
Measured and fitted mass isotopomer abundances.
Fragment M+O M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8
Met-292 Exp 27.5 0.2 25.9 0.2 23.4 0.2 14.4 +0.2 6.3 ± 0.2 1.9±0.2 0.5± 0.1
Calc 27.7 25.9 23.4 14.3 6.2 1.9 0.5
Met-320 Exp 25.1 0.2 22.9 0.2 22.2 0.2 15.5 +0.2 9.1± 0.2 3.7 ± 0.2 1.1 ±0.2 0.3 ±0.1
Calc 25.0 22.8 22.4 15.7 9.0 3.7 1.1 0.3
Phe-302 Exp 58.3±0.3 18.3±0.2 17.9±0.2 4.0 ± 0.2 1.3+0.2 0.2 ±0.1
Calc 58.1 18.3 18.0 4.1 1.3 0.2
Phe-308 Exp 27.7±0.2 18.3±0.2 17.8±0.2 12.5±0.2 10.0±0.2 6.4± 0.2 4.3 ± 0.2 2.0 ± 0.2 0.9 ± 0.1
Calc 27.9 18.0 17.8 12.5 10.0 6.4 4.3 2.0 0.9
Phe-336 Exp 27.3 0.2 17.9 +0.2 14.1 0.2 12.9 +0.2 10.3 0.2 7.5 ± 0.2 4.8 ± 0.2 2.9 ± 0.2 1.4± 0.2
Calc 27.2 17.9 14.3 13.1 10.4 7.6 4.7 2.8 1.3
Asp-302 Exp 45.7±0.2 28.3±0.2 19.4±0.2 5.0 ± 0.2 1.4± 0.2 0.2 ± 0.1
Calc 45.8 28.2 19.4 5.0 1.4 0.2
Asp-376 Exp 41.3±0.2 28.4±0.2 20.8±0.2 6.7 ± 0.2 2.3 ± 0.2 0.5 ± 0.1 0.1 ± 0.1
Calc 41.2 28.4 20.8 6.7 2.3 0.5 0.1
Asp-390 Exp 31.7±0.2 28.9±0.2 22.0±0.2 11.9±0.2 4.0 + 0.2 1.2±+ 0.2 0.2 + 0.1
Calc 31.7 28.9 22.1 11.9 4.0 1.2 0.3
Asp-418 Exp 27.8 0.2 26.1 0.2 21.8 +0.2 14.0 +0.2 7.1 ± 0.2 2.3 ± 0.2 0.7 ± 0.1 0.1 ±0.1
Calc 27.8 26.1 21.9 13.9 7.1 2.3 0.7 0.2
Glu-330 Exp 29.6±0.2 26.1±0.2 23.0±0.2 13.5±0.2 5.8 ± 0.2 1.5 ± 0.2 0.4 +0.1 0.1 ±0.1
Calc 29.5 26.1 23.2 13.4 5.8 1.5 0.4 0.1
Glu-404 Exp 26.7±0.2 25.4±0.2 23.6±0.2 14.6±0.2 6.8 ± 0.2 2.2 ± 0.2 0.6 +0.1 0.1 ± 0.1
Calc 26.6 25.5 23.6 14.5 6.9 2.2 0.6 0.1
Glu-432 Exp 23.5±0.2 22.1±0.2 22.4±0.2 16.6±0.2 9.4 ± 0.2 4.2 ± 0.2 1.3 ± 0.2 0.4 ± 0.1 0.1 ± 0.1
Calc 23.7 22.2 22.4 16.6 9.3 4.1 1.3 0.4 0.1
Tyr-302 Exp 58.1±0.3 18.3±0.2 18.0±0.2 4.0 ± 0.2 1.3 ± 0.2 0.2 ± 0.1
Calc 58.1 18.3 18.0 4.1 1.3 0.2
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Figure 6-8: Metabolic fluxes of E. coli grown in carbon-limited fed-batch culture. Metabolic
fluxes were determined by fitting 8 external fluxes and 191 mass isotopomer abundances to a
detailed flux model of E. coli. Fluxes were normalized to glucose uptake rate. Shown are
estimated fluxes for sample point #12 (at 29.6 hr). The top number is the estimated net flux
and the bottom number (in italics and between brackets) is the estimated exchange flux,
where 'n/d' indicates that the flux could not be estimated.
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Figure 6-9: Time profiles of selected intracellular fluxes. The best fit (solid line) and the
68% confidence interval (shaded area) are shown as a function of time for the 18 sample
points. Fluxes were normalized to glucose uptake rate.
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Figure 6-9 (continued): Time profiles of selected intracellular fluxes. The pentose
phosphate flux increased slightly in time. The TCA flux was constant at 47 ± 2.
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Figure 6-9 (continued): Time profiles of selected intracellular fluxes. The intracellular flux
towards glycerol and PDO increased by 10% from 118±6 to 130+6, whereas the efflux of
PDO fluctuated significantly. The transhydrogenase flux was not significantly different from
zero.
- 208 -
Y c)
,',v+I
I LJ I I I A.I J~ J..i
.D . b..osy.nt.he..si.s ..
I
CHAPTER 6. NONSTATIONARY METABOLIC FLUX ANALYSIS OF E. COLu
6.3.7 Evaluation of estimated D and G parameters
As indicated earlier, the key to successful flux determination in this nonstationary system was
the introduction of two dilution parameters, the D parameter to account for the dilution of
the tracer and the G parameter to account for the dilution of biomass components. Values
for both parameters were estimated together with fluxes from mass isotopomer distributions
of sampled biomass pools. Our initial model contained 12 individual G parameters, i.e. one
G parameter for each of the 12 measured amino acids. The estimated G values for the 12
amino acids were not significantly different from one another, indicating that one G value
could be used for all biomass components. When we repeated flux estimation with a single
G parameter we obtained the same flux results. The sum of squared residuals increased
slightly compared to the model with 12 individual G parameters, however the SSRES was
still within statistically acceptable limits, especially when we took into account the fewer
number of free flux parameters that were fitted. Time profiles of the estimated D and G
parameters are shown in Figure 6-10. We can explain the observed profiles as follows. The
G parameter reflects the fraction of biomass that is labeled. Biomass produced before the
introduction of tracers was unlabeled, and thus the G value was zero. The observed increase
in G value after 18.6 hr reflects the production of labeled biomass, i.e. the fraction of labeled
biomass increased. The G value decreased after tracer was depleted reflecting the fact that
unlabeled biomass was again produced, i.e. the fraction of labeled biomass decreased. Note
that there was a delay between the switch to unlabeled feed at 30.0 h and the first noticeable
decrease in the G value at 31.6 hr. This delay reflect the fact that labeled glucose was still
present in the reactor for several hours after the feed was switched to unlabeled glucose feed
(see Figure 6-5). The D value describes the average enrichment of glucose from which
labeled biomass is produced. Figure 6-10 shows that the D value increased starting at 18.6
hr, i.e. reflecting the approach to isotopic steady state of the glucose pool. Note that the D
value never reaches unity, because there was always a fraction of biomass that was produced
from partially labeled glucose. After the tracer was removed the D value first dropped
slightly, i.e. reflecting the second glucose transient, and then remained constant at about 0.9.
At that point only unlabeled biomass was produced, which was accounted for by the G
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parameter. The constant D value after 31.6 hr indicates biomass turnover was not
significant. We set up the following theoretical model for the D and G parameters.
f (t) - L(t) -p(t) -dt
D(t) = (6.8)
S8(t)- p(t)-dt
8(t)- l(t)-dt
G(t) = (6.9)
fj (t) dt
0 if L(t) < 0.2
with 8(t) ifL(t)<0.2 (6.10)
1 if L(t) > 0.2
Here, L(t) is fractional labeling of glucose in the medium (i.e. which corresponds directly to
the measured glucose labeling shown in Figure 6-4), p(t) is the biomass growth rate, and 6(t)
formally defines what we mean by 'the labeling phase'. In this case, we define the labeling
phase as the timeframe when fractional glucose labeling is at least 20% of isotopic steady
state value. This definition was required, otherwise the D and G parameters became highly
correlated at low glucose enrichments. In this experiment, 6(t) was unity between 19.0 h and
31.3 h, and zero everywhere else. We used Eqs. 6.7 and 6.8 to predict time profiles of D and
G parameters based on measured labeling of glucose and growth rate as a function time. The
predicted time profiles are plotted in Figure 6-10. We found good agreement between the
predicted and estimated D and G values, which result further supports the validity of our
assumptions and this modeling approach.
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Figure 6-10: Time profiles of estimated and predicted D and G parameters. The dots
represent estimated D and G parameters from MFA. The solid line represent the predicted
parameters based on Eqs. 6.8 and 6.9. We found good agreement between the predicted and
estimated parameter values, in support of the validity of our modeling method. The dashed
line in the left panel shows the fractional labeling of glucose, i.e. L(t) in Eq. 6.8. The G
values for individual amino acids (dashed lines in right panel) were not significantly different
from one another, indicating that one G value could be used for all biomass components.
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6.4 Discussion
In this contribution, we presented a novel modeling strategy for metabolic flux analysis in
nonstationary systems. Isotopic transients of precursor (i.e. glucose) and products (i.e.
sampled biomass components) were captured by two dilution parameters, i.e. D and G
parameters, respectively. We applied this modeling strategy to estimate intracellular fluxes of
E. coli in a fed-batch fermentation. Fluxes were determined by fitting an over-determined
data set of external flux measurements and labeling patterns of cellular amino acids to a
detailed model of E. coli. We obtained highly consistent fits with 66 redundant
measurements, which gave us a high degree of confidence in the estimated flux parameters.
Metabolic fluxes were determined for multiple time points, and as such we established for
the first time detailed time profiles of intracellular fluxes during a fed-batch fermentation.
The estimated fluxes provided insight into the overproduction of PDO by E. coli and
confirmed the genotype of this organism. The additional D and G parameters were
estimated together with the fluxes. We related the D and G parameter values to the labeling
history of sampled biomass. The G value was the fraction of labeled biomass in the total
biomass pool, and the D value was the biomass-averaged glucose labeling. The predicted
values for D and G parameters corresponded well with the estimated parameter values from
MFA.
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APPENDIX 6.A
Metabolic network model of E. coi"
Glycolysis
vl G6P (abcdef) <- F6P (abcdef)
V2 F6P (abcdef) + ATP -* FBP (abcdef)
V3 FBP (abcdef) - DHAP (cba) + GAP (def)
v4 DHAP (abc) <-> GAP (abc)
vs5 GAP (abc) -+ 3PG (abc) + ATP + NADH
v6 3PG (abc) <- PEP (abc)
v7 PEP (abc) -> Pyr (abc) + ATP
Pentose Phosphate Pathway
vs8 G6P (abcdef) - 6PG (abcdef) + NADPH
v9 6PG (abcdef) -+ Ru5P (bcdef) + C02 (a) + NADPH
vio Ru5P (abcde) -+ X5P (abcde)
vll Ru5P (abcde) <- R5P (abcde)
V12 X5P (abcde) + R5P (fghij) <- S7P (abfghij) + GAP (cde)
V13 S7P (abcdefg) + GAP (hij) ++ F6P (abchij) + E4P (defg)
V14 X5P (abcde) + E4P (fghi) +- F6P (abfghi) + GAP (cde)
Entner-Doudoroff Pathway
v15 6PG (abcdef) - KDPG (abcdef)
V16 KDPG (abcdef) - Pyr (abc) + GAP (det)
TCA Cycle
v17 Pyr (abc) -+ AcCoA (bc) + C02 (a) + NADH
v18 OAC (abcd) + AcCoA (ef) - Cit (dcbfea)
v19 Cit (abcdef) +- ICit (abcdef)
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v20 ICit (abcdef) -> AKG (abcde) + C02 (f) + NADPH
v21 AKG (abcde) - SucCoA (bcde) + C02 (a) + NADH
v22 SucCoA (abcd) -> Suc (/2 abcd + /2 dcba) + ATP
v23 Suc (/2 abcd + /2 dcba) <- Fum (1/2 abcd + /2 dcba) + FADH2
v24 Fum (1/2 abcd + /2 dcba) <-> Mal (abcd)
v25 Mal (abcd) -> OAC (abcd) + NADH
Amphibolic Reactions
V26 Mal (abcd) - Pyr (abc) + C02 (d) + NADPH
v27 Mal (abcd) -+ Pyr (abc) + C02 (d) + NADH
v28 PEP (abc) + C02 (d) - OAC (abcd)
v29 OAC (abcd) + ATP -> PEP (abc) + C02 (d)
Acetic Acid Formation
v30 AcCoA (ab) -> Ac (ab) + ATP
PDO Biosynthesis
v31 DHAP (abc) + NADH -> Glyc3P (abc)
v32 Glyc3P (abc) -> Glyc (abc)
v33 Glyc (abc) -> HPA (abc)
v34 HPA (abc) + NADPH -> PDO (abc)
Amino Acid Biosynthesis
v35 AKG (abcde) + NADPH + NH3 -- Glu (abcde)
V36 Glu (abcde) + ATP + NH3 -- Gin (abcde)
V37 Glu (abcde) + ATP + 2 NADPH - Pro (abcde)
v38 Glu (abcde) + C02 (f) + Gin (ghijk) + Asp (1mno) +- AcCoA (pq) + 5 ATP + NADPH -+
Arg (abcdef) + AKG (ghijk) + Fum (Imno) + Ac (pq)
v39 OAC (abcd) + Glu (efghi) -> Asp (abcd) + AKG (efghi)
v4oU Asp (abcd) + 2 ATP + NH3 -> Asn (abcd)
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v41 Pyr (abc) + Glu (defgh) -+ Ala (abc) + AKG (defgh)
V42 3PG (abc) + Glu (defgh) -+ Ser (abc) + AKG (defgh) + NADH
V43 Ser (abc) ++ Gly (ab) + MEETHF (c)
V44 Gly (ab) ++ C02 (a) + MEETHF (b) + NADH + NH3
V45 Thr (abcd) -> Gly (ab) + AcCoA (cd) + NADH
v46 Set (abc) + AcCoA (de) + 3 ATP + 4 NADPH + S04 -4 Cys (abc) + Ac (de)
V47 Asp (abcd) + Pyr (efg) + Glu (hijkl) + SucCoA (mnop) + ATP + 2 NADPH -+
LL-DAP (abcdgfe) + AKG (hijkl) + Suc (/2 mnop + /2 ponm)
v48 LL-DAP (abcdefg) - Lys (abcdef) + C02 (g)
V49 Asp (abcd) + 2 ATP + 2 NADPH -+ Thr (abcd)
v50 Asp (abcd) + METHF (e) + Cys (fgh) + SucCoA (ijkl) + ATP + 2 NADPH --
Met (abcde) + Pyr (fgh) + Suc (/2 ijkl + /2 lkji) + NH3
Vsl Pyr (abc) + Pyr (def) + Glu (ghijk) + NADPH -+ Val (abcef) + C02 (d) + AKG (ghijk)
V52 AcCoA (ab) + Pyr (cde) + Pyr (fgh) + Glu (ijklm) + NADPH -
Leu (abdghe) + C02 (c) + C02 (f) + AKG (ijklm) + NADH
v53 Thr (abcd) + Pyr (efg) + Glu (hijkl) + NADPH -- Ile (abfcdg) + C02 (e) + AKG (hijkl) + NH3
V54 PEP (abc) + PEP (def) + E4P (ghij) + Glu (klmno) + ATP + NADPH -+
Phe (abcefghij) + C02 (d) + AKG (klmno)
V55 PEP (abc) + PEP (def) + E4P (ghij) + Glu (klmno) + ATP + NADPH -
Tyr (abcefghij) + C02 (d) + AKG (klmno) + NADH
V56 Ser (abc) + R5P (defgh) + PEP (ijk) + E4P (lmno) + PEP (pqr) + Gin (stuvw) + 3 ATP + NADPH -+
Trp (abcedklmnoj) + C02 (i) + GAP (fgh) + Pyr (pqr) + Glu (stuvw)
V57 R5P (abcde) + FTHF (f) + Gin (ghijk) + Asp (lmno) + 5 ATP e
His (edcbaf) + AKG (ghijk) + Fum (Imno) + 2 NADH
One-Carbon Metabolism
v58 MEETHF (a) + NADH 4 METHF (a)
vs59 MEETHF (a) --> FTHF (a) + NADPH
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Oxidative Phosphorylation
v60 NADH + /2 02 -- 3 ATP
v61 FADH2 + /2 02 - 2 ATP
Transhydrogenation
V62 NADH <- NADPH
ATP Hydrolysis
v63 ATP -> ATP:ext
Transport
v64 Gluc:ext (abcdef) + ATP -+ G6P (abcdef)
V65 Cit:ext (abcdef) -- Cit (abcdef)
v66 Glyc (abc) +<- Glyc:ext (abc)
V67 PDO (abc) -+ PDO:ext (abc)
v68 Ac (ab) -> Ac:ext (ab)
V69 C02 (a) -> C02:ext (a)
V70 02:ext -- 02
V71 NH3:ext 
-+ NH3
v72 SO4:ext -) S04
Biomass Formation*
V73 0.488 Ala + 0.281 Arg + 0.229 Asn + 0.229 Asp + 0.087 Cvs + 0.250 Glu + 0.250 Gin + 0.582 Gly +
0.090 His + 0.276 Ile + 0.428 Leu + 0.326 Lys + 0.146 Met + 0.176 Phe + 0.210 Pro + 0.205 Ser + 0.241
Thr + 0.054 Trp + 0.131 Tyr + 0.402 Val + 0.205 G6P + 0.071 F6P + 0.754 R5P + 0.129 GAP + 0.619
3PG + 0.051 PEP + 0.083 Pyr + 2.510 AcCoA + 0.087 AKG + 0.340 OAC + 0.443 MEETHF + 33.247
ATP + 5.363 NADPH --> 39.68 Biomass + 1.455 NADH
* The biomass formation reaction is based on precursor and cofactor requirements for E. coli
as described by Neidhardt.
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APPENDIX 6.B
Validation of carbon balance and degree of reduction balance
External fluxes were checked for gross errors by validating the carbon balance and the
degree of reduction balance. The carbon balance is given by:
carbonin 
_ ci Vi,in
carbonout ci Vi,out
6 -glucose 6 -citrate
Vbiom.ass 3- vPDO +3-V glycerol VCO 2 + 2 vacetate
The degree of reduction balance is given by:
free electronsin _ i ' Vi,in _
free electronsout Yi vi,out
2 4- Vglucose + 1 8- citrate -4 - o2
4.2 -v biomass +16VD
o +14 - glycerol +8 -vacetate
In the above equations ci is the number of carbon atoms, vi is the rate of production, and Ti
is the degree of reduction for metabolite i. The degree of reduction corresponds to the
number of free electrons, defined such that yi=0 for the following small molecules: H20, H +,
C0 2, HCO 3-, NH4+ , SO 42-, PO 43-. These metabolites are therefore not included in Eq. 6.B2.
In general, the degree of reduction for any arbitrary metabolite CcHHOoNNS sPp(charge) is
calculated as follows:
y = 4-C + H - 20 - 3N + 6-S + 5-P -charge (6.B3)
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APPENDIX 6.C
Fermentation data
Unlabeled Labeled Reactor Sample
Sample Time Feed Feed Volume Volume OD 55o Glucos
(#) (hr) (g)"' (g) (L) (mL) (-) (mM)
0 0.1 45.1 0.0 0.99 11 0.1 112.2
1 15.4 47.1 0.0 0.98 11 3.2 55.3
2 18.3 56.4 0.0 0.98 21 6.3 40.5
3 19.6 65.6 10.6 0.97 11 8.1 47.0
4 20.6 65.6 22.6 0.97 11 9.8 46.9
5 22.6 65.6 51.6 1.00 15 14.0 37.4
6 23.6 65.6 71.9 0.99 11 16.1 41.1
7 24.6 65.6 93.8 0.99 11 18.8 43.0
8 25.6 65.6 118.6 1.00 11 20.8 47.8
9 26.6 65.6 145.3 1.01 12 22.0 52.8
10 27.6 65.6 169.0 1.02 11 23.5 45.6
11 28.6 65.6 197.7 1.03 11 24.7 50.7
12 29.6 65.6 227.2 1.04 16 26.0 56.9
e Glycerol Acetate PDO Citrate
(mM) (mM-) (mM) (mM)*
0.0
75.4
109.3
114.5
120.6
133.4
135.7
137.9
137.4
0.0
0.0
0.0.
0.0
1.3
1.8
2.4
3.2
3.9
1.5
N/A
28.3
57.4
88.1
175.0
221.7
281.8
350.3
9.2
14.6
14.1
13.8
13.6
13.0
12.6
12.2
11.5
132.8 3.8 424.9 10.8
124.8 4.2 499.7
114.5 3.8 577.3
103.7 4.4 657.7
10.2
9.6
9.4
13 30.6 76.8
14 31.6 104.8
15 32.6 130.4
16 33.6 154.2
17 35.0 185.2
18 36.6 220.4
19 40.7 288.2
20 42.6 315.9
21 44.6 345.1
240.0
240.0.
240.0
240.0
2 40....................
240.0
240.0
240.0240.0
240.0
1.01 11 27.2
1.07 12 28.2
1.06 11 28.8
1.07 11 30.0
1 10 11 30.4
1.11 11 31.2
1.16 11 33.0
1.17 11 31.8
1.19 17 31.2
46.4 96.8 4.2
48.5 89.8 4.6
44.5 86.8 4.0
45.6 84.9 5.6
43.9 82.0 5.7
49.3 80.8 5.4
47.8 75.8 5.9
52.9 74.5 5.0
62.0 70.3 4.5
742.4 9.1
806.1 8.7
872.0 8.3
932.4 7.9
1006.6 7.5
1070.8 7.3
1246.4 6.9
1304.1 6.9
1312.0 6.7
* The specific gravity of medium was 1.030 g/mL.
** Citrate data may be inaccurate, i.e. citrate co-eluted with another metabolite in the HPLC analysis.
*** Unlabeled feed contains 46.2 wt% glucose. Labeled feed contains 46.2 wt% glucose (75 wt% o1-
'
3C]glucose and 25wt0 o [U-' 3C]glucose).
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APPENDIX 6.D
Off-gas analysis data
Sample Time Flow Rate O2,in N 2,in 12CO2,out 13CO2,out O2,out N 2,out
(hr) (SLPM)* (%)
0.1 0.500 20.88
15.4 0.500 20.86
18.3 0.500 20.87
19.6 0.500 20.88
20.6 0.500 20.87.
22.6 0.500 20.87
23.6 0.500 20.87
24.6 0.500 20.87.
25.6 0.500 20.87
26.6 0.500 20.87
27.6 0.500 20.87.
28.6 0.500 20.8728.6 0.500 20.87
29.6 0.500 20.87
30.6 0.500 20.87
(%)
78.19
78.21
78.20
78.19
78.20.
78.20
78.21
78.20.
78.20
78.20
78.20.
78.2078.20
78.21
78.20
(%)
0.02
1.24
2.77
2.79
2.84
3.33
3.60
3.93
4.23
4.48
4.64
4.74
4.73
6.05
(%) (%)
0.00 20.87
0.01 20.05
0.06 19.30
0.85 18.89
1.48 18.57
2.50 17.81
2.90 17.53
3.28 17.24
3.59 17.02
3.83 16.85
3.98 16.76
4.11 16.74
4.20 16.75
2.61 16.87
14 31.6 0.500 20.88 78.19 7.57 0.80 17.00 73.77
15 32.6 0.500 20.87 78.20 7.59 0.40 17.19 73.97
16 33.6 0.500 20.86 78.21 7.30 0.26 17.35 74.23
17 35.0 0.500 20.86 78.21 6.72 0.18 17.64 74.59
18 36.6 0.500 20.88 78.20 6.09 0.17 17.90 74.98
19 40.7 0.500 20.87 78.20 4.79 0.12 18.42 75.78
20 42.6 0.500 20.87 78.20 4.30 0.09 18.63 76.11
21 44.6 0.500 20.87 78.20 3.91 0.07 18.78 76.35
* SLPM (standard liters per minute) defined at 1 Atm and 250C.
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(#)
0
1
2
3
4
5
6
7
8
9
10
11
12
13
(%)
78.21
77.80
76.98
76.58
76.23
75.49
75.10
74.69
74.31
73.98
73.75
73.56
73.47
73.62
......
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APPENDIX 6.E
Calculated external fluxes
Sample Time Glucose 02 C02 Biomass Glycerol Acetate PDO Citrate
(#) (hr) (mmol/h) (mmol/h) (mmol/h) (mCmol/h) (mmol/h) (mmol/h) (mmol/h) (mmol/h)
2 18.3 -21.7 -15.5 35.3 17.5 9.4 0.2 17.1 -0.1
19.6 -29.2 -19.6 45.6 22.6 8.4 0.4
20.6 -33.3 -22.3 54.4 25.0 6.6 0.5
29.1 -0.1
35.4 -0.1
-45.3 -29.6
-50.2 -32.1
74.1 31.6 5.8 0.6
83.1 32.9 4.3 0.7
24.6 -54.8
25.6 -59.4
-34.7 92.5 31.6 2.3 0.6 68.2
-36.4 100.9 29.4 0.0 0.5 77.9
-0.4
-0.4
9 26.6 -63.0 37.5 107.8 26.0 -3.2 0.2 84.9
10 27.6 -65.6 -38.0 112.2 24.4 -6.2 0.2 89.7 -0.3
11 28.6 -68.0 -37.7 115.4 21.6 -8.0 0.2 88.6 -0.3
12 29.6 -68.6 -37.2 116.5 23.2 -7.1 0.2 94.3 -0.2
13 30.6 -68.7
14 31.6 -67.0
15 32.6 -63.3
16 33.6 -60.2
-36.3 112.8 22.0 -5.2 0.2 93.0 -0.2
-35.1 108.9 22.3 -2.8 0.3 90.9 -0.2
-33.0 103.5 21.8
-31.6 97.7 16.4
-1.0 0.5 89.5 -0.1
-0.8 0.4 77.8 -0.2
17 35.0 -54.7 -29.0 88.8 15.8
18 36.6 -49.2 -27.2 80.1 13.5
19 40.7 -37.2 -22.9 62.2
0.4
0.1
73.6 -0.1
68.0 0.0
5.4 -0.3 -0.1 52.1 0.0
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Chapter 7
Quantification of net and reversible
hepatic fluxes through the combined use
of 13C and 2H-tracers
7.1 Introduction
Flux determination in mammalian systems is of great importance for detailed analysis of cell
physiology. The most powerful method for metabolic flux determination in complex
biological systems is based on the use of stable isotopes that, unlike radioisotopes, can be
administrated safely to subjects in high-risk population groups such as infants, children and
pregnant women, making them suitable for in vivo studies. Metabolic conversion of
isotopically labeled substrates generates molecules with distinct labeling patterns (i.e.
positional isotopomers, or simply isotopomers) that can be detected by gas chromatography
mass spectrometry (GC/MS) and nuclear magnetic resonance (NMR). To interpret these
data we use large-scale mathematical models that describe the relationship between
metabolic fluxes and the observed isotopomer abundances. In the forward calculation, these
models simulate a unique profile of isotopomer abundances for given steady-state fluxes. In
metabolic flux analysis we solve the more challenging inverse problem, i.e. calculating
metabolic fluxes from the enrichments of metabolites using nonlinear least-squares
procedures. Powerful mathematical and statistical tools have been developed for quantitative
interpretation of isotopomer data. Recently, a generic flux analysis tool was developed,
Metran (see Chapter 3), that accepts as input observed isotopomer profiles of metabolites
and returns estimated fluxes and their confidence intervals. The accuracy and precision of
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estimated fluxes depends on the choice of isotopic tracer, the quality of isotopomer data,
and the number of redundant measurements. Methods for experiment design aim at finding
the most informative tracer(s) using criteria from linearized statistics (Chapter 3). To
maximize the number of redundant measurements, labeling patterns of multiple metabolite
pools are sampled. For example, metabolic fluxes have been estimated in cultured cells and
in perfused organs by measuring isotopomer distributions of intracellular metabolites such as
citrate, alpha-ketoglutarate, succinate, malate, and amino acids by GC/MS (Fernandez, 1995;
KIhairallah et al., 2004). As powerful as current computational methods may be, many fluxes
are still unobservable due to insufficient flux constraints. To address this problem we
developed a novel framework for estimating fluxes in complex biological systems through
the combined analysis of multiple tracer experiments. Data from experiments with different
isotopic tracers are combined and analyzed simultaneously, taking full advantage of the flux
information content from each experiment. We illustrate this approach with the detailed
analysis of the gluconeogenesis pathway in cultured primary hepatocytes. Here, we applied
three isotopic tracers, i.e. [U-13C3]glycerol, [2Hlglycerol, and 2H20, and measured mass
isotopomer distributions of two glucose fragments by GC/MS. From comprehensive
analysis of the combined data allowed us to calculate net and reversible fluxes in the
gluconeogenesis pathways, which were otherwise unobservable.
7.2 Methods
7.2.1 Metabolic network model
Figure 7-1 shows the gluconeogenesis model used in this study to calculate fluxes. Table 7-1
provides the stoichiometry and atomic transitions for the 21 network reactions. The model
contains two explicit gluconeogenic precursors, i.e. oxaloacetate and glycerol. Oxaloacetate is
the intrahepatic precursor to glucose that is derived from lactate, pyruvate, glutamine, and
other related metabolites. In the metabolic route to glucose oxaloacetate is first converted to
phosphoenolpyryvate by the irreversible reaction catalyzed by phosphoenolpyryvate
carboxykinase (PEPCKI) (reaction 16). The second gluconeogenic precursor, glycerol, enters
the gluconeogenesis pathway via DHAP (reactions 10-11). Reactions 8 and 9, i.e.
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phosphorylase and phosphoglucomutase, describe glycogenolysis, i.e. breakdown of
endogenous glycogen as the second major pathway for glucose production in hepatocytes.
Reaction reversibilities and absolute stereochemistry for carbon and hydrogen atom
transitions in the model were assigned based on current knowledge. For example, it is
known that phosphoglocose isomerase (PGI) transfers specifically the pro-R hydrogen at C1
of fructose 6-phosphate (F6P) to the C2 position of glucose 6-phosphate (G6P). Hydrogen
exchange with the solvent was also observed for PGI (Malaisse, 1990; Malaisse, 1991;
Seeholzer, 1993). Malaisse et al. (1990, 1991) reported for a single passage in the direction
F6P->G6P, 65% intramolecular hydrogen transfer and 35% hydrogen exchange, and for a
single passage in the direction G6P-+F6P, 72% intramolecular hydrogen transfer and 28%
hydrogen exchange. It is also known that triose phosphate isomerase (TPI) has the same
stereochemistry as PGI. Phosphomannose isomarase (PMI), on the other hand, has the
opposite stereochemistry, i.e. PMI specifically abstracts the pro-S hydrogen of F6P and
exchanges it with the solvent. No intramolecular hydrogen transfer was observed for this
reaction, i.e. the hydrogen at C2 of mannose 6-phosphate (M6P) always originates from the
solvent. The last five reactions in the model (reactions 17-21) account for hydrogen
incorporation/metabolism of oxaloacetate and NADH. Oxaloacetate may incorporate
hydrogen atoms at C3 from the solvent in reactions of the tricarboxylic acid cycle, e.g.
fumarase, or via alanine aminotransferase. Reactions 17-18 describe hydrogen exchange of
the pro-S and pro-R hydrogen atoms, respectively. Our model further includes three explicit
sources for NADH hydrogen, i.e. 1,3-biphosphoglycerate via GAPDH (reaction 11),
hydrogen exchange with the solvent (reaction 19), and from unlabeled endogenous sources
(reaction 20). In this model, all fluxes are expressed as percentages of the glucose output
flux, which was fixed at 100. There are 17 unknown independent fluxes in this model: flux of
glycerol and oxaloacetate to glucose (reactions 10 and 16), hydrogen exchange of pro-S and
pro-R hydrogen atoms of oxaloacetate with the solvent (reactions 17-18), fractional
contribution of the solvent and unlabeled endogenous sources to NADH (reactions 19-20),
and 11 reversible reactions.
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Glucose
t
G6P G1 P *- Glycogen
H+
EC2+ E4P +- F6P -* M6P
t
FBP
DHAP
NADH
NAD+
Glyc3P
t
Glycerol
GAP$ NAD+
NADH
BPG
Oxaloacetate
Figure 7-1: Reactions of the gluconeogenesis network model used for flux calculations. The
corresponding reaction stoichiometry and atomic transitions for network reactions are given
in Table 7-1.
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Table 7-1
Stoichiometry and atom transitions for reactions in the gluconeogenesis network model. For
each compound carbon atoms are identified using lower case letters to represent successive
carbon atoms of each compound. Atom transitions for hydrogen atoms are same as for the
corresponding carbon atoms, unless otherwise indicated.
No. Enzyme Reaction stoichiometry Atom transformations
Upper gluconeogenesis
1 Glucose 6-phosphatase G6P - Gluc abcdef -+ abcdef
2 Phosphoglucose isomerase F6P + 0.3 H <- G6P + 0.3 H abcdef <- abcdef
(70%) C1-HproR <- C2-H
(30%) C1-HproR + H -> H + C2-H
3 Fructose 1,6-bisphosphatase FBP -- F6P abcdef -+ abcdef
4 Aldolase DHAP + GAP +-+ FBP + H abc + def <- cbadef
(DHAP)C1-Hpros ++ H
5 Triose phosphate isomerase DHAP + 0.3 H +- GAP + 0.3 H abc +-> abc
(70%) C1-HproR <- C2-H
(30%) C1-HproR + H +- H + C2-H
6 Phosphomannose isomerase F6P + H -> M6P + H abcdef <+ abcdef
C1-Hpros + H <- H + C2-H
7 Transketolase F6P <- E-C2 + E4P abcdef + ab + cdef
Glycogenolysis
8 Phosphorylase Glycogen -- GIP abcdef - abcdef
9 Phosphoglucomutase GIP +~ G6P abcdef -> abcdef
Glycerol metabolism
10 Glycerol kinase Glyc -+ Glyc3P abc -4 abc
11 Glycerol 3-phosphate Glyc3P <- DHAP + NADH abc <- abc
dehydrogenase C2-H -+ NADH
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Table 7-1 (continued)
Stoichiometry and atom transitions for reactions in the gluconeogenesis network model.
Lower gluconeogenesis
12 Glyceraldehyde 3- BPG + NADH -> GAP abc +-> abc
phosphate dehydrogenase NADH -> Cl-H
13 Phosphoglycerate kinase 3PG -+ BPG abc +-> abc
14 Phosphoglycerate mutase 2PG <-> 3PG abc +-4 abc
15 Enolase PEP + H +-4 2PG abc --+ abc
H <- C2-H
16 Phosphoenolpyruvate OAC -4 PEP + C02 abcd -> abc + d
carboxykinase
Hydrogen incorporation into oxaloacetate and .NADH
17 - OAC + -> OAC + H
18 -
19 -
abcd - abcd
C3-Hpr' s + H -- H + C3-Hpros
OAC + H - OAC + H abcd - abcd
C3-HproR + H <- H + C3-HtproR
1- -> NADH H -+ NADH
unlabeled - NADH
NADH - other
Hunabel cd -- NADH
NADH -- HFlther
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7.2.2 Estimating gluconeogenesis fluxes using MIDA
Mass isotopomer distribution analysis (MIDA) was proposed as a method for estimating
fractional gluconeogenesis from measurements of glucose labeling after incorporation of
[13C]glycerol, [13 C]lactate, or other 13C-labeled precursors (Neese, 1995). In MIDA, glucose is
considered a dimer of two triose phosphate molecules. [13 C]Glucose produced by
gluconeogenesis may be diluted by unlabeled glucose molecules from glycogenolysis. The
mass isotopomer distribution (MID) of glucose is fully determined by the fractional
contribution of GNG to glucose production and the labeling of triose phosphates. For
example, consider the synthesis of [13C]glucose from [U- 13C]glycerol. Assuming there is no
scrambling of 13C-labeling via the TCA cycle, or reactions of the pentose phosphate
pathway, the steady-state MID of glucose is given by:
M0 = f (1- m3,DHAP) (1-m3,GAP) + (l-) (7.1)
M3 =f (m3,DHAP (1 m3,GAP) + (1- m3,DHAP) * m3,GAP ) (7.2)
M 6  f m 3,DHAP m3,GAP  (7.3)
Here, f is the fraction of glucose produced by GNG, Mi are the mass isotopomers of
glucose, and mi are mass isotopomers of the two triose phosphate pools, i.e. DHAP and
GAP. Assuming that TP pools may be unequally labeled, we can introduce the parameter a
to describe the extent of equilibration of triose phosphates:
a = m3,GAP / m3,DHAP (7.4)
Note that a= 1 assumes complete equilibrium of the TP pools. We can solve Eqs. 7.2, 7.3,
and 7.4 for the unknown variables m3,DHAP, m3,GAP, and (, and obtain the following
expression for fractional GNG as a function of glucose mass isotopomers M3 and M 6, and
the parameter a:
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(c (M 3 +2-M 6) 2
f 2 1 (7.5)(1 + )2 M6
From the overall 13C-labeling balance we can additionally derive the following expression for
the total flux of [U- 13C]glycerol to glucose:
Flux [ T13C]glycerol-+glucos = (IMI1 + 2-M 2 + 3-M 3 + 4M 4 + 5·iMs + 6.fM6 ) / 3 (7.6)
7.2.3 Simulating isotopomer distributions for 13C and 2H tracer experiments
For given steady state fluxes a unique profile of isotopomer abundances can be calculated
for all metabolites (Chapter 2). This is done by first enumerating material balances for all
possible positional isotopomers, thus generating a comprehensive mathematical model
relating isotopomer abundances to fluxes. Positional isotopomers (termed isotopomers from
now on) are isomers of a metabolite that differ only in the labeling state of their individual
atoms, for example, 13C vs. 12C in carbon-labeling studies, and 2H vs. IH in hydrogen-
labeling studies. For a metabolite comprising N atoms that may be in one of two (labeled or
unlabeled) states, 2" isotopomers are possible. Consequently, the number of isotopomers
becomes prohibitively large when we consider both carbon and hydrogen atoms. For
example, there are only 64 (=26) carbon atom isotopomers of glucose and 128 (=27)
hydrogen atom isotopomers, but there are 8192 (=26+7) isotopomers of glucose carbon and
hydrogen atoms. Note that only the seven stable (i.e. carbon-bound) hydrogen atoms of
glucose are considered, i.e. carboxyl and hydroxyl hydrogen atoms of metabolites exchange
rapidly with the solvent and are lost during chemical derivatization in preparation for
GC/MS analysis. Thus, a typical mathematical model may contain thousands of isotopomers
of carbon and hydrogen atoms. To reduce the computational burden of isotopomer
simulations we constructed two isotopomer simulation models for the gluconeogenesis
network model (Figure 7-1), one isotopomer model where we consider only carbon atom
isotopomers, and a model where we consider only hydrogen atom isotopomers. The first
model will be used for carbon-labeling simulations, in our case to simulate the [U-
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13C]glycerol experiment, and the second model for hydrogen-labeling simulations, in this
case for [2H5]glycerol and 2H20 experiments.
7.2.4 Analysis of a single tracer experiment
The goal of Metabolic Flux Analysis (MFA) is to estimate metabolic fluxes from measured
enrichments of metabolites. Previously we described the MFA algorithm for the analysis of a
single tracer experiment (Chapter 3). In short, fluxes are estimated by minimizing the
difference between the observed and simulated measurements using a least-squares
minimization procedure. The objective of this routine is to evaluate a set of feasible fluxes
that best accounts for the observed isotopomer and flux measurements:
min (= u-Xobs T x _1 ) X(() - xobs
Here, the objective function D is the covariance-weighted sum of squared residuals, x(u) is
the vector of simulated measurements , Xobs is the vector of experimental data, Ex is the
measurement covariance matrix, and u is the vector of independent flux parameters. Eq. 7.7
is nonlinear and requires an iterative solution scheme, where at each iteration the following
quadratic programming (QP) subproblem is solved (see Chapter 3):
min AC = 2- Au T J + Au T H Au (7.8)
Au
dx U b dx 1(dx)
with J= T.du '-x(u) xob ) and H =_x 9)\du) Kdu) ' du)
In other words, J is the Jacobian and H is the Hessian matrix. The optimal search direction
for the fluxes (Au) at each iteration is given by:
Au = -H - -J (7.10)
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Thus, to determine Au at each iteration we first simulate the measurements x(u), calculate
the sensitivity matrix of the simulated measurements with respect to fluxes (dx/du), and then
evaluate J and H (Eq. 7.9).
7.2.5 Simultaneous analysis of multiple tracer experiments
The above procedure was generalized to allow simultaneous analysis of isotopomer data
from multiple experiments for the calculation of the search direction of fluxes at each
iteration. In this scheme J and H are constructed as follows:
dx,/du E, 0 0 0 x,(u-x bs
0 o . O
dxm/du 00 0 0 Y~m xm(u)- obs
dx,/du [ O o 0 0 o dx,/du
dx,/du 0 2 0 0 dx 2 /duH = (7.12)
00 *. O
dxm/du 0 0 0 x m dxm/du-
Here, xi(u) and dxi/du are the simulated measurements and measurement sensitivities for
experiments i= 1,...m; and Zxi are the corresponding measurement covariance matrices. The
two underlying assumptions are: (i) measurements from each experiment are independent,
and (ii) metabolic fluxes are identical in each experiment. The first assumption is trivial, and
the second assumption is easily validated experimentally by demonstrating reproducible
results from multiple experiments for the same conditions. Figure 7-2 shows schematically
the proposed algorithm for flux determination through combined analysis of multiple tracer
experiments. Flux estimation is initiated with random values for all fluxes. At each iteration,
measurements and sensitivities are simulated for each experiment individually, using the
same fluxes for each simulation. The simulated isotopomer distributions are then used to
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Start with random
initial fluxes
Simulate measurements an
sensitivities for each experimi
I x,=fj(u), dx1/du=f 1'(u)
I 2=f 2(u) , dx 2/du=f 2'()
I Xm=fm(U), dxm/du=f m'(U)
d
ent
iil
Calculate Jacobian and Hess
(Eqs. 7.11 and 7.12)
Au = -H-1J (Eq. 7.10)
Is the convergence
criterion satisfied?
ian Update
flux vector
uk+l = uk + A
No
Yes
Evaluate goodness-of-fit
and calculate confidence
intervals of estimated fluxes
I Report fluxes, confidence intervals
and network structure
Figure 7-2: A schematic of the algorithm for flux determination through combined analysis
of multiple tracer experiments.
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construct the Jacobian and Hessian matrices using Eqs. 7.11 and 7.12. The optimal search
direction for fluxes is calculated using Eq. 7.10, and the flux vector is updated. The flux
estimation algorithm continues until a predefined convergence criterion is met. At
convergence, confidence intervals for all fluxes are determined using nonlinear statistical
techniques. A nice feature the described method is that the computational effort for
calculating J and H increases only linearly with the number of experiments that are included
in the analysis. Note that inequality constraints on fluxes can be included without difficulty
in this general scheme, and all kinds of step controlling strategies can be applied (Byrd et al.,
1999; Gill et al., 1991). This generalized algorithm for MFA was incorporated into our flux
analysis software Metran.
7.2.6 Statistical analysis
After the fluxes were calculated, nonlinear statistical techniques were applied to obtain
confidence intervals of fluxes by evaluating the sensitivity of the objective function with
respect to fluxes as described by previously (Chapter 3). Flux validation was accomplished by
a statistical test for the goodness-of-fit (i.e. chi-square test for model adequacy), and a
normality test for the weighted residuals. To ensure a global optimum, flux estimation was
repeated at least four times starting with random initial values. Sensitivity analysis was
employed to determine the relative importance of measurements for individual fluxes as
described previously (Chapter 3).
7.2.7 Materials
Biochemicals were obtained from Sigma Chemicals (St. Louis, MO). [U- 13C]glycerol, and [U-
13C]glutamine were obtained from Cambridge Isotope Laboratories (Andover, MA).
[2Hs]glycerol was obtained from Isotec (Miamisburg, OH). Tissue culture media were
obtained from Sigma (St. Louis, MO). Hepatocyte Medium Base was DMEM powder
(Sigma) supplemented with 3.7 g/L NaHCO 3, 30 mg/L proline, 100 mg/L ornithine, 610
mg/L niacinimide, 0.544 mg/L ZnCl2, 0.75 mg ZnSO 4.7H 20, 0.2 mg/L CuSO 4.5H20, 0.025
mg/L MnSO 4, 2 g/L bovine serum albumin, 100,000 U penicillin, and 100,000 U
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streptomycin. Hepatocyte Attachment Medium consisted of Hepatocyte Medium Base
supplemented with 5 nM insulin, 100 nM dexamethasone and 20 mM glucose. Hepatocyte
Growth Medium consisted of Hepatocyte Medium Base supplemented with 1 nM insulin,
100 nM dexamethasone and 20 mM glucose.
7.2.8 Hepatocyte isolation and cell culture
Hepatocytes were isolated from C57BL/6 mice fed ad libitum by modified two step-
collagenase perfusion as described by Seglen (1976). The cell yield was between 1.0-1.5x10 6
cells/g mouse with viabilities between 85-90% (Trypan Blue staining). Crude cell suspension
was scraped from the liver sac and purified by coarse 100 jpm filtration, a second 70 gm
filtration, and Percoll fractionation for hepatocytes. Purified cells were suspended in
Hepatocyte Attachment Medium (HAM) and seeded in 6-well plates (1.3x106 cells/well) for
90 minutes at 37 0C. Attached cells were washed once with PBS and cultured overnight in
Hepatocyte Growth Medium (HGM). After 18 hr incubation at 37 0C and 5% CO 2 the
attached hepatocytes were washed once with PBS, and subsequently cultured in glucose-free
HGM enriched with gluconeogenic carbon sources: 1mM glycerol, 10 mM lactate, 1 mM
pyruvate, 5 mM glutamine, and 2 mM acetate. Four chemically identical isotopically-labeled
media were prepared, containing either [U- 13C]glycerol, [zHs]glycerol, 10% 2H20, or no
tracers (as control). The cells were then incubated for 2, 5, or 8 hr at 370C and 5% CO 2 in
the labeled media. At the end of the incubation period medium samples were collected and
stored at -80 0C prior to analysis.
7.2.9 Derivatization of glucose
Glucose labeling patterns were determined by GC/MS analysis of aldonitrile pentaacetate
(Szafranek, 1974) and di-O-isopropylidene acetate derivatives of glucose (Hachey, 1999). For
each derivatization 200 piL of sample was deproteinized by addition of 500 IL of acetone
(-40 C). The mixture was centrifuged and the supernatant evaporated to dryness under air
flow. For aldonitrile pentaacetate derivatization, 50 tL of 2 wt%/o hydroxylamine
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hydrochloride in pyridine was added to the dry residue and the sample was heated at 90 0 C
for 60 min. This was followed by addition of 100 jiL of propionic anhydride and heating at
60 0 C for additional 30 min. The sample was then evaporated to dryness, dissolved in 100 iL
of ethyl acetate and transferred to an injection vial for GC/MS analysis. For di-O-
isopropylidene acetate derivatization, 500 p.L of 0.38 M sulfuric acid in acetone was added to
the dry residue and the sample incubated at room temperature for 60 min. 400 ýPL of 0.44 M
sodium carbonate was added to neutralize the reaction, followed by addition of 1 mL of
saturated sodium chloride. Di-O-isopropylidene derivatives were extracted by partitioning
with 1 mL of ethyl acetate. The upper, organic layer was evaporated to dryness, followed by
addition of 150 ptL of acetic anhydride in pyridine (2:1 v/v) and heating at 60 0 C for 30 min.
The sample was then evaporated to dryness, dissolved in 100 11L of ethyl acetate and
transferred to an injection vial for GC/MS analysis.
7.2.10 GC/MS analysis
Gas Chromatography-Mass Spectrometry (GC/MS) analysis was performed using HP 5890
Series II GC (Gas Chromatograph) equipped with a DB-1701 [30 m x 0.25 mm (inner
diameter) x 0.25 tpm] capillary column, connected to HP 5971 MSD (Mass Selective
Detector) operating under ionization by electron impact (EI) at 70 eV. The mass
spectrometer was calibrated using the 'Max Sensitivity Autotune' setting. Helium flow was
maintained at 0.737 mL/min by electronic control. The temperatures of the injector and the
detector were kept at 2500 C and 3000 C, respectively. The temperature of the column was
started at 80'C for 1 min, increased to 2800 C at 200C/min, and held for 4 min. For analysis
of aldonitrile pentaacetate glucose, mass spectra were recorded in the mass range 314-322 at
12 scans/sec. The fragment at m/z 314 (C13H 160 8N) corresponded to C1-C5 carbon atoms,
and H2-H5 hydrogen atoms of glucose. For the analysis of di-O-isopropylidene acetate
glucose, mass spectra were recorded in the mass range 287-292 at 12 scans/sec. The
fragment at m/z 287 (C13H1 90 7) corresponded to all six carbon and all seven carbon-bound
hydrogen atoms of glucose. Measured intensities were corrected for noise (baseline
correction), and mass isotopomer distributions were obtained by integration. All mass
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isotopomer values were expressed as fractional abundances, i.e. for each fragment the sum
of all mass isotopomers equals one. Reported mass isotopomer distributions are averaged
values from at least six injections per sample.
7.2.11 Measurement of metabolite concentrations
Glucose and lactate concentrations were determined by YSI 2300 Stat Plus glucose/lactate
analyzer (YSI Inc., Yellow Springs, OH). Glycerol and glutamine concentrations were
determined by GC/MS analysis with internal standards. We prepared 1:1 mixtures of the
medium sample and a standard with known concentration, in this case either [U-
13C]glutamine (10 mM), [U- 13C]glycerol (1 mM), or unlabeled glycerol (1 mM), which were
then derivatized to yield the respective TBDMS derivatives (Chapter 4). Measured intensities
for glutamine (m/z 432-444) and glycerol (m/z 173-200) were corrected for natural isotope
enrichments, and glutamine and glycerol concentrations were determined from the fractions
of labeled/unlabeled molecules.
7.3 Results
7.3.1 External fluxes
Figure 7-3 shows the dynamics of glucose and lactate production, and glycerol and glutamine
consumption by cultured hepatocytes over 8 hr period. A linear fit of the data (R2>0.99)
yielded the following values (in mM/hr/106 cells): glucose production 0.204±0.005, lactate
production 0.263±0.029, glycerol uptake 0.133+0.006, and glutamine uptake 0.333±0.026.
Fluxes expressed as percentages of glucose production were 129±14 for lactate production,
65±3 for glycerol uptake, and 163±13 for glutamine uptake. No glycerol was detected in the
samples taken at 8 hr. Based on the linear fit shown in Figure 7-3 we estimated that glycerol
was depleted after about 7-7.5 hrs.
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Figure 7-3: Time profiles of glucose, glycerol, lactate and glutamine in hepatocytes cultures.
Glucose and lactate accumulated in the medium, while glycerol and glutamine were taken up
by hepatocytes and served as precursors for glucose production.
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7.3.2 Reproducibility of cell experiments
To characterize the well-to-well variability in our experiments, hepatocytes were incubated in
three wells in medium containing 2H20 at 10% enrichment, and a control well with no
tracers. Table 7-2 shows the mass isotopomer distribution of two glucose derivatives assayed
by GC/MS. The MIDs from three replicate wells were not statistically different from one
another (P>0.1), but were significantly different from the experiment with no tracers
(P<0.001). This confirmed that biological variability between wells was small in our
experiments.
7.3.3 Characterization of glycerol
Figure 7-4 shows the measured mass isotopomer distributions (MIDs) of glycerol in the
medium at 0, 2 and 5 hr from [U-13C]glycerol, [2Hs]glycerol, and 2H20 experiments (data
shown were corrected for natural isotopes). The MID of glycerol from the [U-13C]glycerol
experiment at time zero was characterized by 97% M+3 and 3% M+2 isotopomers. The
M+2 isotopomer resulted from incomplete labeling of the tracer, i.e. 99 AtO/ 13C-labeling
according to manufacturers' specifications. The MID of [2H5]glycerol at time zero was
characterized by 96% M+5 and 4% M+4 isotopomers, which was slightly more labeled than
98 AtO/ 2H-labeling according to manufacturers' specifications. The enrichment of both
glycerol tracers decreased after 5 hr to 75% M+3 enrichment for [U- 13C]glycerol, and 79%
M+5 enrichment for [2Hs]glycerol. The decrease in enrichment occurred mostly due to the
release of unlabeled glycerol in the [U- 13C]glycerol experiment, and release of M+0, M+1,
M+2, and M+3 isotopomers in the [2Hs]glycerol experiment. Figure 7-5 shows in more
detail the accumulation of M+0 to M+4 glycerol isotopomers in the medium in the
[2Hs]glycerol experiment. The release of unlabeled/partially labeled glycerol isotopomers
corresponded to about 8-10% of glycerol uptake rate. In the 2H20 experiment we observed
a small but significant incorporation of deuterium into glycerol, i.e. the M+1 enrichment of
glycerol increased from 0.2±0.2 mol% at time zero to 3.7±0.2 mol%/o at 5 hr (after correction
for natural isotope enrichments).
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Table 7-2
Assessment of biological variability in cell culture experiments. Mass isotopomer abundances
(mol%) of aldonitrile pentaacetate and di-O-isopropylidene acetate derivatives of glucose
from hepatocyte experiments were measured by GC/MS. Experiments were performed in
separate wells in a 6-well plate in medium containing 10% 2H20 (wells 1-3), or no tracers
(well 4). Mass isotopomer abundances were not significantly different between the three
replicate 2H 20 experiments, but were significantly different from the experiment with no
tracers.
Aldonitrile pentaacetate glucose (m/ z 314)
m/z 10% 2 H20 (well 1) 10% 2H20 (well 2) 10% 2H 20 (well 3) no tracers (well 4)
287 54.3 ± 0.5 53.8 ± 0.5 53.4 ± 0.5 84.5 ± 0.5
288 32.7 ± 0.4 32.9 + 0.4 33.2 + 0.4 13.0 ± 0.4
289 10.4 ± 0.3 10.6 ± 0.3 10.7 ± 0.3 2.2 ± 0.2
290 2.2 ± 0.2 2.3 ± 0.2 2.3 + 0.2 0.2 + 0.1
291 0.4 ± 0.2 0.4 ± 0.2 0.4 ± 0.2 0.0 ± 0.1
292 0.0 ± 0.1 0.0 ± 0.1 0.0 ± 0.1 0.0 + 0.1
Ii-O-isopropylidene acetate glucose (m/ Z 287)
m/z 10% 2H20 (well 1) 10% 2H20 (well 2) 10% 2H20 (well 3) no tracers (well 4)
314 62.8 ± 0.4
315 28.9 ± 0.3
316 7.1 ± 0.2
317 1.2 ± 0.2
318 0.1 + 0.1
319 0.0 + 0.1
62.4 ± 0.4
29.2 ± 0.3
7.2 ± 0.2
1.2 ± 0.2
0.0 ± 0.1
0.0 ± 0.1
62.4 ± 0.4
29.2 + 0.3
7.2 ± 0.2
1.2 ± 0.2
0.1 ± 0.1
0.0 ± 0.1
84.9 ± 0.4
12.8 ± 0.3
2.2 ± 0.2
0.1 ± 0.1
0.0 ± 0.1
0.0 ± 0.1
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Figure 7-4: Mass isotopomer distributions of glycerol in the medium. Labeling distribution
of glycerol from [U-13C]glycerol (top), [2H5]glycerol (middle), and 2H20 (bottom)
experiments was analyzed by GC/MS, after TBDMS derivatization. Data shown were
corrected for natural isotope enrichments.
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Figure 7-5: Loss of 2H from [2H5]glycerol in cultured hepatocytes. Mass isotopomer
distributions of TBDMS derivatized glycerol were measured by GC/MS. Data shown were
corrected for natural isotope enrichments.
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7.3.4 Incorporation of deuterium into lactate and ketone bodies
We identified two metabolites in the medium that incorporated significant amounts of
labeling from [2Hs]glycerol and 2H 20, i.e. lactate and 3-hydroxybutyrate. Figure 7-6 shows
the enrichment of lactate and 3-hydroxybutyrate, respectively (enrichment = Y Mixi). Lactate
incorporated labeling from [2Hs]glycerol and 2H20, but not from [U-13C]glycerol. The
amount of labeling incorporated from 2H 20 (at 10% enrichment) could not be explained
solely by de novo synthesis of lactate, indicating that there was significant exchange between
intracellular pyruvate pool and extracellular lactate pool. Pyruvate can incorporate deuterium
at C3 in the reaction catalyzed by alanine aminotransfererase and lactate can incorporate
deuterium at C2 from NADH via lactate dehydrogenase. The amount of labeling
incorporated from [2Hs]glycerol was about 6 times less than from 10% 2H20. However, we
should note that [2Hs]glycerol can only transfer deuterium atoms to lactate via [2H5]glycerol
-* [2H]NADH -> [2 H]lactate catalyzed by glycerol-3-phosphate dehydrogenase and lactate
dehydrogenase, respectively. Taking into account that lactate was present at 10 mM at time
zero and the concentration increased to 12.8 mM at 8 hr, and that lactate enrichment
increased from 0.0% to 2.9±0.6%, we estimated that about 13±5% of NADH atoms were
derived from glycerol (=2.9%x12.8/(12.8-10)). In contrast, we found that 3-hydroxybutyrate
incorporated labeling only from 2H 20, and not from [2Hs]glycerol or [U- 13C]glycerol. In
these experiments, 3-hydroxybutyrate was derived solely from de novo synthesis, i.e. there was
no 3-hydroxybutyrate at time zero (validated by GC/MS analysis). In the 10% 2H20
experiments the enrichment of 3-hydroxybutyrate was more or less constant over 8-hrs at
about 22% indicating that on average 2.2 of the 5 hydrogen atoms of 3-hydroxybutyrate
were derived from the solvent.
7.3.5 Incorporation of 3C and 2H into glucose
Table 7-3 shows the mass isotopomer distributions of two glucose fragments measured at 2,
5 and 8 hr from [U- 13C]glycerol, [2Hs]glycerol, and 2H 20 experiments, and Table 7-4 shows
the corresponding corrected MIDs. The last column in Table 7-4 shows the total enrichment
of glucose, i.e. enrichment = I Mixi. The di-O-isopropylidene acetate derivative of glucose
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Figure 7-6: Incorporation of deuterium from [2Hs]glvcerol and 2H20 into lactate and 3-
hydroxybutyrate. Mass isotopomer distributions of TBDMS derivatized lactate and 3-
hydroxybutyrate were measured by GC/MS, and isotope enrichment was calculated after
correcting for natural isotope enrichments.
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Table 7-3
Incorporation of labeling from [13C]glycerol, 2H]glycerol and 2H20 into glucose. Shown are
the uncorrected mass isotopomer distributions of glucose (molar abundances; mol% ), for
aldonitrile pentaacetate (m/z 314) and di-O-isopropylidene acetate (m/z 287) derivatives.
Time of Glucose mass isotopomers
Tracer Sample M+0 M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8
m/z 287 ion fragment (C1-6, H1-6)
[U- 13C]glycerol 2 hr 42.5 7.3 3.0 29.5 4.0 1.8 10.9 0.9 0.1
5 hr 41.8 7.3 3.2 30.7 4.1 1.8 10.1 0.9 0.1
8 hr 48.8 8.5 3.3 26.2 3.5 1.4 7.6 0.6 0.1
.... . . . .......... . . . .--- ---.- -----. ---- --.. . . . . . . . . . .. . . .. . . . .. .. .. .. . . .. . . .. .. . . .. .. .. .. ... . . . . .. ...... .. . . . . . . . . . . . . . . . .
[2Hs]glycerol 2 hr 43.1 17.4 20.2 11.1 5.7 2.2 0.3 0.0 0.0
5 hr 42.2 18.0 20.8 11.1 5.4 2.1 0.5 0.1 0.0
8 hr 45.8 18.6 19.5 9.6 4.4 1.6 0.4 0.1 0.0
2H20 2 hr 56.9 31.2 9.6 2.1 0.2 0.0 0.0 0.0 0.0
5 hr 54.7 32.5 10.2 2.2 0.4 0.0 0.0 0.0 0.0
8 hr 53.7 33.0 10.6 2.3 0.3 0.0 0.0 0.0 0.0
no tracers 2 hr 85.2 12.6 2.1 0.2 0.0 0.0 0.0 0.0 0.0
5 hr 84.5 13.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0
8 hr 83.9 13.5 2.3 0.3 0.0 0.0 0.0 0.0 0.0
m/z 314 ion fragment (C1-5, H2-5)
[U-' 3C]glycerol 2 hr 43.1 7.5 14.0 19.7 3.3 11.1 1.0 0.2 0.0
5 hr 42.3 7.6 14.8 20.5 3.4 10.3 0.9 0.2 0.0
8 hr 49.4 8.8 13.2 17.3 2.8 7.7 0.7 0.1 0.0
2H5]glycerol 2 hr 65.2 25.3 8.0 1.4 0.1 0.0 0.0 0.0 0.0
5 hr 64.5 25.8 8.1 1.4 0.1 0.0 0.0 0.0 0.0
8 hr 67.0 24.4 7.2 1.2 0.1 0.0 0.0 0.0 0.0
...... .... . ..... ...... . .... . . .. .. . . . . ...... .......... .. . . . . ... . . . . . .. ..... . . . ... . . . .. ... .. ... ... .... . ..... . . . ... . . ........ ...... ..... . .... . . . . . . . . . . . . . ... . . ...
2H20 2 hr 65.0 27.4 6.5 1.0 0.1 0.0 0.0 0.0 0.0
5 hr 63.0 28.8 6.9 1.1 0.2 0.0 0.0 0.0 0.0
8 hr 62.6 29.1 7.1 1.1 0.1 0.0 0.0 0.0 0.0
no tracers 2 hr 85.2 12.6 2.1 0.1 0.0 0.0 0.0 0.0 0.0
5 hr 84.9 12.8 2.1 0.1 0.0 0.0 0.0 0.0 0.0
8 hr 84.6 13.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0
8 hr 84.6 13.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0
- 243
CHAPTER 7. OUANTIFICATION OF HEPArIC FLUXES FROM 13C AND 2H-TRACERS
Table 7-4
Corrected mass isotopomer distributions of glucose fragments. Total enrichment of glucose
was calculated from mass isotopomer data after correction for natural isotope enrichments.
Time of Glucose mass isotopomers Enrichment*
Tracer Sample M+0 M+1 M+2 M+3 M+4 M+5 M+6 (%)
m/z 287 ion fragment (C1-6, H1-6)
[U-13C]glycerol 2 hr 49.9 1.2 2.1 33.1 0.7 1.3 11.8 184.5 ± 0.8
5 hr 49.1 1.3 2.3 34.5 0.6 1.2 10.9 183.7 ± 0.8
8 hr 57.3 1.5 2.2 29.3 0.5 0.9 8.2 149.9 ± 0.8
[2Hs]glycerol 2 hr 50.6 13.0 20.6 9.6 4.7 1.6 0.0 109.6 ± 0.7
5 hr 49.5 13.8 21.2 9.4 4.4 1.5 0.2 110.8 ± 0.7
8 hr 53.8 13.9 19.5 7.9 3.5 1.1 0.2 97.4 + 0.7
2H20 2 hr 66.8 26.7 5.7 0.8 0.0 0.0 0.0 40.5 ± 0.6
5 hr 64.2 28.7 6.2 0.8 0.1 0.0 0.0 43.9 ± 0.6
8 hr 63.1 29.5 6.6 0.9 0.0 0.0 0.0 45.1 ± 0.6
no tracers 2 hr 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ± 0.3
5 hr 99.4 0.6 0.0 0.0 0.0 0.0 0.0 0.6 ± 0.3
8 hr 98.8 1.2 0.0 0.0 0.0 0.0 0.0 1.2 ± 0.3
m/z 314 ion fragment (C1-5, H2-5)
[U-13C]glycerol 2 hr 50.9 1.1 14.7 20.5 1.0 11.8 154.9 ± 0.8
5 hr 49.9 1.4 15.6 21.2 1.0 10.9 154.6 ± 0.8
8 hr 58.3 1.5 13.5 17.8 0.7 8.1 125.4 ± 0.8
[2Hs]glycerol 2 hr 76.9 18.2 4.6 0.2 0.0 0.0 28.1 ± 0.5
5 hr 76.2 18.9 4.6 0.2 0.0 0.0 28.9 ± 0.5
8 hr 79.2 16.9 3.8 0.2 0.0 0.0 24.9 ± 0.5
2H20 2 hr 76.8 20.7 2.5 0.0 0.0 0.0 25.7 ± 0.5
5 hr 74.4 22.8 2.7 0.1 0.1 0.0 28.6 ± 0.5
8 hr 73.9 23.2 2.9 0.0 0.0 0.0 29.0 ± 0.5
no tracers 2 hr 100.0 0.0 0.0 0.0 0.0 0.0 0.0 ± 0.3
5 hr 99.6 0.4 0.0 0.0 0.0 0.0 0.4 ± 0.3
8 hr 99.3 0.7 0.0 0.0 0.0 0.0 0.7 ± 0.3
* Enrichment = I Mixi.
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(m/z 287) contained all six carbon atoms and all seven carbon-bound hydrogen atoms of
glucose, and the aldonitrile pentaacetate derivative (m/z 314) contained carbon atoms C1-C5
of glucose and hydrogen atoms at positions C2-C5. In hepatocytes incubated with [U-
13C]glycerol the main labeled glucose isotopomers were M+3 (-30 mol%/o) and M+6 (-10
mol%/o), with much lower abundances of the other labeled isotopomers (<2.5 molO/). The
presence of M+1, M+2, M+4 and M+5 isotopomers can be explained by transketolase
activity as suggested by Kurland et al. (2000), or by scrambling of glycerol labeling in the
TCA cycle as suggested by Previs et al. (1995). In light of our previous observation that
lactate was not labeled from [U-13C]glycerol, we concluded the cycling between glycerol and
TCA cycle was not significant in our experiments. Thus, there must be some residual
transketolase activity in cultured hepatocytes. The higher abundance of M+3 (20.5 mol%; i.e.
C1-C3 of glucose) compared to M+2 (14.7 mol%/o; i.e. C4-C5 of glucose) in the aldonitrile
pentaacetate derivative of glucose indicated that DHAP was more labeled than GAP, i.e. the
two triose phosphate pools were only at 72% equilibrium (=14.7/20.5). The enrichment of
glucose from [U-13C]glycerol was constant over the first 5 hrs, indicating a constant
contribution of [U- 13C]glycerol to glucose production. The lower enrichments at 8 hr can be
explained by the depletion of [U- 13C]glycerol after about 7 hr (see section 7.3.1). To interpret
the data more quantitatively we applied MIDA equations to estimate fractional contribution
of GNG to glucose production and the net flux of [U- 13C]glycerol to glucose. Table 7-5
shows that fractional contribution of GNG was estimated at 66%, 71%, and 63% at 2, 5, and
8 hr, respectively. The value at 8 hr is likely to be an underestimation of GNG due to the
depletion of the [U-13Cqglycerol tracer after 7 hr, i.e. MIDA assumes isotopic steady-state.
In experiments with [2H5]glycerol we observed significant production of glucose mass
isotopomers M+1 to M+5. Similar to the [U-13C]glycerol experiment, we found that the
fractional contribution of [2Hs]glycerol to glucose production remained constant over the
first 5 hrs (i.e. constant enrichment of glucose), and then declined due to [2H5]glycerol
depletion. The amount of deuterium incorporated into glucose from [2Hs]glycerol provided
rich information on the relative activity of various gluconeogenic reactions. Deuterium
atoms of [2Hs5]glycerol may be lost at various points in the pathway from glycerol to glucose.
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Table 7-5
Metabolic fluxes estimated by mass isotopomer distribution analysis (MIDA). Glucose mass
isotopomers from [U- 13C]glycerol experiments were measured by GC/MS and corrected for
natural isotope enrichments. MIDA equations were used to estimate fluxes of
gluconeogenesis pathway. Fluxes shown are expressed as percentages of glucose production
rate.
Flux* 2 hr 5 hr 8 hr
Glucose production (fixed at 100) 100 100 100
Gluconeogenesis (parameter f) 66.3 71.0 62.5
Glycogenolysis 33.7 29.0 37.5
Glycerol to glucose flux 61.5 61.2 50.0
Oxaloacetate to glucose flux 71.1 80.8 75.0
Triose phosphate equilibration (%/o) 72 % 74 % 76 %
* Parameter f was calculated from Eq. 7.5.
* Glycogenolysis = 100 - f.
* Glycerol to glucose flux was calculated from Eq. 7.6.
* Oxaloacetate to glucose flux = 2-f - (glycerol to glucose flux).
* Triose phosphate equilibration (a in Eq. 7.5) was estimated from the ratio of mass isotopomers
(m/z 316)/(m/z317)x100% of aldonitrile pentaacetate derivative of glucose (after correction).
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For example, the deuterium at C2 is transferred to NADH in the reaction catalyzed by
glycerol-3-phosphate dehydrogenase. The pro-R hydrogen at C1 may be lost in the reaction
catalyzed by TPI, and the pro-S hydrogen in reactions catalyzed by aldolase and GAPDH.
Finally, the pro-R hydrogen at C3 may be lost in the reaction catalyzed by PGI, and the pro-
S hydrogen by PMI and glucose-6-phosphate dehydrogenase reactions. In other words, the
presence of M+1 to M+5 mass isotopomers of glucose indicated that one or more of the
above reactions were not fully equilibrated. However, without a proper mathematical model
it is difficult, if not impossible, to interpret the isotopomer data from [2H5]glycerol
experiments quantitatively.
In 2H20 experiments deuterium enrichment of glucose increased from 40.5% to 43.9% and
45.1% at 2, 5, and 8 hr, respectively, indicating that gluconeogenesis flux increased by about
11% over the course of the experiment. On average 4.0 to 4.5 of the 7 atoms of glucose
were derived from the solvent. The enrichment of the aldonitrile pentaacetate fragment of
glucose increased from 25.5% to 28.6% and 29.0% (an increase of 13%), i.e. on average 2.6
to 2.9 of the 4 hydrogen atoms at C2-C5 were derived from the solvent. Note that in the
control experiment with no tracers we found a slight increase in glucose enrichment that
could not be explained by natural isotope abundances, i.e. from 0.0±0.3 at time zero to
1.2±0.3 at 8 hr. One potential explanation was cross-contamination between adjacent wells
in the 6-well plate, i.e. the unlabeled wells were adjacent to the wells with 2H20.
To summarize, qualitative analysis of glucose enrichment data revealed that the flux of
glycerol to glucose was constant over the first 5 hrs of the experiment, and that the
contribution of non-glycerol precursors to glucose increased by about 10-13%. Finally, we
found evidence of some residual transketolase activity in the cultured hepatocytes.
7.3.6 Flux estimation and model validation
To better characterize metabolic fluxes in this system we performed comprehensive analysis
of the observed MIDs with the network model shown in Figure 7-1 and Metran software.
Fluxes and their confidence intervals ware estimated from three data sets individually and
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using the combined data of all three experiments. Table 7-6 compares the information
content of the data sets. For example, [U-13C]glycerol experiments provided 13 mass
isotopomers of glucose from which 4 independent fluxes could be estimated, i.e. net fluxes
of glycerol and oxaloacetate to glucose, and exchange fluxes of TPI and TK reactions. Thus,
there were 9 (=13-4) redundant measurements in the [U-' 3C]glycerol data. We found
excellent agreement between the observed mass isotopomer abundances and abundances
predicted by the model for the optimally fitted fluxes, as judged by the small magnitude of
the sum of squared residuals, i.e. 1.8, which was smaller than the critical value 19.0 for the
statistical test of model adequacy (at 95% confidence level with 9 degrees of freedom), which
indicated that the fit was statistically acceptable. Fits for the [2Hs]glycerol and 2H20 data sets
were also statistically acceptable. However, our initial attempts to reconcile data from all
three experiments failed. The sum of squared residuals was consistently larger than the
critical value for the statistical test. Further analysis revealed that MIDs of glucose from the
[U-' 3C]glycerol and [2Hs]glycerol experiments were incompatible with the MIDs of glucose
from the 2H20 experiment. Previously, Previs et al. (1998) showed that glycerol and lactate
tracers consistently underestimated GNG by 10-30% in isolated hepatocytes. This effect
could not be explained from lack of equilibrium of triose phosphates, zonation of glycerol
kinase, or differences in substrate concentrations. The authors concluded that there must be
different cell populations of hepatocytes that utilize glycerol and lactate/pyruvate to different
extent for the production of glucose. The net observed effect was an increased abundance of
unlabeled glucose and decreased abundances of labeled glucose isotopomers, resulting in
underestimation of GNG. To account for this effect in our model we introduced dilution
parameters for glucose labeling from [U-' 3C]glycerol and [2H5]glycerol experiments, i.e. these
parameters quantify the apparent dilution of labeled glucose isotopomers due to differential
metabolism of cell populations. Note that these parameters also capture the apparent
dilution due to depletion of tracers. Further analysis revealed that no dilution parameter was
required for the 2H20 data, i.e. the goodness-of-fit was not statistically improved by adding a
dilution parameter for the 2H20 data. Therefore, our model included only two dilution
parameters, i.e. for [U- 13C]glycerol and [2H5]glycerol experiments. With the updated model
we successfully fitted the combined data from all thee experiments and estimated fluxes.
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Table 7-6
Comparison of information content of experimental data. Individual data sets from [U-
13C]glycerol, [2Hs]glycerol, and 2H20 experiments were fitted to a detailed model of glucose
metabolism. Fluxes were estimated and confidence intervals were evaluated. Analysis of the
combined data required two additional parameter to describe the apparent glucose labeling
when glycerol tracers were used. The flux results were then statistically evaluated to test for
goodness-of-fit.
Combined analysis of
10% 2H20 [2Hs]glycerol [U-13C]glycerol all three experiments
No. of fitted mass isotopomers 7 9 13 29
No. of estimated fluxes * 2 6 4 11 + 2**
No. of redundant measurements*** 5 3 9 16
Sum of weighted squared residuals 1.2 1.8 2.7 12.1
Fit statistically acceptable Yes Yes Yes Yes
* Number of estimated fluxes equals the number of independent fluxes that were statistically different
from zero, as judged by the 95% confidence interval.
** Combined analysis of all three experiments required two additional parameters to account for
apparent dilution of glucose labeling from glycerol tracers.
*** Number of redundant measurements = (no. of fitted isotopomers) - (no. of estimated flux)
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The minimized sum of squared residuals of 12.1 was smaller than the critical value of 24.8
(at 95% confidence level with 13 degrees of freedom) indicating a statistically acceptable fit.
The apparent fractional labeling of glucose was estimated at 87%_±3 and 86%0+3 for the [U-
13C]glycerol and [2Hs]glycerol experiments, respectively, indicating that for both glycerol
tracers there was an apparent dilution of glucose by about 13% (i.e. a value of 100% would
indicate no dilution). 'Table 7-7 shows the 95% confidence intervals for the estimated fluxes
for the 2-hr experiments.
After comparing the information content of separate data sets with the combined data
(Table 7-6), two advantages of our method become apparent: (i) we can estimate more
fluxes, and (ii) the number of redundant measurements is significantly increased. Here, 11
fluxes were estimated from the combined data, compared to 2 fluxes from the 2H20
experiment, 6 fluxes from [2H5]glycerol experiment, and 4 fluxes from [U- 13C]glycerol
experiment. The number of redundant measurements for the combined data was 16
compared to 5, 3, and 9 for 2H20, [2Hs]glycerol, and [U-' 3C]glycerol data, respectively.
Redundant measurements are important for metabolic flux analysis, because they allow more
accurate estimation of fluxes, validation of modeling assumptions, and identification of
missing reactions in the network model. In this study, many modifications to the initially
assumed network model were examined for their ability to accurately account for the
observed isotopomer data. If a modification explained the data significantly better, i.e.
resulted in a statistically smaller magnitude of sum of squared residuals, it was accepted. Such
a posteriori changes to the model were the inclusion of the transketolase (TK) and
phosphomannose isomerase (PMI) reactions, resulting in a reduction of the sum of squared
residuals by more than 80%. The results is shown in Table 7-7 further illustrate that the
different isotopic tracers provide different flux information. For example, exchange fluxes of
TK and TPI were estimated precisely from ILL- 13C]glycerol data, however, PGI and PMI
exchange fluxes could not be determined. On the other hand, [2Hs]glycerol data provided
sufficient information to estimate PGI, TPI and PMI exchange fluxes, however, the
estimated TK exchange flux was less precise. Note that 2H20 data alone did not provide
enough information to determine net and exchange fluxes in this system with precision,
however, when supplemented with data from [U- 13C]glycerol and [2Hs]glycerol tracers, the
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Table 7-7
Estimated 95% confidence intervals of fluxes for the samples taken at 2 hr. Metabolic fluxes
and their confidence intervals were estimated by fitting glucose mass isotopomer
distributions to detailed gluconeogenesis model using Metran software.
Combined analysis of
Netfluxes 10% D20 [2Hs]glycerol [U-13C]glycerol all three experiments
Glucose production (fixed at 100) 100 100 100 100
Gluconeogenesis (GNG)* 53 - 100 63 - 80 69 - 73 75 - 87
Glycogenolysis (GL)* 0 - 47 20 - 37 27 - 31 13 - 25
Glycerol to glucose flux 0 - 150 57 - 64 60 - 62 65 - 75
Oxaloacetate to glucose flux 29 - 183 65 - 102 77 - 85 85 - 100
Exchange fluxes**
Phosphoglucose isomerase (PGI) nd 140 - 380 nd 262 - 728
Aldolase nd nd nd nd
Triose phosphate isomerase (TPI) nd 180 - 510 230 - 360 280 - 405
Phosphomannose isomerase (PMI) nd 0 - 27 nd 0 - 41
Transketolase (TK) nd 7 - 83 5 - 9 6 - 10
Phosphoglucomutase (PGM) nd nd nd nd
Glycerol 3-phosphate dehydr. nd nd nd nd
Glyceraldehyde 3-phosphate dehydr. nd nd nd nd
Cycling between GAP and PEP nd nd nd nd
Additional model parameters
Apparent fractional glucose labeling 87% ± 3
in [U-13C]glycerol experiment
Apparent fractional glucose labeling 86% ± 5
in [2Hs]glycerol experiment
* GNG and GL are not independent fluxes, i.e. GNG = (Vglycerol + voxaioacetate)/2; GL = 100-GNG.
** 'nd' (=not determined) indicates that the exchange flux could not be determined, as judged by
having a 95% confidence interval from zero to infinity.
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2H2 0 experiment provided the most informative mass isotopomers for accurate estimation
of the gluconeogenesis flux (results based on sensitivity analysis).
7.3.7 Evaluation of estimated fluxes
Table 7-8 shows the estimated fluxes for the 2, 5, and 8-hr samples obtained from analysis of
combined isotopomer data for each time point. The small magnitude of the sum of squared
residuals and the large number of redundant measurements gave us very high degree of
confidence in the fidelity of the calculated fluxes. The estimated fluxes provided important
insight into the physiology of cultured hepatocytes. Our results suggest that the
phosphoglucose isomerase (PGI) reaction and triose phosphate isomerase (TPI) were not
fully equilibrated. The estimated PGI exchange flux of 380±15 corresponds to 79%+4
labeling equilibrium between F6P and G6P. Furthermore, the estimated TPI exchange flux
of 330±32 corresponds to 76%±2 labeling equilibrium between DHAP and GAP. These
results are surprising, because it is generally assumed that the PGI and TPI reactions are fully
equilibrated. For example, these assumptions are crucial for the widely used 2H20 method
for estimating the contribution of gluconeogenesis to hepatic glucose production, as was
initially proposed by Landau and colleagues (1995). In this method, fractional
gluconeogenesis is determined from the ratio of deuterium labeling at C5 vs. C2 of glucose
in experiments with 2H20. Deuterium is incorporated at C5 of glucose in reactions catalyzed
by enolase and TPI, whereas deuterium is incorporated at C2 of glucose via PGI reaction.
Our flux results indicated that the labeling of GAP-C2 (that eventually becomes C5 of
glucose) is >95% equilibrated with the solvent mainly via enolase reaction, but G6P-C2 (that
becomes C3 of glucose) is only 80% equilibrated with the solvent. Thus, in our experiments
the C5/C2 ratio would overestimate fractional gluconeogenesis by 20%.
7.3.8 Comparing estimated fluxes vs. MIDA
The estimated fluxes shown in Table 7-8 were significantly different from the fluxes
determined by MIDA shown in Table 7-5. MIDA underestimated fractional GNG and the
contribution of oxaloacetate to glucose by 18-31%, and overestimated glycogenolysis flux.
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Table 7-8
Metabolic fluxes in the gluconeogenesis pathway estimated by combined analysis of multiple
tracer data. Fluxes and their confidence intervals (shown as best fit ± SD) were estimated for
the 2, 5, and 8-hr samples by fitting all data for each sample point with Metran.
Netfluxes 2 hr 5 hr 8 hr
Glucose production (fixed at 100) 100 100 100
Gluconeogenesis (GNG) 81 ± 3 90 ± 4 91 ± 4
Glycogenolysis (GL) 19 ± 3 10 ± 4 9 + 4
Glycerol to glucose flux 70 ± 3 72 ± 3 67 + 3
Oxaloacetate to glucose flux 92 ± 4 108 ± 5 114 ± 5
Exchange fluxes and percent equilibration*
Phosphoglucose isomerase (PGI)
Aldolase
Triose phosphate isomerase (TPI)
Phosphomannose isomerase (PMI)
Transketolase (TK)
Phosphoglucomutase (PGM)
Glycerol 3-phosphate dehydr.
Glyceraldehyde 3-phosphate dehydr.
Cycling between GAP and PEP
380 ± 115
(79% ± 4)
nd
330 ±+ 32
(76% ± 2)
10 ± 10
8.2 ± 1
nd
nd
> 295
nd
390 ± 150
(81% / 4)
nd
380 +± 40
(79% ± 2)
13 ± 14
9.6 ± 1
nd
nd
> 300
nd
527 ± 200
(86% ± 5)
nd
394 ± 46
(80% ± 2)
13± 18
11.2 ± 1
nd
nd
> 385
nd
Additional modelparameters
Apparent fractional glucose labeling
87% + 3 85% + 3 75% + 3
in [U-13C]glycerol experiment
Apparent fractional glucose labeling
86% + 5 84% ± 5 82% ± 6
in [2Hs]glycerol experiment
* Values in parentheses for PGI and TPI reactions denote the estimated degree of equilibration.
* Percent equilibration = 100% x (exchange flux) / (100 + exchange flux).
- 253 -
CAAPTER 7. OliANTIFICATION OF HEPATIC FLUlXES FROM 13C AND 2H-TRACERS
The difference was most striking for the 5-hr and 8-hr samples, where we estimated 90%±4
contribution of GNG to glucose production, whereas MIDA estimated 71% and 63%,
respectively. Note that our method correctly accounted for the depletion of glycerol tracers,
as is indicated by the lower estimate for fractional glucose labeling at 8 hr, i.e. 75% at 8 hr vs.
85% at 2 and 5 hr for the [U-13C]glycerol experiments. The estimated GNG flux at 8 hr
(900%o±4) as identical to the estimated flux at 5 hr (91%±04).
7.3.9 Sources of NADH
The flux results further allowed us to predict the contribution of various sources to the
production of NADH. Table 7-9 shows the predicted fractional contribution of glycerol,
water, and unlabeled sources to NADH. We estimated that 10% of NADH hydrogen atoms
were derived from glycerol, 30-37% from the solvent via hydrogen exchange, and 52-60%
from other unlabeled endogenous sources, presumably mainly from lactate via lactate
dehydrogenase. The estimated contribution of glycerol to NADH of 10% corresponded well
with our previous observation that [2Hs]glycerol transferred deuterium atoms to lactate, from
which we estimated that about 13±5% of NADH was derived from glycerol.
Table 7-9
Predicted fractional contribution of glycerol, water, and unlabeled sources to NADH
hydrogen atoms. From the estimated fluxes shown in Table 7-8 we determined the various
sources of NADH hydrogen atoms and calculated the following fractional contributions.
2 hr 5 hr 8 hr
Glycerol 10±3% 9±3% 10±3%
Water 30±3% 39±3% 37±+3%
Unlabeled sources 60±3% 52±3% 53±3%
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7.4 Discussion
To our best knowledge, this is the first detailed analysis of net and reversible fluxes in the
gluconeogenesis pathway in cultured hepatocytes. We demonstrated that an over-determined
data set of mass isotopomer abundances obtained from 13C and 2H-labeling experiments
fitted to a detailed model of gluconeogenesis pathway provides precise fluxes, and allows
validation of model assumptions using redundant measurements. Our results have wide
implications for in vivo studies of glucose metabolism from 13C- and 2H-tracers. MIDA was
originally introduced by Neese et al. (1995) as a method for analysis of the gluconeogenesis
pathways from 13C-labeled substrates. This method treats glucose as a dimer of triose
phosphates with a constant labeling. Neese et al. showed that lack of equilibrium between
the enrichments of triose phosphates had a small impact on the calculation of fractional
gluconeogenesis. However, one of the disadvantages of the MIDA framework is that it
required the use of 13C-tracers, i.e. it cannot be applied for analysis of mass isotopomer data
from 2H-labeling experiments. Furthermore, MIDA does not accurately capture scrambling
of 13C-labeling in the TCA cycle and pentose phosphate pathway reactions resulting in
underestimation of the gluconeogenesis pathway. Here, we have developed novel
comprehensive analysis tools for analysis of experimental data from multiple tracer
experiments. In this contribution, [U- 13C]glycerol, [2H5]glycerol, and 2H20 tracer
experiments was accomplished with a detailed model of glucose metabolism and rigorous
methods for balancing of isotopomers within a reaction network. Analysis of the combined
data revealed that MIDs of glucose from glycerol tracers were incompatible with MIDs of
glucose from 2H20 experiments. We demonstrated that glycerol tracers consistently
underestimated GNG in our experiments. Previs et al. (1995, 1998) reported the same
finding from experiments with perfused livers and isolated hepatocytes from starved rats.
They attributed the underestimation of GNG to the presence of different cell populations
that utilize glycerol to different extent for the production of glucose. Our results support this
hypothesis. We concludes that any tracer method that requires the formation of labeled
glucose isotopomers from the condensation of two labeled triose phosphate molecules will
always underestimate GNG due to differences in enrichments of triose phosphates, and due
to zonation and depletion of isotopic tracers. The extent of underestimation of GNG cannot
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be determined from MIDA analysis. Here, we applied 2H20 in addition to [U- 13C]glycerol
and [2H5]glycerol tracers to quantify the underestimation of GNG from glycerol tracers. We
showed that in our experiments [13C]glycerol and [2H]glycerol tracers consistently
underestimated GNG by about 14%.
Previs et al. used [2H5]glycerol in experiments with perfused livers and noted release of M+0
to M+4 mass isotopomers of glycerol from [2Hs]glycerol. However, without a detailed
mathematical model they could only provide qualitative interpretation of the observed mass
isotopomers. Based on the release of the M+1 mass isotopomer of glycerol they concluded
that there must be cycling between glycerol, PEP, oxaloacetate and pyruvate. In our
[2Hs]glycerol experiments we also observed release of M+0 to M+3 mass isotopomers of
glycerol from [2H5]glycerol tracer. However, our results provided a different explanation for
the release of M+1 to M+3 isotopomers. The estimated fluxes indicated that there is not any
significant cycling between [2Hs]glycerol and pyruvate. In contrast, the presence of M+1 of
glycerol was fully explained from deuterium incorporation via [2Hs]glycerol -4 NADI2H] -4
[2H]glycerol (M+ 1), catalyzed by glycerol-3-phosphate dehydrogenase. In support of this
result we found that deuterium atoms from [2Hs]glycerol were incorporated into lactate,
presumably via lactate dehydrogenase (i.e. [2Hs]glycerol. 4- NAD[2H] - [2H]llactate), and
that no 13C-labeling was incorporated into lactate from [U- 13C]glycerol. Thus, we concluded
that in cultured hepatocytes glycerol contributed significantly to the production of NADH.
We estimated that about 10% of NADH was derived from glycerol, 30% from the solvent
via hydrogen exchange, and 60%/o from other unlabeled endogenous sources. Our results
further indicated that there was rapid exchange between the A- and B-hydrogen atoms of
NADH, which was in agreement with the result published by Vind et al. (1987), where the
authors showed that in isolated hepatocytes that there is near-equilibrium between the A-
and B-hydrogen atoms of NADH.
Our results indicated that the 2H20 method has the best potential to provide an unbiased
estimate of GNG flux in vivo. However, the 2H 20 method is not without assumptions. For
example, it is generally assumed that there rapid incorporation of deuterium at C2 position
of glucose via PGI, and at C5 via TPI and enolase. In practice, the extent of equilibration of
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these reactions is not easily validated in vivo. In this study, we validated the equilibrium
assumptions for the 2H 20 method explicitly by estimating reaction reversibilities for PGI
and TPI reactions, mainly from the [2H5]glycerol data. We found that the PGI and TPI
reactions were only 80-86% equilibrated. We estimated that the C2 hydrogen of glucose was
no more than 80% equilibrated with the solvent, but the C2 hydrogen of GAP (that
eventually becomes C5 of glucose) was more than 95% equilibrated with the solvent, mainly
via enolase reaction. Thus, the ratio of deuterium labeling at C5 vs. C2 resulted in 20%
overestimation of GNG in our experimental setup. To summarize, we have demonstrated
that through combined analysis of mass isotopomer data from [ 3C]glycerol, [2H]glycerol and
2H 20 tracers we can estimate unbiased net and reversible fluxes in the gluconeogenesis
pathways and correctly accounted for lack of complete equilibration of reversible reactions
in the gluconeogenesis pathway. Furthermore, we provided a method to account for the
apparent dilution of glucose labeling from glycerol tracers due to inhomogeneity of
hepatocyte populations and depletion of tracers.
- 257 -
- 258 -
Chapter 8
Application of elementary metabolite
units and [U- 13C,2H ]glycerol to estimate
fluxes of gluconeogenesis
8.1 Introduction
Methods for measuring the metabolic rate of gluconeogenesis (GNG) in vivo, relative to
hepatic glucose production (HGP), rely on the use of stable isotopes (13C and 2H) and the
assessment of glucose labeling distribution by gas chromatography mass spectrometry
(GC/MS) and nuclear magnetic resonance (NMR) spectroscopy. It has been argued that the
algebraic relationships based on the [U-13C]glucose tracing method underestimate
gluconeogenesis in vivo. A major reason is the failure to consider the exchange of labeled
precursors in the TCA cycle and the contribution of glycerol to gluconeogenesis. In the early
1990s condensation polymerization methods offered a new approach to estimating
biosynthesis. [13C]Glycerol tracers were used for quantifying gluconeogenesis using mass
isotopomer distribution analysis (MIDA). However, the possibility of zonation of the tracer
across the liver has led to questions about the validity of this method. Several studies with
isolated hepatocytes, perfused livers, and in whole animals have shown that mass isotopomer
distribution (MID) of glucose from [3C]qglycerol tracers are incompatible with a single
constant pool of triose phosphates, presumably due to multiple cell populations with
differential preference for various gluconeogenic precursors. Malloy and colleagues (1998)
proposed a quantitative approach based on the fate of [U-' 3qpropionate and the analysis of
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hepatic glutamate and glucose. This method uncovered a discrepancy between the analyses
of different compounds indicative of compartmentation of metabolism. This important
finding further complicated the search for a clear quantitative method for estimating hepatic
fluxes from carbon labeling data. Recently, we have applied [2H5]glycerol, [U-13C]glycerol
and 2H 20 to measure net and exchange fluxes in the gluconeogenesis pathway (Chapter 7).
From detailed analysis mass isotopomer distributions of glucose fragments we estimated the
extent of equilibration of phosphoglucose isomerase (PGI) and triose phosphate isomerase
(TPI) reactions with precision, i.e. 80-86% equilibration for PGI and 79-81% equilibration
for TPI in isolated hepatocytes. However, our results also suggested that [2Hs]glycerol and
[U- 13C]glycerol underestimated the flux of GNG by about 15% in our experiments.
Currently, the most widely used method for measuring GNG in vivo is the 2H20 method
that was proposed by Landau et al. (1995). It has been argued that this method provides an
unbiased estimate of the GNG flux. However, currently this method assumes complete
equilibration of PGI and TPI reactions, which is not true in all situations. For example, we
have shown previously in isolated hepatocytes that lack of complete equilibration of PGI
resulted in 20% overestimation of GNG with the 2H20 method (Chapters 5 and 7). Thus,
despite many decades of experiments, the search for a well-accepted method for quantifying
gluconeogenesis from stable isotope tracers continues.
Here, we present a novel two-tracer method for accurate determination of net and reversible
fluxes in the gluconeogenesis pathway in vivo. Our method builds on Landau's 2H20
method with the addition of a novel doubly-labeled glycerol tracer, i.e. [U- 13C,2H8]glycerol.
In this method we apply the two tracers, i.e. 2H20 and [U- 13C, 2H8]glycerol, simultaneously
and measure the incorporation of 2H from 2H20, and 2H and 13C from [U- 13C,2H5]glycerol
into glucose. Here, we make use of GC/MS analysis to measure the labeling distributions of
six fragments of glucose based on three glucose derivatives that were recently introduced, i.e.
aldonitrile pentapropionate ion fragments at m/z 173, 259, 284, and 370; methyloxime
pentapropionate ion fragment at m/z 145; and di-O-isopropylidene propionate ion fragment
at m/z 301. The mass isotopomer distributions of these fragments provide an over-
determined data set with 25 redundant measurements from which accurate metabolic fluxes
and their confidence intervals are determined. Quantitative interpretation of the complex
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labeling patterns was accomplished through the use of rigorous mathematical tools based on
the elementary metabolite units (EMU) framework, which was recently developed and
shown to be the most efficient method for analyzing mass isotopomer data from labeling
experiments. We will illustrate that the proposed two-tracer method allows measurement of
net fluxes and the extent of equilibration of reactions in the gluconeogenesis pathway.
Furthermore, we show that fluxes estimated with this method are independent of the
isotopic steady-state assumption and independent of any potential zonation of glycerol.
8.2 Methods
8.2.1 Metabolic network model
The gluconeogenesis network model that we used for flux calculations was described
previously (see Chapter 7; Figure 7-1 and Table 7-1). In sort, the network model is
comprised of 24 reactions utilizing 26 metabolites, with 5 substrates (oxaloacetate, glycerol,
glycogen, water, and NADH from endogenous sources), 3 products (glucose, CO2, and a
metabolic sink for NADH), and 18 balanced intracellular metabolites. Stereospecific atom
transitions were assigned for all reactions in the model based on current knowledge.
8.2.2 Simulating isotopomer distributions using elementary metabolite units
Quantitative interpretation of isotopomer data requires the use of mathematical models that
describe the relationship between metabolic fluxes and isotopomer abundances. Recently, we
presented a novel framework for the modeling of isotopic tracer systems that significantly
reduces the number of system variables without any loss of information. The elementary
metabolite units (EMU) framework is based on a highly efficient decomposition method that
identifies the minimum amount of information needed to simulate isotopic labeling within a
reaction network using the knowledge of atomic transitions occurring in the network
reactions. Here, the gluconeogenesis network model was decomposed into 60 independent
EMU reaction networks with a total of 204 EMU variables, as opposed to the complete set
of 42,224 cumomers that would be required to simulate this system using the traditional
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cumomer modeling strategy (i.e. a reduction of 99.5%). The functional units generated by
the decomposition algorithm, called EMUs, formed the new basis for generating system
equations that described the relationship between fluxes and isotopomer abundances
(Chapter 2). To simulate the isotopic labeling of glucose, the EMU networks can be solved
sequentially starting with the smallest EMU-size network up to the largest EMU-size
network. The mathematical simulation model was constructed with the Metran software.
8.2.3 Computational methods
Metabolic fluxes and their confidence intervals were determined by fitting mass isotopomer
abundances of glucose fragments to the detailed gluconeogenesis metabolic network model
using Metran software. In short, Metran estimates fluxes by minimizing the difference
between the observed and simulated measurements using an iterative least-squares
minimization procedure. The objective of this routine is to evaluate a set of feasible fluxes
that best accounts for the observed isotopomer measurements. After metabolic fluxes were
calculated, statistical analysis was automatically performed to obtain accurate standard
deviations and confidence intervals of fluxes by evaluating the sensitivity of the objective
function with respect to fluxes as described in Chapter 3. Flux validation was accomplished
by a statistical test for the goodness-of-fit (i.e. chi-square test for model adequacy), and a
normality test for the weighted residuals. To ensure a global optimum, flux estimation was
repeated at least four times starting with random initial values. Sensitivity analysis was
employed to determine the relative importance of measurements for the estimation of
individual fluxes as described previously (Chapter 3).
8.2.4 Determining deuterium enrichment of glucose
The amount of deuterium enrichment at each carbon position of glucose from 2H 20
experiments was determined using a least-squares approach that was previously described in
Chapter 5. In short, we constructed a simulation model that predicts the mass isotopomer
distributions of selected ion fragments of glucose for given isotopomer distribution of
glucose hydrogen atoms, while taking into account natural isotope enrichments. The
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isotopomer distribution was determined from experimental data by solving a least-squares
regression problem, where the objective was to minimize the sum of squared deviations
between simulated and measured mass isotopomer abundances. From the estimated
isotopomer distribution we then obtained positional deuterium enrichments via linear
transformation. We identify the deuterium enrichment of C-H in carbon 1 as D1, the
enrichment in carbon 2 as D 2, and so forth. Since there are two hydrogen atoms at carbon 6
that cannot be distinguished by GC/MS, we could only determine the average enrichment at
carbon 6, i.e. D 6 = D66/2.
8.2.5 Materials
Biochemicals were obtained from Sigma Chemicals (St. Louis, MO). The custom synthesized
glycerol tracer [U-13C,2H8]glycerol (99+ At%/o 13C, 98+ Ato 2H) was purchased from
Omicron Biochemicals (South Bend, IN). The isotopic purity was of the tracer validated by
GC/MS analysis. Tissue culture media were obtained from Sigma (St. Louis, MO).
Hepatocyte medium was DMEM powder (Sigma) supplemented with 3.7 g/L NaHCO 3, 30
mg/L proline, 100 mg/L ornithine, 610 mg/L niacinimide, 0.544 mg/L ZnC12, 0.75 mg
ZnSO 4.7H 20, 0.2 mg/L CuSO 4.5H 20, 0.025 mg/L MnSO 4, 2 g/L bovine serum albumin,
100,000 U penicillin, and 100,000 U streptomycin, and further enriched with gluconeogenic
carbon sources: 1mM glycerol, 10 mM lactate, 1 mM pyruvate, 5 mM glutamine, and 2 mM
acetate. Four chemically identical labeling media were prepared, containing either 2H20 (at
10% enrichment); [U-13C,2H8]glycerol + unlabeled glycerol (1:3 mol/mol, i.e. 25%
enrichment of tracer); [U- 13C, 2H8]glycerol + unlabeled glycerol (1:3 mol/mol, i.e. 25%
enrichment) prepared in 2H20 (at 10% enrichment); and medium with no tracers (as
control).
8.2.6 Hepatocyte isolation and hepatocyte suspension experiments
Hepatocytes were isolated from C57BL/6 mice by modified two step-collagenase perfusion
as described by Seglen (1976). Two mice ('25 gram) were fed ad libitum, and two mice (-25
gram) were fasted 12 hrs prior to hepatocyte isolation. The mice were anesthetized with
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tribromoethanol (500 mg/kg IP) for the duration of the procedure. In short, the surgeon
exposed the intraperitoneal abdominal contents including the liver, portal vein and inferior
vena cava. The portal vein was cannulated with a 24.5G catheter, and the liver was perfused
for 15 minutes at a rate of 7 mL/min with calcium-free perfusion buffer to remove blood
from the fibrous liver sac. Mouse euthanasia followed exsanguinations after cutting the
inferior vena cava to complete the perfusion circuit. The blanched liver was perfused with
collagenase solution (200U/mL) for 10 minutes at 7 mL/min to release hepatocytes from
the extracellular matrix. The digested liver was excised and placed in preservation buffer,
where the digested cells were gently scraped from the liver sac, washed and purified with
Percoll to remove dead cells and enrich the hepatocyte fraction. At this point cells were
counted and viability assessed by Trypan Blue exclusion. Typical viabilities were between 85-
90%, with cell yields of 1.0-1.5x10 6 cells/g mouse (25-40x10 6 cells). Purified cells were
suspended in media with isotopic tracers and seeded in 6-well plates (106 cells/well) and
incubated for 30 minutes at 370 C and 5% CO 2. At the end of the incubation period medium
samples were collected (approx. 1 mL), centrifuged for 10 sec, and the supernatant separated
from cells pellet. Cells and supernatant were stored at -80 OC prior to analysis.
8.2.7 Derivatization of glucose
Mass isotopomer distributions of glucose were determined from three glucose derivatives,
i.e. aldonitrile pentapropionate, methyloxime pentapropionate and di-O-isopropylidene
propionate glucose. For each derivatization procedure, 100 tL of medium sample was
deproteinized by addition of 300 piL of cold acetone, followed by vortexing vigorously for 30
sec, and centrifugation at 2000xg for 1 min. The supernatant was evaporated to dryness
under airflow and the residue derivatized as previously described (Chapter 5). In short, for
the aldonitrile pentapropionate and methyloxime pentapropionate derivatizations, 50 pL of 2
wt%/o hydroxylamine hydrochloride in pyridine, or 2 wt0 /o methoxylamine hydrochloride in
pyridine, respectively, was added to the dry residue and the sample heated at 90 0C for 60
min. This was followed by addition of 100 pL of propionic anhydride and heating at 60 0 C
for additional 30 min. The sample was then evaporated to dryness, dissolved in 100 pL of
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ethyl acetate and transferred to an injection vial for GC/MS analysis. For di-O-
isopropylidene propionate derivatization, 500 [LL of 0.38 M sulfuric acid in acetone was
added to the dry residue and the sample incubated at room temperature for 60 min. 400 IiL
of 0.44 M sodium carbonate was added to neutralize the reaction, followed by addition of 1
mL of saturated sodium chloride. Di-O-isopropylidene derivatives were extracted by
partitioning with 1 mL of ethyl acetate. The upper, organic layer was evaporated to dryness,
followed by addition of 150 yL of propionic anhydride in pyridine (2:1 v/v) and heating at
60 0 C for 30 min. The sample was then evaporated to dryness, dissolved in 100 ptL of ethyl
acetate and transferred to an injection vial for GC/MS analysis.
8.2.8 GC/MS analysis
Gas Chromatography-Mass Spectrometry (GC/MS) analysis was performed using HP 5890
Series II GC (Gas Chromatograph) equipped with a DB-1701 [30 m x 0.25 mm (inner
diameter) x 0.25 pm] capillary column, connected to HP 5971 MSD (Mass Selective
Detector) operating under ionization by electron impact (EI) at 70 eV. The mass
spectrometer was calibrated using the 'Max Sensitivity Autotune' setting. Helium flow was
maintained at 0.737 mL/min by electronic control. The temperatures of the injector and the
detector were kept at 2500 C and 3000 C, respectively. The temperature of the column was
started at 80 0C for 1 min, increased to 2800 C at 200C/min, and held for 4 min. For the
analysis of aldonitrile pentapropionate glucose, ion intensities were recorded for the
following four ion fragments: m/z 173-178 (C5-6, H-6), m/z 259-265 (C4-6, H4-6), m/z 284-
289 (C1-4, H2-4), and m/z 370-379 (Cl-5, H2-5). For di-O-isopropylidene propionate glucose,
ion intensities were recorded at m/z 145-149 (C1-2, H 1-2). For methyloxime pentapropionate
glucose, ion intensities were recorded at m/z 301-313 (C1-6, Hi-6). Measured intensities were
corrected for noise (baseline correction), and mass isotopomer distributions were obtained
by integration. All mass isotopomer values were expressed as fractional abundances, i.e. for
each fragment the sum of all mass isotopomers equals one. Samples were injected at least six
times and the measured mass isotopomer abundances were averaged. Ions at m/z 148, 149,
178, 288, and 289 contained constant contaminating ions amounting to 0.03, 0.05, 0.27, 0.18,
and 0.25 mol% enrichment, respectively, which was corrected by subtraction. In experiments
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with [U- 13C,2H5]glycerol, intensities of ions at m/z 145, 146, and 147 could be inaccurate (up
to 2 mol% inaccuracy) due by overlapping mass spectra from smaller ion fragments. To
exclude these data from flux determination we assigned relatively high measurement errors
to these ions, i.e. 2 mol% assumed measurement error (compared to <0.4 mol% for all other
ions). We should note that sensitivity analysis revealed that ions 145-147 were not important
for flux determination, i.e. only the ratio of m/z 148 relative to m/z 149 contained flux
information. Thus, inaccuracies in ions 145-147 did not affect flux results.
8.3 Results
8.3.1 Incorporation of deuterium into glucose from 2H20
In the pathway of gluconeogenesis labeled hydrogen atoms are incorporated into glucose
from medium containing deuterated water. The amount of deuterium incorporated at each
carbon position depends on the deuterium enrichment of the solvent, and relative activity of
various reversible reactions in the gluconeogenesis pathway. In this study, fresh hepatocytes
isolated from fasted and fed mice were incubated in medium containing 2H20 at 10%
enrichment. All experiments were performed in triplicate, i.e. hepatocytes were cultured in 6-
well plates for 30 min (106 cells/well). At the end of the incubation period medium samples
were collected and glucose was analyzed by GC/MS. The amount of deuterium incorporated
at each carbon position was determined by regression analysis of mass isotopomer
distributions of six glucose fragments as described previously (Chapter 5). As control,
hepatocytes were also cultured in medium with no tracers. Tables 8-1 and 8-2 show the
measured mass isotopomer distributions of the six selected glucose fragments from
experiments with fasted and fed hepatocytes, respectively. The observed mass isotopomer
abundances from the triplicate experiments were not statistically different (P>0.10). This
confirmed that biological variability between wells was small in our experiments. Table 8-3
shows the deuterium enrichments at all six carbon positions of glucose for the experiments
with fasted and fed hepatocytes.
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Table 8-1
Mass isotopomer distributions of glucose fragments from 2H20 experiments with isolated
hepatocytes from fasted mice. Hepatocytes were cultured in 6-wells plates in medium
containing 2H 20 at 10% enrichment for 30 min, and one control well with no tracers (well
#4). Glucose labeling was analyzed by GC/MS. Shown are measured mass isotopomer
distributions of six selected glucose fragments (molar percentages, mol0/o).
m/z C-H
(formula) positions Well # M+0 M+1 M+2 M+3 M+4
301 1,2,3,4,5,6,6 1 50.2 34.7 11.9 2.7 0.5
(C14H 210 7) 2 50.4 34.5 11.9 2.7 0.5
3 50.2 34.6 11.9 2.7 0.5
4 84.1 13.4 2.4 0.1 0.0
145 1,2 1 79.1 18.5 2.2 0.2 0.0
(C6H11O3N) 2 78.8 18.8 2.2 0.2 0.0
3 78.9 18.7 2.2 0.2 0.0
4 92.5 6.7 0.8 0.0 0.0
173 5,6,6 1 72.3 23.4 3.8 0.4 0.0
(CsH 130 4) 2 72.2 23.5 3.8 0.4 0.0
3 72.3 23.4 3.8 0.4 0.0
4 90.7 8.1 1.1 0.1 0.0
.. . .................. . .. ............ . . ... .. .. . .. ..... .. ... .. ... .. .. ... .. ... .. ... .. .. ... .. .. . .. ..... .. ... . . ... ......... .............................. .. .. ..... .. . ..... .. ..
259 4,5,6,6 1 64.4 28.1 6.4 1.0 0.0
(C12H190 6) 2 64.3 28.1 6.4 1.1 0.0
3 64.4 28.2 6.3 1.0 0.1
4 86.3 11.6 1.9 0.2 0.0
284 2,3,4 1 68.4 25.7 5.1 0.8 0.0
(C13H1sO6N) 2 68.2 25.8 5.4 0.7 0.0
3 68.1 26.0 5.2 0.7 0.0
4 85.1 12.6 2.1 0.2 0.0
370 2,3,4,5 1 58.5 31.1 8.5 1.7 0.2
(C17H24 0sN) 2 58.3 31.2 8.6 1.7 0.3
3 58.4 31.1 8.6 1.7 0.2
4 81.2 15.6 2.9 0.4 0.0
Data shown are the integrated mass isotopomer distributions not corrected for natural isotope
enrichments. Measurements errors were <0.3 mol%. Data from the triplicate wells were not
statistically different.
- 267 -
CHAPTER 8. APPLICATION OF [U- 3C.2H•]GLYCEROL TO ESTIMATE GNG FLUXES
Table 8-2
Mass isotopomer distributions of glucose fragments from 2H20 experiments with isolated
hepatocytes from fed mice. Hepatocytes were cultured in 6-wells plates in medium
containing 2H 20 at 10% enrichment for 30 min, and one control well with no tracers (well
#4). Glucose labeling was analyzed by GC/MS. Shown are measured mass isotopomer
distributions of six selected glucose fragments (molar percentages, mol%).
m/z C-H
(formula) positions Well # M+0 M+1 M+2 M+3 M+4
301 1,2,3,4,5,6,6 1 66.0 25.2 7.1 1.5 0.2
(C14H210 7) 2 65.0 25.8 7.5 1.6 0.2
3 65.9 25.3 7.2 1.5 0.2
4 84.2 13.3 2.3 0.2 0.0
145 1,2 1 84.5 13.7 1.7 0.2 0.0
(C6H 10 3N) 2 84.5 13.7 1.6 0.1 0.0
3 84.3 13.9 1.7 0.1 0.0
4 92.4 6.7 0.9 0.0 0.0
173 5,6,6 1 82.6 14.9 2.2 0.2 0.0
(C8H 1304) 2 81.9 15.5 2.3 0.2 0.0
3 82.2 15.3 2.3 0.2 0.0
4 90.7 8.0 1.1 0.1 0.0
259 4,5,6,6 1 76.2 19.3 3.8 0.6 0.1
(C 12H190 6) 2 75.4 19.8 4.0 0.6 0.1
3 75.6 19.7 4.0 0.6 0.1
4 86.3 11.6 1.9 0.2 0.0
284 2,3,4 1 75.2 20.3 3.8 0.6 0.0
(C13H180 6N) 2 74.7 20.7 3.9 0.6 0.0
3 75.1 20.4 3.8 0.6 0.0
4 84.9 12.7 2.1 0.2 0.0
370 2,3,4,5 1 68.5 24.4 6.0 1.1 0.1
(C17 H2408N) 2 68.0 24.7 6.1 1.1 0.1
3 68.3 24.5 6.0 1.1 0.1
4 81.1 15.6 2.9 0.3 0.0
Data shown are the integrated mass isotopomer distributions not corrected for natural isotope
enrichments. Measurements errors were <0.4 mol%. Data from the triplicate wells were not
statistically different.
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Table 8-3
Deuterium enrichment of glucose from 2H20 experiments with hepatocytes isolated from
fasted and fed mice. Hepatocytes isolated from fasted and fed mice were cultured in 6-wells
plates in medium containing 2H 20 at 10% enrichment for 30 min, and one control well with
no tracers (well #4). Deuterium enrichment at all six glucose carbon position was
determined by least-squares regression as described in the Methods section. Results shown
are molar percent enrichments (best fit ± SD).
Hepatocytes from fasted mouse
Carbon well #1 well #2 well #3 well #4
position 2H20 2H20 2H20 no tracers
Di 7.3 + 0.4 6.3 + 0.4 6.8 + 0.4 0.1 + 0.2
D2 7.9 ± 0.4 9.1 ± 0.4 8.5 ± 0.4 0.0 ± 0.2
D3 6.5 ± 0.3 5.8 ± 0.3 6.4 ± 0.3 0.0 ± 0.2
D4 6.6 ± 0.2 6.7 ± 0.2 6.5 ± 0.2 0.0 ± 0.2
Ds 10.6 ± 0.2 10.5 ± 0.2 10.5 ± 0.2 0.0 ± 0.2
D66/2 5.7 ± 0.2 5.8 ± 0.2 5.7 ± 0.2 0.0 ± 0.2
well # 1
2H20
4.1 ± 0.3
4.9 ± 0.3
4.3 ± 0.4
3.4 ± 0.2
5.0 ± 0.2
2.3 ± 0.2
Hepatocytes from fed mouse
well #2 well #3
2H20 2H20
4.3 ± 0.3 3.7 ± 0.3
4.6 ± 0.3 5.4 ± 0.3
4.9 ± 0.4 3.6 ± 0.4
3.6 ± 0.2 3.7 ± 0.2
5.0 ± 0.2 5.1 ± 0.2
2.7 ± 0.3 2.5 ± 0.2
Total 50.3 ± 0.3 50.0 ± 0.3 50.1 ± 0.3 0.1 ± 0.2 26.4 ± 0.3 27.7 ± 0.4 26.5 ± 0.3 0.1 ± 0.2
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well #4
no tracers
0.0 + 0.2
0.0 ± 0.2
0.0 ± 0.2
0.1 ± 0.2
0.0 ± 0.2
0.0 ± 0.2
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To better interpret these results consider Figure 8-1 that schematically illustrates the
reactions involved in hydrogen exchange/incorporation into glucose. For example, it is well
known that PGI stereospecifically transfers the pro-R hydrogen at C1 of fructose 6-
phosphate (F6P) to the C2 position of glucose 6-phosphate (G6P), however, hydrogen
exchange with the solvent has also been observed for the PGI reaction (Malaisse, 1990;
Malaisse, 1991; Seeholzer, 1993). Malaisse et al. (1990, 1991) reported for a single passage in
the direction F6P-+G6P, 65% intramolecular hydrogen transfer and 35% hydrogen
exchange, and for a single passage in the direction G6P--F6P, 72% intramolecular hydrogen
transfer and 28% hydrogen exchange. It is generally assumed that there is rapid exchange
between F6P and G6P, in which case we would expect that the labeling at C2 of glucose is
equilibrated with the solvent. However, in our experiments the deuterium enrichment at C2
deviated significantly from 10%, i.e. solvent enrichment. In experiments with hepatocytes
isolated from fasted and fed mice we found 7.9-9.1% and 4.6-5.4% deuterium enrichment
at C2, respectively. These results clearly indicated that the PGI reaction was not fully
equilibrated.
Incorporation at C5 of glucose occurs in the gluconeogenesis pathway, mainly via the
reactions catalyzed by enolase and TPI (see Figure 8-1). Therefore, the ratio of enrichment
of C5 to that of the solvent is a measure of gluconeogenesis relative to total glucose
production. In experiments with fasted hepatocytes we found 10.5-10.6% enrichment at C5,
indicating that 100% of glucose was produced by GNG, as expected in glycogen-deprived
hepatocytes. The observed 0.5 mol% difference between the solvent enrichment and C5
enrichment may have been caused by measurement errors, inaccuracies in our media
preparation, or due to a slight isotope effect. In experiments with fed hepatocytes we found
5.0-5.1% enrichment at C5, indicating that about 50% of glucose was produced by GNG.
This result is in line with the expected contribution of GNG in hepatocytes isolated from
fed mice. Note that in both cases the C5/C2 ratio would overestimate fractional GNG
significantly, i.e. if we had used the C5/C2 ratio as a measure of fractional GNG, as
proposed by Landau, we would have obtained 123% and 100% for fractional GNG in fasted
and fed hepatocytes, respectively, which are both irrational results.
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Figure 8-1: A schematic of reactions involved in hydrogen exchange and hydrogen
incorporation into glucose in the gluconeogenesis pathway.
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Deuterium incorporation at C1 and C6 positions occurs in the pyruvate -> oxaloacetate -+
PEP pathway, more precisely, in reactions catalyzed by alanine aminotransferase and
fumarase. Deuterium is additionally incorporated at C1 via reactions catalyzed by
phosphomannose isomerase (PMI) and glucose 6-phosphate dehydrogenase (G6PDH).
Thus, deuterium enrichment at C6 relative to the solvent enrichment is a measure of the
contribution of PEP to glucose production, and the difference between C1 and C6
enrichments is indicative of the combined activity of PMI and G6PDH. In our experiments
with fasted hepatocytes we found 5.7-5.8% enrichment at C6 and 6.3-7.3% enrichment at
C1, indicating that 57% of glucose was derived from PEP, and that PMI/G6PDH reactions
resulted in additional - 1% deuterium incorporation at C1. In experiments with fed
hepatocytes we found 2.3-2.7% enrichment at C6 and 3.7-4.3% enrichment at C1,
indicating that about 25% of glucose was derived from PEP and that also here there was
some PMI/G6PDH activity.
8.3.2 Incorporation of labeling into glucose from [U- 13C,2H,]glycerol
Isolated hepatocytes were also incubated with [U- 13C,2H8]glycerol at 25% enrichment, i.e. in
medium containing a mixture of [U- 13C,2Hs]glycerol and unlabeled glycerol in the proportion
of 1:3. Tables 8-4 and 8-5 show the measured mass isotopomer distributions of glucose from
experiments with fasted and fed hepatocytes, respectively. Measured mass isotopomer
abundances from triplicate experiments were not statistically different, i.e. the maximum
observed deviation between replicate wells was 0.2 mol/o. Qualitative interpretation of mass
isotopomer distributions from these experiments is more difficult than from 2H20
experiments, thus we will only highlight a few important observations. Detailed quantitative
analysis will be performed in section 8.3.4, where we apply rigorous flux analysis tools to
calculate fluxes and confidence intervals from this data. It is important to note that mass
isotopomer abundances from [U- 13C,2Hs]glycerol experiments cannot be corrected for
natural isotope enrichments as is often done for other tracer experiments, because here two
different isotopes (1 3C and 2H) are incorporated into glucose simultaneously. Thus, we must
always analyze the uncorrected data directly.
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Table 8-4
Mass isotopomer distributions of glucose from [U- 13C, 2Hs]glycerol labeling experiments with
isolated hepatocytes from fasted mice. Hepatocytes were cultured in 6-wells plates in
medium containing [U- 13C,2Hs]glycerol at 25% enrichment for 30 min. Glucose labeling was
analyzed by GC/MS. Shown are mass isotopomer distributions of six selected glucose
fragments (molar percentages, mol%/o).
m/z Well
(positions) # M+0 M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8 M+9 M+10 M+11
301 1 71.2 13.0 2.5 1.3 2.8 6.1 2.3 0.4 0.1 0.2 0.2 0.1
(C1-6, Hi-6) 2 71.1 13.1 2.6 1.3 2.9 6.0 2.3 0.4 0.1 0.2 0.2 0.1
3 71.2 13.1 2.5 1.3 2.8 6.0 2.3 0.4 0.1 0.2 0.2 0.0
145* 1 82.5 7.7 3.0 4.2 2.7
(C1- 2, H1-2) 2 82.3 7.7 3.0 4.2 2.8
3 82.4 7.7 2.9 4.1 2.8
173 1 85.8 8.0 1.1 0.4 4.2 0.5
(C5-6, H5-6) 2 85.8 7.9 1.2 0.5 4.2 0.5
3 85.8 8.0 1.1 0.4 4.2 0.5
259 1 80.1 12.5 2.1 0.4 0.3 3.7 1.0
(C4-6, H4-6) 2 80.0 12.5 2.1 0.4 0.3 3.7 1.0
3 80.1 12.3 2.1 0.4 0.3 3.7 1.0
284 1 72.5 16.6 3.7 2.7 3.1 1.4
(C1-4, H2-4) 2 72.7 16.6 3.7 2.6 3.0 1.4
3 72.6 16.6 3.7 2.7 3.0 1.4
370 1 69.4 15.2 6.4 3.6 3.2 1.6 0.5 0.1 0.0 0.0
(C-s5, H2-5) 2 69.6 15.1 6.5 3.6 3.2 1.5 0.4 0.1 0.0 0.0
3 69.6 15.1 6.5 3.6 3.2 1.5 0.4 0.1 0.0 0.0
Data shown are the integrated mass isotopomer distributions not corrected for natural isotope
enrichments. Measurements errors were <0.3 mol%. Data from the triplicate wells were not
statistically different.
* M+0 to M+2 mass isotopomer abundances of ion fragment at m/z 145 may be inaccurate due to
overlapping mass spectra.
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Table 8-5
Mass isotopomer distributions of glucose from [U- 13C,2Hs]glycerol labeling experiments with
isolated hepatocytes from fed mice. Hepatocytes were cultured in 6-wells plates in medium
containing [U- 13C,2Hs]glycerol at 25% enrichment for 30 min. Glucose labeling was analyzed
by GC/MS. Shown are mass
(molar percentages, mol%).
isotopomer distributions of six selected glucose fragments
m/z Well
(positions) # M+O M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8 M+9 M+10 M+11
301 1 77.3 13.1 2.4 0.9 1.6 3.4 1.1 0.1 0.0 0.0 0.0 0.0
(CI-6, H1-6) 2 77.3 13.1 2.4 0.9 1.6 3.4 1.1 0.2 0.0 0.1 0.0 0.0
3 77.3 13.1 2.4 0.9 1.6 3.3 1.1 0.2 0.0 0.0 0.0 0.0
145* 1 87.2 7.4 2.1 2.0 1.3
(C1-2, HI-2) 2 87.2 7.4 2.1 2.0 1.3
3 87.2 7.4 2.1 2.0 1.3
173 1 87.6 8.0 1.2 0.4 2.6 0.3
(C5-6, H5-6) 2 87.6 8.0 1.2 0.4 2.6 0.3
3 87.6 8.0 1.2 0.4 2.6 0.3
259 1 82.5 12.0 2.0 0.3 0.4 2.3 0.5
(C4-6, H4-6) 2 82.4 1.2.0 2.0 0.3 0.4 2.3 0.6
3 82.5 12.0 2.0 0.3 0.4 2.3 0.6
284 1 78.3 15.1 2.9 1.6 1.5 0.6
(C1-4, H2-4) 2 78.3 15.1 2.9 1.6 1.5 0.6
3 78.2 15.1 2.9 1.6 1.5 0.6
370 1 75.1 15.3 5.1 2.2 1.5 0.6 0.1 0.0 0.0 0.0
(Ci-5, H2-5) 2 75.2 15.3 5.1 2.1 1.5 0.7 0.2 0.0 0.0 0.0
3 75.1 15.3 5.1 2.1 1.5 0.7 0.1 0.0 0.0 0.0
Data shown are the integrated mass isotopomer distributions not corrected for natural isotope
enrichments. Measurements errors were <0.3 mol%. Data from the triplicate wells were not
statistically different.
* M+0 to M+2 mass isotopomer abundances of ion fragment at m/z 145 may be inaccurate due to
overlapping mass spectra.
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First, consider the mass isotopomer distribution of ion fragment at m/z 301 that contains all
carbon and hydrogen atoms of the glucose molecule. In fasted and fed hepatocyte
experiments we observed significant abundances of mass isotopomers up to M+6. These
isotopomers were formed from the incorporation of a single [U- 13C, 2H8]glycerol molecule
into glucose. To minimize probability of condensation of two labeled triose phosphates, we
used only 25% enrichment of the tracers in the medium that was further diluted from
unlabeled endogenous sources, i.e. oxaloacetate-+GAP. This reduced the chance of
condensation of two labeled TPs to less than 1%. Of the 8 deuterium atoms in [U-
13C,2H8]glycerol only 5 atoms are stable, i.e. hydroxyl hydrogen atoms are rapidly exchanged
with the solvent. Furthermore, the C2 hydrogen of glycerol is transferred to NADH in the
reaction catalyzed by glycerol 3-phosphate dehydrogenase. Thus, DHAP derived from [U-
13C,2Hs]glycerol is M+7 labeled. If we consider the fate of atoms of DHAP (that eventually
becomes the top half of glucose), we find that the pro-S hydrogen at C1 of DHAP is lost to
the solvent in the aldolase reaction (see Figure 8-1), and in the PGI reaction the pro-R
hydrogen at C1 of F6P may be exchanged with the solvent resulting in M+5 glucose, or
transferred to C2 of G6P via intramolecular transfer resulting in M+5 glucose. M+4 and
M+3 isotopomers of glucose may be formed via additional loss of deuterium atoms in the
TPI reaction (loss of C3 hydrogen of glucose), and in the PMI/G6PDH reactions (loss of
C1 hydrogen of glucose). In conclusion, the top half of the glucose molecule may be labeled
as M+3 to M+6 from [U- 13C, 2Hs]glycerol depending on the relative fluxes in the pathway
from glycerol to glucose. When we trace the path from glycerol to the bottom half of
glucose, i.e. glycerol->GAP--+glucose, we find that the bottom half of glucose may be
labeled as M+5, M+6, or M+7 depending on relative fluxes of TPI, GAPDH, and aldolase
reactions. Taken together, the significant abundances of M+5 and M+6 isotopomers
compared to the M+3 isotopomer indicated that one or more reactions in the
gluconeogenesis pathway was not fully equilibrated. Consider also the m/z 145 fragment of
glucose that contains the first two carbon and two hydrogen atoms of glucose. We observed
significant M+3 and M+4 abundances for this fragment from both fasted and fed
hepatocytes. The M+4 isotopomer is formed only if all four atoms are derived from [U-
13C,2Hs]glycerol, whereas M+3 reflects the fraction of glucose molecules where one of the
two deuterium atoms has been lost, i.e. either via PGI (loss of C2 hydrogen), or via
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PMI/G6PDH (loss of C1 hydrogen). Thus, the significant abundance of M+4 vs. M+3
provided further evidence that the PGI reaction was not fully equilibrated.
8.3.2 Labeling incorporation into glucose from [U-13C, 2H8]glycerol and 2H 20
Preliminary simulation experiments of the pathway suggested that a combination of [U-
13C, 2H8]glycerol and 2H20 tracers would provide much more detailed flux information than
could be obtained from either of these tracers alone. The two tracers provide
complementary information. With the 2H 20 tracer flux information is obtained from the
incorporation of 2H into glucose, whereas with the [U-13C, 2H8]glycerol tracer flux
information is obtained from the incorporation of 2H relative to '3C incorporation into
glucose. The 13C-carbon backbone of [U-13C, 2H8]glycerol is critical for this method, because
it provides a measure of the total amount of [U-13C,2Hs]glycerol incorporated into glucose,
i.e. 13C-labeling is not lost in the pathway from glycerol to glucose as opposed to 2H-labeling.
Thus, [2H8]glycerol would provides much less flux information than [U- 13C, 2H8]glycerol,
because the loss of all deuterium atoms from [2H8]glycerol yields M+O glucose, which cannot
be distinguished from endogenous glucose and glucose derived from glycogenolysis.
Preliminary simulation experiments further indicated that we would be able to estimate
fluxes in this system independent of the amount of [U-13C,2H8]glycerol that is incorporated
into glucose and independent of the isotopic steady state assumption, i.e. fluxes are strictly
derived from ratios of labeled mass isotopomers of glucose. Thus, endogenous M+O glucose
will not affect the estimation of fluxes. As such, this method for estimating is fundamentally
different from other methods to estimate gluconeogenesis fluxes, e.g. like MIDA, where
fluxes are estimated by measuring absolute incorporation of 13C-tracers into glucose and
assuming isotopic steady state.
Here, isolated hepatocytes were incubated in medium containing the two tracers, i.e. [U-
13C,2H8]glycerol at 25% enrichment and 2H20 at 10% enrichment. Tables 8-6 and 8-7 show
the measured mass isotopomer distributions of glucose fragments from triplicate
experiments with fasted and fed hepatocytes, respectively. Measured mass isotopomer
abundances from triplicate experiments were not statistically different, i.e. the maximum
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Table 8-6
Mass isotopomer distributions of glucose from [U- 13C,2H8]glycerol + 2H 20 labeling
experiments with isolated hepatocytes from fasted mice. Hepatocytes were cultured in 6-well
plates in medium containing [U-13C,2Hs]glycerol at 25% enrichment and 2H20 at 10%
enrichment for 30 min. Glucose labeling was analyzed by GC/MS. Shown are mass
isotopomer distributions of six selected glucose fragments (molar percentages, mol0 /o).
m/z Well
(positions) # M+0 M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8 M+9 M+10 M+11
301 1 42.6 30.1 10.8 3.2 2.6 5.1 3.6 1.2 0.3 0.2 0.2 0.1
(C1-6, HI-6) 2 42.4 30.2 10.9 3.2 2.6 5.1 3.6 1.3 0.3 0.2 0.2 0.1
3 42.5 30.1 10.8 3.2 2.6 5.1 3.6 1.2 0.3 0.2 0.2 0.1
145" 1 69.7 18.2 4.2 4.5 3.4
(C1-2, H1-2) 2 69.6 18.4 4.2 4.4 3.5
3 69.9 18.2 4.2 4.4 3.3
173 1 68.7 22.1 3.6 0.8 3.9 0.9
(C5-6, H5-6) 2 68.7 22.2 3.6 0.8 3.9 0.9
3 68.7 22.2 3.6 0.8 3.9 0.9
259 1 60.5 27.0 6.3 1.2 0.4 3.2 1.5
(C4-6, H4-6) 2 60.4 27.1 6.3 1.2 0.4 3.2 1.5
3 60.5 27.0 6.3 1.2 0.4 3.2 1.5
284 1 58.5 26.5 7.0 3.0 3.2 1.8
(C1-4, H2-4) 2 58.4 26.6 7.1 3.0 3.1 1.8
3 58.4 26.5 7.0 3.1 3.2 1.8
370 1 50.4 27.8 10.4 4.8 3.6 2.1 0.7 0.2 0.0 0.0
(C-s, H2-5) 2 50.4 27.7 10.4 4.8 3.6 2.2 0.7 0.2 0.0 0.0
3 50.3 27.7 10.4 4.9 3.7 2.1 0.8 0.2 0.0 0.0
Data shown are the integrated mass isotopomer distributions not corrected for natural isotope
enrichments. Measurements errors were <0.3 mol%. Data from the triplicate wells were not
statistically different.
* M+O to M+2 mass isotopomer abundances of ion fragment at m/z 145 may be inaccurate due to
overlapping mass spectra.
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Table 8-7
Mass isotopomer distributions of glucose from [U- 13C,2H8]glycerol + 2H20 labeling
experiments with isolated hepatocytes from fed mice. Hepatocytes were cultured in 6-well
plates in medium containing [U-13C, 2H8]glycerol at 25% enrichment and 2H20 at 10%
enrichment for 30 min. Glucose labeling was analyzed by GC/MS. Shown are mass
isotopomer distributions of six selected glucose fragments (molar percentages, mol%).
m/z Well
(positions) # M+0 M+1 M+2 M+3 M+4 M+5 M+6 M+7 M+8 M+9 M+10 M+11
301 1 61.8 22.7 6.5 1.8 1.5 2.9 1.9 0.6 0.1 0.1 0.1 0.0
(C1-6, HI-6) 2 62.1 22.7 6.4 1.7 1.5 2.9 1.8 0.6 0.1 0.1 0.1 0.0
3 62.0 22.8 6.6 1.8 1.5 2.9 1.9 0.5 0.0 0.0 0.0 0.0
145* 1 79.4 14.1 2.8 2.1 1.6
(C1i 2, HI 2) 2 79.3 14.1 2.8 2.1 1.6
3 79.1 14.3 2.8 2.2 1.6
173 1 80.1 14.2 2.2 0.5 2.4 0.6
(C5-6, H5-6) 2 80.1 14.3 2.2 0.5 2.4 0.5
3 80.1 14.2 2.2 0.5 2.5 0.5
259 1 73.6 18.6 3.9 0.7 0.4 2.0 0.9
(C46, H4-6) 2 73.6 18.6 3.9 0.7 0.4 2.0 0.9
3 73.5 18.7 3.9 0.7 0.4 2.0 0.9
284 1 69.9 21.0 4.8 1.8 1.6 0.8
(Ci-4, H2-4) 2 70.1 20.9 4.8 1.8 1.5 0.8
3 69.8 21.1 4.8 1.8 1.6 0.8
370 1 64.5 22.6 7.2 2.9 1.7 0.9 0.3 0.0 0.0 0.0
(Ci-3, Hs-) 2 64.5 22.5 7.2 2.9 1.8 0.9 0.3 0.0 0.0 0.0
3 64.3 22.5 7.2 2.8 1.8 0.9 0.3 0.0 0.0 0.0
Data shown are the integrated mass isotopomer distributions not corrected for natural isotope
enrichments. Measurements errors were <0.3 mol%. Data from the triplicate wells were not
statistically different.
* M+0 to M+2 mass isotopomer abundances of ion fragment at m/z 145 may be inaccurate due to
overlapping mass spectra.
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observed deviation was 0.3 mol%. Glucose produced in these experiments was significantly
more labeled than in experiments with [U-13C,2Hs]glycerol alone, which reflected additional
incorporation of 2H from 2H20 into glucose. For example, we found significant M+7 mass
isotopomers (up to 1.2 mol%/o) for the ion fragment at m/z 301 that contains all carbon and
hydrogen atoms of glucose, compared to 0.4 mol% for the experiment with [U-
13C,2H8]glycerol alone. Quantitative analysis of the over-determined mass isotopomer data
from these experiments is performed in the next section.
8.3.3 Flux estimation and model validation
To better characterize metabolic fluxes in this system we performed comprehensive analysis
of the observed mass isotopomer distributions using the network model shown in Figure 8-1
and Metran software. Fluxes and their confidence intervals ware estimated for all six
experimental data sets, i.e. fasted and fed hepatocytes incubated with either 2H 20, [U-
13C,2H8]glycerol, or 2H20+[U- 13C, 2H8]glycerol as tracers. Table 8-8 compares the
information content of the data sets. For example, the 2H20 experiment with fasted
hepatocytes provided 22 mass isotopomers of glucose from which 4 independent fluxes
were estimated. Thus, there were 18 (=22-4) redundant measurements in this data. We found
excellent agreement between the observed and predicted mass isotopomer abundances for
the optimally fitted fluxes, as judged by the small magnitude of the sum of squared residuals,
i.e. 2.1, which was smaller than the critical value of 31.5 for the statistical test of model
adequacy (at 95% confidence level with 18 degrees of freedom) indicating that the fit was
statistically acceptable. Fits for all six data sets were statistically acceptable. Note that 39
mass isotopomers from the [U- 13C,2Hs]glycerol experiment allowed estimation of 6 fluxes,
whereas the 39 mass isotopomers from the 2H20+[U- 13C,2H8]glycerol experiment provided
9 or 10 fluxes. Clearly, the combined use of 2H20 and [U- 13C,2H8]glycerol provided the most
informative data set, as was expected based on preliminary simulations.
8.3.4 Evaluation of fluxes in the gluconeogenesis pathway
Table 8-9 shows the estimated fluxes and standard deviations of fluxes for each of the six
data set. Fluxes obtained from the different isotopic tracers were in good agreements.
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Table 8-8
Comparison of information content of isotopomer data. Mass isotopomer distributions from
six labeling experiments were fitted to a detailed model of glucose metabolism. Fluxes and
confidence intervals were determined by nonlinear least-squares regression. The fits were
statistically evaluated for the goodness-of-fit.
Isotopic tracers
[U-13C, 2H5]glycerol
Mouse 2H20 [U-13C, 2Hs]glycerol and 2H20
Fasted 22 39 39
No. of fitted mass isotopomers
Fed 22 37 38
Fasted 4 6 10
No. of estimated fluxes*
Fed 2 6 9
Fasted 18 33 29
No. of redundant measurements "
Fed 20 31 29
Fasted 2.1 24.3 21.1
Sum of weighted squared residuals
Fed 2.2 17.3 13.0
Fasted Yes Yes Yes
Fit statistically acceptable
Fed Yes Yes Yes
* Number of estimated fluxes equals the number of independent fluxes that were statistically different
from zero, as judged by 95% confidence interval.
** Number of redundant measurements = (no. of fitted isotopomers) - (no. of estimated flux)
- 280 -
CHAPTER 8. APPLICATION OF [IU- 3C32H_]GLYCEROL TO ESTIMATE GNG FLUXES
For example, the GNG flux was estimated at 100±5 and 50±5 for fasted and fed
hepatocytes, respectively, based on 2H20 data, which was in good agreement with the values
of 95±2 and 42+2, respectively, estimated from the 2H20+ [U-13C,2H8]glycerol data. Note
that [U-13C,2Hs]glycerol data alone did not allow precise estimation of the GNG flux, i.e. the
68% confidence interval was 65-100 and 26-100, respectively. Thus, only a lower bound
could be determined. This limitation of [U-13C,2H8]glycerol tracer was anticipated based on
simulation experiments, which was one of the reasons to use the combination of [U-
13C,2Hs]glycerol and 2H20. Note that the fractional contribution of glycerol and oxaloacetate
to glucose was more precisely determined from the 2H20+ [U- 13C,2H8]glycerol data than
could be determined from either of the two tracers alone. It is clear from the results shown
in Table 8-9 that [U- 13C,2H8]glycerol primarily provides information regarding the
reversibility of reactions in the gluconeogenesis pathway. Reaction reversibilities were
accurately determined from both [U-13C,2Ha]glycerol and 2H20+ [U-13C, 2H8]glycerol
experiments, but not from 2H20 data alone. Fractional equilibration for the following four
reactions was estimated precisely: 63%+5 equilibration for PGI, 72%±4 equilibration for
TPI, 8%±3 equilibration for transketolase, and 18%±6 equilibration for the combined
activity of PMI and G6PDH reactions. It was interesting that the estimated reaction
reversibilities were identical for fasted and fed hepatocytes, suggesting that these fluxes may
have a physiological role. To our best knowledge, this is the first methods that allows the
estimation of reaction reversibilities in the gluconeogenesis pathway in vivo, which opens up
many opportunities for future research. For example, it would be interesting to compare
reaction reversibility of healthy hepatocytes with insulin-resistant hepatocytes, or with
hepatocytes responding to hormones.
8.3.5 Estimation of fluxes using extended model
In the previous analysis we assumed that all glucose was newly produced and that the
enrichment of the tracers was constant and known. These assumptions were clearly satisfied
in our well-controlled experiments, however, if we apply these tracers to larger systems, e.g.
perfused livers, or whole animal models then these assumptions may not be valid.
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Table 8-9
Metabolic fluxes estimated from labeling experiments. Metabolic fluxes and their confidence
intervals were estimated by fitting glucose mass isotopomer distributions to a detailed model
of gluconeogenesis. Values shown are estimated flux + SD, or the 68% confidence interval.
Isotopic tracers
[U- 13C, 2H 5]glycerol
Net fluxes Mouse 2H 20 [U-13C, 2Hs]glycerol and 2H0O
Glucose production (fixed at 100) Both [100] [100] [100]
Fasted 100 ± 5 65 - 100 95 ± 2Gluconeogenesis (GNG)* Fed 0 ± 5 26 - 100 42 ± 2Fed 50 + 5 26 - 100 42 + 2
Fasted 0 + 5 0 - 35 5 + 2
Glycogenolysis (GL)* Fed 50 5 0 - 74 58 2Fed 50±5 0-74 58+2
Fasted 57 ± 25 52 ± 4 52 ± 1
Glycerol to glucose flux Fed 33 + 20 29 + 1 29 ± 1
Fasted 137 ± 24 76 - 150 137 + 4Oxaloacetate to glucose flux Fed 67 + 22 24-173 55 2
Exchange fluxes and percent equilibration (%)**
Fasted 0 - 1000 (0 - 91%0) 173 ± 35 (63% + 4) 180 + 35 (64% + 4)
Phosphoglucose isomerase PGI) Fed 0 - 1250(0-- 56 1) ±64 3 D (62% ± 6) 145 ± 35 (59% ± 5)
Aldolase Fasted nd nd nd
Fed nd nd nd
Fasted 0 - 400 (0 - 80%) 295 + 60 (74% 0 4) 280 ± 45 (73% 0 3)Triose phosphate isomerase (TPI)
Fed nd 260 .. 150 (72% ± 8) 240 ± 130 (71% 8.......................................................   . .... . .... . .... . ....  .................. ............. I ..... d .................................................    ....... ............ ..... ....
Phosphomannose isomerase (PMI) + Fasted 0 - 520 (0 - 83%) 20 ± 8 (16% + 6) 9 ± 7 (8% + 6)
Glucose 6-phosphate dehvdr. (G6PDH) Fed nd 24 .. 12 (190% 7) 25± 12 (20% ± 7
Fasted nd 10 ± 2 (9% 0 2) 8 ± 4 (7% + 3)Transketolase (TK) Fed ndFed nd 10.. 4.(9% ± 3) . 8±5(7% 4)....................................   .................................................................. ........... .................. ....................................... ...........     + I - - ...... . .. . . . +... .+ ...... ..............
Fasted nd nd nd
Phosphoglucomutase (PGM) Fed nd nd ndFed nd nd nd
Glycerol 3-phosphate dehydr. Fed nd nd ndFed nd nd nd
Glyceraldehyde 3-phosphate dehydr. Fasted nd > 320 (>76%) > 260 (>75%)
Fasted nd nd nd
Cycling between GAP and PEP Fed nd nd nd
* GNG and GL are not independent fluxes, i.e. GNG = (Vglycerol + voxailoacemte)/ 2 ; GL = 100-GNG.
** 'nd' (=not determined) indicates that the flux could not be determined, i.e. the confidence interval
was 0 -- infinity (i.e. 0 - 100% equilibration).
** Percent equilibration = 100% x (exchange flux) / (100 + exchange flux).
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Therefore, we tested the sensitivity of estimated fluxes with respect to these assumptions.
For that purpose we created an extended mathematical model that included three additional
parameters that were estimated: (i) fraction of newly produced glucose from tracers, as
opposed to endogenous unlabeled glucose; (ii) fractional enrichment of 2H 20, i.e. in our
experiments 10%; and (iii) fractional enrichment of [U-13C,2H8]glycerol tracer, i.e. in our
experiments 25%. Fluxes and confidence intervals were estimated for the extended model
using Metran. Table 8-10 compares the flux results obtained using the basic model from the
previous section with the flux results obtained using the extended model. For example, our
results indicate that with the extended model it is not possible to estimate the GNG flux
from 2H 20 data. The best estimate for the GNG flux was 100±6 for fasted hepatocytes and
44-100 for fed hepatocytes, thus only a lower bound could be determined in the latter
experiment. The fraction of newly synthesized glucose was accurately estimated at 100%±5
for fasted hepatocytes, but was less precisely estimated for fed hepatocytes, i.e. 1000/26.
The enrichment of 2H20 was slightly overestimated at 11%±0.4 and 10.9%±0.4 for fasted
and fed hepatocyte experiments, respectively, compared to 10% true enrichment. For the
[U- 13C,2H8]glycerol experiments the quality of flux results was not significantly affected using
the extended model, as we indeed expected based on preliminary simulation experiments.
For example, fractional equilibration of fluxes were determined with similar precision as with
the basic model. The additional model parameters could not be determined precisely, i.e. the
fraction of newly synthesized glucose was estimated at 1000/%±36 and 100%± 2 2 for fasted
and fed hepatocyte experiments, respectively, and the enrichment of [U-' 3C, 2H8]glycerol was
estimated at 16-100% and 8-100%, respectively (25% true enrichment). These results were
encouraging, because they illustrated that fluxes could be estimated from [U- 13C,2H8]glycerol
data independent of the amount of glycerol incorporated and independent of the presence of
unlabeled endogenous glucose. The same was true for the 2H20+[U- 13C,2H8]glycerol
experiments. Here, both the net and exchange fluxes were estimated precisely with the
extended model. For example, with the extended model the GNG flux was estimated at
93±4 and 43±5 for fasted and fed hepatocytes, respectively, which corresponded well with
95±2 and 42±2, respectively, as estimated using the basic model. The slight decrease in
precision was due to the reduced number of redundant measurement for the estimation of
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Table 8-10
Metabolic fluxes estimated using the basic and extended network models. The extended
model included three additional parameters that had to be estimated: fraction of newly
produced glucose, fractional enrichment of water, and fractional enrichment of glycerol
tracer. Values shown are estimated flux ± SD, or the 68% confidence interval.
Isotopic tracers
2H20 [U-13C, 2H5]glycerol JU- 13C, 2H5]glycerol
and 2H20
Basic Extended Basic Extended Basic Extended
Net fluxes Mouse Model Model Model Model Model Model
Glucose production (fixed at 100) Both 1100] [100] 1100] [100] [100] [100]
Fasted 100 5 100 ± 6 65-100 53-100 95 ± 2 93 ± 4
Fed 50 5 44-100 26-100 25-100 42 + 2 43 ± 5
Fasted 0+5 0+6 0 - 35 0 - 47 5+2 7+4
Glycogenolysis (GL Fed 50 5 0 - 56 0 - 74 0 - 75 58 2 57 + 5
Fasted 57 ± 25 66 + 30 52 + 4 13 - 92 52 ± 1 36 ± 12
Glycerol to glucose flux Fed 33 + 20 51 ± 45 29 + 1 7 - 175 29 + 1 31 ± 12
Fasted 137 24 132 30 76-150 76-187 137 ± 4 157 ± 15Oxaloacetate to glucose flux Fed 67 ± 22 98 ± 40 24- 173 14- 193 55 + 2 73 ± 15
Percent equilibration 0/o)*
Phoshogucose soerase ) Fasted 0-91% 0 - 91% 63% ± 4 62% ± 5 64% + 4 62% ± 4
Fed 0 - 56% nd 62% + 6 63% ± 7 59% / 5 62% + 6
Fasted 0 - 80% 0 - 81% 74% + 4 75% + 3 73% 0 3 75% + 3Triose phosphate isomerase (TPI) Fed nd 23 - 100% 72% ± 8 80% + 6 71% ± 8 74% ± 8
Phosphomannose isomerase (PMI) + Fasted 0 - 83% 0 - 83% 16% ± 6 16% ± 5 8% + 6 5% ± 4
Glucose 6-phosphate dehydr. (G6PDI) Fed nd nd 190/± 7 20% ± 8 200/% ±7 17% ± 8
Fasted nd nd 9% + 2 9% + 3 7% + 3 8% + 4Transketolase (K Fasted nd nd 9% ± 3 9% ± 4 7% ± 4 8% + 5
Glyceraldehyde 3-phosphate dehydr. Fasted nd nd > 76% > 74% > 72% > 67%
Additional modelparameters
Fasted [100%] 100% + 5 [100%] 100% + 36 [1000/%] 87% ± 12Fraction newly produced glucose Fed [100%] 100% ±26 10000 ± 22 10000 96 12
....................................................................................................................................................................................................   .  -  .........  ..............  - ...................... [ . ............... - ..
Fasted [100/%] 11.0% ± 0.5 [0% 1  [0%] [10%] 9.9% ± 0.4Water enrichment Fed 0 ± 0.4
............................................................................................................................................................... .  .................. 1   ' /  [ 1 ...... 1 9 + .5  [  [0  '.o   1. o 9 y  ... 0
Fasted [0%] [] 0%] [25%] 16 - 100% [25%] 22 - 100%
Glycerol enrichment Fed [0%] 10%] [25%] 8- 100% 125%] 13- 100%
* 'nd' (=not determined) indicates that the 68% confidence interval was 0 - 100%.
* Percent equilibration = 100% x (exchange flux) / (100 + exchange flux).
- 284 -
CHAPTER 8. APPLICATION OF [U- 13C.2Hd]GLYCEROL TO ESTIMATE GNG FLUXES
the gluconeogenesis flux, i.e. three additional parameters were estimated in the extended
model from the same number of mass isotopomers.
8.4 Discussion
Previously we have shown that net and exchange fluxes in the gluconeogenesis pathway may
be estimated through the combined analysis of 2H20, [U-13 C]glycerol, and [2Hs]glycerol
experimental data (Chapter 7). Here, we provide a novel two-tracer strategy that allows
accurate estimation of the same fluxes from a single experiment. Quantitative analysis of
mass isotopomer distributions of glucose resulting from the incorporation of [U-
13C,2H8]glycerol into glucose required the use of the elementary metabolite units framework
for modeling isotopic distributions. The EMU method reduced the computational problem
of isotopic simulations from 42,224 variables, which could not be solved computationally, to
only 204 EMU variables that were easily computed. Using the Metran software fluxes and
confidence intervals were determined and the fits were statistically evaluated. The methods
developed in this study and the insight obtained from these experiments have wide
implications for in vivo studies of glucose metabolism in vivo. We have clearly shown that
PGI and TPI reactions are not fully equilibrated in isolated hepatocytes. In hepatocytes
isolated from fasted and fed mice we found that PGI was only 630/±5 equilibrated and TPI
was only 72%±4 equilibrated. This resulted in incomplete equilibration of hydrogen at C2 of
glucose and the solvent in 2H20 experiments, and thus overestimation of fractional GNG
from the ratio of deuterium enrichment at C5 vs. C2 of glucose, i.e. 123% for fasted
hepatocytes and 100% for fed hepatocytes, compared to the true values of 95% and 42%,
respectively. Furthermore, we have illustrated that using [U- 13C,2Hs]glycerol metabolic fluxes
can be determined independent of the isotopic steady state assumption and independent of
the amount of glycerol incorporated into glucose, i.e. independent of zonation of glycerol.
Thus, this method can be applied to perfused livers and whole animal models without
difficulty. And because this method does not require isotopic steady state, tracer experiments
can be much shorter (i.e. less expensive) than current experiments that require 4-5 hr
constant infusion of tracer to reach isotopic steady state of glucose labeling.
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Appendix A
GC/MS analysis of TBDMS derivatized
amino acids
GC/MS analysis of unlabeled and [U- 13C]-labeled (99 At%) amino acids was performed
using HP 5890 Series II GC (Gas Chromatograph) connected to HP 5971 MSD (Mass
Selective Detector). The mass spectrometer was calibrated using the 'Max Sensitivity
Autotune' setting.
Column Specifications
* Agilent Technologies 122-0732 DB-1701 (Serial No. US4823442H)
* Length: 30 m
* ID: 0.25 mm
* Film: 0.25 pm
* Temperature limits: -200 C to 2800 C
MSD
*
*0
*
*
Settings
Scan mode
7 min solvent delay
23 min recording time
Mass range: 195 to 445 amu (approx. 2.7 scans/sec)
GC Settings
* Constant flow 0.737 ml/min (= 6 psi at 80 0 C; 31.6 cm/sec)
* Injector temp: 2700 C
* Transferline temp: 3000 C
* Temperature program:
o 100 0C (hold 1.5 min)
o 200C/min to 130 0 C
o 100C/min to 2200 C (hold 3 min)
o 50C/min to 2800 C (hold 3 min)
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Total Ion Chromatogram
4e+006-
2e+006-
le+006s
Dath Run : 24 Apr 105 3:21 pm FCMethod : TBDMS005
Leu
Ala
Val
Ser
Pb Glu
TP r Tyr
_. . . , .. . , . . . . . , , . ., . ; . . . . . . ,. , •
rme(mintoo 10.oo 12. 14.oo0 16.00 100 20.00 22.00 24.00
Date Run : 24 Apr 1 3:21 pm Fr C
Method : TBDMS005
+005 Leu
00- lie
Ala
+006 Val
+0gO
P(n
Time(min)i.) 9.40 9.0 9.80 10.0 1020 10.40 10.50 10.80 11.00 11 11.40 11.0 11.0 12.00
Date Run : 24 Apr 105 3:21 pm¶ic
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Recommended fragment ions and corresponding precursor metabolites
(for E. colibiosynthesis pathways)
Amino Mass Carbon atoms Fragmentation Precursor metabolite(s)
acid Range
Ala 232 - 238 2-3 M - C5H90 Pyr(23)
260 - 267 1-2-3 M - C4H 9  Pyr(1-2-3)
Gly 218 - 223 2 M - CsH 90 3PG(2) and C-1 and OAC2
246 - 252 1-2 M - C4H 9  3PG(1-2) and 3PG(3) + CO2 and other
Val 260 - 268 2-3-4-5 M - CsH 9O Pyr(2-3) + Pyr(2-3)
288 - 297 1-2-3-4-5 M - C4H 9  Pyr(1-2-3) + Pyr(2-3)
Leu 274 - 283 2-3-4-5-6 M - C5H 90 AcCoA(2) + Pyr(2-3) + Pyr(2-3)
Ile 200 - 208 2-3-4-5-6 M - C7H 150 2Si OAC(2-3-4) + Pyr(2-3)
274 - 283 2-3-4-5-6 M - CsH 90 OAC(2-3-4) + Pyr(2-3)
Ser 288 - 294 2-3 M - C7H1 50 2Si 3PG(. 3) and Gly(2) + C-1 and other
302 - 308 1-2 M - C7H 17OSi 3PG(1-2) and Gly(_-2)
362 - 369 2-3 M - C5H 90 3PG(2-3) and Gly(2) + C-1 and other
390 - 398 1-2-3 M - C4H 9  3PG(1-2-3) and Gly(1-2) + C-1 and other
Thr 376 - 382 2-3-4 M - C5H90 OAC(2-3-4)
404 - 413 1-2-3-4 M - C4H9 OAC(1-2-3-4)
Met 218 - 226 2-3-4-5 M - C7H150 2Si OAC(2-3-4) + C-1
292 - 298 2-3-4-5 M - C5H 90 OAC(2 -3-4) + C-1
320 - 327 1-2-3-4-5 M - C4H 9  OAC(1-2-3-4) + C-1
Phe 234 - 243 2-3-4-5-6-7-8-9 M - C7H15O2Si PEP(2-3) + PEP(2-3) + E4P(1-2-3-4)
302 - 307 1-2 M - C7H7  PEP(1-2)
308 - 316 2-3-4-5-6-7-8-9 M - C5H 90 PEP(2-3) + PEP(2 -3) + E4P(1-2-3-4)
336 - 345 1-2-3-4-5-6-7-8-9 M - C4H 9  PEP(1-2-3) + PEP(2-3) + E4P(1-2-3-4)
Asp 302 - 308 1-2 M - C8H 170 2Si OACo(.2)
376 - 382 1-2 M - C6H110O OAC(1-2)
390 - 398 2-3-4 M - C5H 90 OAC(2 -3-4)
418 - 427 1-2-3-4 M - C4H 9  OAC(1-2-3- 4)
Glu 330 - 336 2-3-4-5 M - C7H 15O 2Si AKG(2 3.4- 5)
432 - 442 1-2-3-4-5 M - C4H9  AKG(1-2-3-4-5)
Tyr 302 - 305 1-2 M - C13H 210Si PEP(1-2)
3PG: 3-phosphoglycerate
PEP: phosphoenolpyruvate
Pyr: pyruvate
E4P: erythrose-4-phosphate
AKG: a-ketoglutarate
OAC: oxaloacetate
AcCoA: acetyl coenzyme-A
R5P: ribose-5-phosphate
C-1: One-carbon unit
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Rejected fragment ions and reason for rejection
Carbon atoms
1-2 and 1-2-3-4,5
2-3-4-5-6
1-2 and 1-2-3-4-5-6
1-2 and 1-2-3-4-5-6
2-3-4-5
1-2-3-4-5
unknown
unknown
unknown
unknown
unknown
2-3-4
unknown
1-2-3-4-5
2-3-4-5
2-3-4-5-6
1-2-3-4-5-6
2-3-4-5-6-7-8
Reason for rejection
Overlapping fragments
Inaccurate. M+2 too high (+0.9 mol%)
Overlapping fragments
Overlapping fragments
Co-eluting with other compounds
Co-eluting with other compounds
Unknown fragmentation
Inaccurate. M+0 too low (-4.0 mol%)/
Unknown fragmentation
Unknown fragmentation
Inaccurate. M-1 too high (4.4 % of M+0)
Inaccurate. M+3 too high (+0.7 mol0/o)
Unknown fragmentation
Inaccurate. M-1 too high (1.8 % of M+0)
Inaccurate. M+0 too low (-0.6 mol0/o)
Low signal-to-noise ratio
Inaccurate. M-1 too high (1.7 % of M+0)
Low signal-to-noise ratio
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Amino
acid
Val
Leu
Leu
Ile
Pro
Pro
Ser
Thr
Met
Asp
Asp
Asp
Glu
Glu
Glu
Lys
Lys
Tvr
Mass
Range
302 - 308
200 - 208
302 - 312
302 - 312
258 - 266
286 - 295
230 - 237
417 - 424
244 - 250
244 - 249
258 - 266
316 - 323
272 - 280
358 - 367
404 - 408
329 - 336
431 - 441
364 - 375
Alternative
fragment
n/a
Leu-274
n/a
n/a
Glu-330
Glu-432
unknown
unknown
unknown
unknown
unknown
Asp-390
unknown
Glu-432
Glu-330
none
none
Phe-308
ADDCN.ThTVT A CCr/MS AMTArVCT n A~MT~hn ArTne
Alanine (Ala)
veraed Scan:360 to 36 TIC :13739 EP-4W9185
23220 260.15
7060
40.
20
to 302.20
0ý1 1'240,;ý 3i .4d
CH3 CH3  0 CH3 OH3I I H H II
H3 C-CSi-N-CCCO--Si-C-CH 3I I I I ICH3 CH3 OH3 CH3 CH3 C15H35NO2Si2Exact Mass: 317.2206
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Ala 232
76.5
76
755
74.5 "
Peak area 7
.10O
M+3 M+4
0.5
2 3 0 1 2 3
Peak area 7 Peak area
.,G0
0 1 2 3 0 1 2 3
7 Peak area 7 Peak area 75 Io10 1x i
[U-13C]-Ala 232
1.5
0.5
0 1 2 3
Peak area x
x 10
M+1
P.5
0 1 2 3
Peak area 7
.10
M+2 M+3 M+4
76 75
76 165
75.5
7515 * " _.. . . . .. . . . . 6.5
0 1 2 3 0 1 2 3 0 1 2 3
Peak area 7 Peak area 7 Peak area 7105 . , .6
M+5 M+6 M+7
i 0.5.
55 1.5
S 1 2 3 0 1 2 0 1 2 3
Peak area 7K 10 Peak area 7ý 1 0 Peak area 7x 10
Ala 232
Formula : CloH 26ONSi2
Exact mass : 232.155
C-atoms: 2-3
m/z theory data difference
231 0.0 0.0 0.0
232 100.0 100.0 0.0
233 21.9 22.1 0.2
234 9.0 9.1 0.1
235 1.3 1.3 0.0
236 0.2 0.2 0.0
237 0.0 0.0 0.0
238 0.0 0.0 0.0
239 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U-13C]-Ala
m/z theory data difference
231 0.0 0.1 0.1
232 0.0 0.3 0.3
233 2.0 0.1 -1.9
234 100.0 100.0 0.0
235 19.8 20.8 1.0
236 8.5 8.9 0.4
237 1.1 1.2 0.1
238 0.2 0.2 0.0
239 0.0 0.0 0.0
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Ala 260
75.5
75
74 , ,.
73.5
0 1 2
Peak area 7
[U-13C]-Ala 260
0 0.5 1 15 2 2.5
Peak area x 107
x 10
M+1
17.5
17 --
16,5
0 1 2 3
Peak area 7
M+1
M+2
7.5
65
0 1 2
Peak area 7M11
M+2
Peak area 7 Peak area 7
M+3
0.5
o i 2 3
Peak area 7
xM+3
M+3
0 0.5 1 1.5 2 2.5
Peak area 7x 10
M+5 M+6
0 0.5 1 15 2 2.5 0 0.5 1 15 2 2.5
Peak area x 107 Peak area 7X 10 ý10
Ala 260
Formula : CiiH 260 2NSi2
Exact mass : 260.150
C-atoms: 1-2-3
m/z theory data difference
259 0.0 0.0 0.0
260 100.0 100.0 0.0
261 23.0 23.2 0.2
262 9.4 9.4 0.0
263 1.4 1.4 0.0
264 0.3 0.2 0.0
265 0.0 0.0 0.0
266 0.0 0.0 0.0
267 0.0 0.0 0.0
268 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U- 13C]-Ala
m/z theory data difference
259 0.0 0.0 0.0
260 0.0 0.3 0.3
261 0.0 0.4 0.4
262 3.1 3.3 0.2
263 100.0 100.0 0.0
264 19.9 20.5 0.6
265 8.7 9.0 0.3
266 1.1 1.2 0.1
267 0.2 0.1 -0.1
268 0.0 0.0 0.0
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Gly 218
76.5 3
76 
75.5 e
0 1 2 3
Peak area x 10
7
X 10
[U-13C]-Gly 218
M+1
165 .
16
15.515,5
0 1 2 3
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7
.10
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7.5
7 •
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, 1 2 3
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M+3
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0.5
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M+4
0.5
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Peak area 7X10
M+5
o 0
0 0.5 1 e.5 2 2.5
Peak area 
7
X10
Gly 218
Formula : C9H240NSi2
Exact mass : 218.140
C-atoms : 2
m/z theory data difference
217 0.0 0.0 0.0
218 100.0 100.0 0.0
219 20.8 20.7 -0.1
220 8.8 8.7 -0.1
221 1.2 1.2 0.0
222 0.2 0.2 0.0
223 0.0 0.0 0.0
224 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U-13C]-Gly
m/z theory data difference
217 0.0 0.9 0.9
218 1.0 0.0 -1.0
219 100.0 100.0 0.0
220 19.7 20.4 0.7
221 8.5 8.7 0.2
222 1.1 1.2 0.1
223 0.2 0.2 0.0
224 0.0 0.0 0.0
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Gly 246
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Gly 246
Formula : CloH 240 2NSi2
Exact mass : 246.135
C-atoms : 1-2
m/z theory data difference
245 0.0 0.0 0.0
246 100.0 100.0 0.0
247 21.9 21.8 -0.1
248 9.2 9.1 -0.1
249 1.3 1.3 0.0
250 0.2 0.2 0.0
251 0.0 0.0 0.0
252 0.0 0.0 0.0
253 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U-13C]-Gly
m/z theory data difference
245 0.0 0.0 0.0
246 0.0 0.4 0.4
247 2.0 0.6 -1.4
248 100.0 100.0 0.0
249 19.8 20.3 0.5
250 8.7 8.9 0.2
251 1.1 1.2 0.1
252 0.2 0.2 0.0
253 0.0 0.0 0.0
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Valine (Val)
d egarevS Scan : 553 tD 557100
200 250 300 34 450 /
00 Averaed Scan : 557 to 561 TIC : 1010105 BVP - 293072
45o m/a
CH 3 CH 3  0 CH3 CH3I I H i I I
H3C-C-SiN-CC--O--Si-C-CH 3I I I I I
CH 3 CH 3  CH CH3 CH3
H3C \CH3
C17H39NO2Si2Exact Mass: 345.2519
- 305 -
302.20
216.05 .151 245.15 3 331.20
293.20
201.00 720 241.15 33520
|[ · . . . . " · ·.' .· ·.  ·"2· . . . " 2 ? " . . . .)
~ · · · · · · · · · · · · · · · · · · · · · · · I········ · · · · · ·
,:ou.l•)
288.15
302.20
216.05 
! 
I
• 
I.. 
z4s.. 
15 
,I 
i 
33t..z°
APPENDIX A. GC/MS ANALYSIS OF AMINO ACIDS
Val260
74.5
73.5 
. *
73
72.5 X
72
Peak area 7
[U-13C]-Val 260
1.5
0 5 lo 15
Peak area 6
M+5
15.5
i
15.5
0 5 10 15
Peak area 6
M+1
19i
18
0 I 2 3
Peak area 7Peak area S10
M+1
0.5
0 5 10 15
Peak area 
6
X If)
M+2
7.5 a
6.5
0 1 2 3
Peak area 7
M+2
00
S5 1area
Peak area 
6
M+6 M+7
7.5
71.5
0.5
0 5 10 15 0 5 10 15
Peak area 6 Peak area
M+3
;_..- ....
P1 ar
Peak area 7
M+4
0.5
0120 1 2 3
Peak area 7feI
M+3 M+4
73
71.5
0 5 10 15 0 5 10 15
Peak area 6
x 10
M+8
15 P
0 5 10 i
Peak area 6
Peak area X 10
M+9
0.5
0 5 10 15
Peak area
* Val 260
Formula: C12H3oONSi2
Exact mass : 260.187
C-atoms : 2-3-4-5
m/z theory data difference
259 0.0 0.0 0.0
260 100.0 100.0 0.0
261 24.2 24.7 0.5
262 9.5 9.6 0.1
263 1.5 1.5 0.1
264 0.2 0.3 0.1
265 0.0 0.0 0.0
266 0.0 0.0 0.0
267 0.0 0.0 0.0
268 0.0 0.0 0.0
269 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
molO/) and M+1 is slightly too high (+0.2 molo).
[U- 13C]-Val
m/z theory data difference
259 0.0 0.0 0.0
260 0.0 0.4 0.4
261 0.0 0.2 0.2
262 0.0 0.2 0.5
263 4.1 4.9 0.8
264 100.0 100.0 0.0
265 20.0 21.1 1.1
266 8.5 8.9 0.4
267 1.1 1.1 0.0
268 0.2 0.2 0.0
269 0.0 0.0 0.0
Note, however, that M+0 is slightly too low (-0.3
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M+5
71.5
P 5 10
Peak area °
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M+6
155
*
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Peak area 6
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Val 288
Formula: C13H 300 2NSi 2
Exact mass : 288.182
C-atoms : 1-2-3-4-5
m/z theory data difference
287 0.0 0.0 0.0
288 100.0 100.0 0.0
289 25.3 25.2 -0.1
290 10.0 9.8 -0.2
291 1.7 1.6 -0.1
292 0.3 0.2 -0.1
293 0.0 0.0 0.0
294 0.0 0.0 0.0
295 0.0 0.0 0.0
296 0.0 0.0 0.0
297 0.0 0.0 0.0
298 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
M+2
7.5
7:
6.5
o 0.5 1 1.5 2
Peak area 7X 10
M+3
S 0.5 1.5 2
Peak area 7
x 1O
M+3
1
0.5
o0
o 5 00
Peak area 6
× 10
M+4
0.5
o
0 0.5 1 1.5 2
Peak area 7
M+4
4.5
3.5
0 5 10
Peak area x 
6
X 10
M+7 M+8 M+9
1.5 1.5
*:.. -.. , I.
05 0.5
0 5 10 0 5 10 0 5 10
Peak area 6 Peak area 6  Peak area 6
X10 X 10 110
[U- 13C]-Val
m/z theory data difference
287 0.0 0.0 0.0
288 0.0 0.3 0.3
289 0.0 0.2 0.2
290 0.0 0.1 0.1
291 0.0 0.3 0.3
292 5.2 5.8 0.6
293 100.0 100.0 0.0
294 20.1 20.5 0.4
295 8.7 8.8 0.1
296 1.1 1.2 0.1
297 0.2 0.2 0.0
298 0.0 0.0 0.0
- 307 -
Val 288
72.5
72 °° 
°
P 0.5 1 1.5 2
Peak area 
7
M+1
175
0 0.5 1 1.5 2
Peak area x 
7
.10
[U-13C]-Val 288 M+1 M+2
0.5 05 0,5
P ae
10 0 5 10 0 5 10
Peak area 6 los Peak area x 1o6 Peak area 6 1os
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Val 302
0 2 4 6 8 10 0 2 4 6 8 10
Peak area 6 Peak area 6X 10
0 2 4 6 8 10 0 2 4 6 9 10
Peak area a Peak area 6X 10 X 10
[U-13C]-Val 302 M+1 M+2 M+3 M+4
64.5
1.5 1.5 17
640 .
0.5 05 1651 .
63" . .'
. . .. . .. . .. .-- ... . . . . . . .... . . ..
0 2 4 6 0 2 4 6 0 2 4 0 2 6 6 0 2 4 6
Peak area C6 Peak area G Peak area 6 Peak area 6 Peak area o
. 10 K 10 . 10 f o .,a1
M+6 M+7
. 0
0 o 2 4 6 0 2 a 6
Peak area lPeak area a Peak area 8
.10 410 X10
Val 302
Formula : C1 4H 3202NSi2
Exact mass : 302.197
C-atoms : unknown
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 26.5 0.1
304 10.3 10.1 -0.2
305 1.8 1.7 -0. 1
306 0.3 0.3 0.0
307 0.0 0.5 0.5
308 0.0 0.1 0.1
309 0.0 0.0 0.0
[U-13C]-Val
m/z theory data difference
301 0.0 0.0 0.0
302 0.0 0.5 0.5
303 2.0 1.3 -0.7
304 100.0 100.0 0.0
305 24.3 25.4 1.1
306 9.7 22.4 12.7
307 1.5 4.6 3.1
308 0.3 1.5 1.2
309 0.0 0.2 0.2
This fragment should not be used. The presence of significant M+2 and M+4 abundances in IU-' 3C]-
valine suggests that two fragments are overlapping.
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.10
M+5
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Leucine (Leu)
oAveraed Sca : 616 to 622 TIC 2367657 BP = 163997 <
90 200.20
70
60
so50
40
30 274.20
302.20
20
10
S 20 2 . 300 35 40 4500 m/
9 Sveraged Scan : 621 it 624 TIC: 2926685 BP - 1451008 <
100
so
70
60
40-
200
CH3 CH 3  O CH3 CH3
I I I I I
CH 3 CH 3  CH2  CH3 CH3I
CH
H3C CH3
C18H41NO2Si2Exact Mass: 359.2676
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Leu 200
32
815
80 .1
79.5
785[
Peak area 7
[U-13C]-Leu 200
1-n
-1
0.5
0
Peak area 7
M+5
79
rs
P r
Peak area 
7
M+1
155
15
145
14
Peak area 7
M+1
05 Peak area 7
Peak area 7
, 10
M+6
M+2
.. w
4.5
35
3
Peak area 7
M
+
2
Peak area 7
1 11
M+3
0.5
024 8
Peak area 7
K 10
M+3 M+4
15 155
0.5 ' r- *-- 4.5
0  a 1
Peakarea 7 Peakarea 7
M+7
Peak area 7 Peak area 7XJU ý 10
Leu 200
Formula : CIIH26NSi
Exact mass : 200.183
C-atoms : 2-3-4-5-6
m/z theory data difference
199 0.0 0.0 0.0
200 100.0 100.0 0.0
201 17.9 18.2 0.3
202 4.8 5.7 0.9
203 0.5 0.7 0.2
204 0.0 0.1 0.1
205 0.0 0.0 0.0
206 0.0 0.0 0.0
207 0.0 0.0 0.0
208 0.0 0.0 0.0
209 0.0 0.0 0.0
[U-13C]-Leu
m/z theory data difference
199 0.0 0.0 0.0
200 0.0 0.3 0.3
201 0.0 0.1 0.1
202 0.0 0.1 0.1
203 0.0 0.6 0.6
204 5.2 5.9 0.7
205 100.0 100.0 0.0
206 12.5 13.8 1.3
207 3.9 4.1 0.2
208 0.3 0.3 0.0
209 0.0 0.0 0.0
This fragment should not be used. It has a significant bias, M+0 is too low (-1.0 mol%) and M+2 is
too high (+0.6mo1%). Fragment Leu-274 is preferred.
310
M+4
05
02468
Peak area 7X10
M+9M+815
0,
Peak area 7 Peak area
i.5
05
0 I
S 2 A 6
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Leu 274
74
73.5
72
715
0 1 2 3
Peak area 7
[U-13C]-Leu 274
0.5
01
Peak area x 7
M+5
72.5 r .
72
715
71 -0 0.5 1 1.5 2
Peak area 
7
M+1
Is ."
0 1 2 3
Peak area 7
050 M+1
01
o 0 05 1 1.5 2
Peak area 7
M+6
15.5
15
o 0.5 1 1.5 2
Peak area 1
7
x 10
M+2
75
7
6.5
Peak area 7
M+2
1 5
0.5
0 0.5 1 1.5 2
Peak area 7
M+7
0 0.5 1 1.5 2
Peak area x 
7
.10
M+3
1.5
I
Peak area x lO7
0 1 10 .5 1 I 2
Peak area 7x10
M+8
0.5
0
0 0.5 1 1.5 2
Peak area 7
x 10
M+4
0.5
1.'--- --
0123
Peak area 7
M+4
45 .
0 0.5 1 1.5 2
Peak area 7
M+9
1.5
1
0,5
0.5 1 1.5 2
Peak area 7X 10
Leu 274
Formula: C13H32ONSi 2
Exact mass : 274.202
C-atoms : 2-3-4-5-6
m/z theory data difference
273 0.0 0.0 0.0
274 100.0 100.0 0.0
275 25.3 25.2 -0.1
276 9.8 9.6 -0.2
277 1.6 1.6 0.0
278 0.3 0.3 0.0
279 0.0 0.0 0.0
280 0.0 0.0 0.0
281 0.0 0.0 0.0
282 0.0 0.0 0.0
283 0.0 0.0 0.0
284 0.0 0.1 0.1
This fragment can be used for quantitative analysis.
[U- 13C]-Leu
m/z theory data difference
273 0.0 0.0 0.0
274 0.0 0.3 0.3
275 0.0 0.2 0.2
276 0.0 0.1 0.1
277 0.0 0.3 0.3
278 5.2 6.0 0.8
279 100.0 100.0 0.0
280 20.1 20.7 0.6
281 8.5 8.6 0.1
282 1.1 1.1 0.0
283 0.2 0.2 0.0
284 0.0 0.0 0.0
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Leu 302
73
72.5
72
71.5 f e"
71 . .
0 0.5 1 1.5 2 2.5
Peak area 7X 10
0 0.5 1 1.5 2 2.5 0 0.5 1 1.5 2 2.5
Peak area 7 Peak area 7x 10 X 10
0 0.5 1 1.5 2 2.5
Peak area 7x 10
M+4
05
0 0.5 1 1.5 2 2.5
Peak area 7110
[U-13C]-Leu 302 M+1
C
0o.5 0.5
0 5 10 15 0 5 io 15
Peak area x Peak area xx 10 fo1
M+2
5 -
45
0 5 10 15
Peak area xK fa
M+3 M+4
2
0.5
0 5 10 15 0 5 10 15
Peak area Peak area a
. 10 x fo
M+6 M+7 M+8 M+9
665 1
14.5 6.5
14 a '. ,
65.5ee e 1
13.5 ' 5.5
0 5 10 15 0 10 15 D b 10 15 0 5 10 15
Peak area x 
6  
Peak area x lo
s  
Peak area x lo
6  
Peak area x l
6
. 10 X 10 . 10 X 10
Leu 302
Formula: C 14H320 2NSi 2
Exact mass : 302.197
C-atoms : 1-2 and 1-2-3-4-5-6
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 26.6 0.2
304 10.3 10.2 -0.1
305 1.8 1.8 0.0
306 0.3 0.3 0.0
307 0.0 0.0 0.0
308 0.0 0.0 0.0
309 0.0 0.0 0.0
310 0.0 0.0 0.0
311 0.0 0.0 0.0
312 0.0 0.0 0.0
313 0.0 0.0 0.0
[U- 3C]-Leu
m/z theory data difference
301 0.0 0.0 0.0
302 0.0 0.3 0.3
303 0.0 0.3 0.3
304 0.0 8.1 8.1
305 0.0 2.6 2.6
306 0.0 1.3 1.3
307 6.3 7.2 0.9
308 100.0 100.0 0.0
309 20.2 20.6 0.4
310 8.7 8.8 0.1
311 1.1 1.2 0.1
312 0.2 0.2 0.0
313 0.0 0.0 0.0
This fragment should not be used. The presence of significant M+2 and M+6 abundances in [IU- 13C]-
leucine shows that two fragments with the same chemical formula are overlapping.
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M+5
4.5
o 5 10 15
Peak area xX 10
APPPNnTYYK CCr~/MS ANALYSTS OP AMITNO Armse
Isoleucine (Ile)
Averaaed Scan: 669 to 673 TIC :2263202 BP = 1102080
90 200.20
80
70
60
S40
302.20
30 274.20
20
10
216.15
S 200 250 300 3 4 40
CH3 CH3  0 CH3 CH3I I H H I
H3C-C-Si-N- C--O--Si--C-CH3I I I I I
CH3 CH3  HC-CH3  CH3 CH3I
CH2
CH 3
C18H41NO2Si2Exact Mass: 359.2676
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lie 200 M+1
Peak area 7 Peak area 7
.'0 .10
M+2
41
3.5
0 2 4 6
Peak area 7X 10
[U-13C]-lIe 200 M+1 M+2
0.5 .5 0o.5
0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
Peak area x 107 Peak area 107 Peak area 70
M+3
M+4
05
0 2 4 6
Peak area 7
M+4
0 1 2 3 4
Peak area 7 Peak area 7
x 107. InI
0 .1 2 3 4 0 1 2 3 4
Peak area 7 Peak area 7
x 10 x in
M+7
3.5
3 .
0 1 2 3 4
Peak area 7
'10g
M+9
2 3 4 0 1 2 3 4
Peak area 7 Peak area 7ý10 .10
Ile 200
Formula: CI H26NSi
Exact mass : 200.183
C-atoms : 2-3-4-5-6
m/z theory data difference
199 0.0 0.0 0.0
200 100.0 100.0 0.0
201 17.9 17.9 0.0
202 4.8 5.0 0.2
203 0.5 0.6 0.1
204 0.0 0.1 0.0
205 0.0 0.0 0.0
206 0.0 0.0 0.0
207 0.0 0.0 0.0
208 0.0 0.0 0.0
209 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U-13C]-Ile
m/z theory data difference
199 0.0 0.0 0.0
200 0.0 0.3 0.3
201 0.0 0.1 0.1
202 0.0 0.2 0.2
203 0.0 0.8 0.8
204 5.2 6.1 0.9
205 100.0 100.0 0.0
206 12.5 13.4 0.9
207 3.9 3.9 0.0
208
209
-314-
c
APPENDIX A. GC/MS ANALYSIS OF AMINO ACIDS
lie 274
74
73 5  
-
73.5
72
0 0.5 1 1.5 2 2.5
Peak area 7
x 1o
[U-13C]-Ile 274
0.5
4L 0
o 5 10
Peak area 6
M+5
19.5
17.5
0 0.5 1 1.5 2 2.5
Peak area 7
M+1
15
050 5 10
Peak area 6
M+6
M+2
75
0 0.5 i 1.5 2 25
Peak area 7
M+2
o
0.5
o 5 10
Peak area 6
M+7
0 5Peak 10 5 10area
Peak area 
6  
Peak area 
6
x 10 x 10
Ile 274
Formula : C13H 32ONSi2
Exact mass : 274.202
C-atoms : 2-3-4-5-6
m/z theory data difference
273 0.0 0.0 0.0
274 100.0 100.0 0.0
275 25.3 25.4 0.1
276 9.8 9.6 -0.2
277 1.6 1.6 0.0
278 0.3 0.3 0.0
279 0.0 0.0 0.0
280 0.0 0.0 0.0
281 0.0 0.0 0.0
282 0.0 0.0 0.0
283 0.0 0.0 0.0
284 0.0 0.1 0.1
This fragment can be used for quantitative analysis.
P0 5 10 0 5 10
Peak area x 
6  
Peak area x lo
6
.10 .10
0 5 10
Peak area 
6
x 10
[U-13C]-Ile
m/z theory data difference
273 0.0 0.0 0.0
274 0.0 0.3 0.3
275 0.0 0.1 0.1
276 0.0 0.4 0.4
277 0.0 0.4 0.4
278 5.2 6.1 0.9
279 100.0 100.0 0.0
280 20.1 20.9 0.8
281 8.5 8.5 0.0
282 1.1 1.1 0.0
283 0.2 0.2 0.0
284 0.0 0.0 0.0
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1
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Peak area 7
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lie 302
S 0 k5 1 1.5 2 2.5
Peak area 17X 10
M+1
195 Pa
19
185
Poa5 1 15 2 2.5
Peak area 
7
ý 10
M+2
0 0.5 1 5 2 2.5
Peak area x 107ý 10
M+3
e.5 a .ara_ 2
1 0 1.5 2 2.5
Peak area 7
x 10
M+4
0 .5 1 15 2 25
Peak area 7
[U-13C]-lIe 302 M+1 M+2 M+3 M+4
25 t
251
< 05a 24.5
0 5 10 15 0 5 10 15 0 5 10 15 0 5 10 P 5 e 1 15
Peak area 1 Peak area 6 Peak area l°0 Peak area 10
6  
Peak area X0
Pekae 106 r !06 x x0 x 106
3
or
M+5
Peak 15
Peak area 
6
X 10
M+6
5 10area 1
Peak area 1
'10
0s95gi
o
Ile 302
Formula: C14H 320 2NSi2
Exact mass : 302.197
C-atoms : 1-2 and 1-2-3-4-5-6
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 25.8 -0.6
304 10.3 10.0 -0.3
305 1.8 1.7 -0.1
306 0.3 0.3 0.0
307 0.0 0.0 0.0
308 0.0 0.0 0.0
309 0.0 0.0 0.0
310 0.0 0.0 0.0
311 0.0 0.0 0.0
312 0.0 0.0 0.0
313 0.0 0.0 0.0
M+7
Peak area 5
xlrn
M+8
Peak area 6
M+9
Peak area 8
[U-' 3C]-Ile
m/z
301
302
303
304
305
306
307
308
309
310
311
312
313
theorv
0.0
0.0
0.0
0.0
0.0
0.0
6.3
100.0
20.2
8.7
1.1
0.2
0.0
data
0.0
0.5
1.1
54.6
14.0
5.8
8.0
100.0
20.3
8.8
1.2
0.2
0.0
difference
0.0
0.5
1.1
54.6
14.0
5.8
1.7
0.0
0.1
0.1
0.1
0.0
0.0
This fragment should not be used. The presence of significant ŽM+2 and M+6 abundances in [U- 13C]-
isoleucine shows that two fragments with the same chemical formula are overlapping.
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Proline (Pro)
d egarevA Scan : 757 to 761100
Ls ' -• .'a ' "' ' " . . . ,•o I .' . ." ..a o . . I ' ' I• .• I4. I2260  03M 40 450im
Averaged Scan : 758 to 768 TIC : 52685 BP - 40475 <
CH3 CH3
H3C---Si 0 CH3 CH3
I H II I I
CH3 CH3 N-C-C-O-Si-C-CH3
H2C0 /CH 2  CH3 CH3
H2
C17H37NO2Si2Exact Mass: 343.2363
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Pro 258 M+1 M+2 M+3 M+4
4 18" 7. °74s
C 73.5. 7 -- - - - "-
..5 0
72 5 176 ýi - - - -
O 5 10 15 0 5 10 15 0 5 10 5 0 5 10 i5 0 5 10 15
Peak area 
6  
Peak area 
6  
Peak area 
6  
Peak area 6 Peak area 6X 10 .10 i 10x nI G
[U-13C]-Pro 258 M+1 M+2 M+3 M+4
3 · rI,, 1,725
' • · N 7P
-- . ..'2 -2 ,
. . ... . . . .
- 0.55 05% :. 0.
. .05,1 0715
0~
2 4 6 0 2 4 G 0 2 4 0 0 2 4 6 0 2 4 5
Peak area 6 Peak area 6 Peak area s Peak area 6 Peak area 6
X 10 x 10 0 1) In
M+5 M+6 M+7 M+8 M+9
:1 -'
Peak area ý 10
Pro 258
Peak area 6 Peak area 6 Peak area 6 Peak area 610 ýim 10 , 10
[U- 13C]-Pro
Ci2H28ONSi 2
258.171
2-3-4-5
theory data difference
0.0 0.0 0.0
100.0 100.0 0.0
24.1 24.5 0.4
9.5 9.4 -0.1
1.5 1.4 -0.1
0.2 0.8 0.6
0.0 0.1 0.1
0.0 0.1 0.1
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
m/z
257
258
259
260
261
262
263
264
265
266
267
theory data difference
0.0 0.1 0.1
0.0 0.3 0.3
0.0 0.7 0.7
0.0 1.5 1.5
4.1 5.7 1.6
100.0 100.0 0.0
20.0 20.0 0.0
8.5 8.6 0.1
1.1 2.0 0.9
0.2 0.3 0.1
0.0 0.1 0.1
This fragment should be used with caution. Proline co-elutes with other compounds , which may
result in inaccurate values. M+0 is slightly too low (-0.5 mol%) and M+4 is slightly too high (+0.4
mol%). Fragment Glu-330 is preferred.
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Formula :
Exact mass :
C-atoms :
m/z
257
258
259
260
261
262
263
264
265
266
267
--
i
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Pro 286
7(
o 5 1o
Peak area l 6X10
M+1
19
18
17.5
17
16.5 "
16
15.5
15 %
o 5 tO
Peak area 
6
0 1
M+2
8
6.5
S5 .
6 4
55
o 5 10
Peak area 
6
X 10
[U-13C]-Pro 286 M+1 M+2
0.5 05 0.5
0 1 2 3 4 5 0 1 2 3 4 5 0 1 2 3 4 5
Peak area 6 Peak area 6 Peak area 6
M+5
61.5
cc 60.5
P59. e a
S 1 2 3 4 5
Peak area 6
Pro 286
Formula:
Exact mass :
C-atoms :
m/z
285
286
287
288
289
290
291
292
293
294
295
296
297
M+6
13.5
13
12.5
12
11.5
0 1 2 3 4 5
Peak area 6rlO
M+7
55*
0 1 2 3 4 5
Peak area 6
M+3
1.5
o.5 *
o 5 1o
Peak area 6
x1O
M+3
0 1 2 3 4 5
Peak area 6 °
M+8
14 a
13.5
13 5
125
0 1 2 3 4 5
Peak area 6
M+4
4. o 5 lOPeak area 6
M+4
S -.
3.5 a
0 1 2 3 4 5
Peak area 6* 10
M+9
Peak area 6
o10
[U- 13C]-Pro
theory
0.0
100.0
25.3
10.0
1.6
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
C13H28NO 2Si2
286.166
1-2-3-4-5
data
0.0
100.0
25.2
9.9
1.7
25.4
6.3
2.4
0.5
0.0
0.0
0.0
0.0
lifference
0.0
0.0
-0.1
-0.1
0.1
25.1
6.3
2.4
0.5
0.0
0.0
0.0
0.0
m/z
285
286
287
288
289
290
291
292
293
294
295
296
297
theory
0.0
0.0
0.0
0.0
0.0
5.2
100.0
20.1
8.7
1.1
0.2
0.0
0.0
This fragment should not be used. Proline co-elutes with other compounds, which results in
inaccurate values. Here, M+4 is significantly too high. Fragment Glu-432 is preferred.
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data
0.0
0.2
0.3
0.2
0.9
6.4
100.0
20.2
10.1
29.2
5.9
2.7
0.3
difference
0.0
0.2
0.3
0.2
0.9
1.2
0.0
0.1
1.4
28.1
5.7
2.7
0.3
[U-13C]-Pro
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Serine (Ser)
1eraged Scan :1129 tn 1138 TIC :397575 BP - 119923
go 290.15
so
70 393.30
304.20
304.20
40
30
20 232.10
10 207.00 261.20
..Ill I .J I 1.1|4320.. . .
CH3 CH3  0 CH3 CH3I I H H I
H3C-C-Si-N-C-C-O-Si-C-CH 3I I I I I
CH 3 CH3  CH2  CH3 CH3
01
IH3C-Si-CH3
H 3C-COCH3
CH3
021 H49NO3Si3Exact Mass: 447.302
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Ser 230
67
66.5
1 65.
64.5
Peak area 6
[U-13C]-Ser 230
.05
Peak area 06
x 10
M+1
22
21.5
21
205
Peak area x
M+1
2 P
05
Peak area oý10
M+5 M+6
3
2.5
S 1 2 3 4 0 1 2 3 4
Peak area 16  Peak area 60Ser 23010
Ser 230
Formula:
Exact mass :
C-atoms :
M+2
10
9.5
0 1 2 3 4 5
Peak area o
M+2
66
65.5
55
64.5
0 1 2 3 4
Peak area 6
x10
M+7
0.5
0 1 2 3 4
Peak area ax10
unknown
unknown
unknown
m/z theory data difference
229 0.0
230 100.0
231 33.8
232 15.0
233 n/a 3.5 n/a
234 1.1
235 0.2
236 0.1
237 0.1
M+3
2 .5
M+3
20.5 a
20
Peak area 6
M+4
M+4
P a.50 . 4
Peak area 6o
[U-13C]-Ser
m/z theory data difference
229 0.0
230 0.3
231 2.9
232 100.0
233 n/a 31.8 n/a
234 14.5
235 3.4
236 1.0
237 0.1
This fragment cannot be used because the fragmentation is unknown. Furthermore, this fragment is
not very abundant and therefore somewhat noisy.
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Ser 288
72.5 2.
Peak area 72
71.5
S 0.5 1 1.5 2 2.,
Peak area 
7
X 10
[U-13C]-Ser 288
M+1
Peak 1 2 2.5
Peak area 
7
X 10
M+1
10 15 i s 1U 11
Peak area x Peak area 1
M+5 M+6
M+2
0 .5 1 1.5 2 2.5
Peak area 7
M+3
0 e.5 1 1.5 2 2
Peak area 7
. 10
M+4
P i
0 05 1 15 2 25
Peak area 7
S10
M+3 M+4
18
S 5 10 15 a 105 10 15
Peak area
x 10
Peak area 
6
Peak area 
6
x Io
1 1;
So0.5 0 5
5 10 15 0 5 10 15 0 10 15
Peak area 6 Peak area 6 Peak area a
Ser 288
Formula: C14H 34NOSi2
Exact mass : 288.218
C-atoms : 2-3
m/z theory data difference
287 0.0 0.0 0.0
288 100.0 100.0 0.0
289 26.4 26.3 -0.1
290 10.1 10.0 -0.1
291 1.7 1.8 0.1
292 0.3 0.3 0.0
293 0.0 0.0 0.0
294 0.0 0.0 0.0
295 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U-13C]-Ser
m/z theory data difference
287 0.0 0.0 0.0
288 0.0 0.6 0.6
289 2.0 1.7 -0.3
290 100.0 100.0 0.0
291 24.3 24.8 0.5
292 9.5 9.7 0.2
293 1.5 1.6 0.1
294 0.2 0.3 0.1
295 0.0 0.0 0.0
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Ser302
72.5 **
Ca
S 72 -- -
71.5
0 5 10 15
Peak area o
[U-13C]-Ser 302
0
0 2 4 6 8 10
Peak area 6
x 10
M+1
19.5
19 -
0 5 10 15
Peak area 6
M+1
4
3.
0 2 4 6 8 10
Peakarea x 
6
X10
M+5 M+6
0< 5 o600 .s3 . ,.
0 2 4 6 8 10 0 2 4 8 10
Peak area x 
6  
Peak area x 1' 10 .10
Ser 302
Formula: C14H320 2NSi 2
Exact mass : 302.197
C-atoms : 1-2
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 26.2 -0.2
304 10.3 10.2 -0.1
305 1.8 1.9 0.1
306 0.3 0.4 0.1
307 0.0 0.0 0.0
308 0.0 0.0 0.0
309 0.0 0.0 0.0
M+2
7.5
6.5
0 5 10 15
Peak area o
M+2
71
695
0 2 4 8 8 10
Peak area 6
M+7
05
0 2 4 6 8 10
Peak area 
6
X 10
M+3
0 5 10 15
Peak area x 
6
M+3
17.5
17
16.5
0 2 4 6 8 10
Peak area x 6X 10
M+4
0.5
0 5 10 15
Peak area 6
x.1
M+4
15
6.5
Peak area 61 00
[U-13C]-Ser
m/z theory data difference
301 0.0 0.0 0.0
302 0.0 0.5 0.5
303 2.0 4.5 2.5
304 100.0 100.0 0.0
305 24.3 24.8 0.5
306 9.7 10.1 0.4
307 1.5 1.7 0.2
308 0.3 0.3 0.0
309 0.0 0.0 0.0
This fragment can be used for quantitative analysis. Note, however, that M+2 of [U-'13C]-serine is
slightly higher than expected.
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Ser 362 M+1 M+2 M+3 M+4
65.5 22
4. 5 .. _ 21 .5 105 2
64521
0 055 1 15 2 05 1 2 1 .5 2 0.5 1 1.5 2 0 05 1 15 2
Peak area 7 Peak area 7 Peak area 7 Peak area 7 Peak area 7
K 10 .10 t1 211 210
[U-13C]-Ser 362 M+1
15  5
S 55 1 5 10
Peak area 
6  
Peak area cX 10 r10
M+5
M+2
Peak area
Peak area 6
Y1o
M+3
Peak area Peak 5 10
Peak area Peak area
S 10 x o10
M+6 1 11 i: I5
55 ,
Peak area Peak area Peak area Peak area
Peakarea Peak area 6 Peak area 6 Peak area 6are 0 lx
t
× l x lO x lO
C16H4002NSi3
362.237
2-3
theory data difference
0.0 0.0 0.0
100.0 100.0 0.0
33.8 33.5 -0.3
15.7 15.4 -0.3
3.5 3.5 0.0
0.8 0.8 0.0
0.1 0.2 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
[U-13C]-Ser
m/z theory data difference
361 0.0 0.0 0.0
362 0.0 0.3 0.3
363 2.2 1.5 -0.7
364 100.0 100.0 0.0
365 31.7 31.9 0.2
366 15.0 14.9 -0.1
367 3.2 3.2 0.0
368 0.7 0.7 0.0
369 0.1 0.1 0.0
370 0.0 0.0 0.0
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M+4
95~
Ser 362
Formula :
Exact mass :
C-atoms :
m/z
361
362
363
364
365
366
367
368
369
370
This fragment can be used for quantitative analysis.
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Ser 390
65
603.5 1
63
0 0.5 1 1.5 2
Peak area 7X10
M+1 M+2
0 0.5 1 1.5 2 0 0.5 1 1.5 2
Peak area 7 Peak area 7110 KIO
[U-13C]-Ser 390 M+1
- 0. 5 0.5
0 0
0 5 10 15 0 5 10 15
Peak area 6  Peak area 6
.1. x IQ
M+2
3 .
1.5
0 5 10 15
Peak area a
.10
M+4
Peak area 7 Peak area t
110 10
M+3 M+4
21.94.5
83D
0 5 10 15 0 5 10 15
Peak area x Peak areaxtO X to
M+5
10.5
10
9.5
0 5 10 15
Peak area e
M+6 M+7 M+8 M+9
1.5
0
f. ,to
5 10 15 0 5 10 15 0 5 10 15 0 5 10 15
Peak area a Peak area Peak area x Peak area 6
alO .10 X19 .10
Ser 390
Formula: C17H400O3NSi3
Exact mass : 390.232
C-atoms: 1-2-3
m/z theory data difference
389 0.0 0.0 0.0
390 100.0 100.0 0.0
391 35.0 34.3 -0.7
392 16.3 15.9 -0.4
393 3.8 3.7 -0.1
394 0.9 0.8 -0.1
395 0.1 0.1 0.0
396 0.0 0.0 0.0
397 0.0 0.1 0.1
398 0.0 0.0 0.0
399 0.0 0.0 0.0
This fragment can be used for quantitative analysis. Note, however, that M+0 is
(+0.5 mol%) and M+1 is slightly too low (-0.4 mol%/o).
slightly too high
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0 0.0 1 1.5 2
[U-13C]-Ser
data
0.0
difference
0.0
m/z
389
390
391
392
393
394
395
396
397
398
399
theory
0.0
0.0
0.0
3.1
100.0
31.8
15.2
3.3
0.8
0.1
0.0
0.3
0.3
3.3
100.0
31.9
15.1
3.3
0.8
0.1
0.0
0.3
0.3
0.2
0.0
0.1
-0.1
0.0
0.0
0.0
0.0
3
2.5
2
1.5
0
[U-lsC]-Ser
AnPr:Mrnvu A c~r/MS A NSA!VP~n f Axsmsin AVI'TT-
Threonine (Thr)
0 0 veraed Scan : 1169 to 1178 TIC : 109162 BP - 55386
o30 303.20
70
so]
0 40
30 404.25
20 376.25
10 207.00 220.95 2410 2.10
0250 300 300 40 450 m
120. .. .2.. .&. . .
276Io 284157 10
CH3 CH3  0 CH3 CH3I I H H I I
H3C-COSi-N-C-C-O-Si-C-CH 3I I I I I
CH3 CH3  HC-CH3  CH CH3I
O
H3C-Si-CH3I
H3 0-C-CH 3
CH3
C22H51NO3Si 3Exact Mass: 461.3177
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Thr 376
as i
05
P4a
0 1 2 3
Peak area•
.10
0 0.5 1 1.5 2 2.5
Peak area x 10
M+1
23.5
22.5
22
21.5
21
0 1 2 3
Peak area 6110
M+6
2.5
.9
1.5
0 0.5 1 1.5 2 2.5
Peak area 6
.10
M+2
11.5
10.5
9.5
0 1 2 3
Peak area
M+2
as " ....
2 "
1.5
o o.5 1 1.5 2 2.5
Peak area x
M+7
1.5
0.5
0 0.5 1 1.5 2 2.5
Peak area a
.10
M+3
2.5
2
01230 1 2 3
Peak area a
M+3
9.5
as
0 0.5 1 1.5 2 25
Peak area
M10
M+8
13
0.5
0 0.5 1 1.5 2 2.5
Peak area ax 10
M+4
012.
0 1 2 3
Peak area 6oIG
M+4
21.5 "
21
20
19.5
0 0.5 1 1.5 2 2.5
Peak area a
.10
M+9
0 0.5 1 1.5 2 2.5
Peak area 1
Thr 376
Formula: C17H420 2NSi3
Exact mass : 376.252
C-atoms: 2-3-4
m/z theory data difference
375 0.0 0.0 0.0
376 100.0 100.0 0.0
377 34.9 34.5 -0.4
378 16.1 15.9 -0.2
379 3.7 3.7 0.0
380 0.9 0.7 -0.2
381 0.1 0.0 -0.1
382 0.0 0.0 0.0
383 0.0 0.2 0.2
384 0.0 0.1 0.1
385 0.0 0.0 0.0
[U- 13C]-Thr
m/z theory data difference
375 0.0 0.0 0.0
376 0.0 0.1 0.1
377 0.0 0.5 0.5
378 3.1 2.8 -0.3
379 100.0 100.0 0.0
380 31.8 31.7 -0.1
381 15.0 14.8 -0.2
382 3.2 3.1 -0.1
383 0.7 0.9 0.2
384 0.1 0.1 0.0
385 0.0 0.0 0.0
This fragment can be used for quantitative analysis. Note, however, that this fragment is noisy at low
concentrations.
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[U-13C]-Thr 376 M+1
1.5 1.5
10
0 0.5 1 1.5 2 2.S 0 0.5 1 1.5 2 2.5
Peak area a Peak areaX10 . 10
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Thr 404
64.5
625
Peak area 6
[U-13C]-Thr 404
Peak area 6
M+1
235
23
0 2 4 6
Peak area 
6
M+1
Pa a
Peak area
x 10
M+2
11
0 2 4 6
Peak area i t0
M+2
Peak area 6
x Io
M+3
2 2 4 6-
Peak area
aI : -- in25
0 23 4
Peak area 6
Peak area 6
M+5 M+6 M+7 M+8 M+9
21"5 1 15
< 20 0 3 05
S 2 3 4 0 t 2 3 4 0 1 2 2 3 4 0 1 2 3 4
Peak area 6 Peak area 
6  
Peak area 6 Peak area 6 Peak area 6
11 0 10 110 11 0 ý 10
Thr 404
Formula: C18H420 3NSi 3
Exact mass : 404.247
C-atoms : 1-2-3-4
m/z theory data difference
403 0.0 0.0 0.0
404 100.0 100.0 0.0
405 36.1 35.8 -0.3
406 16.7 16.5 -0.2
407 4.0 3.9 -0.1
408 0.9 0.8 -0.1
409 0.2 0.1 -0.1
410 0.0 0.0 0.0
411 0.0 0.0 0.0
412 0.0 0.0 0.0
413 0.0 0.0 0.0
414 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U- 13C]-Thr
m/z theory data difference
403 0.0 0.0 0.0
404 0.0 0.2 0.2
405 0.0 0.1 0.1
406 0.0 0.2 0.2
407 4.1 4.4 0.3
408 100.0 100.0 0.0
409 31.9 31.6 -0.3
410 15.2 15.2 0.0
411 3.3 3.0 -0.3
412 0.8 0.6 -0.2
413 0.1 0.0 -0.1
414 0.0 0.0 0.0
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Thr 417
a8 59
0 05 1 15 2 25
Peak area 6 1°
6
[U-13C]-Thr 41705
0 5 10 15
Peak area 105
M+5
56.5r0 0.5 1 1. 5 2 25Peak area x O
X 10
M+1
27.5 •
27 . ,.
26.5
25
25
245
24
23
0 05 1 15 2 2.5
Peak area o
M+1
2
1.5
1
0.5
0 5 10 15
Peak area 5
M+6
0 5 10 15
Peak area s
. 10
M+2
12
11.5
S1 0
0 05 1 15 2 2.5
Peak area x
M+2
59 t
58.5
58 .
57+5
57
0 5 10 15
Peak area s
x10
M+7
1.5
0.5
0 s 10 15
Peak area 5× 10
M+3
4.5
4
3
2.5
0 0-5 1 15 2 25
Peak area x
M+3
22.5
22
21.5
21 *
2.5 ,
20
0 5 10 15
Peak area x lX10
M+8
0.5
0 5 10 15
Peak area 5X 10
M+4
0 05 1 15 2 2.5
Peak area x 6.10
M+4
15.5 k
15 e
14.5
14
13.5
0 5 10 15
Peak area x o
5
X 10
Thr 417
Formula: C20H47NO 2Si3
Exact mass : 417.292
C-atoms : unknown
m/z theory data difference
416 0.0 0.0 0.0
417 100.0 100.0 0.0
418 38.3 46.4 8.1
419 17.3 20.1 2.8
420 4.3 5.5 1.2
421 1.0 1.0 0.0
422 0.2 0.0 -0.2
423 0.0 0.0 0.0
424 0.0 0.0 0.0
425 0.0 0.1 0.1
[U- 13C]-Thr
m/z theory data difference
416 0.0 0.0 0.0
417 0.0 0.3 0.3
418 2.0 1.1 -0.9
419 100.0 100.0 0.0
420 36.2 35.5 -0.7
421 16.4 25.0 8.6
422 3.9 6.9 3.0
423 0.9 1.8 0.9
424 0.1 0.1 0.0
425 0.0 0.0 0.0
This fragment should not be used. M+0 is too low (-4 mol%) and M+1, M+2, and M+3 are too high.
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Met 218 M+1 M+2 M+3 M+4
9 14 75
78.5
7 .. . 55. .--
-0 77.5 13.5 n J.
0 2 4 6 8 0 2 4 6 8 0 2 4 6 8 0 2 4 6 8 0 2 4 6 8
Peak area a Peak area 6 Peak area 6  Peak area lPeak area x
X 10 X 10 X 10 610 X 10
[U-13C]-Met 218
Peak area x 6
M+5
10.5
10
Peak area 6x 10
M+1 M+2 M+3 M+4
4-5
76.5 
-
75.5
05
0 2 4 6 8 0 2 4 6 8 0 2 4 68 0 2 4 6 8
Peak area 6 Peak area Peak area 6  Peak area 1
.10 X.10 X610 .10
M+6 M+7 M+8 M+9
15 1 1
65
0.5 05 05
0 2 4 6 8 0 2 4 6 8 0 2 4 6 8 0 2 4 6 8
Peak area 6  Peak area 6  Peak area 6  Peak area 6
.10 .10 x 10 10
Met 218 [U-13C]-Met
Formula:
Exact mass :
CloH24NSiS
218.114
C-atoms : 2-3-4-5
m/z theory data difference
217 0.0 0.0 0.0
218 100.0 100.0 0.0
219 17.6 17.3 -0.3
220 9.1 9.0 -0.1
221 1.2 1.2 0.0
222 0.2 0.3 0.1
223 0.0 0.1 0.1
224 0.0 0.0 0.0
225 0.0 0.0 0.0
226 0.0 0.0 0.0
227 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
m/z theory data difference
217 0.0 0.7 0.7
218 0.0 0.6 0.6
219 0.0 0.6 0.6
220 0.0 0.9 0.9
221 4.1 5.3 1.2
222 100.0 100.0 0.0
223 13.5 14.1 0.6
224 8.5 8.5 0.0
225 0.8 0.9 0.1
226 0.2 0.2 0.0
227 0.0 0.0 0.0
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Met 244 M+1
*69. 521.5 .
6 20: "2
19.5
59.5
0 2 4 6 8 10 0 2 4 6 10I
Peak area s Peak area s
x 10 .10
M+2 M+3
)i 4.5
9.5 .• .4
85 3
S 25.
0 2 4 6 a 10 1 2 4 6 8 10
Peak area 5 Peak area 5
x 10 ' 10
M+4
4
3.5
1.5
0 2 4 6 8 10
Peak area 5
O10
[U-13C]-Met 244 M+I M+2 M+3 M+4
15 15 4 65 165
3.5 16
1 I. 6765 .* 15.81as - 67.5
25 672515
S0.5 0.5 2 6545
2 "t
0 - - ." ..". -. - .- . .. ..... .. 1 4
0 0 5 10 0 0 5 10 0 5 10
Peak area 10o5 Peak area s Peak area x lo Peak area 5 Peak area x o5
8.5 3. 3
3 33
25 .h 13
.1.5
0 5 10 0 5 10 0 5 10 0 b 10
Peak area 5  Peak area s  Peak area x Peak area 5
X 10 x.10 .10 '10
Met 244
Formula: unknown
Exact mass : unknown
C-atoms : unknown
m/z theory data difference
243 0.1
244 100.0
245 34.4
246 15.5
247 n/a 5.5 n/a
248 5.1
249 3.5
250 1.2
251 0.2
252 0.3
[U-13C]-Met
m/z theory data difference
243 0.1
244 0.2
245 0.8
246 3.9
247 n/a 100.0 n/a
248 23.1
249 11.8
250 3.8
251 3.8
252 4.1
This fragment cannot be used because the fragmentation is unknown. However, the relatively high
M+ 1 (34% of M+0) suggests that two fragments are overlapping here.
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Met 292
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Met 292
Formula : C12H 3oNOSi2S
Exact mass : 292.159
C-atoms : 2-3-4-5
m/z theory data difference
291 0.0 0.0 0.0
292 100.0 100.0 0.0
293 25.0 24.8 -0.2
294 14.1 14.0 -0.1
295 2.6 2.6 0.0
296 0.7 0.8 0.1
297 0.1 0.1 0.0
298 0.0 0.0 0.0
299 0.0 2.1 2.1
300 0.0 0.5 0.5
301 0.0 0.2 0.2
This fragment can be used for quantitative analysis.
from the mass range 292-298.
[U- 13C]-Met
m/z theory data difference
291 0.0 0.0 0.0
292 0.0 0.1 0.1
293 0.0 0.2 0.2
294 0.0 0.2 0.2
295 4.1 5.1 1.0
296 100.0 100.0 0.0
297 20.9 21.1 0.2
298 13.1 12.8 -0.3
299 2.1 2.0 -0.1
300 0.6 0.5 -0.1
301 0.1 0.0 -0.1
Mass isotopomer distributions should be obtained
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Met 320
[U-i 3C]-Met 32070.5
69
6M8.5
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Peak area 
6
[U-13C]-Met 320
Peak area o
M+5
68,5
(8
Peak area 5
IQ0
Met 320
Formula :
Exact mass :
C-atoms :
m/z
319
320
321
322
323
324
325
326
327
328
329
330
331
theory
0.0
100.0
26.1
14.6
2.8
0.8
0.1
0.0
0.0
0.0
0.0
0.0
0.0
M+1
1985
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17.5
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0 1 2 3 4
Peak area 6
x 10
M+1
05
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Peak area
M+2
1o 0
95
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Peak area 6
X10
M+2
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Peak area 6
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M+3
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Peak area 6
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1
0
Peak area 6
*10
0 1 2 3 1 5 0 1 2 3 4 5 0 1 2 3 4 5
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[U-13 C]-Met
C13H3oNO2Si2S
320.154
1-2-3-4-5
data d
0.0
100.0
25.9
14.5
2.8
0.8
0.1
0.0
0.0
0.3
0.1
0.2
0.1
ifference
0.0
0.0
-0.2
-0.1
0.0
0.1
0.0
0.0
0.0
0.3
0.1
0.2
0.1
m/z
319
320
321
322
323
324
325
326
327
328
329
330
331
theory
0.0
0.0
0.0
0.0
0.0
5.2
100.0
21.1
13.3
2.1
0.6
0.1
0.0
This fragment can be used for quantitative analysis. Mass isotopomer distributions should be obtained
from the mass range 320-327.
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Phenylalanine (Phe)
Averaged Scan: 1470 to 1477 TIC :467545 BP = 117371
90 234.20 302.20
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70
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10 L ,
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Phe 234
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0.0
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0.0
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C14H24NSi
234.168
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data difference
0.0 0.0
100.0 0.0
21.3 0.2
5.7 0.3
0.8 0.1
0.1 0.1
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.1 0.1
0.5 0.5
3.7 3.7
1.4 1.4
m/z
233
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238
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theory
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8.6
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12.6
3.9
0.3
0.0
data
4.1
1.7
0.5
0.1
0.0
0.0
0.1
0.8
9.2
100.0
13.7
4.2
0.6
0.6
difference
4.1
1.7
0.5
0.1
0.0
0.0
0.1
0.8
0.6
0.0
1.1
0.3
0.3
0.6
This fragment can be used for quantitative analysis. Mass isotopomer distributions should be obtained
from the mass range 234-243.
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Phe 302
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Phe 302
Formula: C14H 3202NSi2
Exact mass : 302.197
C-atoms : 1-2
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 26.1 -0.3
304 10.3 9.9 -0.4
305 1.8 1.7 -0.1
306 0.3 0.3 0.0
307 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
[U- 13C]-Phe
m/z theory data difference
301 0.0 0.0 0.0
302 0.0 0.3 0.3
303 2.0 0.6 -1.4
304 100.0 100.0 0.0
305 24.3 25.0 0.7
306 9.7 9.9 0.2
307 1.5 1.6 0.1
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Phe 308
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Phe 308
Formula : C16H 300NSi2
Exact mass : 308.187
C-atoms : 2-3-4-5-6-7-8-9
m/z theory data difference
307 0.0 0.0 0.0
308 100.0 100.0 0.0
309 28.5 28.8 0.3
310 10.6 10.6 0.0
311 1.9 2.0 0.1
312 0.3 0.4 0.1
313 0.0 0.0 0.0
314 0.0 0.0 0.0
315 0.0 0.0 0.0
316 0.0 0.0 0.0
317 0.0 0.4 0.4
318 0.0 0.3 0.3
319 0.0 0.1 0.1
320 0.0 0.2 0.2
321 0.0 0.1 0.1
This fragment can be used for
from the mass range 308-316.
71
15.5
70
14.5r
0 b 110 0 10
Peak area Peak area a
X lO 10
[U-13C]-Phe
m/z
307
308
309
310
311
312
313
314
315
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317
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319
320
321
theory
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8.5
100.0
20.2
8.5
1.1
0.2
0.0
data difference
3.5
0.8
0.2
0.1
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0.1
0.4
8.7
100.0
21.1
8.8
1.3
0.2
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3.5
0.8
0.2
0.1
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0.0
0.1
0.4
0.2
0.0
0.9
0.3
0.2
0.0
0.0
quantitative analysis. Mass isotopomer distributions should be obtained
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Phe 336
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[U-' 3C]-Phe
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336.182
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data difference
0.0 0.0
100.0 0.0
29.4 -0.3
11.1 -0.1
2.1 0.0
0.4 0.0
0.1 0.1
0.1 0.1
0.0 0.0
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Phenylalanine must not be M+9 or M+8 labeled
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Formula :
Exact mass :
C-atoms :
m/z
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
theory
0.0
100.0
29.7
11.2
2.1
0.4
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
m/z
335
336
337
338
339
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346
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theory
0.0
0.0
0.0
0.0
0.0
0.0
0.0
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0.0
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20.3
8.7
1.1
0.2
data
108.4
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0.1
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0.7
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8.9
1.3
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difference
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26.4
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0.3
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0.1
0.1
0.7
0.1
0.0
0.5
0.2
0.2
0.0
This fragment can be used for quantitative analysis.
for this fragment to be accurate.
I --
[U-13C]-Phe
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Aspartate (Asp)
0 veraged Scan : 15899 to 1596 TIC :594406 BP - 232054 c
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Asp 244
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[U-13C]-Asp 244
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Asp 244
Formula: unknown
Exact mass : unknown
C-atoms: unknown
m/z theory data difference
243 0.0
244 100.0
245 27.2
246 18.3
247 n/a 3.6 n/a
248 1.6
249 0.7
250 0.2
251 0.0
252 0.0
[U- 13C]-Asp
m/z theory data difference
243 0.1
244 0.3
245 1.8
246 100.0
247 n/a 27.2 n/a
248 11.7
249 3.2
250 8.2
251 1.9
252 0.8
This fragment should not be used. The relatively high M+2 (18% of M+0) suggests that two
fragments are overlapping. [4- 13C]-aspartate contains peaks at 244 and 247, which further suggests
that two fragments are overlapping.
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Asp 258
Peak area
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x 10 ,10
[U-13C]-Asp 258 M+1
1'%
o 2 3 0 2 3
Peak area 
6  
Peak area a10 10
M+6
2Peak area
Peak area 6
. 10
2
Peak area
M+2
4.5
3 2 3
Peak area a• o
=
M+7
M+3
0 1 2 3 4 5 0 1 2 3 4 5
Peak area 6 Peak area
K 10 x10
M+3 M+4
645 1" "
S,1 4
63 P
Peak area a Peak area
x 10 10
M+9
05~
3 2 3 0 2
6 Peak area a Peak area a6 Peak area a
,C) r10 0 O 10
Asp 258
Formula: unknown
Exact mass : unknown
C-atoms : unknown
m/z theory data difference
257 4.4
258 100.0
259 25.6
260 16.0
261 n/a 3.3 n/a
262 2.1
263 1.8
264 0.5
265 0.0
266 0.0
267 0.0
[U-13C]-Asp
m/z theory data difference
257 1.8
258 1.0
259 2.4
260 7.6
261 n/a 100.0 n/a
262 23.2
263 16.6
264 4.2
265 0.8
266 0.1
267 0.0
This fragment should not be used. M-1 is too high (4.4 mol%) and the fragmentation is unknown. [4-
13C]-aspartate contains a peak at 259 but not at 258, thus this fragment contains C-4.
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Asp 302
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Asp 302
Formula: C14H320 2NSi2
Exact mass : 302.197
C-atoms: 1-2
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 26.4 0.0
304 10.3 10.2 -0.1
305 1.8 1.8 0.0
306 0.3 0.3 0.0
307 0.0 0.0 0.0
308 0.0 0.0 0.0
309 0.0 0.0 0.0
[U-13C]-Asp
m/z theory data difference
301 0.0 0.0 0.0
302 0.0 0.5 0.5
303 2.0 3.1 1.1
304 100.0 100.0 0.0
305 24.3 24.7 0.4
306 9.7 9.8 0.1
307 1.5 1.6 0.1
308 0.3 0.4 0.1
309 0.0 0.0 0.0
This fragment can be used for quantitative analysis. [4-13C]-aspartate contains a peak at 302 but not at
303, thus this fragment does not contain C-4.
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Asp 316
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Asp 316
Formula: C 15H34NO 2Si2
Exact mass : 316.213
C-atoms: 2-3-4
m/z theory data difference
315 0.0 0.0 0.0
316 100.0 100.0 0.0
317 27.5 27.3 -0.2
318 10.6 10.5 -0.1
319 1.9 2.6 0.7
320 0.3 0.6 0.3
321 0.0 0.1 0.1
322 0.0 0.0 0.0
323 0.0 0.0 0.0
324 0.0 0.0 0.0
[U- 13C]-Asp
m/z theory data difference
315 0.0 0.0 0.0
316 0.0 0.2 0.2
317 0.0 0.6 0.6
318 3.1 3.7 0.6
319 100.0 100.0 0.0
320 24.4 24.5 0.1
321 9.7 10.3 0.6
322 1.5 1.9 0.4
323 0.3 0.4 0.1
324 0.0 0.1 0.1
This fragment should not be used. It has a significant bias, M+0 is too low (-0.3 mol%/o) and M+3 is
too high (4-0.7 mol%).[4--1 C]-aspartate contains a peak at 317 but not at 316, thus this fragment
contains C-4.
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Asp 376
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Asp 376
Formula: C16H380 3NSi3
Exact mass : 376.216
C-atoms : 1-2
m/z theory data difference
375 0.0 0.1 0.1
376 100.0 100.0 0.0
377 33.8 33.5 -0.3
378 15.9 15.8 -0.1
379 3.6 3.4 -0.2
380 0.8 0.7 -0.1
381 0.1 0.0 -0.1
382 0.0 0.0 0.0
383 0.0 0.1 0.1
384 0.0 0.0 0.0
This fragment can be used for quantitative analysis.
377, thus this fragment does not contain C-4.
[U-UC]-Asp
m/z theory data difference
375 0.0 0.0 0.0
376 0.0 0.2 0.2
377 2.0 3.2 1.2
378 100.0 100.0 0.0
379 31.7 31.7 0.0
380 15.2 15.0 -0.2
381 3.3 3.1 -0.2
382 0.8 0.5 -0.3
383 0.1 0.0 -0.1
384 0.0 0.0 0.0
[4- 13C]-aspartate contains a peak at 376 but not at
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Asp 390
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Asp 390
Formula : C 17H 4003NSi 3
Exact mass : 390.232
C-atoms : 2-3-4
m/z theory data difference
389 0.0 0.0 0.0
390 100.0 100.0 0.0
391 35.0 34.8 -0.2
392 16.3 16.1 -0.2
393 3.8 3.7 -0.1
394 0.9 0.8 -0.1
395 0.1 0.0 -0.1
396 0.0 0.0 0.0
397 0.0 0.0 0.0
398 0.0 0.0 0.0
399 0.0 0.0 0.0
[U-13C]-Asp
m/z theory data difference
389 0.0 0.0 0.0
390 0.0 0.2 0.2
391 0.0 0.3 0.3
392 3.1 3.1 0.0
393 100.0 100.0 0.0
394 31.8 31.8 0.0
395 15.2 15.0 -0.2
396 3.3 3.2 -0.1
397 0.8 0.7 -0.1
398 0.1 0.0 -0.1
399 0.0 0.0 0.0
This fragment can be used for quantitative analysis. [4- 3C]-aspartate contains a peak at 391 but not at
390, thus this fragment contains C-4.
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Asp 418
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Asp 418
Formula : C18H 400 4NSi3
Exact mass : 418.227
C-atoms : 1-2-3-4
m/z theory data difference
417 0.0 0.0 0.0
418 100.0 100.0 0.0
419 36.1 35.8 -0.3
420 16.9 16.7 -0.2
421 4.0 3.9 -0.1
422 1.0 0.9 -0.1
423 0.2 0.1 -0.1
424 0.0 0.0 0.0
425 0.0 0.0 0.0
426 0.0 0.0 0.0
427 0.0 0.0 0.0
428 0.0 0.0 0.0
[U- 13C]-Asp
m/z theory data difference
417 0.0 0.0 0.0
418 0.0 0.2 0.2
419 0.0 0.1 0.1
420 0.0 0.6 0.6
421 4.1 4.7 0.6
422 100.0 100.0 0.0
423 31.9 31.9 0.0
424 15.4 15.3 -0.1
425 3.3 3.3 0.0
426 0.8 0.8 0.0
427 0.1 0.1 0.0
428 0.0 0.0 0.0
This fragment can be used for quantitative analysis. [4- 13C]-aspartate contains a peak at 419 but not at
418, thus this fragment contains C-4.
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Glu 272
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0 0.5 1 1.5 2
Peak area 7
[U-13C]-Glu 272
0.5
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x10
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x 10
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Peak area 7
X10
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1 5
0.5
0 . . . .
0 2 4 56 8 10
Peak area 6 ox 10
M+6 M+7
M+3
1.5
0 0.5 1 1.5 2
Peak area 7x 1o
M+4
05
o5 4 -. -..
0 0.5 1 1.5 2
Peak area 7
x10
Peak area 6 Peak area 6
x M+ x 10
M+8
2
1
0 2 4 6 8 t
Peak area 6  Peak area 6
.10 ý10 Peak area 06r 10
Glu 272
Formula: unknown
Exact mass : unknown
C-atoms : unknown
m/z theory data difference
271 0.0
272 100.0
273 24.4
274 11.5
275 n/a 2.2 n/a
276 0.6
277 0.1
278 0.0
279 0.1
280 0.0
[U- 13C]-Glu
m/z theory data difference
271 0.0
272 0.2
273 0.1
274 0.4
275 n/a 4.9 n/a
276 100.0
277 20.8
278 10.5
279 1.7
280 0.5
This fragment cannot be used because the fragmentation is unknown. [5-' 3C]-glutamine contains a
peak at 273 but not at 272, thus this fragment contains C-5. Fragment Glu-432 is preferred.
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Glu 330 M+1
Peak area 7 Peak area o7X 10 xlo Peak area 7 Peak area 7A to . ,
[U-13C]-Glu 330 M+1
S05 0.5
o I' ol3m --.- -
o0 to I5 0 5 0o 1
Peak area 6 Peak area 6
M+5 M+6
M+2
15
0 5 10 15
Peak area 6X 10l
M+7
Peak area a Peak area o
x 10 o10
M+8 M+9
7
0 5 a0 i5 0 5 10 15
Peak area o Peak area 6
.10 rt
Glu 330
Formula: C16H3602NSi2
Exact mass : 330.228
C-atoms : 2-3-4-5
m/z theory data difference
329 0.0 0.0 0.0
330 100.0 100.0 0.0
331 28.7 28.5 -0.2
332 10.9 10.9 0.0
333 2.0 2.1 0.1
334 0.3 0.3 0.0
335 0.0 0.0 0.0
336 0.0 0.0 0.0
337 0.0 0.4 0.4
338 0.0 0.1 0.1
339 0.0 0.1 0.1
P 5 10 i5
Peak area 6
.10O
0 5 10 iS
Peak area 6 Peak area 6I'Ux 10
[U- 13C]-Glu
m/z theory data difference
329 0.0 0.0 0.0
330 0.0 0.2 0.2
331 0.0 0.1 0.1
332 0.0 0.8 0.8
333 4.1 4.8 0.7
334 100.0 100.0 0.0
335 24.5 25.0 0.5
336 9.7 10.0 0.3
337 1.6 1.7 0.1
338 0.3 0.3 0.0
339 0.0 0.0 0.0
This fragment can be used for quantitative analysis. Mass isotopomer distributions should be obtained
from the mass range 330-336. [5-' 3C]-glutamine contains a peak at 331 but not at 330, thus this
fragment contains C-5.
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Glu 358
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0 a69 ..J.,
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012345
Peak area 6
[U-13C]-Glu 358
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Glu 358
Formula : C17H36NO 3Si2
Exact mass : 358.223
C-atoms : 1-2-3-4-5
m/z theory data difference
357 0.0 1.8 1.8
358 100.0 100.0 0.0
359 29.8 30.0 0.2
360 11.4 11.9 0.5
361 2.2 2.5 0.3
362 0.4 0.8 0.4
363 0.0 0.1 0.1
364 0.0 0.0 0.0
365 0.0 0.0 0.0
366 0.0 0.0 0.0
367 0.0 0.0 0.0
368 0.0 0.0 0.0
[U- 13C]-Glu
m/z theory data difference
357 0.0 0.2 0.2
358 0.0 0.0 0.0
359 0.0 0.0 0.0
360 0.0 0.1 0.1
361 0.0 2.9 2.9
362 5.2 6.6 1.4
363 100.0 100.0 0.0
364 24.5 25.4 0.9
365 9.9 10.9 1.0
366 1.6 1.4 -0.2
367 0.3 0.2 -0.1
368 0.0 0.0 0.0
This fragment should not be used. M-1 is too high (1.8 mol%). Fragment Glu-432 is preferred. [5-
13C]-glutamine contains a peak at 359 but not at 358, thus this fragment contains C-5.
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Glu 404
< 6:
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Peak area 6 Peak area 0P 10 ý 10
[U-13C]-Glu 404
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Glu 404
Formula: Cs 8H420 3NSi3
Exact mass : 404.247
C-atoms : 2-3-4-5
m/z theory data difference
403 0.0 0.0 0.0
404 100.0 100.0 0.0
405 36.1 35.7 -0.4
406 16.7 16.4 -0.3
407 4.0 3.9 -0.1
408 0.9 0.8 -0.1
409 0.2 1.3 1.1
410 0.0 0.3 0.3
411 0.0 0.0 0.0
412 0.0 0.0 0.0
413 0.0 0.0 0.0
[U- 13C]-Glu
m/z theory data difference
403 0.0 0.0 0.0
404 0.0 0.0 0.0
405 0.0 0.0 0.0
406 0.0 0.1 0.1
407 4.1 3.8 -0.3
408 100.0 100.0 0.0
409 31.9 31.7 -0.2
410 15.2 14.6 -0.6
411 3,3 2.7 -0.6
412 0.8 0.5 -0.3
413 0.1 0.0 -0.1
This fragment should be used with caution. It is not very abundant and therefore noisy. Fragment
Glu-330 is preferred. [5- 13C]-glutamine contains a peak at 405 but not at 404, thus this fragment
contains C-5.
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Glu 432
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Glu 432
Formula: C19H420 4NSi3
Exact mass : 432.242
C-atoms : 1-2-3-4-5
m/z theory data difference
431 0.0 0.0 0.0
432 100.0 100.0 0.0
433 37.2 37.1 -0.1
434 17.3 17.5 0.2
435 4.2 4.4 0.2
436 1.0 1.1 0.1
437 0.2 0.2 0.0
438 0.0 0.0 0.0
439 0.0 0.0 0.0
440 0.0 0.0 0.0
441 0.0 0.0 0.0
442 0.0 0.0 0.0
443 0.0 0.0 0.0
[U- 13C]-Glu
m/z theory
431 0.0
432 0.0
433
434
435
436
437
438
439
440
441
442
443
0.0
0.0
0.0
5.2
100.0
32.0
15.4
3.3
0.8
0.1
0.0
13C]-glutamine contains a peak at 433 but not
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data difference
0.0
0.2
0.1
0.1
0.3
5.8
100.0
32.5
15.4
3.4
0.8
0.1
0.0
0.0
0.2
0.1
0.1
0.3
0.6
0.0
0.5
0.0
0.1
0.0
0.0
0.0
This fragment can be used for quantitative analysis. [5-
at 432, thus this fragment contains C-5.
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Lysine (Lys)
Averaqed Scan :2211 to 2222 TIC :2610941 BP = 441367
90 98.20 300.20
70
50
40 272.20
30 329.30
20 431.30
10 225.15
242.10 256.15
z0 ' ' 250 300 3 400 '450
,, veraged Scan :2185 to 2191 TIC : 1448952 BP = 216202 <
CH3 CH3  O CH3 CH 3I I H i I I
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CH 3 CH 3  CH2  CH 3 CH 3
CH2
CH2
CH2
NH
H3C-Si-CH3
H3C-C-CH3
OH3
C24H56N20 2Si3Exact Mass: 488.365
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Lys 329 M+1 M+2 M+3 M+4
70.5 22
70 215 8 55
68.5 20
68 195 65
0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4 0 1 2 3 4
Peak area 0Peak area x 106  Peak area 6 Peak area 6 Peak area 6
[U-13C]-Lys 329 M+1 M+2 M+3 M+4
2 25
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05 05 . 4.
0 2 4 6 8 10 0 2 4 6 10 0 2 4 6 8 10 0 2 4 6 8 10 0 2 4 10
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175 3, 75
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165 6 .5 
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16 25
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.10 .10 .10 .10
U-13C]-Lys
C17H41N 2Si2
329.2808
2-3-4-5-6
data difference
0.6 0.6
100.0 0.0
29.9 -0.2
11.3 0.4
2.2 0.2
0.5 0.2
0.0 0.0
0.0 0.0
0.0 0.0
0.3 0.3
0.1 0.1
m/z theory
328 0.0
329 0.0
330 0.0
331 0.0
332 0.0
333 5.2
334 100.0
335 24.8
336 9.4
337
338
1.5
0.2
data difference
0.0 0.0
0.5 0.5
0.1 0.1
1.8 1.8
2.5 2.5
9.4 4.2
100.0 0.0
25.7 0.9
10.5 1.1
3.8 2.3
0.9 0.7
This fragment should be used with caution. Lysine peak is not very abundant and therefore very
noisy.
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Formula:
Exact mass :
C-atoms :
m/z
328
329
330
331
332
333
334
335
336
337
338
theory
0.0
100.0
30.1
10.9
2.0
0.3
0.0
0.0
0.0
0.0
0.0
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Lys 431
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7 mol%/o). Lysine peak is not very abundant and
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Lys 431
Formula:
Exact mass :
C-atoms :
m/z
430
431
432
433
434
435
436
437
438
439
440
441
442
443
data differencetheory
0.0
100.0
38.7
17.4
4.3
1.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.0
theory
0.0
0.0
0.0
0.0
0.0
0.0
6.3
100.0
32.4
15.0
3.2
0.7
0.1
0.0
0.0
0.0
0.0
0.0
0.0
1.4
9.4
100.0
33.5
16.5
3.4
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.4
3.2
0.0
1.1
1.5
0.2
-0.4
-0.1
0.0
This fragment should not be used. M-1
therefore very noisy.
is too high (1.
- -
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Tyrosine (Tyr)
d~ ergýscan I 27 2 o 8lot '~a3"••_• ::'-:u •o. .. ., -~-'u . -, __ _ __ _ __,._ __ _ __ _ _ __ _ _
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C27H53 NO3Si3Exact Mass: 523.3333
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Tyr 302
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Tyr 302
Formula: C 14 H 320 2NSi2
Exact mass : 302.197
C-atoms : 1-2
m/z theory data difference
301 0.0 0.0 0.0
302 100.0 100.0 0.0
303 26.4 26.3 -0.1
304 10.3 10.1 -0.2
305 1.8 1.7 -0.1
306 0.3 0.6 0.3
307 0.0 0.8 0.8
308 0.0 0.5 0.5
309 0.0 0.2 0.2
This fragment can be used for quantitative analysis.
from the mass range 302-305.
[U-13C]-Tyr
m/z theory data difference
301 0.0 0.1 0.1
302 0.0 0.4 0.4
303 2.0 1.8 -0.2
304 100.0 100.0 0.0
305 24.3 24.9 0.6
306 9.7 9.7 0.0
307 1.5 1.6 0.1
308 0.3 0.3 0.0
309 0.0 0.0 0.0
Mass isotopomer distributions should be obtained
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Tyr 364
Formula :
Exact mass :
C-atoms:
m/z
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[U- 13C]-Tyr
theory
0.0
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33.0
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2.4
0.4
0.1
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0.0
0.0
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0.0
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0.0
C20H38NOSi2
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data
0.5
100.0
33.1
12.7
3.0
0.7
0.1
0.0
0.0
0.0
0.0
0.2
0.0
0.8
0.3
difference
0.5
0.0
0.1
0.7
0.6
0.3
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.8
0.3
m/z
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
theory
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
8.5
100.0
24.6
9.5
1.5
0.2
0.0
data
0.1
0.4
0.2
3.6
1.0
0.3
0.0
1.3
10.1
100.0
25.9
9.9
1.6
0.2
0.0
difference
0.1
0.4
0.2
3.6
1.0
0.3
0.0
1.3
1.6
0.0
1.3
0.4
0.1
0.0
0.0
It is not very abundant and therefore very noisy. Fragment Phe-
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This fragment should not be used.
308 is preferred.
[U-13C]-Tyr
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Histidine (His)
Histidine fragments were not investigated in detail because of low signal-to-noise ratio.
Histidine was not found in all samples.
d egareva Sc n : 
7100lo-- -- - -- -- ------ , ..... . .. .-....... . ....
so 440.25
70
so0 338.20
40
30
302.10
S. 365.10 303.05 412.05
200 . 250 300 350 400 450 m
eragaed Scan : 3448 tD 3463 TIC: 86445 8P 68014 <
446.30
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CH3 CH3  0 CH3 CH3I I H H I I
H3C-C-Si-N-C-C-O-Si-C-CH 3I I I I I
CH3 CH3  O 2  CH3 CH3
H -C CH CH3ICe \ II N-Si-C-CH3N / I I
H CH3 C H3
C24H51 N302 Si3Exact Mass: 497.3289
- 360 -
60
343.25
30
20 304.10
10. 1 , I 365.10 383.05 417.30
40
`L' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
APPENDIX A. GC/MS ANALYSIS OF AMINO ACIDS
Arginine (Arg)
veaged Scan : 3113 to 3127 TIC : 55567 BP = 50393 <
44830
345.25
70
360
20
5140
10' 315.15 3 BU1 419.20
200
CH3 H3  0 CH3 CH3I I H H 11 1 I
H3C-C-Si-N-C-C-0-Si-C-CH 3I I I I I
CH 3 CH3  CH2  CH3 CH3
CH2
NH
OCH H3II I /%
H3C-C-Si-N NHI I H
CH3 CH3
C24H55N40 2Si3Exact Mass: 515.363
Arginine peak is found at 22.5 min with peaks at m/z 442 (M-57-16) and m/z 340 (M-159-
16). The arginine derivative corresponds to a nitrile form derived from loss of a guanidino
nitrogen (see Petterson BW et al., Biol Mass Spectrom, 22(9), 518-523). Arginine fragments
were not investigated in detail because of low signal-to-noise ratio.
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Appendix B
GC/MS analysis of glucose derivatives
GC/MS analysis of unlabeled glucose derivatives was performed using HP 5890 Series II
GC (Gas Chromatograph) connected to HP 5971 MSD (Mass Selective Detector). The mass
spectrometer was calibrated using the 'Max Sensitivity Autotune' setting.
Column Specifications
* Agilent Technologies 122-1262 DB-XLB (Serial No. 8758214)
* Length: 30 m
* ID: 0.25 mm
* Film: 0.25 im
* Temperature limits: 30 0C to 340 0C
MSD Settings
* Scan mode
* 5 min solvent delay
* 10 min recording time
* Mass range: 100 to 500 amu (approx. 2.0 scans/sec)
GC Settings
* Constant flow 0.88 mL/min
* Injector temp: 2500C
* Transferline temp: 3000C
* Temperature program:
o 800C (hold I min)
o 200C/min to 2800C (hold 4 min)
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Pentaacetate glucose
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APPENDIX B. GC/MS ANALYSIS OF GLUCOSE
Pentatrimethylsilyl glucose
I
Permethyl glucose
Scan886 to 896 TIC: 103201 8P - 1844793
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Di-O-isopropylidene acetate glucose
\veraged Scan : 373 in 381 TIC : 562007 BP = 955353
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APPENDIX B. GC/MS ANALYSIS OF GLUCOSE
Di-O-isopropylidene trimethylsilyl glucose
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Aldonitrile pentaacetate glucose
io erAw Scan : 759 to 792 TIC: 1132552 BP - 13716%99 <
145.05
103.00
7060
187.10 212.05
24205 314.10
'-b6 s2o n30ý
2do' 290 540o
- 367 -
Aldonitrile pentapropionate glucose
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APPENDIX B. GC/MS ANALYSIS OF GLUCOSE
Aldonitrile pentabutanoate glucose
. Avweraed Scan : 799 to 811 TC:4759522 BP - 546330
Aldonitrile pentatrimethylsilyl glucose
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Methyloxime pentapropionate glucose
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"Until you measure the fluxes, you don't even know
if a cell is dead or alive !"
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